Sentence,class,file
"CASE REPORT A 26-year-old male with no significant past medical www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:   Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/8 Copyright: © 2011 Lee V. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/3c/9c/JCIS-1-8.PMC3169899.pdf
J Clin Imaging Sci 2011;1:8Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/3c/9c/JCIS-1-8.PMC3169899.pdf
"Taste isn ’t just for taste buds anymore Thomas E. Finger1* and Sue C. Kinnamon2 Addresses:1Anschutz Medical Campus, University of Colorado Denver, School of Medicine, Rocky Mountain Taste & Smell Center, Department of Cell and Developmental Biology, RC-1 South, Room 11118, PO Box 6511, Mail Stop 8108, Aurora, CO 80045, USA; 2Anschutz Medical Campus, University of Colorado Denver, School of Medicine, Rocky Mountain Taste & Smell Center, Department of Otolaryngology, 12700 E 19th Avenue, MS 8606, Aurora, CO 80045, USA * Corresponding author: Thomas E. Finger (tom.finger@ucdenver.edu) F1000 Biology Reports 2011, 3:20 (doi:10.3410/B3-20) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/b/3/20 Abstract Taste is a discriminative sense involving specialized receptor cells of the oral cavity (taste buds) and at least two distinct families of G protein-coupled receptor molecules that detect nutritionally importantsubstances or potential toxins.,Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
"Page 2 of 7 (page number not for citation purposes)F1000 Biology Reports 2011, 3:20 http://f1000.com/reports/b/3/20",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
"[9] demonstrated that the taste signaling cascade is necessary Page 3 of 7 (page number not for citation purposes)F1000 Biology Reports 2011, 3:20 http://f1000.com/reports/b/3/20",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
"Page 4 of 7 (page number not for citation purposes)F1000 Biology Reports 2011, 3:20 http://f1000.com/reports/b/3/20",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
"In the trachea, T2R agonists causemuscle relaxation (see above) but it is not clear how a bitter substance would have access to the smooth muscle Page 5 of 7 (page number not for citation purposes)F1000 Biology Reports 2011, 3:20 http://f1000.com/reports/b/3/20",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
"Hass N, Schwarzenbacher K, Breer H: A cluster of gustducin- expressing cells in the mouse stomach associated with two Page 6 of 7 (page number not for citation purposes)F1000 Biology Reports 2011, 3:20 http://f1000.com/reports/b/3/20",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
"F1000 Factor 11 Evaluated by Sue Kinnamon 07 Jun 2011, Tom Finger 30 Jun 2011 Page 7 of 7 (page number not for citation purposes)F1000 Biology Reports 2011, 3:20 http://f1000.com/reports/b/3/20",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/biolrep-03-20.PMC3169900.pdf
"Amyotrophic lateral sclerosis: new genes, new models, and new mechanisms Christine Vande Velde 1,3 *, Patrick A. Dion 2,3 and Guy A. Rouleau 1,3 Addresses: 1 Department of Medicine, Université de Montréal, 1560 Sherbrooke East, Montreal, Canada, H2L 4W1; 2 Department of Pathology and Cell Biology, Université de Montréal, 1560 Sherbrooke East, Montreal, Canada, H2L 4W1; 3 CHUM Research Centre, 1560 Sherbrooke East, Montreal, Canada, H2L 4W1 * Corresponding author: Christine Vande Velde (c.vande.velde@umontreal.ca) F1000 Biology Reports 2011, 3:18 (doi:10.3410/B3-18) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/b/3/18 Abstract Research aimed at understanding amyotrophic lateral sclerosis (ALS) has seen exceptional growth in the past few years.,Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
"Thus, it is now widely Page 2 of 6 (page number not for citation purposes) F1000 Biology Reports 2011, 3:18 http://f1000.com/reports/b/3/18",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
"Perhaps customized, combination therapies Page 3 of 6 (page number not for citation purposes) F1000 Biology Reports 2011, 3:18 http://f1000.com/reports/b/3/18",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
"Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW: Long pre-mRNA depletion and RNA Page 4 of 6 (page number not for citation purposes)F1000 Biology Reports 2011, 3:18 http://f1000.com/reports/b/3/18",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
"Page 5 of 6 (page number not for citation purposes)F1000 Biology Reports 2011, 3:18 http://f1000.com/reports/b/3/18",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
[http://jaxmice.jax.org/manual/ index.html#als] 56.,Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
"Page 6 of 6 (page number not for citation purposes)F1000 Biology Reports 2011, 3:18 http://f1000.com/reports/b/3/18",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/biolrep-03-18.PMC3169903.pdf
"Illuminating the deleterious effects of light at night Laura K. Fonken* and Randy J. Nelson Address: Department of Neuroscience and The Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH 43210, USA * Corresponding author: Laura K. Fonken (fonken.1@osu.edu) F1000 Medicine Reports 2011, 3:18 (doi:10.3410/M3-18) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/m/3/18 Abstract Technological advances, while providing many benefits, often create circumstances that differ from the conditions in which we evolved.",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"Page 2 of 7 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:18 http://f1000.com/reports/m/3/18",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"At the opposite end of the spectrum to exposure totoo much light (at night), depression is often considered in the context of individuals who experience too little Page 3 of 7 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:18 http://f1000.com/reports/m/3/18",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"Because ofthe rapid increase in obesity paralleling increasing lightlevels and the association between shift work and elevated body mass index (BMI) [12,13], we further Page 4 of 7 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:18 http://f1000.com/reports/m/3/18",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"Page 5 of 7 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:18 http://f1000.com/reports/m/3/18",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, Sauer LA, Rivera-Bermudez MA, Dubocovich ML, Jasser SA, Lynch DT, Rollag MD, Zalatan F: Melatonin-depleted Page 6 of 7 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:18 http://f1000.com/reports/m/3/18",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"Page 7 of 7 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:18 http://f1000.com/reports/m/3/18",Non-OADS,/arxiv_data1/oa_pdf/fa/77/medrep-03-18.PMC3169904.pdf
"50 years of debate resolved Jean-Pierre Changeux 1 * and Stuart Edelstein 2 Addresses: 1 Collège de France and Institut Pasteur, CNRS URA 2182, 25 rue du Dr Roux, 75015 Paris, France; 2 European Bioinformatics Institute and University of Geneva, Wellcome Trust Genome Campus, Hinxton, CB10 1SD, UK * Corresponding author: Jean-Pierre Changeux (changeux@pasteur.fr) F1000 Biology Reports 2011, 3:19 (doi:10.3410/B3-19) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/b/3/19 Abstract Exactly 50 years ago, biochemists raised the question of the mechanism of the conformational change that mediates “allosteric ”interactions between regulatory sites and biologically active sites in regulatory/receptor proteins.",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"However, at low concentrations of X, formation of R0 may be sufficiently rapid for binding to utilize mainly Page 2 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Page 3 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Theenzyme is composed of two types of subunits: the two larger catalytic subunits are each composed of three Page 4 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Nicotinic acetylcholine receptor We can attribute the muscle target for nicotine and curareto the original definition in 1905 by Langley [42] of areceptor for a neurotransmitter (acetylcholine) and thecharacterization of its ionic response as the opening of a cation channel by electrophysiological recording by Page 5 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"The recently determined structure ofthe homopentameric glutamate-gated ionic channel- a from Caenorhabditis stabilized in an open conformation Page 6 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"A rich literature exists onGPCR-mediated signal transduction and only a few features relevant to the allosteric transition mechanism shall be mentioned here: (a) GPCRs can adopt multiple oligomeric states The relationship between the formation of GPCR homo-or hetero-dimers and signal transduction is still debated,and may vary with the GPCR class (A, B, or C) [64-69].Rhodopsin and the b2-adrenergic receptor, which belong to class A GPCRs, signal efficiently through G proteins when reconstituted into lipid nanodiscs containing onlya single receptor molecule, and thus, these class A GPCRsmay function without the need for oligomerization.Numerous studies, however, have revealed more com-plex activation mechanisms due to the ability of diverseGPCRs to adopt several conformations, each linkedto specific signaling cascades (see section below: (d) Different ligands may activate different pathways in Page 7 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Movements on helices V to VII are Page 8 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Page 9 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Progress will likely result from the rapid advances in computational power and improved algorithms, permit-ting longer simulations for complex systems that occurover time frames (microseconds to milliseconds) rele-vant to the phenomena discussed here; in particular, thiscould be achieved using a special purpose machine forlong molecular dynamics simulations [106] involving protein molecules and ligands that can reveal new Page 10 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Page 11 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Page 12 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Page 13 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Page 14 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"F1000 Factor 6 Evaluated by Jean-Pierre Changeux 18 Aug 2011 Page 15 of 15 (page number not for citation purposes)F1000 Biology Reports 2011, 3:19 http://f1000.com/reports/b/3/19",Non-OADS,/arxiv_data1/oa_pdf/9a/93/biolrep-03-19.PMC3169905.pdf
"Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon Caroline J. Aalbers1,2, Paul P. Tak1,2* and Margriet J. Vervoordeldonk1,2 Addresses:1Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, The Netherlands;2Arthrogen BV, Amsterdam, The Netherlands * Corresponding author: Paul P. Tak (p.p.tak@amc.uva.nl) F1000 Medicine Reports 2011, 3:17 (doi:10.3410/M3-17) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/m/3/17 Abstract Gene therapy is a promising new therapeutic strategy that has been explored in a wide variety of diseases, ranging from cancer to hemophilia, and ocular disorders to autoimmune diseases, among others.",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"Page 2 of 8 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:17 http://f1000.com/reports/m/3/17",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"As five patients with a previous Page 3 of 8 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:17 http://f1000.com/reports/m/3/17",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"Although thisdoes not interfere with the transduction of cells in vivo after the first administration of the vector, it can Page 4 of 8 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:17 http://f1000.com/reports/m/3/17",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"Several investigators have demonstrated induction of Page 5 of 8 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:17 http://f1000.com/reports/m/3/17",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"Page 6 of 8 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:17 http://f1000.com/reports/m/3/17",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"Boutin S, Monteilhet V, Veron P, Leborgne C, Benveniste O, Montus MF, Masurier C: Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in Page 7 of 8 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:17 http://f1000.com/reports/m/3/17",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"F1000 Factor 6 Evaluated by Margriet Vervoordeldonk 19 Aug 2011 Page 8 of 8 (page number not for citation purposes)F1000 Medicine Reports 2011, 3:17 http://f1000.com/reports/m/3/17",Non-OADS,/arxiv_data1/oa_pdf/dd/59/medrep-03-17.PMC3169911.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2011/2/1/42/84279 Copyright: © 2011  Kamat S.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and  reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2b/3f/JPI-2-42.PMC3169920.pdf
"J Pathol Inform 2011, 2:42  http://www.jpathinformatics.org/content/2/1/42test cases that are examined by each cytotechnologist.",Non-OADS,/arxiv_data1/oa_pdf/2b/3f/JPI-2-42.PMC3169920.pdf
"J Pathol Inform 2011, 2:42  http://www.jpathinformatics.org/content/2/1/42of the CSF showed atypical monocytes.",Non-OADS,/arxiv_data1/oa_pdf/2b/3f/JPI-2-42.PMC3169920.pdf
"J Pathol Inform 2011, 2:42  http://www.jpathinformatics.org/content/2/1/42the PQAT has been an effective tool which has helped  to improve our practice without significantly changing  the workflow for case signout.",Non-OADS,/arxiv_data1/oa_pdf/2b/3f/JPI-2-42.PMC3169920.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2011/2/1/40/84233 Copyright: © 2011  Lyttleton O.,Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"J Pathol Inform 2011, 2:40  http://www.jpathinformatics.org/content/2/1/40be used by a single research study.",Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"J Pathol Inform 2011, 2:40  http://www.jpathinformatics.org/content/2/1/40Computer applications may not understand plain English  definitions for CDEs such as the above.",Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"For example, the definition attribute  for the core_organism CDE is: Organism name at species level for organism whose  tissue is represented in the donor block, Comment: URI  for taxonomy.dat is ftp://ftp.ebi.ac.uk/pub/databases/ taxonomy/taxonomy.dat The correct entry for human  tissue is “9606 human”Figure 5: CDEs from TMA DES XML data",OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"J Pathol Inform 2011, 2:40  http://www.jpathinformatics.org/content/2/1/40emphasizes the importance of XML providing logic and  meaning to data, allowing it to be part of the “Semantic  Web.”[3] The use of RDF to encode TMA DES metadata  could potentially enable applications to process TMA  DES data with greater autonomy.",OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"J Pathol Inform 2011, 2:40  http://www.jpathinformatics.org/content/2/1/40not specify syntax for encoding data.",Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"J Pathol Inform 2011, 2:40  http://www.jpathinformatics.org/content/2/1/40T able 3: Triples generated by W3C RDF parser from TMA DES RDF file Subject Predicate Object http://www.w3.org/RDF/Validator/run/ histo http://www.w3schools.com/rdf/Version ""1.0"" http://www.w3.org/RDF/Validator/run/ histo http://www.w3schools.com/rdf/ RegistrationAuthority""Association for Pathology Informatics"" http://www.w3.org/RDF/Validator/run/ histo http://www.w3schools.com/rdf/Language ""en"" http://www.w3.org/RDF/Validator/run/ histo http://www.w3schools.com/rdf/Obligation ""Required"" http://www.w3.org/RDF/Validator/run/ histo http://www.w3schools.com/rdf/Datatype ""Empty"" http://www.w3.org/RDF/Validator/run/ histo http://www.w3schools.com/rdf/ MaximumOccurrence""One"" http://www.w3.org/RDF/Validator/run/ histo http://www.w3schools.com/rdf/Definition ""Root element of the Tissue Microarray  document"" 11179 data When an RDF parser processes an RDF file, it should  be able to extract the object or concept which is being  described, the attribute names of that object/concept,  and the values of these attributes (this combination  of data is known as a “triple”).",Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"J Pathol Inform 2011, 2:40  http://www.jpathinformatics.org/content/2/1/40specification: A community-based, open source tool for sharing tissue  microarray data.",OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
Available from: http://www.xperanto.snubi.org/TMA/.,Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
Available from: http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
Available from: http://www.w3.org/TR/REC-rdf-syntax/  [Last accessed on 2010 Dec 03].,OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
Available from: http://www.biomedcentral.com/content/supplementary/1472- 6947-3-5-s1.htm.,Non-OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
Available  from: http://www.hitsw.com/xml_utilites/ [Last accessed on 2010 Dec 03].,OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"XML Schema validator, Available from: http://tools.decisionsoft.com/ schemaValidate/ [Last accessed on 2010 Dec 03].",OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"XML DTD validator, Available from: http://www.xmlvalidation.com.",OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
"W3C Validation service, Available from: http://www.w3.org/RDF/Validator/  [Last accessed on 2010 Dec 03].",OADS,/arxiv_data1/oa_pdf/ed/96/JPI-2-40.PMC3169921.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2011/2/1/41/84276 Copyright: © 2011  Ramey J.,Non-OADS,/arxiv_data1/oa_pdf/c5/25/JPI-2-41.PMC3169922.pdf
"J Pathol Inform 2011, 2:41  http://www.jpathinformatics.org/content/2/1/41of digital technology in radiology has been the poster  child for this change, allowing access to well-trained and  alert specialists for patients seen in a host of settings, and  at virtually any hour of the day or night.",Non-OADS,/arxiv_data1/oa_pdf/c5/25/JPI-2-41.PMC3169922.pdf
"J Pathol Inform 2011, 2:41  http://www.jpathinformatics.org/content/2/1/41seconds per slide.",Non-OADS,/arxiv_data1/oa_pdf/c5/25/JPI-2-41.PMC3169922.pdf
"J Pathol Inform 2011, 2:41  http://www.jpathinformatics.org/content/2/1/41Diagnostic accuracy is also comparable with literature  ranges for FS interpretation using routine measures[9] and  also compare favorably with other studies using WSI for  FS interpretation.",OADS,/arxiv_data1/oa_pdf/c5/25/JPI-2-41.PMC3169922.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm242295.htm.,Non-OADS,/arxiv_data1/oa_pdf/c5/25/JPI-2-41.PMC3169922.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2011/2/1/39/84232 Copyright: © 2011  Isaacs M.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and  reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
"J Pathol Inform 2011, 2:39  http://www.jpathinformatics.org/content/2/1/39as telepathology consultations,[5-7] but also to improve  service to underserved areas;[8,9] educational activities;[10-14]  and laboratory quality assurance (QA) activities are all  well established.",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
"J Pathol Inform 2011, 2:39  http://www.jpathinformatics.org/content/2/1/39$2,000,000 (for hardware and software), and a yearly  indirect cost of approximately $650,000 for support  personnel and $10,000 for data storage.",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
"J Pathol Inform 2011, 2:39  http://www.jpathinformatics.org/content/2/1/39educational activities.",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
"J Pathol Inform 2011, 2:39  http://www.jpathinformatics.org/content/2/1/39OUTCOMES We also sought to evaluate whether the value added  approach was successful in guiding integration of WSI  into our clinical practice in ways that enhanced our  patient care, research, and education activities.",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
"J Pathol Inform 2011, 2:39  http://www.jpathinformatics.org/content/2/1/39development of a secure infrastructure in which all  data are housed in an HIPAA approved environment.",OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
Available from: http://it.toolbox.com/blogs/enterprise-solutions/determining- the-valueadded-activities-of-a-process-20700[Last  accessed on 2011 Apr 17].,OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
Available from: http://www.darkdaily.com/pathology-groups- and-clinical-labs-prepare-to-deliever-test-results-to-smart-phones-070210 .,Non-OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
Available from: http://www.healthimaging.,Non-OADS,/arxiv_data1/oa_pdf/bf/fa/JPI-2-39.PMC3169923.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2011/2/1/38/84231 Copyright: © 2011  McKay RR.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/JPI-2-38.PMC3169924.pdf
"J Pathol Inform 2011, 2:38  http://www.jpathinformatics.org/content/2/1/38image quality for WSI.",OADS,/arxiv_data1/oa_pdf/fc/06/JPI-2-38.PMC3169924.pdf
"J Pathol Inform 2011, 2:38  http://www.jpathinformatics.org/content/2/1/38µm spacing (for a total of 20 µm).",OADS,/arxiv_data1/oa_pdf/fc/06/JPI-2-38.PMC3169924.pdf
"J Pathol Inform 2011, 2:38  http://www.jpathinformatics.org/content/2/1/38feasibility of a highly accurate and rapid scanning system  with potential application to digital pathology.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/JPI-2-38.PMC3169924.pdf
"J Pathol Inform 2011, 2:38  http://www.jpathinformatics.org/content/2/1/38while maintaining a reasonably short scan time.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/JPI-2-38.PMC3169924.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS 2011 plr019 doi:10.1093/aobpla/plr019, available online at www.aobplants.oxfordjournals.org &The Authors 2011 1",Non-OADS,/arxiv_data1/oa_pdf/7d/07/plr019.PMC3169925.pdf
"Data content and sources The data in IntOGen consists of publicly available cancer genomic studies collected from databases such as GeneExpression Omnibus (GEO) ( 3), ArrayExpress ( 4), Cosmic (5), Progenetix ( 6), the Sanger Cancer Genome Project (http://www.sanger.ac.uk/genetics/CGP/) and the data portal of The Cancer Genome Atlas ( 7).",OADS,/arxiv_data1/oa_pdf/0a/66/bar039.PMC3169995.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/66/bar039.PMC3169995.pdf
"The browser of IntOGen facilitates the explorationand intuitive visualization of results at different levels (available at: http://www.intogen.org), while the Biomart portal ( 2) (available at: http://biomart.intogen.org) allows Figure 2.",OADS,/arxiv_data1/oa_pdf/0a/66/bar039.PMC3169995.pdf
"Another advantage of using IntOGen is that the data downloaded can directly be analyzed in Gitools ( 11) (http://www.gitools.org), which is a stand-alone tooldesigned for the analysis and visualization of high- throughput data.",OADS,/arxiv_data1/oa_pdf/0a/66/bar039.PMC3169995.pdf
"For example,one can easily perform enrichment analyses on IntOGen data with modules or gene sets from various Biomart portals to explore large-scale patterns in cancer genomicsdata (see http://help.gitools.org/xwiki/bin/view/Tutorials/ for examples).",Non-OADS,/arxiv_data1/oa_pdf/0a/66/bar039.PMC3169995.pdf
"BMC Genomics ,10, 22. http://www.biomedcen- tral.com/1471-2164/10/22.3.",Non-OADS,/arxiv_data1/oa_pdf/0a/66/bar039.PMC3169995.pdf
http://www.who.int/classifications/icd/adaptations/oncology/en/.,Non-OADS,/arxiv_data1/oa_pdf/0a/66/bar039.PMC3169995.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2011.",Non-OADS,/arxiv_data1/oa_pdf/d6/d8/FNR-55-8642.PMC3170047.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2011.",Non-OADS,/arxiv_data1/oa_pdf/58/57/FNR-55-7153.PMC3170048.pdf
Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements; http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri /C30CON SLEG:2002L0046:20060421:EN:PDF [cited 10 June 2011].,Non-OADS,/arxiv_data1/oa_pdf/58/57/FNR-55-7153.PMC3170048.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/5d/evr054.PMC3170098.pdf
"The sequences of RM11-1a and YJM789 wereobtained from the Broad Institute Fungal Genome Initiative(http://www.broad.mit.edu/annotation/fungi/fgi/ ) and the Stanford Genome Technology Center (version 2, http:// med.stanford.edu/sgtc/research/yjm789.html ), respectively.",OADS,/arxiv_data1/oa_pdf/f2/5d/evr054.PMC3170098.pdf
Notebook The complete laboratory notebook describing these experi- ments is available at http://www.genomics.princeton.edu/ glang/notebooks.htm .,OADS,/arxiv_data1/oa_pdf/f2/5d/evr054.PMC3170098.pdf
"The sequences of RM11-1a and YJM789 were obtained from the Broad Institute Fungal Genome Initiative ( http://www.broad.mit.edu/annotation/fungi/fgi/ )a n dt h eS t a n - ford Genome Technology Center (version 2, http://med.stanford.edu/sgtc/ research/yjm789.html ), respectively.",OADS,/arxiv_data1/oa_pdf/f2/5d/evr054.PMC3170098.pdf
Positions and efﬁciencies from the Saccharomyces Genome Database ( http://www.yeastgenome.org ).,OADS,/arxiv_data1/oa_pdf/f2/5d/evr054.PMC3170098.pdf
http://www.neuropsychiatryreviews.,Non-OADS,/arxiv_data1/oa_pdf/db/13/11060_2011_Article_565.PMC3170120.pdf
Available at: http://neurosurgery.ucsf.edu/tl_ﬁles/ NS_Main/Caregiver%20Needs%20Questionnaire.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/11060_2011_Article_534.PMC3170122.pdf
Available at: http://neurosurgery.ucsf.edu/tl_ﬁles/NS_Main/Pat ient%20Needs%20Questionnaire.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/11060_2011_Article_534.PMC3170122.pdf
Available at: http://www.cancer.ca/Ontario/Support%20 Services/OD-Patient%20and%20caregiver%20needs%20surveys.aspx?sc_lang=en .,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/11060_2011_Article_534.PMC3170122.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Annals of Botany 108: 777–787, 2011 doi:10.1093/aob/mcr180, available online at www.aob.oxfordjournals.org",Non-OADS,/arxiv_data1/oa_pdf/29/f5/mcr180.PMC3170158.pdf
", 2004 ;Sung and Amasino, 2004 )(http://www.arabidopsis.org/ ).Arabidopsis halleri subsp.",Non-OADS,/arxiv_data1/oa_pdf/29/f5/mcr180.PMC3170158.pdf
"At the Evolution 2010 meeting in Oregon in June 2010, a symposium on ‘Moving towards ascience of evolutionary prediction’ suggested that the next chal-lenge will be to improve the accuracy of evolutionary prediction(http://www.evolutionsociety.org/SSE2010 ), although the pre- diction of evolution is still difﬁcult.",Non-OADS,/arxiv_data1/oa_pdf/29/f5/mcr180.PMC3170158.pdf
This article aims to give a comprehensive overview of the Ensembl and Ensembl Genomes BioMarts as well as some useful examples and a description of current data content and future objectives.Database URLs: http://www.ensembl.org/biomart/martview/; http://metazoa.ensembl.org/biomart/martview/; http://plants .ensembl.org/biomart/martview/; http://protists.ensembl.org/biomart/martview/; http://fungi.ensembl.org/biomart/martview/; http://bacteria.ensembl.org/biomart/martview/ ............................................................................................................................... ............................................................................................................................... ............................... Project description The Ensembl project (http://www.ensembl.org) was launched in 2000 and is a joint effort by the European Bioinformatics Institute (EBI) and the Wellcome Trust Sanger Institute (WTSI).,Non-OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
Four of the 56 supported species are in a pre-release state and can be viewed at http://pre.ensembl.org.,Non-OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
"The Ensembl Genomes project (http://www.ensemblgen omes.org) is comprised of separate websites for five distinct domains of life: bacteria, fungi, protists, plants and inver-tebrate metazoa (8).",OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
The Ensembl genome browser at http://www.ensembl.org (14) provides a comprehensive visualization for accessing and using Ensembl data.,OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
"Ensembl Regulation 61 Regulation data for human, mouse and Drosophila melanogaster (annotated, regulatory and external features) Vega 41 Manually curated genes for human, mouse and zebrafish by the HAVANA group at WTSI and displayed in the VEGA database (21) Reactome Manually curated and peer-reviewed pathways from the BioMart (22) at http://www.reactome.org/ cgi-bin/mart PRIDE (EBI UK) Proteomics data from the PRIDE PRoteomics IDEntifications (17) BioMart database at http://www.ebi.ac.uk/pride/prideMart.do ............................................................................................................................... ............................................................................................................................... ...............................",Non-OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
The Ensembl BioMart tables are made available for download from the FTP site (ftp://ftp.ensembl.org/pub) foreach release (e.g.,OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
Ensembl Genes 61 BioMart databaseavailable from ftp://ftp.ensembl.org/pub/release-61/mysql/ensembl_mart_61).,OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
"Users can access the BioMarts by webinterface, BioMart API, biomaRt package from bioconduc-tor (19), SOAP based and RESTful webservices and by pub-licly available MySQL server offering direct access to the BioMart databases (http://www.ensembl.org/info/data/ mysql.html).",OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
The Ensembl and Ensembl GenomesBioMarts are also displayed on the main BioMart centralportal http://www.biomart.org.,OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
"These mirrors, located on thewest and east coasts of the USA (http://uswest.ensembl.org,http://useast.ensembl.org) and in Asia (http://asia.ensembl.org) also contain the Ensembl BioMarts to facilitate moreeffective data access.Query examples To demonstrate the utility of the Ensembl and Ensembl Genomes BioMarts we present several biologically relevantqueries that can be performed using available tools and interfaces.",OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
Summary of sources of help and documentation at Ensembl Information resource URL or Email address Ensembl frequently asked questions http://www.ensembl.org/Help/Faq BioMart frequently asked questions http://www.biomart.org/faqs.html Tutorials http://www.ensembl.org/info/website/tutorials YouTube videos http://www.youtube.com/user/EnsemblHelpdesk Ensembl news containing information about updates to mart databases http://www.ensembl.org/info/website/news Ensembl Blog http://www.ensembl.info Ensembl archives containing archived BioMart databases http://www.ensembl.org/info/website/archives Ensembl helpdesk mailing list helpdesk@ensembl.org Ensembl Genomes helpdesk mailing list helpdesk@ensemblgenomes.org Ensembl Genomes portal website containing project information http://www.ensemblgenomes.org ............................................................................................................................... ............................................................................................................................... ...............................,Non-OADS,/arxiv_data1/oa_pdf/a4/22/bar030.PMC3170168.pdf
"The InterPro BioMart is supplementary to the primaryInterPro web interface (http://www.ebi.ac.uk/interpro), providing a web service and the ability to build complex, custom queries that can efficiently return thousands of rows of data in a variety of formats.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
This article describes the information available from the InterPro BioMart and illustrates its utility with examples of how to build queries that return usefulbiological information.Database URL : http://www.ebi.ac.uk/interpro/biomart/martview.,OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"............................................................................................................................... ............................................................................................................................... ............................... Introduction The InterPro Resource (http://www.ebi.ac.uk/interpro) ( 1) provides an integrated set of computational models (or sig-natures) for protein family classification and the predictionof structural and functional domains, sites and repeats.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"matches to these signatures for the whole of the UniProt Knowledge Base (UniProtKB, http://www.uniprot.org) andthe UniParc sequence archive ( 13).Figure 2 illustrates a set of matches to a single UniProtKB protein sequence, which matches three InterPro entries.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"The InterPro BioMart is builton the technology developed by the BioMart project(http://www.biomart.org) ( 14,15), a collaboration between the Ontario Institute for Cancer Research (OICR) and the European Bioinformatics Institute (EBI).",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
The InterProBioMart is available at http://www.ebi.ac.uk/interpro/bio- mart/martview.,Non-OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
It is also incorporated into the BioMart Central Server at http://www.biomart.org/biomart/martview ( 16).,Non-OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"If the user wishes to query using protein accessions or identifiers from third-party sequence databases, variousservices are available that allow protein identifier cross-referencing, including the Protein Identifier Cross Reference service, PICR (http://www.ebi.ac.uk/Tools/picr/)(20) and the UniProt ID mapping service (http://www.uniprot.org/).",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"In thisrespect, the InterPro BioMart is different in structure to theEnsembl BioMart (http://www.ensembl.org/biomart/martview) ( 17,18) which is organized into species-specific data sets.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"The InterPro BioMart web service is the data source behind the InterPro Distributed Annotation System (DAS)service ( 21), available from http://www.ebi.ac.uk/das-srv/ interpro/das.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"External data sources included in the InterPro BioMart Source URL BioMart URL Description of contents UniProtKB http://www.uniprot.org http://www.ebi.ac.uk/ uniprot/biomart/ martviewA comprehensive, high quality and freely accessible resource of protein sequence and functional infor- mation, comprising the human-curated Swiss-Prot data set and the automatically annotated TrEMBLdata set.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"PRIDE http://www.ebi.ac.uk/pride http://www.ebi.ac.uk/pride/ biomart/martviewA database of identifications of proteins and peptides, arising from mass spectrometry-based proteomics.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
"Reactome Pathway Databasehttp://www.reactome.org http://www.reactome.org/ cgi-bin/martA human-curated database of biological pathways, focusing on human pathways, but providing auto-mated prediction of pathways in other species.",OADS,/arxiv_data1/oa_pdf/73/75/bar033.PMC3170169.pdf
modENCODE data can be found at http://www.modencode.org.,OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
Database URL: http://www.modencode.org.,OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
The Cancer Genome Atlas Project; http://cancergenome.nih.gov/wwd/program).,OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
"As a resource, modENCODE serves the model organism research commu-nities, and complements the related human ENCODE pro-ject (http://www.genome.gov/10005107), with the ultimateobjective of advancing comparative genomics.",OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
"Of particular relevance is the draft of the MinimumINformation about a high-throughput SEQuencingExperiment (MINSEQE) (http://www.mged.org/minseqe/),although this proposal is still in draft form and does notyet have a concrete specification.",Non-OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
(The modENCODE datarelease policy is available at http://www.genome.gov/27528022).,OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
"The modENCODE wiki (http://wiki.modencode.org) uses MediaWiki software, with an additional plug-in developedby the DCC.",OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
The processed files and related wiki pages aremade available via several avenues: immediately from the pipeline ‘list’ interface (http://submit.modencode.org/ submit/public/list) or the bulk downloads selection interface(http://submit.modencode.org/submit/bulk_download/);GBrowse for viewing data in the context of the genome(http://modencode.oicr.on.ca/fgb2/gbrowse/worm/ orhttp://modencode.oicr.on.ca/fgb2/gbrowse/fly/); modMine ............................................................................................................................... ............................................................................................................................... ...............................,OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
Requirements and instructions fordownload and installation can be found on our wiki athttp://wiki.modencode.org/project/index.php/Open_Source.,OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
"Forsignal intensity data, we accepted the UCSC-developeddata formats BED and WIG (http://genome.ucsc.edu/goldenPath/help/wiggle.html).",OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
"For peak calls andgenomic features, we accepted only the GFF3 format(http://www.sequenceontology.org/gff3.shtml).",Non-OADS,/arxiv_data1/oa_pdf/09/5d/bar023.PMC3170170.pdf
"Database URL: http://www.netpath.org/pathways?path_id=NetPath_21 ............................................................................................................................... ............................................................................................................................... ............................... Introduction The paracrine system involved in many tissues includes nu- merous cytokines and growth factors necessary for the dif- ferentiation and maturation of cells of which amongst tumor necrosis factor (TNF) family assumes a vital role.The TNF superfamily consists of numerous ligand/receptor proteins involved in various cellular processes such as devel- opment, homeostasis and apoptosis.",OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
Our group has previously developed a signalingpathway resource called NetPath (http://www.netpath.,OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
RANKL/ RANK-signaling pathway resource is a NetPath module freely available at http://www.netpath.,OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
Allthe RANK receptor activated reactions were reviewed bya pathway authority (http://www.netpath.org/pathway_authority?path_id=NetPath_21).,OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
Data formats and availability The RANKL pathway data described in this work is inte-grated into NetPath which is publicly available at (http://www.netpath.org).,OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
"citation containing description of each of the reactions, PTM status, site and residue of modification mapped to specific RefSeq accession and PubMed identifiers arealso available to download at http://www.netpath.org/netslim/rankl_pathway.html.",OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
A download- able version of this map is available with the description for each of the reactions and the inclusion criteria for selection of thereaction in the map at http://www.netpath.org/netslim/rankl_pathway.html.,OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
The RANKL/RANK pathway reactions are availableto download at (http://www.netpath.org/pathways?path_id=NetPath_21).,OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
We encourage interested members of thescientific community to help us improve the quality of theinformation in NetPath by submitting their suggestionsand critical comments through http://www.netpath.org/comments.,Non-OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
Available from Nature Precedings<http://dx.doi.org/10.1038/npre.2009.3115.1 >(2009).,OADS,/arxiv_data1/oa_pdf/94/61/bar021.PMC3170171.pdf
Acoustic Transducer Model in COMSOL Multiphysics 3.4 (http://www.comsol.com/showroom/gallery/1477/ )w a s used to simulate the acoustic pressure distribution withinmethyl cellulose solution according to manufacturer ’s instructions.,Non-OADS,/arxiv_data1/oa_pdf/47/21/424_2011_Article_993.PMC3170465.pdf
"Since microarray analysis was shown to be sensitive to the choice ofpreprocessing algorithm [ 22], we analyzed the hybridiza- tion data also by two other commonly used algorithms, GC-RMA [ 23] ,a n dM A S 5( http://www.affymetrix.com ), followed by comparable filtering steps (see Supplemen- tal Material for details).",Non-OADS,/arxiv_data1/oa_pdf/cd/36/109_2011_Article_773.PMC3170468.pdf
http://www.accesseconomics.,Non-OADS,/arxiv_data1/oa_pdf/c9/01/11239_2011_Article_602.PMC3170471.pdf
"Adopted 1964, last amended 2004: World Medical Association 2004. http://www.wma.net/e/ policy/b3.htm .",Non-OADS,/arxiv_data1/oa_pdf/c9/01/11239_2011_Article_602.PMC3170471.pdf
METHODS Data ManagementThis work was performed within the framework of the Dutch Top Institute Pharma project: mechanism-basedpopulation PK-PD modeling ( http://www.tipharma.com ).,OADS,/arxiv_data1/oa_pdf/8c/40/11095_2011_Article_477.PMC3170473.pdf
2009. http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/8c/40/11095_2011_Article_477.PMC3170473.pdf
"The fluorescence data were processed with ImageJ, version 1.43U (freeware, http://rsbweb.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/28/58/424_2011_Article_999.PMC3170475.pdf
AFM raw data were processed with Punias 3Dversion 1.0 release 1.1 ( http://punias.voila.net/ ).,OADS,/arxiv_data1/oa_pdf/28/58/424_2011_Article_999.PMC3170475.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/7a/awr170.PMC3170530.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/9e/awr184.PMC3170533.pdf
The conven-tions of the Human Genome Variation Society nomenclature (http://www.hgvs.org/mutnomen) were used for the description of the iden-tiﬁed mutations.,OADS,/arxiv_data1/oa_pdf/92/9e/awr184.PMC3170533.pdf
We also wish to thank the Genetic Service Facility (VIB) for the sequencing support (http://www.vibgeneticservicefacility.be/).,Non-OADS,/arxiv_data1/oa_pdf/92/9e/awr184.PMC3170533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/fb/awr196.PMC3170535.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/1d/awr197.PMC3170536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/d7/awr198.PMC3170537.pdf
"Volumetric analysis of grey matter cortical and subcortical (hippocampus, amygdala, caudate,putamen and brainstem) areas was performed using the Freesurferimage analysis suite (version 4.0.3; http://surfer.nmr.mgh.harvard.",OADS,/arxiv_data1/oa_pdf/73/d7/awr198.PMC3170537.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/65/awr205.PMC3170540.pdf
Grey matter associations were assessed over the whole brainand within the regions of interest speciﬁed by our prior anatomical hypotheses; small volumes covering temporal and parietal lobe regions speciﬁed in our prior anatomical hypotheses were created manually inMRIcron /C213(http://www.cabiatl.com/mricro/mricron/index.html) from a study-speciﬁc template image (further details in Supplementary material).,OADS,/arxiv_data1/oa_pdf/db/65/awr205.PMC3170540.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/32/34/err026.PMC3170542.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/94/c7/err098.PMC3170543.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/48/9c/err124.PMC3170544.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/b6/14/err137.PMC3170545.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/6e/ae/err145.PMC3170546.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/34/46/err159.PMC3170547.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/b9/3d/err160.PMC3170548.pdf
"identiﬁed by HarvEST software ( http://harvest.ucr.edu ; Wheat 1 Array, version 1.54) as annotating to Arabidopsis GDSL-lipase At5g45670.",OADS,/arxiv_data1/oa_pdf/b9/3d/err160.PMC3170548.pdf
"PAST: Paleontological Statistics Software Package for Education and Data Analysis.Palaeontologia Electronica 4,(9) .http://palaeo-electronica.org/ 2001_1/past/issue1_01.htm .",Non-OADS,/arxiv_data1/oa_pdf/b9/3d/err160.PMC3170548.pdf
http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/b9/3d/err160.PMC3170548.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/64/7b/err161.PMC3170549.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/88/1d/err163.PMC3170550.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
"Gene expression analysis Total RNA was extracted from young seedlings using an RNeasy mini kit (Tiangen, http://www.tiangen.com ).",OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
"For RT-PCR, 2 lgo f total RNA was reverse-transcribed with Super-Script II reverse transcriptase (TAKARA, http://www.takara.com.cn ) as described by the manufacturer.",Non-OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
ChIP assay ChIP experiments were performed as described in the UPSTATE chip kit ( http://www.millipore.com/catalogue/item/17-295 ) with 11- d-old Col-0 seedlings.,Non-OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
Microarray data also indicate that most CESA genes are induced solely following BR treatment ( http://bbc.botany.,Non-OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
utoronto.ca/efp/cgi-bin/efpWeb.cgi ;http://www.arabidopsis.,Non-OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
"Interestingly, according to our analysed chip data, it is suggested thatmost CESA genes can be induced by BRs, but other growth-promoting hormones do not have such broad effect on the expression of CESA genes ( https://www.genevestigator.",Non-OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
(https://www.genevestigator.com/gv/user/serveApplet.jsp ).,OADS,/arxiv_data1/oa_pdf/67/b9/err164.PMC3170551.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/6a/c5/err168.PMC3170552.pdf
"Distance trees were constructe d using the Neighbor–Joining (NJ) method, implemented usi ng the NEIGHBOR program in BIOLOGY WORKBENCH ( http://www.workbench.sdsc.edu ).",OADS,/arxiv_data1/oa_pdf/6a/c5/err168.PMC3170552.pdf
(D) Multiple sequence alignment of the ubiquitin domain of EVE1 and ubiquitin superfamily proteins from Arabidopsis using CLUSTALW ( http://workbench.sdsc.edu ).,Non-OADS,/arxiv_data1/oa_pdf/6a/c5/err168.PMC3170552.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/b5/95/err169.PMC3170553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/01/4a/err171.PMC3170554.pdf
were deposited in the GenBank; therefore an Arabidopsis AtGSNOR (At5g43940) se- quence was used to blast against the TIGR Plant Transcript Assemblies ( http://plantta.jcvi.org/ ).,OADS,/arxiv_data1/oa_pdf/01/4a/err171.PMC3170554.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/ce/7f/err173.PMC3170555.pdf
"For the identiﬁcation of the proteins, databases were used by similarity or blast searches such as Swiss-Prot ( http://www.expasy.ch/sprot/ ) and EMBL ( http:// www.ebi.ac.uk/Tools/fasta33/index.html ).",OADS,/arxiv_data1/oa_pdf/ce/7f/err173.PMC3170555.pdf
The putative signal peptide was predicted using the SignalP 3.0 server ( http://www.cbs.dtu.dk/services/SignalP ;Bendtsen et al.,OADS,/arxiv_data1/oa_pdf/ce/7f/err173.PMC3170555.pdf
"For homology modelling, a three-dimensional model of NrChit1 was built with the automated comparative modelling program SWISS-MODEL ( http://swissmodel.expasy.org/work- space ;Guex and Peitsch, 1997 ;Schwede et al.",OADS,/arxiv_data1/oa_pdf/ce/7f/err173.PMC3170555.pdf
"Primers for real-time PCR were designed in order to obtain resulting PCR products of ;100 bp using the Primer3Plus software ( http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3- plus.cgi ): for actin, 5 #-CTC TTA ACC CCA AAG CAA ACA GG- 3#and 5 #-GTG AGA GAA CAG CCT GGA TG-3 #; and for endochitinase, 5 #-AAG GGA TCA AGG TCC TCC TAT C-3 #and 5#- GAG GTA GTT ATT CCA AAG GTA AGC-3 #.",OADS,/arxiv_data1/oa_pdf/ce/7f/err173.PMC3170555.pdf
"Calculation of expression ratios and statistical analyses were performed with the Relative Expression Software Tool (RESTª2009, http://www.gene-quantiﬁcation.de/rest.html ; Pfafﬂ et al.",OADS,/arxiv_data1/oa_pdf/ce/7f/err173.PMC3170555.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/0e/a1/err178.PMC3170556.pdf
"1A , underlined sequence) by the ExPASy (Expert Protein Analysis System) proteomicsserver ( http://ca.expasy.org/prosite/ ).",OADS,/arxiv_data1/oa_pdf/0e/a1/err178.PMC3170556.pdf
The plant membrane protein database Aramemnon ( http://aramemnon.botanik.,Non-OADS,/arxiv_data1/oa_pdf/0e/a1/err178.PMC3170556.pdf
"uni-koeln.de/ ) predicted 10–12 transmembrane domains, and TopPred ( http://mobyle.pasteur.fr/cgi-bin/portal.py?",Non-OADS,/arxiv_data1/oa_pdf/0e/a1/err178.PMC3170556.pdf
S3 atJXB online) based on predictions using the PLACE database ( http://www.dna.affrc.go.jp/PLACE ).,OADS,/arxiv_data1/oa_pdf/0e/a1/err178.PMC3170556.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/a4/e3/err183.PMC3170557.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/8d/b1/err185.PMC3170558.pdf
The sequences of the cleavage products in peptide plus extracellular ﬂuid samples were determined by comparisons with the theoretical m/z of the cleavage products calculated using the Peptide Mass algorithm at the ExPasy Server (http://au.expasy.org/tools/pi_tool.html ).,OADS,/arxiv_data1/oa_pdf/8d/b1/err185.PMC3170558.pdf
"RT-PCR analysis and in situ hybridization The full-length cDNA sequence (Glyma01g04580.1) corresponding to TC267754, the Glycine max homologue of MtCLE36, was retrieved from Phytozome ( http://www.phytozome.net ).",OADS,/arxiv_data1/oa_pdf/8d/b1/err185.PMC3170558.pdf
"Tissue ﬁxation, probe labelling, and subsequent hybridization we re carried out as described by the protocol at http://www.its.caltech.edu/ ;plantlab/html/protocols.html .",Non-OADS,/arxiv_data1/oa_pdf/8d/b1/err185.PMC3170558.pdf
"Similarly, examination of theMedicago expression atlas ( http://mtgea.noble.org/v2/ ) showed that MtCLE36 (Affymetrix ID Mtr.42801.1.S1_at) is expressed at low levels in many tissue types (Supplemen- tary Fig.",Non-OADS,/arxiv_data1/oa_pdf/8d/b1/err185.PMC3170558.pdf
Glycine max CLE34 is expressed in a broad range of tissues including provascular tissue In situ hybridization and quantitative RT-PCR studies in G. max combined with an examination of the M. truncatula expression atlas ( http://mtgea.noble.org/v2/ ) suggest that CLE34 and CLE36 are expressed at low levels.,Non-OADS,/arxiv_data1/oa_pdf/8d/b1/err185.PMC3170558.pdf
Fewexpressed sequence tags exist for CLE34 and CLE36 (http://compbio.dfci.harvard.edu/tgi/plant.html ).,OADS,/arxiv_data1/oa_pdf/8d/b1/err185.PMC3170558.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/err186.PMC3170559.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/92/19/err190.PMC3170560.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cite d.",Non-OADS,/arxiv_data1/oa_pdf/c7/c0/err193.PMC3170561.pdf
"This indicates that the majority of children displaying cognitive delay at 24 months of age do notdisplay atypically low levels of school readiness at 48 months of age.Table 1 Demographic characteristics, gestational and birth factors, and cognitive test scores, early childhood longitudinal study-birth cohort (ECLS-B) study sample ( N=7,200) Mean or percentaStandarddeviation Male 50% Child age (months), ECLS-B wave 2 24.39 1.16Child age (months), ECLS-B wave 3 52.54 4.10Ethnic origin White, non-hispanic 57%Black 14%Hispanic 22%Asian 3%Native American 0.4%Other 4% Mother’s education, 24 month assessment Less than 9th grade 3%From 9th to 12th grade 12%High school graduate 31% Some training/college after high school 27% Four year college degree and above 26% Family income, 24 month assessment Less than $10,000 9%Between $10,001 and $20,000 14%Between $20,001 and $40,000 27%Between $40,001 and $75,000 26%At or above $75,001 24% Mother’s education, 48 month assessment Less than 9th grade 3%From 9th to 12th grade 10%High school graduate 30%Some training/college after high school 30%Four year college degree and above 27% Family income, 48 month assessment Less than $10,000 8% Between $10,001 and $20,000 12%Between $20,001 and $40,000 26%Between $40,001 and $75,000 25%At or above $75,001 28% Maternal age =35 or older 14% Marital status =unmarried, 48 month assessment32% Medical risk factor(s) 0.18 0.52 Behavioral risk factor(s) 0.12 0.33Obstetric procedure(s) 0.59 0.68Labor complication(s) 0.36 0.67Multiple birth 3% Gestation Very preterm B32 weeks 2% Moderately preterm 33–36 weeks 9%Table 1 continued Mean or percentaStandarddeviation Birthweight Very low birthweight B1,500 g 1% Moderately low birthweight 1,501–2,500 grams6% Congenital anomaly b5% Bayley mental score, 24 month assessment 127.75 10.66 Literacy score, 48 month assessment 13.11 7.14Math score, 48 month assessment 22.64 7.42Color knowledge score, 48 month assessment 8.77 2.28Receptive vocabulary score, 48 month assessment8.60 1.92 48 Month assessment score 53.12 16.00 The Bayley mental score was used as the cognitive score at 24 months; at 48 months, literacy, math, color knowledge, and receptive vocabulary scores were converted into z-scores and summed Sample size rounded to nearest 50 in accordance with ECLS-B data conﬁdentiality requirements (available at http://nces.ed.gov/ecls/ birthdatainformation.asp ) aEstimates are weighted to take the complex sampling design into account bAny congenital abnormality identiﬁed on the birth certiﬁcate1004 Matern Child Health J (2011) 15:1001–1010 123",Non-OADS,/arxiv_data1/oa_pdf/57/32/10995_2010_Article_656.PMC3170682.pdf
All sample sizes in this table are rounded to the nearest 50 in accordance with ECLS-B data conﬁdentiality requirements (available at http://nces.ed.gov/ecls/birthdatainformation.asp ) aPercentages and conﬁdence intervals are calculated from actual sample sizes and have not been roundedMatern Child Health J (2011) 15:1001–1010 1005 123,Non-OADS,/arxiv_data1/oa_pdf/57/32/10995_2010_Article_656.PMC3170682.pdf
"The largest of these effects occurs at the very lowest level of mother’s education, when pre- dicting child outcomes at 48 months.Table 3 Logistic regression estimates (odds ratios) of displaying low cognitive scoresat the 24 and 48 month assessments ( N=7,200) *PB0.05, ** PB0.01, ***PB0.001 Literacy, math, color knowledge, and receptive vocabulary scores wereconverted into z-scores and summed to produce cognitive score at 48 months; lowest 10% were deﬁned as low Bayley mental score was used as cognitive score at 24 months; lowest 10% were deﬁned as low Sample size rounded to the nearest 50 in accordance withECLS-B data conﬁdentialityrequirements (available at http://nces.ed.gov/ecls/ birthdatainformation.asp )24 Mo assessment 48 Mo assessment Model 1 Model 2 Model 1 Model 2 Male 1.93*** 2.00*** 1.55*** 1.66*** Child age (months) 0.66*** 0.64*** 0.86*** 0.83***Ethnic origin Black 3.00*** 1.92*** 4.47*** 1.97***Hispanic 2.89*** 2.04*** 5.69*** 2.61***Asian 2.45*** 2.74*** 1.68 * 1.61Native American 1.96 1.46 4.45*** 2.37***Other 1.85* 1.49 2.40*** 1.70*White, non-hispanic 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) Mother’s education at corresponding assessment Less than 9th grade 2.33** 13.65*** From 9th to 12th grade 2.45*** 6.88*** High school graduate 1.97*** 3.13***Some training/college after high school 1.81** 1.83 *Four year college degree and above 1.00 (ref) 1.00 (ref) Family income at corresponding assessment Less than $10,000 1.43 7.01***Between $10,001 and $20,000 1.56 5.13***Between $20,001 and $40,000 1.31 3.92***Between $40,001 and $75,000 1.10 2.52**At or above $75,001 1.00 (ref) 1.00 (ref) Maternal age =35 or older 0.90 0.96 Marital status =unmarried, 48 month assessment 1.10 0.99 Medical risk factor(s) 0.98 0.89Behavioral risk factor(s) 0.79 0.87Obstetric procedure(s) 0.85 0.83* Labor complication(s) 1.04 1.03 Multiple birth 1.52** 1.52*Gestation Very preterm B32 weeks 1.52 1.86 Moderately preterm 33–36 weeks 1.07 1.10 Birthweight Very low birthweight 4.38*** 1.10Moderately low birthweight 1.70*** 1.17 Congenital anomaly 1.19 1.271006 Matern Child Health J (2011) 15:1001–1010 123",Non-OADS,/arxiv_data1/oa_pdf/57/32/10995_2010_Article_656.PMC3170682.pdf
"Multivariate analyses involving children delayed at 24 months indicate that low levels of maternal educationTable 4 Logistic regression estimates (odds ratios) of displaying low cognitive scoresat 48 months, shown separately for children with and without cognitive delay at 24 months *PB0.05, ** PB0.01, ***PB0.001 Literacy, math, color knowledge, and receptive vocabulary scores were converted into z-scores and summed to produce cognitivescore at 48 months; lowest 10% were deﬁned as low Bayley mental Score was used as cognitive score at 24 months;lowest 10% were deﬁned as low aAll sample sizes in this table are rounded to the nearest 50 in accordance with ECLS-B dataconﬁdentiality requirements(available at http://nces.ed.gov/ecls/ birthdatainformation.asp )Children with low cognitive score at the 24 month assessment(n=1,000 a)Children with non-low cognitive score at the 24 month assessment(n=6,250) Model 1 Model 2 Model 1 Model 2 Male 0.88 1.06 1.57*** 1.68*** Child age (months) 0.85*** 0.82*** 0.85*** 0.83***Ethnic origin Black 2.30** 1.60 4.39*** 1.89***Hispanic 2.32** 1.36 6.18*** 2.87***Asian 0.88 1.10 1.73 1.54Native American 0.86 0.38 5.66*** 3.31***Other 3.36* 2.16 2.00* 1.40White, non-hispanic 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) Mother’s education at corresponding assessment Less than 9th grade 30.49*** 11.46***From 9th to 12th grade 10.66*** 5.93***High school graduate 5.61** 2.62**Some training/college after high school 3.03 1.56 Four year college degree and above 1.00 (ref) 1.00 (ref) Family income at corresponding assessment Less than $10,000 7.58*** 6.20***Between $10,001 and $20,000 4.17** 4.85***Between $20,001 and $40,000 3.19 * 3.86***Between $40,001 and $75,000 3.17** 2.31*At or above $75,001 1.00 (ref) 1.00 (ref) Maternal age =35 or older 1.22 0.89 Marital status =unmarried, 48 month assessment 0.78 1.02 Medical risk factor(s) 1.36 0.77Behavioral risk factor(s) 1.17 0.83Obstetric procedure(s) 0.91 0.81*Labor complication(s) 0.98 1.04Multiple birth 1.25 1.48*Gestation Very preterm B32 weeks 0.33 3.07** Moderately preterm 33–36 weeks 0.82 1.17 Birthweight Very low birthweight 3.42* 0.56Moderately low birthweight 1.26 1.13 Congenital anomaly 1.07 1.26Matern Child Health J (2011) 15:1001–1010 1007 123",Non-OADS,/arxiv_data1/oa_pdf/57/32/10995_2010_Article_656.PMC3170682.pdf
Available at: http://www.acf.hhs.gov/ programs/opre/hs/impact_study/reports/impact_study/impactstdy_resrch_plan.pdf .,Non-OADS,/arxiv_data1/oa_pdf/57/32/10995_2010_Article_656.PMC3170682.pdf
Available from: http://www.unaids.org/highband/doc  ument/epidemio/report97.html  [8] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/6d/a8/TOAIDJ-5-80.PMC3170929.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/6d/a8/TOAIDJ-5-80.PMC3170929.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/4b/TONEUJ-5-58.PMC3170930.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/54/TODENTJ-5-139.PMC3170932.pdf
ESBLs have spread threateningly in many regions of the world and now comprise over three hundred variants  (http://www.lahey.org/studies ).,Non-OADS,/arxiv_data1/oa_pdf/de/ae/TOMICROJ-5-91.PMC3170933.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/71/TODENTJ-5-146.PMC3170934.pdf
"Furthermore, the challenges of integration and  interoperability have to be faced when it comes to join the  main flow of whole hospital PACS, as these scanning devices need to accommodate the currently used and accepted standards, including DICOM for image format and HL-7 (http://www.hl7.org/about/index.cfm), for information systems connectivity, which appears far a field.",Non-OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"Towards this end, while working on  images of 3D brain, Gao [24] and Qian [25] have extended  the approach of Local Binary Pattern (LBP) [36] into 3D form to extracting texture information that is subsequently utilized for indexing them in their developed system MIRAGE (http://image.mdx.ac.uk/vin/demo.php ), which is described in details in the next Section.",Non-OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
An image retrieval system with CBIR facility at http://image.mdx.ac.uk/.,Non-OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"Built on the open source GNU Image Finding Tool  (GIFT, http://www.gnu.org/software/gift/), the online  database is based on the Query-by-Example (QBE) paradigm  coupled with a facility of user-relevance feedback whereby retrieved images most closely resemble a query image in appearance (i.e., the content that an image is carrying).",OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"[2] Gray M., MEDINFO 2007, http://www.chi.unsw.edu.au/CHIweb.",Non-OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"Available at http://www.health  imaging.com/index.php?option=com_articles&view=article&id=4384  [14] Koller JS, Lindemann GW.",OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"Available at http://itn.reillycomm.com/node/ 28068/  [15] Gao XW, Müller H, Loomes M, Comley R, Luo S, Eds.",OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"[18] imageCLEF, http://www.imageclef.org/.",Non-OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc  /3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is proper ly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/fb/TOMINFOJ-5-73.PMC3170936.pdf
"To evaluate infarct area and volume, brain slices were stained with cresyl violet, scanned using Axio-Vision software (Carl Zeiss, Jena, Germany), andmeasured by the ImageJ program (NIH, http://rsb.info.",Non-OADS,/arxiv_data1/oa_pdf/74/6d/jcbfm201151a.PMC3170947.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http:// www.nature.com/jcbfm)Neuroprotective effects of exendin-4 S Teramoto et al 1705 Journal of Cerebral Blood Flow & Metabolism (2011) 31, 1696–1705",Non-OADS,/arxiv_data1/oa_pdf/74/6d/jcbfm201151a.PMC3170947.pdf
"Quantitative RT-PCR used the QuantiTect Reverse Transcription and SYBR Green PCR kits, with speciﬁc primer sets.Microarray analyses RNA from 697 precursor-B ALL cell line and cryo-preservedbone marrow or peripheral blood patient samples was extracted using Trizol (Invitrogen) followed by ampliﬁcation, and hybri- dization to Affymetrix HG-U133Plus2.0 oligonucleotide micro- arrays (https://www.affymetrix.com).",Non-OADS,/arxiv_data1/oa_pdf/26/41/leu201150a.PMC3170956.pdf
The entire gene expression data set may be accessed via the National Cancer Institute caArray portal (https://array.nci.nih.gov/caarray) or at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/ geo; accession no.,OADS,/arxiv_data1/oa_pdf/26/41/leu201150a.PMC3170956.pdf
Normalized data wereanalyzed using R (https://www.r-project.org) and Bioconductor.,OADS,/arxiv_data1/oa_pdf/26/41/leu201150a.PMC3170956.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)GSI-I kills precursor-B ALL cells X Meng et al 1146 Leukemia,Non-OADS,/arxiv_data1/oa_pdf/26/41/leu201150a.PMC3170956.pdf
"Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc) REFERENCES Angele S, Lauge A, Fernet M, Moullan N, Beauvais P, Couturier J, Stoppa-Lyonnet D, Hall J (2003) Phenotypic cellular characterization ofan ataxia telangiectasia patient carrying a causal homozygous missensemutation.",Non-OADS,/arxiv_data1/oa_pdf/cf/56/bjc2011266a.PMC3170966.pdf
This article is distributed under the terms of an Attribution–Noncom­ mercial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2d/50/JGP_201110650.PMC3171074.pdf
"After six months it is available under a Creative Com­ mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by ­nc­sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/2d/50/JGP_201110650.PMC3171074.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7e/f9/JGP_201110649.PMC3171075.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/7e/f9/JGP_201110649.PMC3171075.pdf
S1 and S2 are available at http://www.jgp .org/cgi/content/full/jgp.201110649/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7e/f9/JGP_201110649.PMC3171075.pdf
"120–138.Ion selectivity of proteins: lessons from molecular dynamics simulations  on valinomycin George Eisenman Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 © 2011 Eisenman  This article is distributed under the terms of an Attribution–Noncom - mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/86/9e/JGP_201110702.PMC3171076.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de - scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/86/9e/JGP_201110702.PMC3171076.pdf
"The physiological role of the last Perspectives on: Information and coding in mammalian sensory physiology Response kinetics of olfactory receptor neurons and the implications   in olfactory coding Johannes Reisert1 and Haiqing Zhao2 1Monell Chemical Senses Center, Philadelphia, PA 19104 2Department of Biology, Johns Hopkins University, Baltimore, MD 21218 © 2011 Reisert and Zhao  This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/0d/a0/JGP_201110645.PMC3171077.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/0d/a0/JGP_201110645.PMC3171077.pdf
"Sampath1,3 1Department of Physiology and Biophysics, 2Biochemistry and Molecular Biology, and 3Zilkha Neurogenetic Institute,  Keck School of Medicine, University of Southern California, Los Angeles, CA 90033 © 2011 Farley and Sampath  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/2f/be/JGP_201110666.PMC3171078.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/2f/be/JGP_201110666.PMC3171078.pdf
"Letters should be prepared according to the Journal’s instructions and can be submitted electronically at http://www.jgp.org, or as an e-mail attachment to   jgp@mail.rockefeller.edu.Multiple subtypes of somatosensory neurons and end-organs innervate the skin and respond to tactile stimulation through the opening of mechanosensitive ion channels and the subsequent generation of ac - tion potentials.",Non-OADS,/arxiv_data1/oa_pdf/2f/be/JGP_201110666.PMC3171078.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1d/1d/JGP_201110634.PMC3171079.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/1d/1d/JGP_201110634.PMC3171079.pdf
"Peptide synthesis Peptides corresponding to specific sequences of the CL domain of rat Cx26 (Cx26CL), as defined by the UniProt database (http://www.uniprot.org/uniprot/P21994) to be residues 99–139, were tested for their ability to interact with a peptide with sequence corresponding to the Cx26CT (residues 213–226).",OADS,/arxiv_data1/oa_pdf/1d/1d/JGP_201110634.PMC3171079.pdf
"With increasing and CT and its involvement in channel gating have been demonstrated for Cx43 and several other members of the  family of connexins (Stergiopoulos et al., 1999)  (http://www.genenames.org/genefamily/gj.php).",OADS,/arxiv_data1/oa_pdf/1d/1d/JGP_201110634.PMC3171079.pdf
"However, several mutations that affect the Cx26CT  cause nonsyndromic deafness (http://davinci.crg.es/deafness/index.php).",Non-OADS,/arxiv_data1/oa_pdf/1d/1d/JGP_201110634.PMC3171079.pdf
"This array of cutaneous Perspectives on: Information and coding in mammalian sensory physiology Probing mammalian touch transduction Diana M. Bautista1 and Ellen A. Lumpkin2,3 1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720 2Department of Dermatology and 3Department of Physiology and Cellular Biophysics, Columbia University College  of Physicians and Surgeons, New York, NY 10032 © 2011 Bautista and Lumpkin  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/ee/19/JGP_201110637.PMC3171080.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/ee/19/JGP_201110637.PMC3171080.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7b/d6/JGP_201110618.PMC3171082.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/7b/d6/JGP_201110618.PMC3171082.pdf
This article is distributed under the terms of an Attribution–Non - commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/60/48/JGP_201110690.PMC3171083.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/60/48/JGP_201110690.PMC3171083.pdf
"A notable exception is the midget  circuitry in the primate fovea; in this circuit, a midget  ganglion cell receives input from a single cone via a  single midget bipolar cell.Perspectives on: Information and coding in mammalian sensory physiology Nonlinear spatial encoding by retinal ganglion cells: when 1 + 1 ≠ 2 Greg Schwartz and Fred Rieke Howard Hughes Medical Institute and Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195 © 2011 Schwartz and Rieke  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/4a/09/JGP_201110629.PMC3171084.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/4a/09/JGP_201110629.PMC3171084.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/49/ec/JEM_20110538.PMC3171085.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/49/ec/JEM_20110538.PMC3171085.pdf
"Procedures for cell  isolation, sorting, and RNA extractions are outlined in extensive detail at  http://www.immgen.org.",Non-OADS,/arxiv_data1/oa_pdf/49/ec/JEM_20110538.PMC3171085.pdf
doi:10   .1084/jem.189.3.58 7may be viewed at http://www.immen.org.,Non-OADS,/arxiv_data1/oa_pdf/49/ec/JEM_20110538.PMC3171085.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20110538/DC1.,Non-OADS,/arxiv_data1/oa_pdf/49/ec/JEM_20110538.PMC3171085.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/66/71/JEM_20091473.PMC3171086.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/66/71/JEM_20091473.PMC3171086.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/63/d1/JEM_20110128.PMC3171087.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20110128/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/63/d1/JEM_20110128.PMC3171087.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/e3/37/JEM_20102516.PMC3171088.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e3/37/JEM_20102516.PMC3171088.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/48/8e/JEM_20102170.PMC3171089.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/48/8e/JEM_20102170.PMC3171089.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20102170/DC1.,Non-OADS,/arxiv_data1/oa_pdf/48/8e/JEM_20102170.PMC3171089.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/17/d1/JEM_20101805.PMC3171090.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Un - ported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).the development of novel antiviral strategies.",Non-OADS,/arxiv_data1/oa_pdf/17/d1/JEM_20101805.PMC3171090.pdf
Online supple - mental material is available at http://www.jem.org/cgi/content/full/jem   .20101805/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/17/d1/JEM_20101805.PMC3171090.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/4b/71/JEM_20110242.PMC3171091.pdf
"After six months it   is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/4b/71/JEM_20110242.PMC3171091.pdf
Online supplemental material is available  at http://www.jem.org/cgi/content/full/jem.20110242/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/71/JEM_20110242.PMC3171091.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/85/7e/JEM_20110578.PMC3171092.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20110578/DC1.,Non-OADS,/arxiv_data1/oa_pdf/85/7e/JEM_20110578.PMC3171092.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/4d/12/JEM_20110846.PMC3171093.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/4d/12/JEM_20110846.PMC3171093.pdf
This article is distributed under the terms of an Attributio n– Noncommercial–Share Alike–No Mirror Sites license for the first six months   after the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/51/4c/JEM_20110665.PMC3171094.pdf
"After six months it  is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/51/4c/JEM_20110665.PMC3171094.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/df/43/JEM_20110121.PMC3171095.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/82/17/JEM_20110866.PMC3171096.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/82/17/JEM_20110866.PMC3171096.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/48/96/JEM_20102234.PMC3171097.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/48/96/JEM_20102234.PMC3171097.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20102234/DC1.,Non-OADS,/arxiv_data1/oa_pdf/48/96/JEM_20102234.PMC3171097.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/c5/d6/JEM_20110571.PMC3171098.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/c5/d6/JEM_20110571.PMC3171098.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20110571/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/d6/JEM_20110571.PMC3171098.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/f6/c5/JEM_20101757.PMC3171099.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/f6/c5/JEM_20101757.PMC3171099.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20101757/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f6/c5/JEM_20101757.PMC3171099.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/4a/28/JEM_20102358.PMC3171100.pdf
"This sample was taken from the TwinsUK register ( http://www.twinsuk.ac.uk ), a volunteer- based group of healthy adult twins drawn from the UK population.",Non-OADS,/arxiv_data1/oa_pdf/d8/4f/ard-70-10-1740.PMC3171106.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b0/0d/JCB_201103103.PMC3171114.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/b0/0d/JCB_201103103.PMC3171114.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201103103/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/0d/JCB_201103103.PMC3171114.pdf
"All  image-based HCS data associated with  Tools publications will be archived and  made available to the public through the  JCB DataViewer, and all other resources  relevant to Tools publications, such as  interaction network datasets and source  code for computational methods, will be New Tools for JCB Elizabeth H. Williams1 and Tom Misteli2 1Executive Editor, The Journal of Cell Biology 2Editor-in-Chief, The Journal of Cell Biology Correspondence to Liz Williams: lwilliams@rock - efeller.edu© 2011 Williams and Misteli  This article is distributed  under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/08/62/JCB_201108096.PMC3171115.pdf
"For further details about this new article  type, please see JCB’s Instructions for  Authors at http://jcb.rupress.org/site/misc/   ifora.xhtml.",Non-OADS,/arxiv_data1/oa_pdf/08/62/JCB_201108096.PMC3171115.pdf
5  665–667 www.jcb.org/cgi/doi /10.1083/jcb.201108095 JCB 665JCB: Comment Complete screen data http://jcb-dataviewer.rupress.org/jcb/browse/4608/S 1 The Rad52 protein has pivotal functions in double strand  break repair and homologous recombination.,Non-OADS,/arxiv_data1/oa_pdf/63/73/JCB_201108095.PMC3171117.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/63/73/JCB_201108095.PMC3171117.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/63/73/JCB_201108095.PMC3171117.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/f2/ec/JCB_201011027.PMC3171119.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f2/ec/JCB_201011027.PMC3171119.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201011027/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/ec/JCB_201011027.PMC3171119.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub ­ lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/79/2a/JCB_201010118.PMC3171121.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by ­nc­sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/79/2a/JCB_201010118.PMC3171121.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201010118/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/79/2a/JCB_201010118.PMC3171121.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5d/38/JCB_201105143.PMC3171122.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/5d/38/JCB_201105143.PMC3171122.pdf
6 A. Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201105143/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/5d/38/JCB_201105143.PMC3171122.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/90/d2/JCB_201107021.PMC3171123.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/90/d2/JCB_201107021.PMC3171123.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201107021/DC1.,Non-OADS,/arxiv_data1/oa_pdf/90/d2/JCB_201107021.PMC3171123.pdf
"5  789–805 www.jcb.org/cgi/doi/10.1083/jcb.201103168 JCB 789Correspondence to Jennifer L. Rohn: j.rohn@ucl.ac.uk; or Buzz Baum: b.baum@ ucl.ac.uk Abbreviations used in this paper: SCF, Skp1-Cul1-F-box-protein; Slmb, super - numerary limbs.Complete screen data Drosophila : http://jcb-dataviewer.rupress.org/jcb/browse/4609/S 2 Human actinome I: http://jcb-dataviewer.rupress.org/jcb/browse/4609/S 3 Human actinome II: http://jcb-dataviewer.rupress.org/jcb/browse/4609/S 4 Introduction The ability of animal cells to change their shape is essential for  diverse processes from cell division to tissue remodeling during  development, homeostasis, and disease (Rungger-Brändle and  Gabbiani, 1983; Lecuit and Lenne, 2007; St Johnston and   Ahringer, 2010).",Non-OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
"For validation experiments, PCR primers were  based on a genome-wide library purchased from Invitrogen/Ambion, the  DRSC validation library (http://flyrnai.org), or designed de novo using  SnapDragon (http://flyrnai.org/snapdragon_doc1.html; see Table S2 for  details).",Non-OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
"We also determined the human ortho - logues of Drosophila  actin morphology hits by comparing orthologue as - signments from Homologene (http://www.ncbi.nlm.nih.gov/homologene),  Inparanoid (http://inparanoid.sbc.su.se/cgi-bin/index.cgi), and Ensembl  (http://www.ensembl.org/index.html).",OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
"We filtered the set of nominated hits to exclude dsRNAs with (1) >1 pre - dicted amplicon; (2) one or more CAN repeats (a stretch of a particular tri - nucleotide sequence [CA n] repeated five or more times, which is known to  cause nonspecific effects (Echeverri et al., 2006)); (3) >5 predicted off-target  effects (19 bp; Echeverri et al., 2006); and (4) no known protein-encoding  gene target according to FlyBase version 5.23 (http://flybase.org; Table S1).",Non-OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
Hierarchical clustering and network analysis We performed hierarchical clustering of both Drosophila  and human bi - nary RNAi phenotype annotations using the correlation distance and  Wards method using R (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201103168/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/16/JCB_201103168.PMC3171124.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/93/c7/JCB_201008095.PMC3171125.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/93/c7/JCB_201008095.PMC3171125.pdf
Online supplemental material Video 1 is available at http://www.jcb.org/cgi/content/full/jcb   .201008095/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/93/c7/JCB_201008095.PMC3171125.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1b/61/JCB_201104019.PMC3171126.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/1b/61/JCB_201104019.PMC3171126.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/a8/3e/JCB_201103129.PMC3171128.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a8/3e/JCB_201103129.PMC3171128.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201103129/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/3e/JCB_201103129.PMC3171128.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/51/fe/JCB_201103153.PMC3171129.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0 /).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/51/fe/JCB_201103153.PMC3171129.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201103153/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/51/fe/JCB_201103153.PMC3171129.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Medical Education Online 2011, 16: 7133 - DOI: 10.3402/meo.v16i0.7133",Non-OADS,/arxiv_data1/oa_pdf/2b/99/MEO-16-7133.PMC3171175.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2011, 6:8412 - DOI: 10.3402/ljm.v6i0.8412",Non-OADS,/arxiv_data1/oa_pdf/bf/db/LJM-6-8412.PMC3171195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in an y medium, provided the original work is properly cited.1 Citation: Int J Qualitative Stud Health Well-being 2011, 6: 7084 - DOI: 10.3402/qhw.v6i3.7084",Non-OADS,/arxiv_data1/oa_pdf/b2/41/QHW-6-7084.PMC3171197.pdf
"London: College of Occupational Therapists Ltd. Retrieved July 11, 2011, from http://www.cot.co.uk/sites/default/ ﬁles/publications/public/Code_of_ Ethics_2010.pdf Phinney, J. S. (2004).",Non-OADS,/arxiv_data1/oa_pdf/b2/41/QHW-6-7084.PMC3171197.pdf
"South Bend, IN: University of Notre Dame.Retrieved from http://www.nd.edu/ /C2mri/ccd/2004/abstract/ phinney.pdf Phinney, J. S., & Horenczyk, G. (2001).",Non-OADS,/arxiv_data1/oa_pdf/b2/41/QHW-6-7084.PMC3171197.pdf
"Retrieved from http://www.iranian.com/Women/2005/July/Mahram/ Rousseau, C., Key, F., & Measham, T. (2005).",Non-OADS,/arxiv_data1/oa_pdf/b2/41/QHW-6-7084.PMC3171197.pdf
"Retrieved June 22, 2011, from http://www.fsa.akademikerhuset.se/Global/Om_forbundet/.../codeofethics.pdf Triandis, H. C. (1995).",OADS,/arxiv_data1/oa_pdf/b2/41/QHW-6-7084.PMC3171197.pdf
Clinical trial registration: http://www.clinicaltrials.gov; unique ID: NCT01081210.,Non-OADS,/arxiv_data1/oa_pdf/0a/eb/jer108.PMC3171198.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2011.",Non-OADS,/arxiv_data1/oa_pdf/65/bc/FNR-55-7122.PMC3171216.pdf
Emirates J Agricultural Sci 2003; 15: 42 /C150; http://www.cfs.uaeu.ac.ae/research/ejas.html.,Non-OADS,/arxiv_data1/oa_pdf/65/bc/FNR-55-7122.PMC3171216.pdf
The food dome: dietary guidelines for the Arab Countries; http://www.acnut.com/en/view.php?id /C302; 2005.,Non-OADS,/arxiv_data1/oa_pdf/65/bc/FNR-55-7122.PMC3171216.pdf
"Cur- rently, more than 90 different mutations within mito- chondrial tRNA genes have been characterized aspathogenic (MITOMAP: A Human Mitochondrial Gen- ome Database, http://www.mitomap.org ).",Non-OADS,/arxiv_data1/oa_pdf/b8/3a/10072_2011_Article_719.PMC3171650.pdf
http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm070107.pdf .,Non-OADS,/arxiv_data1/oa_pdf/75/32/10637_2010_Article_9477.PMC3171651.pdf
http://www.emea.europa.eu/pdfs/human/ewp/23390en.,Non-OADS,/arxiv_data1/oa_pdf/75/32/10637_2010_Article_9477.PMC3171651.pdf
Permarheum SLEDAI Calculator: http://www.permarheum.org/ SLEDAI.html .,Non-OADS,/arxiv_data1/oa_pdf/ec/82/11_2011_Article_358.PMC3171653.pdf
http://www.invs.sante.fr/surveillance/cancers/estimations_cancers .,Non-OADS,/arxiv_data1/oa_pdf/07/60/404_2010_Article_1747.PMC3171668.pdf
4http://ideas.repec.org/top/top.person.all.html .,Non-OADS,/arxiv_data1/oa_pdf/c2/9e/11192_2011_Article_451.PMC3171670.pdf
5http://www.scopus.com/home.url .,Non-OADS,/arxiv_data1/oa_pdf/c2/9e/11192_2011_Article_451.PMC3171670.pdf
http://www.mhlw.go.jp/english/database/db-hw/vs02.,Non-OADS,/arxiv_data1/oa_pdf/ab/cf/404_2010_Article_1777.PMC3171672.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/b3/evr081.PMC3171675.pdf
Supplementary Material Supplementary ﬁle and table S1 and S2are available at Genome Biology and Evolution online ( http://www.gbe .oxfordjournals.org/ ).,OADS,/arxiv_data1/oa_pdf/ec/b3/evr081.PMC3171675.pdf
http://www.wma.net/ en/30publications/10policies/b3/index.html  ( accessed 4 Aug 2010 ).,Non-OADS,/arxiv_data1/oa_pdf/73/0d/adc-96-10-0960.PMC3171745.pdf
http://www.jrf.org.uk/sites/ﬁ  les/jrf/0365.pdf  ( accessed 9 Aug 2010 ).,Non-OADS,/arxiv_data1/oa_pdf/73/0d/adc-96-10-0960.PMC3171745.pdf
http://www.loc.gov/rr/frd/Military_Law/NTs_war-criminals.html  ( ac cessed 6 Aug 2010 ).,Non-OADS,/arxiv_data1/oa_pdf/73/0d/adc-96-10-0960.PMC3171745.pdf
http://pediatrics.aappublications.org/cgi/reprint/95/2/286   (accessed 19 May 2011).,Non-OADS,/arxiv_data1/oa_pdf/73/0d/adc-96-10-0960.PMC3171745.pdf
http://www.recerca.uab.es/ceeah/docs/CIOMS.pdf  ( accessed 19 May 2011 ).,Non-OADS,/arxiv_data1/oa_pdf/73/0d/adc-96-10-0960.PMC3171745.pdf
http://www.racp.edu.au/page/policy-and-advocacy/paediatrics-and-child-health  ( accessed 19 May 2011 ).,Non-OADS,/arxiv_data1/oa_pdf/73/0d/adc-96-10-0960.PMC3171745.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8f/10/jcav02p0458.PMC3171896.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/jcav02p0467.PMC3171897.pdf
http://seer.cancer.gov/csr/   1975_2005/   14.,Non-OADS,/arxiv_data1/oa_pdf/5d/e1/jcav02p0467.PMC3171897.pdf
"Premashis Kar Department of Medicine Maulana Azad Medical College New Delhi 110 002, India premashiskar@gmail.com References  1. http://www.aasld.org/news/060211/Pages/default.aspx .",Non-OADS,/arxiv_data1/oa_pdf/4a/39/IJMR-134-1.PMC3171900.pdf
"Available 1.  from: http://atlas.idf-bxl.org/content/diabetes , accessed on  September 10, 2010.",Non-OADS,/arxiv_data1/oa_pdf/c2/55/IJMR-134-107.PMC3171903.pdf
"Available from: http://www.aidsandmedia.net/ ,  accessed on May 2, 2010.",Non-OADS,/arxiv_data1/oa_pdf/ab/99/IJMR-134-124.PMC3171907.pdf
"Available from: http://presscouncil.nic.in/norms.htm , accessed  on January 2, 2010.",Non-OADS,/arxiv_data1/oa_pdf/ab/99/IJMR-134-124.PMC3171907.pdf
"Ethical  guidelines for biomedical research on human participants, Available from: http://icmr.nic.in/ethical_guidelines.pdf ,  accessed on January 2, 2010.",Non-OADS,/arxiv_data1/oa_pdf/ab/99/IJMR-134-124.PMC3171907.pdf
Available from: http://news.outlookindia.,Non-OADS,/arxiv_data1/oa_pdf/ab/99/IJMR-134-124.PMC3171907.pdf
"Available from: http://www.hindustantimes.com/ Govt-ready-with-a-draft-law-to-protect-HIV-AIDS-patients/Article1-530462.aspx  , accessed on May 2, 2010.",Non-OADS,/arxiv_data1/oa_pdf/ab/99/IJMR-134-124.PMC3171907.pdf
The persons with disabilities  Available from: http://nhrc.nic.in/Publications/Disability/ Annexure-1.html .,Non-OADS,/arxiv_data1/oa_pdf/e6/b4/IJMR-134-128.PMC3171908.pdf
"Available  from: http://www.un.org/disabilities/countries.asp?id=166  html, accessed on March 15, 2010.",Non-OADS,/arxiv_data1/oa_pdf/e6/b4/IJMR-134-128.PMC3171908.pdf
"Available from: http://nhrc.nic.in/ Publications/Disability/annexure3.html,  accessed on March  15, 2010.",Non-OADS,/arxiv_data1/oa_pdf/e6/b4/IJMR-134-128.PMC3171908.pdf
Available from: http://rehabcouncil.nic.in/pdf/eval_ ment.pdf  or http://socialjustice.nic.in/disabled/mentguide.,Non-OADS,/arxiv_data1/oa_pdf/e6/b4/IJMR-134-128.PMC3171908.pdf
htm#manual  or http://www.ccdisabilities.nic.in/eval2/page6.,Non-OADS,/arxiv_data1/oa_pdf/e6/b4/IJMR-134-128.PMC3171908.pdf
"Available from http://www.marketsandmarkets.com/Market-Reports/ probiotic-market-advanced-technologies-and-global-market-69.html,  accessed on February 15, 2011.",Non-OADS,/arxiv_data1/oa_pdf/18/15/IJMR-134-22.PMC3171912.pdf
"Available from: http://www.marketsandmarkets.com/ Market-Reports/probiotic-market-advanced-technologies- and-global-market-69.html , accessed on February 15, 2011.",Non-OADS,/arxiv_data1/oa_pdf/18/15/IJMR-134-22.PMC3171912.pdf
Available from: http://bbs.bio668.com/simple/index.,OADS,/arxiv_data1/oa_pdf/18/15/IJMR-134-22.PMC3171912.pdf
"Available from: http://www.isapp.net/docs/ probiotic%20standards%20justiﬁ  cation.pdf , accessed on  October 10, 2008.",Non-OADS,/arxiv_data1/oa_pdf/18/15/IJMR-134-22.PMC3171912.pdf
"Available from: http://dsp-psd.pwgsc.gc.ca/ collection_2007/hc-sc/H164-39-2006E.pdf , accessed on  October 9, 2008.",Non-OADS,/arxiv_data1/oa_pdf/18/15/IJMR-134-22.PMC3171912.pdf
"Available from:   http://www.the-icsp.org/ , accessed  on November 14, 2010.",Non-OADS,/arxiv_data1/oa_pdf/18/15/IJMR-134-22.PMC3171912.pdf
"Available from: http://nhrc.nic.in/Documents/sec-3.pdf ,  accessed on May 10, 2010.",Non-OADS,/arxiv_data1/oa_pdf/48/5d/IJMR-134-4.PMC3171915.pdf
"Available from:  http://aapnews.aapublications.org/cgi/content/full/27/9/1-b,   accessed December 24, 2008 .",Non-OADS,/arxiv_data1/oa_pdf/ce/fc/IJMR-134-47.PMC3171917.pdf
"Available 16.  from: http://www.workhealth.org/WCLA%20OHP%202004/ GHQ%20and %20scoring.pfd , accessed on August 10, 2007.",Non-OADS,/arxiv_data1/oa_pdf/ef/47/IJMR-134-61.PMC3171919.pdf
"Global trends in childhood overweight, 2008. http://www.iaso.org/policy/trackingobesity/global-trends-childhood-overweight (accessed 8 Jul 2010).",Non-OADS,/arxiv_data1/oa_pdf/ca/02/jech102319.PMC3171977.pdf
http://www.perseo.aesan.msps.es (accessed 1 Sep 2009).,Non-OADS,/arxiv_data1/oa_pdf/ca/02/jech102319.PMC3171977.pdf
"Education S.L., 2006. http://www.shapeupeurope.net/index.php?page ¼home (accessed 1 Sep 2009).",Non-OADS,/arxiv_data1/oa_pdf/ca/02/jech102319.PMC3171977.pdf
"Barcelona: Generalitat de Catalunya, 2002. http://www.gencat.cat/ salut/depsalut/html/ca/dir2622/doc27549.html (accessed 1 Sep 2009).",Non-OADS,/arxiv_data1/oa_pdf/ca/02/jech102319.PMC3171977.pdf
"By the spring of 2010 mortality data demon- strated that swine ﬂu had been less lethal than feared and case death rates compared favourablywith previous in ﬂuenza pandemics, 6accounting for less than 500 deaths in the UK.7The large disparity between predicted and actual rates became apparentand rendered a mass vaccination programme unnecessary, leaving the government with millions of doses of surplus vaccines (http://news.bbc.co.uk/1/hi/8448080.stm).",Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jech119875.PMC3171979.pdf
"Chan M. World Now At The Start Of 2009 Inﬂuenza Pandemic : World Health Organisation, 2009. http://www.who.int/mediacentre/news/statements/2009/ h1n1_pandemic_phase6_20090611/en/index.html.",Non-OADS,/arxiv_data1/oa_pdf/3d/e7/jech119875.PMC3171979.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Permanent cerebrospinal fluid diversion in subarachnoid  hemorrhage: Influence of physician practice style Domenic P .",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/SNI-2-117.PMC3171999.pdf
Surg Neurol Int 2011;2:117 Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2011/2/1/117/84241 Copyright: © 2011 Esposito DP .,Non-OADS,/arxiv_data1/oa_pdf/b1/8e/SNI-2-117.PMC3171999.pdf
"Surgical Neurology International 2011, 2:117  http://www.surgicalneurologyint.com/content/2/1/117INTRODUCTION Acute hydrocephalus (HCP) after subarachnoid  hemorrhage (SAH) is common, may cause neurological  damage and may persist, resulting in the need for  permanent cerebrospinal fluid (CSF) diversion with a  shunt.",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/SNI-2-117.PMC3171999.pdf
"Surgical Neurology International 2011, 2:117  http://www.surgicalneurologyint.com/content/2/1/117In addition, we sought to determine the level of  correlation between the equation formulated in the prior  study and our current data set.",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/SNI-2-117.PMC3171999.pdf
"Surgical Neurology International 2011, 2:117  http://www.surgicalneurologyint.com/content/2/1/117rate as an outcome variable.",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/SNI-2-117.PMC3171999.pdf
"Surgical Neurology International 2011, 2:117  http://www.surgicalneurologyint.com/content/2/1/117included higher Fisher grade,[5,10,11,19,21,25] higher Hunt  and Hess,[2,3,5,10-12,20,23-25] increased bicaudate diameter  or index,[2,12,19,26] presence of acute HCP ,[3,10,11,17,21,23,27]  intraventricular hemorrhage,[5,10,12,18,19,23] cisternal  hemorrhage,[12,18,24] posterior circulation location of the  ruptured aneurysm,[2,3,12,17,18,21,23,24,27] female sex,[2,3,23,24]  advanced age,[3,10,11,17,24,27] development of nosocomial  meningitis,[10,19,23] admission glucose of greater than or  equal to 126 mg/dL,[19] ventilation on admission[17] and  continuous drainage.",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/SNI-2-117.PMC3171999.pdf
"Surgical Neurology International 2011, 2:117  http://www.surgicalneurologyint.com/content/2/1/117Comparison of rapid and gradual weaning from external ventricular drainage  in patients with aneurysmal subarachnoid hemorrhage: A prospective  randomized trial.",Non-OADS,/arxiv_data1/oa_pdf/b1/8e/SNI-2-117.PMC3171999.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Giant intracranial osteochondroma: A case report and review of  the literature Renuka Inuganti Venkata, Satya Varaprasad Kakarala1, Sailabala Garikaparthi, Seshadri Sekhar Duttaluru1,  Annapoorna Parvatala, Aparna Chinnam  Department of Pathology, Guntur Medical College,1Department of Neurosurgery, Government General Hospital, Guntur, Andhra Pradesh, India   E-mail: *Renuka Inuganti Venkata - repriya56@gmail.com; Satya Varaprasad Kakarala - ksvprasad55@gmail.com; Sailabala Garikaparthi - sailabalagarikapati@gmail.com;  Seshadri Sekhar Duttaluru - drdss2003@yahoo.com; Annapoorna Parvatala - annapurnapotluri@gmail.com, Aparna Chinnam - achinnam893@gmail.com   *Corresponding author  Received: 21 June 11 Accepted: 28 June 11 Published: 30 August 11 This article may be cited as: Venkata RI, Kakarala SV, Garikaparthi S, Duttaluru SS, Parvatala A, Chinnam A.",Non-OADS,/arxiv_data1/oa_pdf/4b/28/SNI-2-118.PMC3172004.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2011/2/1/118/84242 Copyright: © 2011 Venkata RI.,Non-OADS,/arxiv_data1/oa_pdf/4b/28/SNI-2-118.PMC3172004.pdf
"Surgical Neurology International 2011, 2:118  http://www.surgicalneurologyint.com/content/2/1/118Pathological findings An ivory hard lobulated gray blue translucent mass measuring 7 × 7 × 3.5 cm was received.",Non-OADS,/arxiv_data1/oa_pdf/4b/28/SNI-2-118.PMC3172004.pdf
"Surgical Neurology International 2011, 2:118  http://www.surgicalneurologyint.com/content/2/1/118the fronto parietal location as in the present case.",Non-OADS,/arxiv_data1/oa_pdf/4b/28/SNI-2-118.PMC3172004.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Spinal intradural, extramedullary anaplastic ependymoma with an  extradural component: Case report and review of the literature Kern H. Guppy1,2, Lewis Hou1,2, Greg S. Moes3, Kamran Sahrakar1,2   1Departments of Neurosurgery and 3Pathology, Kaiser Permanente Medical Group, Sacramento, CA , 2Department of Neurosurgery, University of California, San Francisco,  CA, USA  E-mail: *Kern H. Guppy - kguppy@yahoo.com; Lewis Hou - Lewis.x.hou@kp.org; Greg S. Moes - Greg.s.moes@kp.org; Kamran Sahrakar - kamran.sahrakar@kp.org   *Corresponding author  Received: 8 July 11 Accepted: 12 July 11 Published: 30 August 11 This article may be cited as: Guppy KH, Hou L, Moes GS, Sahrakar K. Spinal intradural, extramedullary anaplastic ependymoma with an extradural component: Case report and review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/a3/be/SNI-2-119.PMC3172008.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2011/2/1/119/84246 Copyright: © 2011 Guppy KH.,Non-OADS,/arxiv_data1/oa_pdf/a3/be/SNI-2-119.PMC3172008.pdf
"Surgical Neurology International 2011, 2:119  http://www.surgicalneurologyint.com/content/2/1/119having an additional extradural component.",Non-OADS,/arxiv_data1/oa_pdf/a3/be/SNI-2-119.PMC3172008.pdf
"Surgical Neurology International 2011, 2:119  http://www.surgicalneurologyint.com/content/2/1/119Immunohistochemical analysis showed a strong diffuse  immunoreactivity for glial fibrillary acidic protein  (GFAP), strong membrane immunoreactivity for CD56,  and strong nuclear and cytoplasmic immunoreactivity for  S100.",Non-OADS,/arxiv_data1/oa_pdf/a3/be/SNI-2-119.PMC3172008.pdf
"Surgical Neurology International 2011, 2:119  http://www.surgicalneurologyint.com/content/2/1/119The hypothesis for the formation of these intradural,  extrameduallary ependymomas is that the heterotopic  glial tissue is left in the intradural space as the neural  tube closes.",Non-OADS,/arxiv_data1/oa_pdf/a3/be/SNI-2-119.PMC3172008.pdf
"Surgical Neurology International 2011, 2:119  http://www.surgicalneurologyint.com/content/2/1/119REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/a3/be/SNI-2-119.PMC3172008.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Armored brain: A case report and review of the literature Anthony L. Petraglia, Michael J. Moravan, Babak S. Jahromi  Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA   E-mail: *Anthony L. Petraglia - Anthony_Petraglia@urmc.rochester.edu; Michael J. Moravan - Michael_Moravan@urmc.rochester.edu;   Babak S. Jahromi - Babak_Jahromi@urmc.rochester.edu   *Corresponding author  Received: 21 June 11 Accepted: 28 June 11 Published: 30 August 11 This article may be cited as: Petraglia AL, Moravan MJ, Jahromi BS.",Non-OADS,/arxiv_data1/oa_pdf/93/16/SNI-2-120.PMC3172010.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2011/2/1/120/84391 Copyright: © 2011 Petraglia AL.,Non-OADS,/arxiv_data1/oa_pdf/93/16/SNI-2-120.PMC3172010.pdf
"Surgical Neurology International 2011, 2:120  http://www.surgicalneurologyint.com/content/2/1/120hydrocephalus since infancy, treated with a VP shunt,  presented with a 2-month history of abdominal pain  associated with nausea and chills.",Non-OADS,/arxiv_data1/oa_pdf/93/16/SNI-2-120.PMC3172010.pdf
"Surgical Neurology International 2011, 2:120  http://www.surgicalneurologyint.com/content/2/1/120conservatively with observation.",Non-OADS,/arxiv_data1/oa_pdf/93/16/SNI-2-120.PMC3172010.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Nerve transfers in tetraplegia I: Background and technique Justin M. Brown  Department of Neurological Surgery, Center for Nerve Injury and Paralysis, Washington University School of Medicine, St. Louis, MO 63110, USA E-mail: *Justin M. Brown - jmbrown@ucsd.edu   *Corresponding author  Received: 20 May 11 Accepted: 12 July 11 Published: 30 August 11 This article may be cited as: Brown JM.",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2011/2/1/121/84392 Copyright: © 2011 Brown JM.,Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121is consistently rated as the most desired function for  persons with tetraplegia, above bowel and bladder  function, sexual function, standing, and pain control.",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121system (Freehand System©, NeuroControl Corporation),  which allowed him to artificially produce pinch and  grip via a control driven by the contralateral shoulder   [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121The patient was placed in the supine position, with his  arm on an arm board [Figure 3].",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121 Figure 5: T o avoid current spread and activate the specific fascicle of  interest, bipolar stimulation is preferred.",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121nerve were directly stimulated in turn until one was  identified that provided dominant contribution to  wrist and finger flexion of digits 1–3 [Video 3].",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121 Figure 8: Same view as in Figure 7, with fascicular repairs complete.",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121some mixture of the two.",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"Surgical Neurology International 2011, 2:121  http://www.surgicalneurologyint.com/content/2/1/121REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/76/00/SNI-2-121.PMC3172032.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Molecular Human Reproduction, Vol.17, No.10 pp.",Non-OADS,/arxiv_data1/oa_pdf/c0/3d/gar031.PMC3172036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original wo rk is properly cited.J Antimicrob Chemother 2011; 66: 2240–2247 doi:10.1093/jac/dkr284 Advance Access publication 21 July 2011 2240",Non-OADS,/arxiv_data1/oa_pdf/47/e1/dkr284.PMC3172039.pdf
"PCR products were sequenced by Sinogenomax Co. Ltd. Sequence data were assembled by Seqman pro (version 7.1, DNAstarLasergene), and mutations were determined by comparing with the H37Rv sequence of embB from Tuberculist (http://genolist.pasteur.fr/ TubercuList/) and the GenBank database (http://www.ncbi.nih.gov/ gene).",OADS,/arxiv_data1/oa_pdf/47/e1/dkr284.PMC3172039.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original wo rk is properly cited.J Antimicrob Chemother 2011; 66: 2235–2239 doi:10.1093/jac/dkr311 Advance Access publication 3 August 2011 2235",Non-OADS,/arxiv_data1/oa_pdf/88/6c/dkr311.PMC3172042.pdf
The transposon name was designated by the transposon registry (http://www.ucl.ac.uk/eastman/tn/).,Non-OADS,/arxiv_data1/oa_pdf/88/6c/dkr311.PMC3172042.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original wo rk is properly cited.J Antimicrob Chemother 2011; 66: 2336–2345 doi:10.1093/jac/dkr314 Advance Access publication 10 August 2011 2336",Non-OADS,/arxiv_data1/oa_pdf/5c/45/dkr314.PMC3172043.pdf
"EUCAST MIC- and Zone Diameter Breakpoint Tables , 2011. http://www.eucast.",OADS,/arxiv_data1/oa_pdf/5c/45/dkr314.PMC3172043.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0 Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Degradation of cIAPs requires TRAF2 M Darding et al 1386 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/90/59/cdd201110a.PMC3172091.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Sphingoid-base phosphate-induced neurotoxicity N Hagen et al 1365 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/22/70/cdd20117a.PMC3172106.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0 Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Regulation of Drosophila cell death by mitofusins M Thomenius et al 1650 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/51/3c/cdd201126a.PMC3172116.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)DNA-damage-induced cell WG a o et al 1607 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/cc/f6/cdd201133a.PMC3172118.pdf
"The planar polarized  distribution of Ed in the DME cells thus provides a spatial  cue that polarizes the DME cell actin cytoskeleton, defin ­ ing the epidermal leading edge and establishing its con ­ tractile properties.Asymmetric distribution of Echinoid defines the  epidermal leading edge during Drosophila    dorsal closure Caroline Laplante and Laura A. Nilson Department of Biology, McGill University, Montréal, Quebec H3A 1B1, Canada © 2011 Laplante and Nilson  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/9b/ba/JCB_201009022.PMC3172166.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/9b/ba/JCB_201009022.PMC3172166.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201009022/DC1.,Non-OADS,/arxiv_data1/oa_pdf/9b/ba/JCB_201009022.PMC3172166.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/40/cf/JCB_201006040.PMC3172167.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/40/cf/JCB_201006040.PMC3172167.pdf
On - line supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201006040/DC1.,Non-OADS,/arxiv_data1/oa_pdf/40/cf/JCB_201006040.PMC3172167.pdf
"Thus, compliance and dimensionality  ECM mechanosensing pathways independently regulate  specific and distinct microtubule dynamics parameters in  endothelial cells to guide branching morphogenesis in  physically complex ECMs.Distinct ECM mechanosensing pathways regulate  microtubule dynamics to control endothelial cell  branching morphogenesis Kenneth A. Myers,1 Kathryn T. Applegate,2 Gaudenz Danuser,2,3 Robert S. Fischer,1 and Clare M. Waterman1 1Cell Biology and Physiology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 2Laboratory for Computational Cell Biology, Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037 3Laboratory for Computational Cell Biology, Department of Cell Biology, Harvard Medical School, Boston, MA 02115 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress.",Non-OADS,/arxiv_data1/oa_pdf/c7/57/JCB_201006009.PMC3172168.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201006009/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c7/57/JCB_201006009.PMC3172168.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ac/6d/JCB_201007018.PMC3172170.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ac/6d/JCB_201007018.PMC3172170.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201007018/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ac/6d/JCB_201007018.PMC3172170.pdf
"Our results suggest that  cohesin complexes containing RAD21L may be involved  in synapsis initiation and crossover recombination between  homologous chromosomes.RAD21L, a novel cohesin subunit implicated   in linking homologous chromosomes in   mammalian meiosis Jibak Lee and Tatsuya Hirano Chromosome Dynamics Laboratory, RIKEN Advanced Science Institute, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan © 2011 Lee and Hirano  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/cf/17/JCB_201008005.PMC3172173.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/cf/17/JCB_201008005.PMC3172173.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201008005/DC1.,Non-OADS,/arxiv_data1/oa_pdf/cf/17/JCB_201008005.PMC3172173.pdf
"These results reveal a recruitment of L1CAMs to  the DPC to ensure neural integrity is maintained.Neural integrity is maintained by dystrophin   in C. elegans Shan Zhou and Lihsia Chen Department of Genetics, Cell Biology, and Development, Developmental Biology Center, University of Minnesota, Minneapolis, MN 55455 © 2011 Zhou and Chen  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/99/2a/JCB_201006109.PMC3172177.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/99/2a/JCB_201006109.PMC3172177.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201006109/DC1.,Non-OADS,/arxiv_data1/oa_pdf/99/2a/JCB_201006109.PMC3172177.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/72/8c/JCB_201008076.PMC3172178.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/72/8c/JCB_201008076.PMC3172178.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cb/d3/JCB_201007095.PMC3172179.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/cb/d3/JCB_201007095.PMC3172179.pdf
"Yet, proteins fused to a single  Ub moiety were efficiently delivered to the MVB lumen,  which strongly indicates that a single Ub is sufficient in  sorting MVBs in the absence of ESCRT ubiquitination.A single ubiquitin is sufficient for cargo protein entry  into MVBs in the absence of ESCRT ubiquitination Daniel K. Stringer and Robert C. Piper Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52246 © 2011 Stringer and Piper  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/f4/cc/JCB_201008121.PMC3172180.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f4/cc/JCB_201008121.PMC3172180.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201008121/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f4/cc/JCB_201008121.PMC3172180.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f7/9e/JCB_201010013.PMC3172181.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f7/9e/JCB_201010013.PMC3172181.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6f/67/JCB_201005110.PMC3172182.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6f/67/JCB_201005110.PMC3172182.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/26/c2/JCB_201009059.PMC3172183.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/26/c2/JCB_201009059.PMC3172183.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/45/00/3277.PMC3172255.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0a/02/3289.PMC3172256.pdf
"ExPASy PRATT  pattern searches (http://web.expasy.org/pratt; Jonassen et al .,  1995) were used to comparatively evaluate multiple ciliary pro - teins in various combinations for conserved patterns, consistently  identifying related regions in both polycystins and fibrocystin.",OADS,/arxiv_data1/oa_pdf/0a/02/3289.PMC3172256.pdf
Each  vector was fully sequenced by the University of New Mexico Health  Sciences Center (UNM HSC) DNA Research Services (http://hsc.unm   .edu/som/programs/cidi/dna.shtml).,OADS,/arxiv_data1/oa_pdf/0a/02/3289.PMC3172256.pdf
DNA and protein concentrations were quantified using instrumen - tation provided by the Keck-UNM Genomics Resource (KUGR) Fa - cility (http://hsc.unm.edu/som/micro/Genomics).,OADS,/arxiv_data1/oa_pdf/0a/02/3289.PMC3172256.pdf
"Immunofluores - cence images in this paper were generated in the University of New  Mexico Cancer Center Fluorescence Microscopy Facility, supported  as detailed on the webpage: http://hsc.unm.edu/crtc/microscopy/ Facility.html.",OADS,/arxiv_data1/oa_pdf/0a/02/3289.PMC3172256.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/27/72/3306.PMC3172257.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/41/71/3318.PMC3172258.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/li - censes/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ec/36/3331.PMC3172259.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/5b/3344.PMC3172260.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f1/7f/3355.PMC3172261.pdf
Cartilage staining was performed according to Richard  Harland’s lab protocol (http://tropicalis.berkeley.edu/home/gene   _expression/cartilage-stain/alcian.html).,OADS,/arxiv_data1/oa_pdf/f1/7f/3355.PMC3172261.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/42/85/3366.PMC3172262.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/3379.PMC3172263.pdf
(http://www.affymetrix.com/support/technical/manuals.affx).,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/3379.PMC3172263.pdf
"Robust Multichip  Average (RMA) normalization and further analysis were carried out  using the Affymetrix library of procedures (Affy version 1.5.8) in  Bioconductor (version 1.5; http://www.bioconductor.org) within R  (version 2.0.1; http://www.r-project.org; Gentleman et al ., 2004).",OADS,/arxiv_data1/oa_pdf/f9/9f/3379.PMC3172263.pdf
The k-means clustering was performed  on the basis of similarity of profiles (Manhattan Distance) across  the data set using the “Super Grouper” plugin of maxdView soft - ware (available from http://bioinf.man.ac.uk/microarray/maxd/).,OADS,/arxiv_data1/oa_pdf/f9/9f/3379.PMC3172263.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5b/2e/3394.PMC3172264.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/97/6d/3410.PMC3172265.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/98/6f/3420.PMC3172266.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9b/12/3431.PMC3172267.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/78/6f/3442.PMC3172268.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/li - censes/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0c/89/3456.PMC3172269.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6f/e3/3465.PMC3172270.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/a8/3478.PMC3172271.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc- sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/30/da/3491.PMC3172272.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f1/08/3498.PMC3172273.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1b/95/3508.PMC3172274.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/39/97/3520.PMC3172275.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d7/69/3533.PMC3172276.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0e/f6/3541.PMC3172277.pdf
"3: 131-136 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.131 | Original Article | Participation of K ATP Channels in the Antinociceptive  Effect of Pregabalin in Rat Formalin Test  1Department of Anesthesiology and Pain Medicine, 2Anesthesia and Pain Research Institute,  Yonsei University College of Medicine, Seoul, Korea Tae Dong Kweon, MD1,2, Ji Young Kim, MD1,  I l  W o n  K w o n ,  M D1,  Jong Bum Choi, MD1, and Youn Woo Lee, MD1,2 Background:  Pregabalin is an anticonvulsant and analgesic agent that interacts selectively with the voltage-sensitive-Ca2＋-  channel alpha-2-delta subunit.",Non-OADS,/arxiv_data1/oa_pdf/ae/f2/kjpain-24-131.PMC3172325.pdf
"3: 137-140 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.137 | Original Article | Preemptive Use of Ketamine on Post  Operative Pain of Appendectomy Medical University of Isfahan, Trauma Research Center, Kashan University of Medical Sciences Akbar Behdad, Mehrdad Hosseinpour, and Parastoo Khorasani Background:  A l t h o u g h  e a r l y  r e v i e w s  o f  c l i n i c a l  f i n d i n g s  w e r e  m o s t l y  n e g a t i v e ,  t h e r e  i s  s t i l l  a  w i d e s p r e a d  b e l i e f  f o r  t h e   efficacy of preemptive analgesia among clinicians.",Non-OADS,/arxiv_data1/oa_pdf/b9/82/kjpain-24-137.PMC3172326.pdf
"3: 141-145 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.141 | Original Article | Estimation of Stellate Ganglion Block Injection Point Using  the Cricoid Cartilage as Landmark Through X-ray Review 1Department of Anesthesiology and Pain Medicine, 2Anesthesia and Pain Research Institute,  Yonsei University College of Medicine, 3Department of Nursing, Graduate School of Yonsei University,  4Department of Nursing, Yonsei University Severance Hospital, Seoul, Korea Jeong Soo Park, MD1,2, Ki Jun Kim, MD1,2, Youn Woo Lee, MD1,2, Duck Mi Yoon, MD1,2,  Kyung Bong Yoon, MD1,2, Min Young Han, RN3,4, and Jong Bum Choi, MD1,2 Background:  Stellate ganglion block is usually performed at the transverse process of C6, because the vertebral artery  is located anterior to the transverse process of C7.",Non-OADS,/arxiv_data1/oa_pdf/0d/4d/kjpain-24-141.PMC3172327.pdf
"3: 146-153 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.146 | Original Article | Plasma Concentrations of Morphine  during Postoperative Pain Control Department of Anesthesiology and Pain Medicine, School of Medicine, Ewha Womans University, Seoul, Korea H a h c k  S o o  P a r k ,  M D ,  J o n g  H a k  K i m ,  M D ,  Y i  J e o n g  K i m ,  M D ,  a n d  D o n g Yeon Kim, MD Background:  Morphine has been commonly used for postoperative pain control.",Non-OADS,/arxiv_data1/oa_pdf/a1/b0/kjpain-24-146.PMC3172328.pdf
"3: 154-157 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.154 | Original Article | Spinal Cord Stimulation in the Treatment of Postherpetic  Neuralgia in Patients with Chronic Kidney Disease:  A Case Series and Review of the Literature Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Busan, Korea In Yeob Baek, MD, Ju Yeon Park, MD, Hyae Jin Kim, MD, Ji Uk Yoo n, MD,  Gyeong Jo Byoen, MD, and Kyung Hoon Kim, MD Background:  Postherpetic neuralgia (PHN) is usually managed pharmacologically.",Non-OADS,/arxiv_data1/oa_pdf/0b/8e/kjpain-24-154.PMC3172329.pdf
"T4-T7 Lt. T5-T73B 4 3B4 4 44 4 43B 3B5/8  7/10 8/86/9 7/8 7/7  8/10 7/9  8/11 5/6 5/51 2 − 13 1 − 1 −− 2＋ ＋ ＋＋ − −− − −− − Stage of chronic kidney disease (CKD): Stage 1-kidney damage with normal or increased GFR (GFR ≥ 90 ml/min/1.73 m2); Stage 2-kidne y damage with mild reduction in GFR (GFR = 60 −89 ml/min/1.73 m2); Stage 3-Moderate reduction in GFR (Stage 3A: GFR = 45 −59 ml/min/1.73 m2, Stage 3B: GFR = 30 −44 ml/min/1.73 m2); Stage 4-Severe reduction in GFR (GFR = 15 −29 ml/min/1.73 m2); Stage 5-kidney failure (GFR = 15 ml/min/1.73 m2) [modified from http://www.nice.org.uk/nicemedia/live/12069/42116/42116.pdf].",Non-OADS,/arxiv_data1/oa_pdf/0b/8e/kjpain-24-154.PMC3172329.pdf
"3: 158-163 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.158 | Original Article | The Effects of Postoperative Brachial Plexus Block  Using MgSO 4 on the Postoperative Pain  after Upper Extremity Surgery Department of Anesthesiology and Pain Medicine, Kwandong University College of Medicine, Goyang, Korea In Gyu Choi, MD, Young Soon Choi, MD, Yong Ho Kim, MD, Jin Hye Min, MD, Young Keun Chae, MD,  Yong Kyung Lee, MD, So Woon Ahn, MD, Young Shin Kim, MD, and Ae rena Lee, MD Background:  Although a brachial plexus block can be used to provide anesthesia and analgesia for upper extremity surgery,  its effects using MgSO 4 on postoperative pain management have not been reported.",Non-OADS,/arxiv_data1/oa_pdf/35/99/kjpain-24-158.PMC3172330.pdf
Avaiable at http://www.ispub.com/journal/the_internet_journal_ of_anesthesiology/volume_21_number_1/article/role-of-ma gnesium-sulphate-for-brachial-plexus-analgesia.html.,Non-OADS,/arxiv_data1/oa_pdf/35/99/kjpain-24-158.PMC3172330.pdf
"3: 164-168 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.164 |C a s e  R e p o r t| Obturator Nerve Block with Botulinum Toxin Type B for  Patient with Adductor Thigh Muscle Spasm -A Case Report- Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, *Seoul National University College of Medicine, Seoul, Korea Eun Joo Choi, MD, Jong Min Byun, MD*, Francis Sahngun Nahm, MD,  and Pyung Bok Lee, MD Obturator nerve block has been commonly used for pain management to prevent involuntary reflex of the  adductor thigh muscles.",Non-OADS,/arxiv_data1/oa_pdf/bc/bb/kjpain-24-164.PMC3172331.pdf
"3: 169-171 pISSN 2005-9159  eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2011.24.3.169 |C a s e  R e p o r t| Spinal Myoclonus Developed during Cervical Epidural Drug  Infusion in Postherpetic Neuralgia Patient Department of Anesthesiology and Pain Medicine, *School of Dentistry,  School of Medicine, Kyungpook National University Hospital, Daegu, Korea Younghoon Jeon, MD*, Sung Uk Baek, MD, and Jin Seok Yeo, MD Postherpetic neuralgia is the most frequent complication of herpes zoster.",Non-OADS,/arxiv_data1/oa_pdf/42/bf/kjpain-24-169.PMC3172332.pdf
The MS analysis system was applied to identify the characteristic metabolite corresponding to the featured peak in databaseof Metlin ( http://metlin.scripps.edu )[20] and HMDB (http://www.hmdb.ca/ )[21].,OADS,/arxiv_data1/oa_pdf/da/e3/216_2011_Article_5245.PMC3172404.pdf
"5,t h e molecular ion of the metabolite at 7.358 min peaked at 282m/zand the intensity fraction peaked at 150 m/z,exhibiting a well match to the mass spectrum of 1- methyladenosine in HMDB ( http://www.hmdb.ca/ ).",OADS,/arxiv_data1/oa_pdf/da/e3/216_2011_Article_5245.PMC3172404.pdf
A vailable from: http://www.internationaldovesociety.,Non-OADS,/arxiv_data1/oa_pdf/96/1c/265_2011_Article_1210.PMC3172405.pdf
A vailable from: http://www.internationaldovesociety.,Non-OADS,/arxiv_data1/oa_pdf/96/1c/265_2011_Article_1210.PMC3172405.pdf
"Weather dataData on daily temperature and precipitation were obtained from the national meteorological station in De Bilt (52.11°N, 5.18°E; http://www.knmi.nl ).",OADS,/arxiv_data1/oa_pdf/81/d8/442_2011_Article_2007.PMC3172409.pdf
Furtherdetails can be found in the GlaxoSmithKline clinical trial register ( http:// www.gsk-clinicalstudyregister.com/ﬁles/pdf/21118.pdf andhttp://www.gsk-clinical studyregister.com/ﬁles/pdf/21117.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/5d/1a/10928_2011_Article_9210.PMC3172410.pdf
March 2010. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM202140.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/5d/1a/10928_2011_Article_9210.PMC3172410.pdf
January 2001. http://www.ema.europa.eu/pdfs/human/ich/036496en.pdf 32.,Non-OADS,/arxiv_data1/oa_pdf/5d/1a/10928_2011_Article_9210.PMC3172410.pdf
http://www.R-project.org 36.,Non-OADS,/arxiv_data1/oa_pdf/5d/1a/10928_2011_Article_9210.PMC3172410.pdf
"Seoul, October 2008. http://www.wma.net/en/ 30publications/10policies/b3/17c.pdf 40.",Non-OADS,/arxiv_data1/oa_pdf/5d/1a/10928_2011_Article_9210.PMC3172410.pdf
This antibody has been shown to display no cross-reactivity with other structurally related peptides such as human NPS that has only minor differences in amino acid sequence(http://www.bachem.com ).,Non-OADS,/arxiv_data1/oa_pdf/76/ec/726_2011_Article_1058.PMC3172411.pdf
"In addition, Tm was checked using Exiqon Tm prediction ( http://lna-tm.com/ ) and the Raw program from MRC-Holland and secondary structure wasassessed using the mfold server ( http://www.bioinfo.rpi.",OADS,/arxiv_data1/oa_pdf/ec/ec/12033_2011_Article_9389.PMC3172416.pdf
"Available from: http://www.eurofound.europa.eu/pubdocs/2006/98/en/2/ef0698en.pdf(cited: 28-07-2010) Feleus A, Bierma-Zeinstra SM, Miedema HS, Verhagen AP, Nauta AP, Burdorf A, Verhaar JA, Koes BW (2007) Prognostic indicators for non-recovery of non-traumatic complaints at arm,neck and shoulder in general practice–6 months follow-up.",Non-OADS,/arxiv_data1/oa_pdf/6f/f7/420_2011_Article_611.PMC3172420.pdf
Availablefrom: http://www.hse.gov.uk/statistics/swi/index.htm .,OADS,/arxiv_data1/oa_pdf/6f/f7/420_2011_Article_611.PMC3172420.pdf
http://cordis.europa.eu/fp6/experts.htm .,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://cordis.europa.eu/documents/ documentlibrary/66623291EN6.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://www.europarl.europa.eu/ meetdocs/2004 _2009/documents/com/com _com(2005)0705 _/ com _com(2005)0705 _en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
OFF J EU 2006/C 305/16.http://www.nsfb.net/system/storage/c _30520061214en00520053.,OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://ec.europa.eu/ research/science-society/pdf/she _figures _2006 _en.pdf .C i t e d 10 September 2010 European Commission (2007) Seventh Framework Programme (FP7).,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://cordis.europa.eu/fp7/home _en.html .,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
ftp://ftp.cordis.europa.eu/pub/fp7/docs/fp7-evrules _en.,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://ec.europa.eu/ research/evaluations/pdf/archive/fp6-evidence-base/evaluation _- studies _and _reports/ev aluation _studies _and _reports _2008/ fp6_gender _equality _report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
ftp://ftp.cordis.europa.,OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://www.bmwf.gv.at/fileadmin/user _upload/ wissenschaft/frauen/women _gender _impact _fp5_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://unstats.un.org/unsd /methods/m49/m49regin.htm .,Non-OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
http://data.worldbank.org/ indicator .,OADS,/arxiv_data1/oa_pdf/47/16/10389_2011_Article_395.PMC3172421.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use distribution,and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/28/pcr088.PMC3172567.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/4c/evr044.PMC3172574.pdf
"For human, we used SNPs discovered in low-coverage sequencing of 59 Yoruba individuals as part of the 1000 Ge-nomes Pilot Project ( The 1000 Genomes Project Consortium 2010 ), which we downloaded from ftp://ftp-trace.ncbi.nih.",Non-OADS,/arxiv_data1/oa_pdf/da/4c/evr044.PMC3172574.pdf
"2010 ), from the National Institute of Environmental Health Sciences Environmental GenomeProject ( http://egp.gs.washington.edu ), and from the Seat- tleSNPs ( http://pga.gs.washington.edu ).",Non-OADS,/arxiv_data1/oa_pdf/da/4c/evr044.PMC3172574.pdf
[Internet] Available from: http://repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/da/4c/evr044.PMC3172574.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Smaller portion sizes in worksite cafeterias WM Vermeer et al 1207 International Journal of Obesity",Non-OADS,/arxiv_data1/oa_pdf/94/81/ijo2010271a.PMC3172584.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on International Journal of Obesity website (http://www.nature.com/ijo)Native ACSs are CD34þand scattered in adipose stroma M Maumus et al 1153 International Journal of Obesity",Non-OADS,/arxiv_data1/oa_pdf/e8/d8/ijo2010269a.PMC3172585.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Decreasing Trends of Neonatal and Infant Mortality Rates   in Korea: Compared with Japan, USA, and OECD Nations Neonatal mortality rate (NMR) and infant mortality rate (IMR) are two of the most  important indices reflecting the level of public health of a country.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"Key Words:  Public health; Epidemiologic methods; Data collection; Vital statistics;  Mortality; Infant mortality; Neonatal mortality; Korea; Japan; United States; OECD;  EpidemiologyJi-Young Chang1, Kyung Suk Lee1,  Won-Ho Hahn1, Sung-Hoon Chung2,  Yong-Sung Choi2, Kye Shik Shim1  and Chong-Woo Bae1 1Department of Pediatrics, Kyung Hee University  School of Medicine, Seoul; 2Department of  Pediatrics, Kyung Hee University Graduate School  and Department of Neonatology, Asan Medical  Center, University of Ulsan College of Medicine,  Seoul, Korea Received: 29 March 201 1 Accepted: 23 May 201 1 Address for Correspondence: Chong-Woo Bae, MD Department of Pediatrics, Kyung Hee University Hospital at  Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727,  Korea  Tel: +82.2-440-6130, Fax: +82.2-440-7175 E-mail: baecw@khnmc.or.krhttp://dx.doi.org/10.3346/jkms.2011.26.9.1115   •  J Korean Med Sci 2011; 26: 1115-1123REVIEW Pediatrics INTRODUCTION Infant mortality rate (IMR) is one of the most important indices  that represent the level of economy, culture, and society, as well  as the public health of a country.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"• Neonatal and Infant Mortality Rate in Korea 1 1 16   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1115the publication of KMHW as 2007 and 2009 Yearbook of Health,  Welfare and Family Statistics were also collected for IMR and  NMR data (14, 15).",OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
• Neonatal and Infant Mortality Rate in Korea http://jkms.org   1 1 17  http://dx.doi.org/10.3346/jkms.2011.26.9.1115cial IMR data were reported to the UN and UNICEF since 1993  and recently to the OECD as well (17-20).,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"• Neonatal and Infant Mortality Rate in Korea 1 1 18   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1115COMPARISON OF KOREAN INFANT MORTALITY  RATE DATA WITH OTHER COUNTRIES  Infant mortality rates of Korea and OECD member nations By January 2011, there were a total of 33 member nations in the  OECD.",OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"• Neonatal and Infant Mortality Rate in Korea http://jkms.org   1 1 19  http://dx.doi.org/10.3346/jkms.2011.26.9.1115DISCUSSION Over the years, the KMHW of the Korean government has estab - lished nationwide programs to promote improved health care  for pregnant women, childbirth newborns, and infants (23) such  as a test for inborn error of metabolism and care for sick infants  (1991), registration of pre-term and congenital abnormal neo - nates and medical expense support (2000), early diagnosis of  deafness (2007), campaign for preventing blindness of preschool - ers (2000), prevention of maternal hepatitis B infection (2002),  nationwide neonatal intensive care unit (NICU) installation sup - port campaign (2008-2011: project for installing 130 NICU beds  in 13 hospitals nationwide), health care for pregnant women and  children (2008, provision of providing iron supplements and stan - dard mother-child health record book), project for enhancing  health of women at the childbearing age (2005), female repro - ductive health enhancement program providing information on pregnancy, delivery, infant care, breast feeding clinic, creation  of healthy maternal environment (2006), day of pregnant wom - an, pregnant woman care campaign, medical expense support  for pregnancy and delivery of teen-aged pregnant mothers (2011),  prevention of artificial abortion, visiting obstetrics and gynecol - ogy, prevention of infection and safety accidents at postnatal care  houses (2005), post-care for contraception procedure (2005),  and infertile couple support project (2006).",Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"• Neonatal and Infant Mortality Rate in Korea 1 120   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1115in the past 30 yr in the Korean medical community (25) has also  contributed to improvements of NMR and IMR, with the support  of activities conducted by related academic societies.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
• Neonatal and Infant Mortality Rate in Korea http://jkms.org   1 121  http://dx.doi.org/10.3346/jkms.2011.26.9.1115to 10.0% for IMR (39).,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"• Neonatal and Infant Mortality Rate in Korea 1 122   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1115rea, Japan, and in the USA, have been analyzed.",Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://data.un.org/Data.,OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://kostat.go.kr/wnsearch/search.jsp [accessed on 15 July  2011].,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"oecd.org/document/0,3746,en_2649_201185_46462759_1_1_1_1,00.html,  and http://www.oecd.org/dataoecd/4/36/46796773.pdf [accessed on 15  July 2011].",OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://www.who.int/healthinfo/morttables/en/index.html  [accessed on 15 July 2011].,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
• Neonatal and Infant Mortality Rate in Korea http://jkms.org   1 123  http://dx.doi.org/10.3346/jkms.2011.26.9.1115ty rate.,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://www.mhlw.go.jp/english/database/db-hw/ report/3.html [accessed on 15 July 2011].,OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available  at http://www.indexmundi.com/united_states/infant_mortality_rate.,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://kostat.go.kr/wnsearch/search.jsp [ac - cessed on 15 July 2011].,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://nrn.shiga-med.,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at https://neonatal.rti.org/ [ac - cessed on June 2011].,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://www.vtoxford.org/ [accessed  on June 2011].,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at http://www.cdc.gov/nchs/nhis.htm [ac - cessed on 15 July 2011].,OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
Available at https://www.cms.gov/chipra/ [accessed on 15 July 2011].,Non-OADS,/arxiv_data1/oa_pdf/52/6a/jkms-26-1115.PMC3172646.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Factors Associated with Sleep Duration in Korean Adults: Results  of a 2008 Community Health Survey in Gwangju Metropolitan  City, Korea Short (≤ 6 hr) and long (≥ 9 hr) sleep durations are both associated with risk factors for  cardiovascular diseases and diabetes, depression, learning problems, accidents and excess  mortality.",Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
"Key Words:  Sleep; Health Behavior; Socioeconomic FactorsSo Yeon Ryu, Ki Soon Kim   and Mi Ah Han Department of Preventive Medicine, Chosun  University Medical School, Gwangju, Korea Received: 24 January 201 1 Accepted: 21 July 201 1 Address for Correspondence: So Yeon Ryu, MD Department of Preventive Medicine, Chosun University Medical  School, 309 Pilmundaero, Dong-gu, Gwangju 501-759, Korea  Tel: +82.62-230-6483, Fax: +82.62-225-8293  E-mail: canrsy@chosun.ac.kr  This study was supported by research fund from Chosun  University, 2010.http://dx.doi.org/10.3346/jkms.2011.26.9.1124   •  J Korean Med Sci 2011; 26: 1124-1131ORIGINAL ARTICLE Occupation & Environmental Medicine INTRODUCTION Both short (≤ 6 hr) and long (≥ 9 hr) sleep duration have been  reported to be associated with increased risks of morbidity and  mortality (1).",Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
"• Factors Associated Sleep Duration in Some Korean Adults http://jkms.org   1 125  http://dx.doi.org/10.3346/jkms.2011.26.9.1124associations of short and long sleep duration with demograph - ic, socio-economic, behavioral, and health characteristics using  data from a community health survey conducted in five districts  in Gwangju Metropolitan City in 2008.",OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
• Factors Associated Sleep Duration in Some Korean Adults 1 126   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1124RESULTS A total of 37.2% of the subjects had short sleep and 4.0% had  long sleep.,Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
"• Factors Associated Sleep Duration in Some Korean Adults http://jkms.org   1 127  http://dx.doi.org/10.3346/jkms.2011.26.9.1124(1.35-7.92) in those with no formal education, 1.61 (0.74-3.51)  with elementary school, 2.42 (1.13-5.20) with middle school, and  1.27 (0.83-1.97) with high school.",Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
• Factors Associated Sleep Duration in Some Korean Adults 1 128   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1124pression were all associated with greater odds of short sleep.,Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
"• Factors Associated Sleep Duration in Some Korean Adults http://jkms.org   1 129  http://dx.doi.org/10.3346/jkms.2011.26.9.1124the odds ratios for short and long sleep increased significantly,  indicating that emotional instability affected both sleep quality  and duration.",Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
"• Factors Associated Sleep Duration in Some Korean Adults 1 130   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1124ation of underweight with long sleep was reported in a previous  study targeting Americans (7), but no detailed explanation was  provided.",Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
"• Factors Associated Sleep Duration in Some Korean Adults http://jkms.org   1 131  http://dx.doi.org/10.3346/jkms.2011.26.9.1124AUTHOR SUMMARY Factors Associated with Sleep Duration in Korean Adults: Results of a 2008  Community Health Survey in Gwangju Metropolitan City, Korea So Yeon Ryu, Ki Soon Kim and Mi Ah Han This study examined sleep patterns in 4,41 1 Korean adults and identified factors associated with short and long sleep durations.",Non-OADS,/arxiv_data1/oa_pdf/68/23/jkms-26-1124.PMC3172647.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Measurement of Interleukin-33 (IL-33) and IL-33 Receptors   (sST2 and ST2L) in Patients with Rheumatoid Arthritis The interleukin-33 (IL-33)/ST2 pathway has emerged as an intercellular signaling system  that participates in antigen–allergen response, autoimmunity and fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
"Received: 29 January 201 1 Accepted: 24 June 201 1 Address for Correspondence: Jun-Ki Min, MD Division of Rheumatology, Department of Internal Medicine,  Bucheon St. Mary’s Hospital, The Catholic University of Korea,  2-5 Sosa-ro, Wonmi-gu, Bucheon 414-717, Korea Tel: +82.32-340-7016, Fax: +82.32-340-2669 E-mail: rmin6403@hanmail.nethttp://dx.doi.org/10.3346/jkms.2011.26.9.1132   •  J Korean Med Sci 2011; 26: 1132-1139ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Interleukin-33 (IL-33) is a member of the IL-1 family, which in - cludes IL-1 α, IL-1β, IL-1 receptor antagonist, and IL-18.",Non-OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
"• IL-33 and IL-33 Receptor in RA http://jkms.org   1 133  http://dx.doi.org/10.3346/jkms.2011.26.9.1132liferative disease, and autoimmune diseases such as systemic  lupus erythematosus (SLE), progressive systemic sclerosis, We - gener’s granulomatosis, and Behçet’s disease.",Non-OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
"• IL-33 and IL-33 Receptor in RA 1 134   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1132Ethic statement The study protocol was approved by the institutional review  board of The Catholic University of Korea (HCMC08OT006) and  Soonchunhyang University, and signed informed consent was  obtained from each patient.RESULTS Baseline demographic and clinical characteristics The clinical and serological characteristics of the patients are  described in Table 1.",OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
• IL-33 and IL-33 Receptor in RA http://jkms.org   1 135  http://dx.doi.org/10.3346/jkms.2011.26.9.1132healthy controls but that were significantly lower in patients with  OA than RA.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
"• IL-33 and IL-33 Receptor in RA 1 136   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1132widely used to ascertain the degree of inflammatory response,  we also measured the serum level of CRP .",OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
• IL-33 and IL-33 Receptor in RA http://jkms.org   1 137  http://dx.doi.org/10.3346/jkms.2011.26.9.1132and McMaster Universities (WOMAC) for OA.,OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
• IL-33 and IL-33 Receptor in RA 1 138   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1132biologically active.,OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
• IL-33 and IL-33 Receptor in RA http://jkms.org   1 139  http://dx.doi.org/10.3346/jkms.2011.26.9.1132and maintains endotoxin tolerance.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/jkms-26-1132.PMC3172648.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Prevalence of Knee Pain and Its Influence on Quality of Life and  Physical Function in the Korean Elderly Population: A Community  Based Cross-Sectional Study To investigate the prevalence of knee pain and its influence on physical function and  quality of life (QOL), we examined 504 community residents of Chuncheon, aged ≥ 50 yr.  Demographic information was obtained by questionnaire, and radiographic evaluations  consisted of weight-bearing semi-flexed knee anteroposterior radiographs.",Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
"Key Words:  Knee Pain; Osteoarthritis; Quality of LifeIn Je Kim1, Hyun Ah Kim1,2, Young-Il Seo1,  Young Ok Jung1, Yeong Wook Song3,  Jin Young Jeong4 and Dong Hyun Kim4,5 1Department of Internal Medicine, Hallym University  Sacred Heart Hospital, Anyang; 2Institute for  Skeletal Aging, Hallym University, Chuncheon;  3Department of Internal Medicine, Seoul National  University Hospital, Seoul; 4Hallym Research  Institute of Clinical Epidemiology, Hallym University,  Chuncheon; 5Department of Social and Preventive  Medicine, Hallym University, Chuncheon, Korea  Received: 7 February 201 1 Accepted: 21 July 201 1 Address for Correspondence: Hyun Ah Kim, MD Division of Rheumatology, Department of Internal Medicine,  Hallym University Sacred Heart Hospital, 170 Gwanpyong-ro,  Dongan-gu, Anyang 431-070, Korea Tel: +82.31-380-1826, Fax: +82.31-386-2269 E-mail: kimha@hallym.ac.kr This work was supported by a grant from Korea Research  Foundation (KRF-2007-41 1-J01902), the Ministry of Education  and Human Resources Development and a grant from the Korea  Health 21 R & D Project, Ministry of Health and Welfare  (01-PJ3-PG6-01GN1 1-0002), funded by (MOEHRD), Korea.http://dx.doi.org/10.3346/jkms.2011.26.9.1140   •  J Korean Med Sci 2011; 26: 1140-1146ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Knee pain is a common musculoskeletal problem in elderly, and  its prevalence increases with age (1).",Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
• Knee Pain in the Elderly Community Residents of Korea http://jkms.org   1 141  http://dx.doi.org/10.3346/jkms.2011.26.9.114070% of the study cohort.,Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
• Knee Pain in the Elderly Community Residents of Korea 1 142   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1140Ethics statement This study was approved by the institutional review board of the  Hallym University School of Medicine (IRB approval number:  HIRB-2007-001).,Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
• Knee Pain in the Elderly Community Residents of Korea http://jkms.org   1 143  http://dx.doi.org/10.3346/jkms.2011.26.9.1140 The mean scores for the SF-12 items are shown in Table 4.,Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
• Knee Pain in the Elderly Community Residents of Korea 1 144   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1140vs 13.40 sec in men vs women).,Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
"• Knee Pain in the Elderly Community Residents of Korea http://jkms.org   1 145  http://dx.doi.org/10.3346/jkms.2011.26.9.1140factors including economic or education level, physical activity,  muscle strength, pain coping skills, and social support may ac - count for gender difference in functional status and QOL mea - sures (3, 7, 26-29).",Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
Available  at http://www.kosis.kr/index.html [ accessed 11 Jul 2007].,Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
"• Knee Pain in the Elderly Community Residents of Korea 1 146   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1140MC, Kent Kwoh C. The association of osteoarthritis risk factors with local - ized, regional and diffuse knee pain.",Non-OADS,/arxiv_data1/oa_pdf/bd/14/jkms-26-1140.PMC3172649.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Serum Procalcitonin for Differentiating Bacterial Infection from  Disease Flares in Patients with Autoimmune Diseases Early differentiation between bacterial infections and disease flares in autoimmune disease  patients is important due to different treatments.",Non-OADS,/arxiv_data1/oa_pdf/af/90/jkms-26-1147.PMC3172650.pdf
"Key Words:  Procalcitonin; Autoimmune Diseases; C-reactive Protein; Bacterial Infections Kowoon Joo, Won Park, Mie-Jin Lim,   Seong-Ryul Kwon and Jiyeol Yoon Division of Rheumatology, Department of Internal  Medicine, Inha University Hospital, Incheon, Korea Received: 10 February 201 1 Accepted: 1 July 201 1 Address for Correspondence: Won Park, MD Division of Rheumatology, Department of Internal Medicine,  Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon   400-71 1, Korea Tel: +82.32-890-221 1, Fax: +82.32-890-2237 E-mail: parkwon@inha.ac.kr This work was supported by Inha University Research Grant  201 1.http://dx.doi.org/10.3346/jkms.2011.26.9.1147   •  J Korean Med Sci 2011; 26: 1147-1151ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Early differentiation between bacterial infections and disease  flares in patients with autoimmune disease is important due to  different treatment modalities.",Non-OADS,/arxiv_data1/oa_pdf/af/90/jkms-26-1147.PMC3172650.pdf
"• Procalcitonin in Autoimmune Diseases 1 148   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1147MATERIALS AND METHODS Subjects  The serum PCT and CRP levels were measured in 79 patients  (23 males and 56 females) with underlying autoimmune disease  (adult-onset Still’s disease [AOSD], n = 3; ankylosing spondylitis  [AS], n = 9; Behcet’s disease [BD], n = 8; microscopic polyangitis  [MPA], n = 1; polyarteritis nodosa [PAN], n = 1; rheumatoid ar - thritis [RA], n = 33; Sjogren’s disease [SD], n = 2; systemic lupus  erythematosus [SLE], n = 16; systemic sclerosis [SSc], n = 5; We - gener’s granulomatosis [WG], n = 1) who were admitted to the  university hospital between September 2009 and September  2010.",Non-OADS,/arxiv_data1/oa_pdf/af/90/jkms-26-1147.PMC3172650.pdf
• Procalcitonin in Autoimmune Diseases http://jkms.org   1 149  http://dx.doi.org/10.3346/jkms.2011.26.9.1147(Table 1).,Non-OADS,/arxiv_data1/oa_pdf/af/90/jkms-26-1147.PMC3172650.pdf
• Procalcitonin in Autoimmune Diseases 1 150   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1147ly differentiated from disease flares.,Non-OADS,/arxiv_data1/oa_pdf/af/90/jkms-26-1147.PMC3172650.pdf
"• Procalcitonin in Autoimmune Diseases http://jkms.org   1 151  http://dx.doi.org/10.3346/jkms.2011.26.9.1147AUTHOR SUMMARY Serum Procalcitonin for Differentiating Bacterial Infection from Disease Flares   in Patients with Autoimmune Diseases Kowoon Joo, Won Park, Mie-Jin Lim, Seong-Ryul Kwon and Jiyeol Yoon Early differentiation between bacterial infection and disease flares in autoimmune disease patients is important due to conflicting  treatments.",Non-OADS,/arxiv_data1/oa_pdf/af/90/jkms-26-1147.PMC3172650.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Natural Course of Cow’s Milk Allergy in Children with Atopic  Dermatitis Cow’s milk is one of the most common food allergens in children with atopic dermatitis  (AD).",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
"Key Words:  Milk; Food Hypersensitivity; Immunoglobulin E; PrognosisJungmin Suh1, Hyeonyoung Lee1,  Jung Hyun Lee1, Joongbum Cho2,  Jung-Seok Yu1, Jihyun Kim1,  Youngshin Han1, Kangmo Ahn1  and Sang-Il Lee1 1Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Environmental Health Center for Atopic Diseases,  Seoul; 2Department of Pediatrics, Korea Cancer  Center Hospital, Seoul, Korea Received: 14 March 201 1 Accepted: 1 July 201 1 Address for Correspondence: Kangmo Ahn, MD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-3530, Fax: +82.2-3410-0043 E-mail: kmaped@skku.eduhttp://dx.doi.org/10.3346/jkms.2011.26.9.1152   •  J Korean Med Sci 2011; 26: 1152-1158ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Atopic dermatitis (AD), which is a common allergic disease that  often develops during infancy, is a chronic inflammatory skin  disease that occurs concurrently with severe itching.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
• Natural Course of Cow’s Milk Allergy http://jkms.org   1 153  http://dx.doi.org/10.3346/jkms.2011.26.9.1152followed for at least 24 months in the outpatient clinic.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
• Natural Course of Cow’s Milk Allergy 1 154   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1152lution of cow’s milk allergy in patients with AD within the first  24 months after birth is presented in Fig.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
"• Natural Course of Cow’s Milk Allergy http://jkms.org   1 155  http://dx.doi.org/10.3346/jkms.2011.26.9.1152milk was higher in patients without a family history of allergic  disease than in patients with a family history of allergic disease  (HR, 0.41; 95% CI, 0.22-0.78).",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
"• Natural Course of Cow’s Milk Allergy 1 156   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1152contrast, the level of cow’s milk-specific IgE was shown to in - crease and remain high as the age of the patients who had per - sistent cow’s milk allergy increased.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
"• Natural Course of Cow’s Milk Allergy http://jkms.org   1 157  http://dx.doi.org/10.3346/jkms.2011.26.9.1152double-blind, placebo-controlled food challenge test (DBPCFC),  the gold standard for the diagnosis of food allergy, was not per - formed to confirm cow’s milk allergy.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
"• Natural Course of Cow’s Milk Allergy 1 158   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1152AUTHOR SUMMARY Natural Course of Cow’s Milk Allergy in Children with Atopic Dermatitis Jungmin Suh, Hyeonyoung Lee, Jung Hyun Lee, Joongbum Cho, Jung-Seok Yu, Jihyun Kim, Youngshin Han, Kangmo Ahn   and Sang-Il Lee Cow’s milk is one of the most common foods to cause allergy in children with atopic dermatitis (AD).",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/jkms-26-1152.PMC3172651.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Safety of Accelerated Schedules of Subcutaneous Allergen  Immunotherapy with House Dust Mite Extract in Patients with  Atopic Dermatitis The safety of accelerated schedules of allergen immunotherapy (ASAI) in patients with  bronchial asthma (BA) has been reported but there are little data on the safety of ASAI for  patients with atopic dermatitis (AD).",Non-OADS,/arxiv_data1/oa_pdf/0a/bc/jkms-26-1159.PMC3172652.pdf
"Key Words:  Allergens; Desensitization; Dermatitis, Atopic; Bronchial Asthma; Adverse  Effects; Dermatophagoides; Pyroglyphidae Myoung-Eun Kim, Jeong-Eun Kim,   Joon-Mo Sung, Jin-Woo Lee,   Gil-Soon Choi and Dong-Ho Nahm Department of Allergy and Clinical Immunology,  Ajou University Hospital, Suwon, Korea Received: 15 April 201 1 Accepted: 17 July 201 1 Address for Correspondence: Dong-Ho Nahm, MD Department of Allergy and Clinical Immunology, Ajou University  Hospital, 164 Worldcup-ro, Yeongtong-gu, Suwon 443-721,  Korea Tel: +82.31-219-5150, Fax: +82.31-219-5154 E-mail: donghonahm@yahoo.co.kr This study was supported by a grant of the Korean Health  Technology R&D Project, Ministry for Health, Welfare & Family  Affairs, Republic of Korea (A102065).http://dx.doi.org/10.3346/jkms.2011.26.9.1159   •  J Korean Med Sci 2011; 26: 1159-1164ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Allergen immunotherapy is a treatment of administering grad - ually increasing doses of allergen in order to decrease a hyper - sensitivity to the allergen and thereby reduce clinical symptoms  from exposure to the allergen (1).",Non-OADS,/arxiv_data1/oa_pdf/0a/bc/jkms-26-1159.PMC3172652.pdf
• Safety of Rush Immunotherapy for Atopic Dermatitis  1 160   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1159These evidences strongly suggest an important pathogenic role  of allergic responses to HDM in patients with AD and hypersen - sitivity to HDM.,Non-OADS,/arxiv_data1/oa_pdf/0a/bc/jkms-26-1159.PMC3172652.pdf
• Safety of Rush Immunotherapy for Atopic Dermatitis  http://jkms.org   1 161  http://dx.doi.org/10.3346/jkms.2011.26.9.1159performed using three different protocols according to the in - jection intervals and the maximum allergen doses of HDM ex - tract (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/0a/bc/jkms-26-1159.PMC3172652.pdf
• Safety of Rush Immunotherapy for Atopic Dermatitis  1 162   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1159for bronchospasm.,Non-OADS,/arxiv_data1/oa_pdf/0a/bc/jkms-26-1159.PMC3172652.pdf
• Safety of Rush Immunotherapy for Atopic Dermatitis  http://jkms.org   1 163  http://dx.doi.org/10.3346/jkms.2011.26.9.1159than 2.82% in patients with AR without AD (17).,Non-OADS,/arxiv_data1/oa_pdf/0a/bc/jkms-26-1159.PMC3172652.pdf
"• Safety of Rush Immunotherapy for Atopic Dermatitis  1 164   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1159Guidelines of care for atopic dermatitis, developed in accordance with  the American Academy of Dermatology (AAD)/American Academy of  Dermatology Association “ Administrative Regulations for Evidence-Based  Clinical Practice Guidelines” .",Non-OADS,/arxiv_data1/oa_pdf/0a/bc/jkms-26-1159.PMC3172652.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Sensitization to Aeroallergens in Korean Children: A Population- based Study in 2010  We performed this study to assess the prevalence of sensitization to aeroallergens and to  analyze the difference between prevalence rates according to children’s ages and residential  areas.",Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
"Key Words:  Skin Tests; Child; Dermatophagoides pteronyssinus ; Dermatophagoides  farinaeJihyun Kim1,2, Myung-Il Hahm3,  So-Yeon Lee4, Woo Kyung Kim5,  Yoomi Chae6, Yong Mean Park7,  Man Yong Han8, Kee-Jae Lee9,  Ho-Jang Kwon10, Jin-A Jung1 1,  Su Young Kim12 and Kangmo Ahn1,2 1Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul;  2Environmental Health Center for Atopic Diseases,  Samsung Medical Center, Seoul; 3Department of  Health Administration and Management, College of  Medical Science, Soonchunhyang University, Asan;  4Department of Pediatrics, Hallym Sacred Heart  Hospital, Hallym University College of Medicine,  Anyang; 5Department of Pediatrics, Inje University  College of Medicine, Seoul; 6Department of  Occupational and Environmental Medicine, College  of Medicine, Dankook University, Cheonan;  7Department of Pediatrics, Konkuk University  Hospital, Konkuk University School of Medicine,  Seoul; 8Department of Pediatrics, CHA University  School of Medicine, Seongnam; 9Department of  Information and Statistics, Korea National Open  University, Seoul; 10Department of Preventive  Medicine, Dankook University College of Medicine,  Cheonan; 1 1Department of Pediatrics, Dong-A  University College of Medicine, Busan; 12Department  of Preventive Medicine, College of Medicine, Cheju  National University, Jeju, Korea Received: 2 June 201 1 Accepted: 1 August 201 1 Address for Correspondence: Kangmo Ahn, MD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University, 81 Irwon-ro, Gangnam-gu, Seoul  135-710, Korea Tel: +82.2-3410-3530, Fax: +82.2-3410-0043 E-mail: kmaped@skku.edu This research was supported by a fund (2010E3303400) by  Research of Korea Centers for Disease Control and Prevention.http://dx.doi.org/10.3346/jkms.2011.26.9.1165   •  J Korean Med Sci 2011; 26: 1165-1172ORIGINAL ARTICLE Immunology, Allergic Disorders & Rheumatology INTRODUCTION Skin prick testing (SPT) is the standard method to assess IgE- mediated sensitization to inhalant allergens (1).",Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
• Sensitization to Aeroallergen in Children 1 166   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1165most frequent allergens were not definitely shown in a study by  Jung et al.,Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
• Sensitization to Aeroallergen in Children http://jkms.org   1 167  http://dx.doi.org/10.3346/jkms.2011.26.9.1165cedure of SAS version 9.1 was applied to estimating the differ - ences of positive SPT by age and gender and to estimating the  tests for trend for the area of residence.,Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
• Sensitization to Aeroallergen in Children 1 168   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1165children at 12 to 13 yr of age compared to those at 6 to 7 yr of  age.,Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
"• Sensitization to Aeroallergen in Children http://jkms.org   1 169  http://dx.doi.org/10.3346/jkms.2011.26.9.1165class with a monthly income of 4,000,000-5,990,000 Korean won  showed the second-highest sensitization rate in this age group.",Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
"• Sensitization to Aeroallergen in Children 1 170   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1165ferences such as pollen distribution, temperature, and humidi - ty plays an important role.",Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
"• Sensitization to Aeroallergen in Children http://jkms.org   1 171  http://dx.doi.org/10.3346/jkms.2011.26.9.1165from ours, it would be interesting to note whether this trend  might be observed in the general population.",Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
• Sensitization to Aeroallergen in Children 1 172   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.116517.,Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
Available at http://imd.krei.re.kr:8888/pdf/pdfsource/89417p.,Non-OADS,/arxiv_data1/oa_pdf/c4/e3/jkms-26-1165.PMC3172653.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Prevalence of Asymptomatic Carotid Stenosis in Korea Based   on Health Screening Population We attempted to investigate the prevalence and risk factors of carotid artery stenosis in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/jkms-26-1173.PMC3172654.pdf
"Key Words:  Carotid arteries; Stenosis; PrevalenceYoung-Nam Roh1, Shin-Young Woo1,  Nari Kim1, Seonwoo Kim2,  Young-Wook Kim1 and Dong-Ik Kim1 1Division of Vascular Surgery, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul; 2Biostatistics Team, Samsung  Biomedical Research Institute, Seoul, Korea Received: 12 April 201 1 Accepted: 14 July 201 1 Address for Correspondence: Dong-Ik Kim, MD Division of Vascular Surgery, Samsung Medical Center,   81 Irwon-ro, Kangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-3467, Fax: +82.2-3410-0040 E-mail: dikim@skku.eduhttp://dx.doi.org/10.3346/jkms.2011.26.9.1173   •  J Korean Med Sci 2011; 26: 1173-1177ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Internal carotid artery (ICA) atherosclerotic stenosis is responsi - ble for a significant proportion of transient ischemic attacks (TIA)  and approximately 30% of ischemic strokes (1).",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/jkms-26-1173.PMC3172654.pdf
"• Prevalence of Asymptomatic Carotid Stenosis 1 174   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1173the clinical variables (hypertension, diabetes mellitus, ischemic  heart disease, total cholesterol, HDL-cholesterol, LDL-choles - terol, HbA-1c).",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/jkms-26-1173.PMC3172654.pdf
• Prevalence of Asymptomatic Carotid Stenosis http://jkms.org   1 175  http://dx.doi.org/10.3346/jkms.2011.26.9.1173to approximate.,Non-OADS,/arxiv_data1/oa_pdf/7d/ab/jkms-26-1173.PMC3172654.pdf
"• Prevalence of Asymptomatic Carotid Stenosis 1 176   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1173didates, then stroke can be prevented in 2 patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/jkms-26-1173.PMC3172654.pdf
"• Prevalence of Asymptomatic Carotid Stenosis http://jkms.org   1 177  http://dx.doi.org/10.3346/jkms.2011.26.9.1173AUTHOR SUMMARY Prevalence of Asymptomatic Carotid Stenosis in Korea Based on Health Screening  Population Young-Nam Roh, Shin-Young Woo, Nari Kim, Seonwoo Kim, Young-Wook Kim and Dong-Ik Kim Carotid artery (CA) stenosis is responsible for a significant proportion of ischemic attacks in brain.",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/jkms-26-1173.PMC3172654.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 A Novel Biomarker of Coronary Atherosclerosis: Serum DKK1  Concentration Correlates with Coronary Artery Calcification and  Atherosclerotic Plaques DKK1 modulates Wnt signaling, which is involved in the atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
"Key Words:  Dickkopf-1; Atherosclerosis; Vascular calcification; BiomarkerKwang-Il Kim1, Kyoung Un Park2,  Eun Ju Chun3, Sang Il Choi3,  Young-Seok Cho1, Tae-Jin Youn1,  Goo-Yeong Cho1, In-Ho Chae1,  Junghan Song2, Dong-Ju Choi1  and Cheol-Ho Kim1 Departments of 1Internal Medicine, 2Laboratory  Medicine and 3Radiology, Seoul National University  College of Medicine, Bundang Hospital, Seongnam,  Korea Received: 25 April 201 1 Accepted: 14 July 201 1 Address for Correspondence: Cheol-Ho Kim, MD Department of Internal Medicine, Seoul National University  College of Medicine Bundang Hospital, 166 Gumi-ro,   Bundang-gu, Seongnam 463-707, Korea Tel: +82.31-787-7001, Fax: +82.31-787-4052 E-mail: cheolkim@snu.ac.kr This work was supported by the Korea Research Foundation  Grant, funded by the Korean Government (MOEHRD, Basic  Research Promotion Fund) (KRF-2008-331-E00106) and by the  Basic Science Research Program through the National Research  Foundation of Korea (NRF), funded by the Ministry of Education,  Science and Technology (2009-0063258).http://dx.doi.org/10.3346/jkms.2011.26.9.1178   •  J Korean Med Sci 2011; 26: 1178-1184ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION Coronary artery calcium is a marker of subclinical coronary ath - erosclerotic disease and predicts coronary events.",Non-OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
"• DKK1- A Novel Biomarker of Coronary Atherosclerosis http://jkms.org   1 179  http://dx.doi.org/10.3346/jkms.2011.26.9.1178DKK1 expression was observed within advanced carotid plaques,  suggesting that a DKK1-driven inflammatory loop could be op - erating within the atherosclerotic lesion (11).",Non-OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
• DKK1- A Novel Biomarker of Coronary Atherosclerosis 1 180   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1178or DKK1.,Non-OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
"• DKK1- A Novel Biomarker of Coronary Atherosclerosis http://jkms.org   1 181  http://dx.doi.org/10.3346/jkms.2011.26.9.1178183.2] pg/mL in patients without plaque, with non-calcified  plaque, and with mixed or calcified plaque, respectively) ( P =  0.01) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
"• DKK1- A Novel Biomarker of Coronary Atherosclerosis 1 182   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1178 For the prediction of coronary atherosclerotic plaques, im - provement in discrimination compared with the model with con - ventional risk factors was observed with inclusion of CACS ( c- statistic = 0.735) in the model and with DKK1 ( c-statistic = 0.717).",OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
• DKK1- A Novel Biomarker of Coronary Atherosclerosis http://jkms.org   1 183  http://dx.doi.org/10.3346/jkms.2011.26.9.1178characteristic curve analysis) but DKK1 ≥ 68.6 pg/mL showed a  similar probability of having coronary atherosclerotic plaque as  patients with high CACS (Agatston CS ≥ 154.1) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
• DKK1- A Novel Biomarker of Coronary Atherosclerosis 1 184   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.11788.,Non-OADS,/arxiv_data1/oa_pdf/93/3d/jkms-26-1178.PMC3172655.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Non-Dipper Status and Left Ventricular Hypertrophy as Predictors  of Incident Chronic Kidney Disease  We have hypothesized that non-dipper status and left ventricular hypertrophy (LVH) are  associated with the development of chronic kidney disease (CKD) in non-diabetic  hypertensive patients.",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/jkms-26-1185.PMC3172656.pdf
"Received: 22 April 201 1 Accepted: 1 July 201 1 Address for Correspondence: Dong-Ryeol Ryu, MD Department of Internal Medicine, School of Medicine, Ewha  Womans University, 204 Anyangcheon-gil, Yangcheon-gu, Seoul  158-710, Korea Tel: +82.2-2650-2507, Fax: +82.2-2650-2505 E-mail: drryu@ewha.ac.krhttp://dx.doi.org/10.3346/jkms.2011.26.9.1185   •  J Korean Med Sci 2011; 26: 1185-1190ORIGINAL ARTICLE Nephrology INTRODUCTION Chronic kidney disease (CKD) is emerging as a worldwide public  health problem because of the rising prevalence and incidence.",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/jkms-26-1185.PMC3172656.pdf
• Non-Dipper and LVH as Predictors of Incident CKD 1 186   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1185of nocturnal BP or LVH is associated with the development of  CKD in hypertensive patients with preserved renal function.,Non-OADS,/arxiv_data1/oa_pdf/f4/b3/jkms-26-1185.PMC3172656.pdf
• Non-Dipper and LVH as Predictors of Incident CKD http://jkms.org   1 187  http://dx.doi.org/10.3346/jkms.2011.26.9.1185classified as non-dippers.,OADS,/arxiv_data1/oa_pdf/f4/b3/jkms-26-1185.PMC3172656.pdf
• Non-Dipper and LVH as Predictors of Incident CKD 1 188   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1185CKD and without CKD.,OADS,/arxiv_data1/oa_pdf/f4/b3/jkms-26-1185.PMC3172656.pdf
"• Non-Dipper and LVH as Predictors of Incident CKD http://jkms.org   1 189  http://dx.doi.org/10.3346/jkms.2011.26.9.1185 In addition, dyslipidemia is thought to be a risk factor for the  development of CKD.",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/jkms-26-1185.PMC3172656.pdf
"• Non-Dipper and LVH as Predictors of Incident CKD 1 190   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1185AUTHOR SUMMARY Non-Dipper Status and Left Ventricular Hypertrophy as Predictors of Incident  Chronic Kidney Disease  Hye Rim An, Sungha Park, Tae-Hyun Yoo, Shin-Wook Kang, Jung-Hwa Ryu, Yong Kyu Lee, Mina Yu, Dong-Ryeol Ryu,   Seung Jung Kim, Duk-Hee Kang and Kyu Bok Choi  Although hypertension exacerbates all forms of chronic kidney disease (CKD), it is still unclear whether mild-to-moderate essential  hypertension is an initiator of kidney damage.",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/jkms-26-1185.PMC3172656.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Expression of X-linked Inhibitor of Apoptosis Protein   in Neoplastic Thyroid Disorder X-linked inhibitor of apoptosis protein (XIAP) is associated with tumor genesis, growth,  progression and metastasis, and acts by blocking caspase-mediated apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
"Key Words:  X-linked Inhibitor of Apoptosis Protein; Papillary Thyroid Carcinoma; Thyroid  Neoplasms; Lymph Nodes; Metastasis Ji Hye Yim1, Jong Ho Yoon2, Sun A Kim3,  Won Gu Kim1, Min Ji Jeon1, Ji Min Han1, Tae Yon Sung2, Tae Yong Kim1,  Won Bae Kim1, Suck Joon Hong2,  Young Kee Shong1 and Gyungyub Gong3 Departments of 1Internal Medicine, 2Surgery and  3Pathology, Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea Received: 16 March 201 1 Accepted: 28 July 201 1 Address for Correspondence: Jong Ho Yoon, MD Department of Surgery, Asan Medical Center, University of Ulsan  College of Medicine, 88 Olymphic-ro 43-gil, Songpa-gu, Seoul  138-736, Korea Tel: +82.2-3010-3931, Fax: +82.2-3010-6962 E-mail: jjong126@paran.com This study was supported by a grant (2010-475) from the Asan  Institute for Life Sciences, Seoul, Korea.http://dx.doi.org/10.3346/jkms.2011.26.9.1191   •  J Korean Med Sci 2011; 26: 1191-1195ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism INTRODUCTION X-linked inhibitor of apoptosis protein (XIAP) is a member of  the Inhibitor of Apoptosis (IAP) protein family that selectively  binds and inhibits caspases-3, -7, and -9.",Non-OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
• XIAP in Thyroid Disorder 1 192   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1191classification of thyroid tumors.,Non-OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
"R ver - sion 2.11.1 and R libraries car and Cairo were used to analyze  data (R Foundation for Statistical Computing, Vienna, Austria,  http://www.R-project.org) (11).",OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
"• XIAP in Thyroid Disorder http://jkms.org   1 193  http://dx.doi.org/10.3346/jkms.2011.26.9.1191(14%) patients were in the N0 stage, 20 (56%) in the N1a stage  and 11 (33%) in the N1b stage.",Non-OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
• XIAP in Thyroid Disorder 1 194   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1191larger scale is needed to evaluate the diagnostic value of XIAP  expression in these diseases.,Non-OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
Available at http://www.R-project.org [accessed on Dec 5 2007].,Non-OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
"• XIAP in Thyroid Disorder http://jkms.org   1 195  http://dx.doi.org/10.3346/jkms.2011.26.9.1191AUTHOR SUMMARY Expression of X-linked Inhibitor of Apoptosis Protein in Neoplastic Thyroid Disorder Ji Hye Yim, Jong Ho Yoon, Sun A Kim, Won Gu Kim, Min Ji Jeon, Ji Min Han, Tae Yon Sung, Tae Yong Kim, Won Bae Kim,   Suck Joon Hong, Young Kee Shong and Gyungyub Gong X-linked inhibitor of apoptosis protein (XIAP) is associated with tumor genesis, growth, progression and metastasis by blocking  caspase-mediated apopotosis.",Non-OADS,/arxiv_data1/oa_pdf/66/b9/jkms-26-1191.PMC3172657.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Korean Type 2 Diabetes Patients have Multiple Adenomatous  Polyps Compared to Non-diabetic Controls We tested the correlation between diabetes and aggressiveness of colorectal polyps in  diabetic patients and matched non-diabetic controls.",Non-OADS,/arxiv_data1/oa_pdf/94/96/jkms-26-1196.PMC3172658.pdf
"Key Words:  Diabetes Mellitus; Colonic Polyps; Colorectal NeoplasmsSunghwan Suh1, Mira Kang2,  Mi Yeon Kim1, Hye Soo Chung1,  Soo Kyoung Kim1, Kyu Yeon Hur1,  Jae Hyeon Kim1, Myung-Shik Lee1,  Moon Kyu Lee1 and Kwang-Won Kim1 1Division of Endocrinology and Metabolism,  Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul; 2Center for Health Promotion, Samsung  Medical Center, Seoul, Korea  Received: 25 April 201 1 Accepted: 2 August 201 1 Address for Correspondence: Kwang-Won Kim, MD Division of Endocrinology and Metabolism, Department of  Medicine, Samsung Medical Center, Sungkyunkwan University  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710,  Korea  Tel: +82.2-3410-3430, Fax: +82.2-3410-3849 E-mail: kw1234@skku.eduhttp://dx.doi.org/10.3346/jkms.2011.26.9.1196   •  J Korean Med Sci 2011; 26: 1196-1200ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism INTRODUCTION Diabetes mellitus (DM) is a serious and growing health problem  worldwide and is associated with severe acute and chronic com - plications.",Non-OADS,/arxiv_data1/oa_pdf/94/96/jkms-26-1196.PMC3172658.pdf
• T2DM Predicts Multiplicity in Colon Polyps http://jkms.org   1 197  http://dx.doi.org/10.3346/jkms.2011.26.9.1196lowing reason.,OADS,/arxiv_data1/oa_pdf/94/96/jkms-26-1196.PMC3172658.pdf
• T2DM Predicts Multiplicity in Colon Polyps 1 198   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1196Diabetic and non-diabetic groups with colon polyps Baseline characteristics of 495 matched non-diabetic control  subjects with colon polyp are shown in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/94/96/jkms-26-1196.PMC3172658.pdf
• T2DM Predicts Multiplicity in Colon Polyps http://jkms.org   1 199  http://dx.doi.org/10.3346/jkms.2011.26.9.1196groups.,OADS,/arxiv_data1/oa_pdf/94/96/jkms-26-1196.PMC3172658.pdf
• T2DM Predicts Multiplicity in Colon Polyps 1200   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.11962.,OADS,/arxiv_data1/oa_pdf/94/96/jkms-26-1196.PMC3172658.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Association between Dietary Patterns and Blood Lipid Profiles   in Korean Adults with Type 2 Diabetes We aimed to explore the associations of dietary patterns with blood lipid profiles and  obesity in adults with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
"None of the authors have conflicts of  interest to disclose.http://dx.doi.org/10.3346/jkms.2011.26.9.1201   •  J Korean Med Sci 2011; 26: 1201-1208ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism INTRODUCTION Diabetes has emerged as an important social issue worldwide,  particularly in Asian countries (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
"• Dietary Patterns among Type 2 Diabetes 1202   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1201 Recently, several studies on dietary patterns and diabetes  have been reported.",Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
"• Dietary Patterns among Type 2 Diabetes http://jkms.org   1203  http://dx.doi.org/10.3346/jkms.2011.26.9.1201rice, other grains, noodles, and bread.",Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
"• Dietary Patterns among Type 2 Diabetes 1204   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1201 Regarding diabetes treatment and management, the mean  duration of diabetes was 8.5 yr in this population, and the pro -portion of subjects who received anti-diabetic treatment was  61.2% and subjects with A1C less than 6.5% was 30.9%.",Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
"• Dietary Patterns among Type 2 Diabetes http://jkms.org   1205  http://dx.doi.org/10.3346/jkms.2011.26.9.1201est quartile in the ‘Bread & Meat & Alcohol’ pattern, those in the  highest quartile were more likely to be younger and have a higher  level of education and household income.",Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
• Dietary Patterns among Type 2 Diabetes 1206   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1201those in the lowest quartile.,Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
• Dietary Patterns among Type 2 Diabetes http://jkms.org   1207  http://dx.doi.org/10.3346/jkms.2011.26.9.1201‘Korean Healthy’ pattern had favorable effects on blood lipid  profiles by lowering serum cholesterol and triglycerides.,Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
• Dietary Patterns among Type 2 Diabetes 1208   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1201tion to plasma insulin levels and risk of type 2 diabetes in women.,Non-OADS,/arxiv_data1/oa_pdf/2d/40/jkms-26-1201.PMC3172659.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Influence of Diaphragmatic Mobility on Hypercapnia in Patients  with Chronic Obstructive Pulmonary Disease A reduction in diaphragm mobility has been identified in patients with chronic obstructive  pulmonary disease (COPD) and has been associated with a decline in pulmonary function  parameters.",Non-OADS,/arxiv_data1/oa_pdf/d5/1e/jkms-26-1209.PMC3172660.pdf
"Key Words:  Pulmonary Disease, Chronic Obstructive;  Diaphragm mobility ; Hypercapnia ;  UltrasonographyHyun Wook Kang, Tae Ok Kim,   Bo Ram Lee, Jin Yeong Yu, Su Young Chi,  Hee Jung Ban, In Jae Oh, Kyu Sik Kim,   Yong Soo Kwon, Yu Il Kim,   Young Chul Kim and Sung Chul Lim Department of Internal Medicine, Chonnam National  University Hospital, Gwangju, Korea Received: 16 May 201 1 Accepted: 17 July 201 1 Address for Correspondence: Sung Chul Lim, MD Department of Internal Medicine, Chonnam National University  Hospital, 671 Jaebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: +82.62-220-6570, Fax: +82.62-225-8578 E-mail: lscmd@jnu.ac.kr This work was supported by the Chonnam National University  Hospital Research Institute of Clinical Medicine Grant  CRI09047-1.http://dx.doi.org/10.3346/jkms.2011.26.9.1209   •  J Korean Med Sci 2011; 26: 1209-1213ORIGINAL ARTICLE Respiratory Diseases INTRODUCTION Chronic obstructive pulmonary disease (COPD) is character - ized by airflow limitation that is not fully reversible and abnor - mal inflammatory response of the lungs to noxious particles or  gases (1).",Non-OADS,/arxiv_data1/oa_pdf/d5/1e/jkms-26-1209.PMC3172660.pdf
"• Diaphragmatic Mobility on Hypercapnia in COPD 1210   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1209American Thoracic Society (ATS) guidelines (1), were recruited  from January to December 2010 in the study.",Non-OADS,/arxiv_data1/oa_pdf/d5/1e/jkms-26-1209.PMC3172660.pdf
"• Diaphragmatic Mobility on Hypercapnia in COPD http://jkms.org   121 1  http://dx.doi.org/10.3346/jkms.2011.26.9.1209yr, and the mean BMI was 21.2 ± 4.1 kg/m2.",OADS,/arxiv_data1/oa_pdf/d5/1e/jkms-26-1209.PMC3172660.pdf
• Diaphragmatic Mobility on Hypercapnia in COPD 1212   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1209Rapid and shallow breathing in patients with COPD is the con - sequence of an excessive load imposed on the inspiratory mus - cles.,Non-OADS,/arxiv_data1/oa_pdf/d5/1e/jkms-26-1209.PMC3172660.pdf
"• Diaphragmatic Mobility on Hypercapnia in COPD http://jkms.org   1213  http://dx.doi.org/10.3346/jkms.2011.26.9.1209AUTHOR SUMMARY Influence of Diaphragmatic Mobility on Hypercapnia in Patients with Chronic  Obstructive Pulmonary Disease Hyun Wook Kang, Tae Ok Kim, Bo Ram Lee, Jin Yeong Yu, Su Young Chi, Hee Jung Ban, In Jae Oh, Kyu Sik Kim, Yong Soo Kwon,   Yu Il Kim, Young Chul Kim and Sung Chul Lim A reduction in diaphragm mobility has been identified in patients with chronic obstructive pulmonary disease (COPD) and has been  associated with a decline in pulmonary function parameters.",Non-OADS,/arxiv_data1/oa_pdf/d5/1e/jkms-26-1209.PMC3172660.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Clinical Characteristics of a Nationwide Hospital-based Registry of  Mild-to-Moderate Alzheimer’s Disease Patients in Korea: A CREDOS  (Clinical Research Center for Dementia of South Korea) Study  With rapid population aging, the socioeconomic burden caused by dementia care is  snowballing.",Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
http://dx.doi.org/10.3346/jkms.2011.26.9.1219   •  J Korean Med Sci 2011; 26: 1219-1226ORIGINAL ARTICLE Neuroscience,Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
• Clinical Characteristics of Alzheimer’s Disease in Korea  1220   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1219INTRODUCTION Alzheimer’s disease (AD) is the most common cause of demen - tia and accounts for 60%-70% of all dementias.,Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
"• Clinical Characteristics of Alzheimer’s Disease in Korea  http://jkms.org   1221  http://dx.doi.org/10.3346/jkms.2011.26.9.1219included; 1) history of cognitive decline from the caregiver (the  onset time was based on the time stated by the caregiver), 2) Ko - rean version of Mini-Mental State Examination (K-MMSE) (8),  3) CDR (7), 4) Global Deterioration Scale (GDS) (9), 5) Hachin - ski ischemia scale (HIS), 6) neurological examinations, and 7)  Geriatric depression scale (GDS-d) (10).",Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
• Clinical Characteristics of Alzheimer’s Disease in Korea  1222   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1219were 424 (23.7%) patients who had BMI of 25 or greater.,Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
"• Clinical Characteristics of Alzheimer’s Disease in Korea  http://jkms.org   1223  http://dx.doi.org/10.3346/jkms.2011.26.9.1219apathy (49.6%), irritability (42.0%), and anxiety (41.35%) were  common among the patients with neuropsychiatric problems  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
• Clinical Characteristics of Alzheimer’s Disease in Korea  1224   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1219could provide another important consideration in the policy- making process.,Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
• Clinical Characteristics of Alzheimer’s Disease in Korea  http://jkms.org   1225  http://dx.doi.org/10.3346/jkms.2011.26.9.12192.,Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
"• Clinical Characteristics of Alzheimer’s Disease in Korea  1226   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1219AUTHOR SUMMARY Clinical Characteristics of a Nationwide Hospital-based Registry of Mild-to-Moderate  Alzheimer’s Disease Patients in Korea: A CREDOS (Clinical Research Center for  Dementia of South Korea) Study  Hee Kyung Park, Duk L. Na, Seol-Heui Han, Ji-Young Kim, Hae-Kwan Cheong, Seong Yoon Kim, Sang Yun Kim, Chang Hyung Hong,   Do-Kwan Kim, Bon D. Ku, So Young Moon, Jun-Young Lee, Yong S. Shim, Young Chul Youn, Eun-Joo Kim, Beoung-Chae Kim,   Kee Hyung Park, Kyung R. Cha, Sang Won Seo and Jae-Hong Lee This nationwide study shows the demographics and clinical characteristics of mild-to-moderate Alzheimer’s disease (AD) patients  from the Clinical Research Center for Dementia of South Korea (CREDOS) cohort.",Non-OADS,/arxiv_data1/oa_pdf/4e/79/jkms-26-1219.PMC3172661.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Carpal Tunnel Syndrome and Peripheral Polyneuropathy   in Patients with End Stage Kidney Disease  This study was designed to identify the causes of the development of carpal tunnel  syndrome (CTS) associated with end stage kidney disease (ESKD).",Non-OADS,/arxiv_data1/oa_pdf/75/6c/jkms-26-1227.PMC3172662.pdf
"Key Words:  Uremia; Carpal Tunnel Syndrome; Electrodiagnosis; Amyloidosis; Arteriovenous  Fistula Hee-Kyu Kwon1, Sung-Bom Pyun1,  Won Yong Cho2 and Chang Su Boo2 Departments of 1Physical Medicine and  Rehabilitation, and 2Nephrology, Korea University  College of Medicine, Seoul, Korea Received: 24 January 201 1 Accepted: 14 July 201 1 Address for Correspondence: Hee-Kyu Kwon, MD Department of Physical medicine and Rehabilitation, Korea  University Anam Hospital, 73 Inchon-ro, Sungbuk-gu, Seoul  136-705, Korea Tel: +82.2-920-6480, Fax: +82.2-929-9951 E-mail: hkkwon@korea.ac.krhttp://dx.doi.org/10.3346/jkms.2011.26.9.1227   •  J Korean Med Sci 2011; 26: 1227-1230ORIGINAL ARTICLE Neuroscience INTRODUCTION Neuropathy is a common complication of end stage kidney dis - ease (ESKD), typically presenting with a distal symmetric pat - tern with greater involvement of the lower extremities compared  to the upper extremities (1).",Non-OADS,/arxiv_data1/oa_pdf/75/6c/jkms-26-1227.PMC3172662.pdf
"• Carpal Tunnel Syndrome in End Stage Kidney Disease 1228   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1227ness of lateral four fingers, pain and stiffness of the hands were  assessed.",Non-OADS,/arxiv_data1/oa_pdf/75/6c/jkms-26-1227.PMC3172662.pdf
• Carpal Tunnel Syndrome in End Stage Kidney Disease http://jkms.org   1229  http://dx.doi.org/10.3346/jkms.2011.26.9.1227DISCUSSION The development of uremic neuropathy has been related previ - ously to the retention of neurotoxic molecules in the middle mo - lecular range.,Non-OADS,/arxiv_data1/oa_pdf/75/6c/jkms-26-1227.PMC3172662.pdf
"• Carpal Tunnel Syndrome in End Stage Kidney Disease 1230   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1227AUTHOR SUMMARY Carpal Tunnel Syndrome and Peripheral Polyneuropathy in Patients with End Stage  Kidney Disease  Hee-Kyu Kwon, Sung-Bom Pyun, Won Yong Cho and Chang Su Boo Neuropathy is a common complication of end stage kidney disease (ESKD), and carpal tunnel syndrome (CTS) is most common.",Non-OADS,/arxiv_data1/oa_pdf/75/6c/jkms-26-1227.PMC3172662.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Clinical and Immunological Responses in Ocular Demodecosis The purpose of this study was to investigate clinical and immunological responses to  Demodex  on the ocular surface.",Non-OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
"http://dx.doi.org/10.3346/jkms.2011.26.9.1231   •  J Korean Med Sci 2011; 26: 1231-1237ORIGINAL ARTICLE Ophthalmology INTRODUCTION Demodex (class Arachnida, superorder Acariformes) is an elon - gated ectoparasite found on the human body surface including  the face, cheeks, forehead, nose, and eyelids (1).",Non-OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
• Clinical and Immunological Responses in Ocular Demodecosis 1232   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1231Microscopic Demodex  examination Ocular demodecosis was confirmed by microscopic examina - tion of epilated lashes following the method described by Gao  et al.,Non-OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
• Clinical and Immunological Responses in Ocular Demodecosis http://jkms.org   1233  http://dx.doi.org/10.3346/jkms.2011.26.9.1231RESULTS Ocular surface manifestations and Demodex count Demodex was found in all patients (Fig.,OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
"• Clinical and Immunological Responses in Ocular Demodecosis 1234   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1231orders including herpetic stromal keratitis, atopic keratoconjunc - tivitis, allergic conjunctivitis, and severe dry eye.",Non-OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
• Clinical and Immunological Responses in Ocular Demodecosis http://jkms.org   1235  http://dx.doi.org/10.3346/jkms.2011.26.9.1231 A  C  B D  F  E Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
• Clinical and Immunological Responses in Ocular Demodecosis 1236   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.12312002; 82: 3-6.,Non-OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
"• Clinical and Immunological Responses in Ocular Demodecosis http://jkms.org   1237  http://dx.doi.org/10.3346/jkms.2011.26.9.1231AUTHOR SUMMARY Clinical and Immunological Responses in Ocular Demodecosis Jae Hoon Kim, Yeoun Sook Chun and Jae Chan Kim Demodex  is thought to be associated with blepharitis, allergic conjunctivitis, and pathological corneal features on the ocular  surface.",Non-OADS,/arxiv_data1/oa_pdf/04/48/jkms-26-1231.PMC3172663.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 A Case of Exercise-induced Acute Renal Failure with G774A  Mutation in SCL22A12 Causing Renal Hypouricemia Acute renal failure with severe loin pain which develops after anaerobic exercise is rare.",Non-OADS,/arxiv_data1/oa_pdf/4c/db/jkms-26-1238.PMC3172664.pdf
"Key Words:  Acute Kidney Injury; Renal Hypouricemia; MutationYong Hyun Kim and Jong Tae Cho Department of Internal Medicine, College of Medicine,  Dankook University, Cheonan, Korea Received: 24 March 201 1 Accepted: 1 July 201 1 Address for Correspondence: Jong Tae Cho, MD Department of Internal Medicine, College of Medicine, Dankook  University, 359 Manghyang-ro, Dongnam-gu, Cheonan   330-714, Korea Tel: +82.41-550-3925, Fax: +82.41-556-3256 E-mail: jtcho@dankook.ac.krhttp://dx.doi.org/10.3346/jkms.2011.26.9.1238   •  J Korean Med Sci 2011; 26: 1238-1240CASE REPORT Nephrology INTRODUCTION Exercise-induced acute renal failure (ARF) usually reflects mas - sive rhabdomyolysis.",Non-OADS,/arxiv_data1/oa_pdf/4c/db/jkms-26-1238.PMC3172664.pdf
"• Exercise-induced Acute Renal Failure with Renal Hypouricemia http://jkms.org   1239  http://dx.doi.org/10.3346/jkms.2011.26.9.1238of admission, he was discharged with the improvement of renal  function (BUN 17.1 mg/dL, serum creatinine 1.14 mg/dL).",Non-OADS,/arxiv_data1/oa_pdf/4c/db/jkms-26-1238.PMC3172664.pdf
• Exercise-induced Acute Renal Failure with Renal Hypouricemia 1240   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.12385.,Non-OADS,/arxiv_data1/oa_pdf/4c/db/jkms-26-1238.PMC3172664.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Intraperitoneally Placed Foley Catheter via Verumontanum  Initially Presenting as a Bladder Rupture Since urethral Foley catheterization is usually easy and safe, serious complications related  to this procedure have been rarely reported.",Non-OADS,/arxiv_data1/oa_pdf/15/a6/jkms-26-1241.PMC3172665.pdf
"Key Words:  Urethral Catheter; Complication; Bladder Perforation; IntraperitonealOmer A Raheem1 and Young Beom Jeong2 1Department of Surgery, Division of Urology,  University of California San Diego, California, United  States; 2Department of Urology, Chonbuk National  University Medical School and Research Institute of  Clinical Medicine, Jeonju, Korea Received: 20 May 201 1 Accepted: 14 July 201 1 Address for Correspondence: Young Beom Jeong, MD Department of Urology, Chonbuk National University Medical  School, 20 Geongi-ro, Deokjin-gu, Jeonju 561-182, Korea Tel: +82.63-250-191 1, Fax: +82.63-250-1564 E-mail: ybjeong@jbnu.ac.kr This paper was supported by research funds of Chonbuk  National University in 2010.http://dx.doi.org/10.3346/jkms.2011.26.9.1241   •  J Korean Med Sci 2011; 26: 1241-1243CASE REPORT Urology INTRODUCTION Urethral catheterization is one of the most commonly performed  procedures in healthcare settings worldwide, with more than 5  million urinary catheterization in the United States in the year  2000 alone (1).",Non-OADS,/arxiv_data1/oa_pdf/15/a6/jkms-26-1241.PMC3172665.pdf
• Intraperitoneally Placed Foley Catheter via Verumontanum 1242   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1241the entire catheter.,Non-OADS,/arxiv_data1/oa_pdf/15/a6/jkms-26-1241.PMC3172665.pdf
• Intraperitoneally Placed Foley Catheter via Verumontanum http://jkms.org   1243  http://dx.doi.org/10.3346/jkms.2011.26.9.1241sonnel who intent to perform this procedure in the future.,Non-OADS,/arxiv_data1/oa_pdf/15/a6/jkms-26-1241.PMC3172665.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Dopa-responsive Dystonia with a Novel Initiation Codon  Mutation in the  GCH1  Gene Misdiagnosed as Cerebral Palsy Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by childhood-onset  dystonia and a dramatic response to relatively low doses of levodopa.",Non-OADS,/arxiv_data1/oa_pdf/52/ec/jkms-26-1244.PMC3172666.pdf
"Key Words:  Dystonia, Dopa-responsive; GCH1  Gene; Mutation; Cerebral Palsy; Diagnostic  ErrorsJae-Hyeok Lee1, Chang-Seok Ki2,  Dae-Seong Kim1, Jae-Wook Cho1,  Kyung-Phil Park1 and Seonhye Kim1 1Department of Neurology, Research Institute for  Convergence of Biomedical Science and Technology,  Pusan National University Yangsan Hospital,  Yangsan; 2Department of Laboratory Medicine and  Genetics, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea Received: 23 March 201 1 Accepted: 19 July 201 1 Address for Correspondence: Chang-Seok Ki, MD Department of Laboratory Medicine and Genetics, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-2709, Fax: +82.2-3410-2719 E-mail: changski@skku.eduhttp://dx.doi.org/10.3346/jkms.2011.26.9.1244   •  J Korean Med Sci 2011; 26: 1244-1246CASE REPORT Neuroscience INTRODUCTION  Dopa-responsive dystonia (DRD) is a progressive primary dys - tonia that is characterized by onset during childhood, circadian  fluctuation of symptoms and a dramatic and sustained response  to low doses of oral administration of levodopa (1).",Non-OADS,/arxiv_data1/oa_pdf/52/ec/jkms-26-1244.PMC3172666.pdf
"• GCH1-related Dopa-responsive Dystonia Misdiagnosed as Cerebral Palsy  http://jkms.org   1245  http://dx.doi.org/10.3346/jkms.2011.26.9.1244DISCUSSION DRD-causing mutations in GCH1 include point mutations, small  insertions, deletions and whole exon deletions (2, 11).",Non-OADS,/arxiv_data1/oa_pdf/52/ec/jkms-26-1244.PMC3172666.pdf
• GCH1-related Dopa-responsive Dystonia Misdiagnosed as Cerebral Palsy  1246   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1244REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/52/ec/jkms-26-1244.PMC3172666.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 The First Case of Postpartum Acquired Hemophilia A in Korea Acquired hemophilia A (AHA) is a rare coagulopathy caused by autoantibodies to  coagulation factor VIII (FVIII).",Non-OADS,/arxiv_data1/oa_pdf/09/44/jkms-26-1247.PMC3172667.pdf
"Key Words:  Acquired hemophilia A; Postpartum; Factor VIII inhibitor; KoreaJi Hyun Lee1, Dong-Hwan Kim2,  Kiyoung Yoo3, Yongmook Choi3,  Sun-Hee Kim1 and Hee-Jin Kim1 Departments of 1Laboratory Medicine & Genetics  and 2Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul; 3Korea Hemophilia Foundation, Seoul, Korea Received: 17 March 201 1 Accepted: 5 July 201 1 Address for Correspondence: Hee-Jin Kim, MD Department of Laboratory Medicine & Genetics, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Ilwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-2710, Fax: +82.2-3410-2719 E-mail: heejinkim@skku.edu This study was supported by a grant from the Korea Food &  Drug Administration (KFDA).http://dx.doi.org/10.3346/jkms.2011.26.9.1247   •  J Korean Med Sci 2011; 26: 1247-1249CASE REPORT Laboratory Medicine INTRODUCTION Acquired hemophilia A (AHA) is a rare acquired coagulopathy  caused by autoantibodies to coagulation factor VIII (FVIII) (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/09/44/jkms-26-1247.PMC3172667.pdf
"• Postpartum Acquired Hemophilia A 1248   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1247Tests for anti-phospholipid Ab revealed negative results for anti- cardiolipin Abs and anti-beta 2 glycoprotein I Abs, while lupus  anticoagulant (LA) tests were positive (PTT-LA 138.1 sec and  Staclot LA 20.4 sec).",Non-OADS,/arxiv_data1/oa_pdf/09/44/jkms-26-1247.PMC3172667.pdf
• Postpartum Acquired Hemophilia A http://jkms.org   1249  http://dx.doi.org/10.3346/jkms.2011.26.9.1247tality of postpartum AHA.,Non-OADS,/arxiv_data1/oa_pdf/09/44/jkms-26-1247.PMC3172667.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 http://dx.doi.org/10.3346/jkms.2011.26.9.1250   •  J Korean Med Sci 2011; 26: 1250CORRESPONDENCE Letter to the Editor The Supernumerary Phantom Limb and Phantom Limb   Pain-Important Facts Srijit Das   Department of Anatomy, Faculty of Medicine, University Kebangsaan Malaysia, Jalan Raja Muda Abd Aziz, 53000, Kuala Lumpur, Malaysia I read with much interest the article titled ‘ Atypical supernumer - ary phantom limb and phantom limb pain in two patients with  pontine haemorrhage’ by Seung Don Yoo et al.",Non-OADS,/arxiv_data1/oa_pdf/53/67/jkms-26-1250.PMC3172668.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 http://dx.doi.org/10.3346/jkms.2011.26.9.1251   •  J Korean Med Sci 2011; 26: 1251-1252CORRESPONDENCE The Author Response The Supernumerary Phantom Limb and Phantom Limb Pain   in Stroke: Localization and Management Concerns Seung Don Yoo and Jihea Bark Department of Physical Medicine & Rehabilitation, Kyung Hee University College of Medicine, Seoul, Korea The supernumerary phantom limb is the problem of perception  of body scheme (1), and phantom limb pain is one type of cen - tral pain, defined as central neuropathic pain caused by lesions  or dysfunction in the central nervous system (brain, brainstem,  and spinal cord) (2).",Non-OADS,/arxiv_data1/oa_pdf/37/7f/jkms-26-1251.PMC3172669.pdf
Correspondence: The Author Response 1252   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1251tom limb and phantom limb pain in two patients with pontine hemor - rhage.,Non-OADS,/arxiv_data1/oa_pdf/37/7f/jkms-26-1251.PMC3172669.pdf
"This draft version was developed on the basis of existing reportingguidelines, namely STREGA,11REMARK,13and STARD.12These were selected out of all available guidelines (see http://www.equator-network.org) because of their focus on observational study designs and genetic factors (STREGA), prediction models (REMARK), and test evaluation (REMARK and STARD).",OADS,/arxiv_data1/oa_pdf/72/60/ejhg201125a.PMC3172920.pdf
"Subsequently, the 95% conﬁdenceintervals (CIs) of the observed versus expected ratios were calculated using the open source program OpenEpi version 2.3 (http://www.openepi.com).",OADS,/arxiv_data1/oa_pdf/ff/94/ejhg201137a.PMC3172922.pdf
"To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Cancer risk in patients with a PTPN11 mutation MCJ Jongmans et al 874 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/ff/94/ejhg201137a.PMC3172922.pdf
Annotation of meta-analysis resultswas performed with WGA viewer version 1.26E (Dongliang Ge and David B Goldstein; http://people.genome .duke.edu/~dg48/WGAViewer/).,OADS,/arxiv_data1/oa_pdf/bb/d4/ejhg201148a.PMC3172930.pdf
Relationships between genes (emerging from the meta-analysis) and migraine were studied using the Anni text-mining program (Anni version 2.1; http://www.biosemantics.org/anni).36For details see the Supplementary data.,OADS,/arxiv_data1/oa_pdf/bb/d4/ejhg201148a.PMC3172930.pdf
"The infrastructure for the NESDAstudy (http://www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (ZonMw, Grant number 10-000-1002) and is supported by participating universities andmental health care organizations (VU University Medical Center, GGZ inGeest,Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientiﬁc Institute for Quality of Health Care (IQ Healthcare), Netherlands Institutefor Health Services Research (NIVEL) and Netherlands Institute of MentalHealth and Addiction (Trimbos)).",Non-OADS,/arxiv_data1/oa_pdf/bb/d4/ejhg201148a.PMC3172930.pdf
"To view a copy of this licence, visit http:// creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)GWA meta-analysis for migraine L Ligthart et al 907 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/bb/d4/ejhg201148a.PMC3172930.pdf
"GETPrimeprimers have been extensively validated experimentally, demonstrating high transcript specificity in complex samples.Thus, the free-access, user-friendly GETPrime database allows fast primer retrieval and visualization for genes or groups of genes of most common model organisms, and is available at http://updepla1srv1.epfl.ch/getprime/.",OADS,/arxiv_data1/oa_pdf/69/0a/bar040.PMC3173022.pdf
Database URL: http://deplanckelab.epfl.ch.,OADS,/arxiv_data1/oa_pdf/69/0a/bar040.PMC3173022.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/0a/bar040.PMC3173022.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Figs.,Non-OADS,/arxiv_data1/oa_pdf/25/67/zbc31512.PMC3173086.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Figs.,Non-OADS,/arxiv_data1/oa_pdf/b7/ae/zbc31557.PMC3173108.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Figs.,Non-OADS,/arxiv_data1/oa_pdf/db/1b/zbc31565.PMC3173129.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Fig.,Non-OADS,/arxiv_data1/oa_pdf/b0/19/zbc32502.PMC3173165.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Tables 1 and 2 and Figs.,Non-OADS,/arxiv_data1/oa_pdf/ba/0e/zbc32834.PMC3173180.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1 and Fig.,Non-OADS,/arxiv_data1/oa_pdf/f1/60/zbc32513.PMC3173193.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1 .,Non-OADS,/arxiv_data1/oa_pdf/41/0d/zbc32684.PMC3173194.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Figs.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/zbc32533.PMC3173197.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1–S3 and Figs.,Non-OADS,/arxiv_data1/oa_pdf/f6/fb/zbc32617.PMC3173205.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Figs.,Non-OADS,/arxiv_data1/oa_pdf/f8/b9/zbc32586.PMC3173206.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental Figs.,Non-OADS,/arxiv_data1/oa_pdf/b6/af/zbc31993.PMC3173209.pdf
□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental materials .,Non-OADS,/arxiv_data1/oa_pdf/b9/bf/zbc32026.PMC3173223.pdf
"The atomic coordinates and structure factors (code 3ZQS) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics,Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).",OADS,/arxiv_data1/oa_pdf/67/32/zbc32628.PMC3173227.pdf
"□SThe on-line version of this article (available at http://www.jbc.org) contains supplemental “Experimental Procedures,” “Results,” Figs.",Non-OADS,/arxiv_data1/oa_pdf/33/3c/zbc32638.PMC3173232.pdf
"The atomic coordinates and structure factors (code 3SR2) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics,Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).",OADS,/arxiv_data1/oa_pdf/33/3c/zbc32638.PMC3173232.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/da/c0/JEM_20101558.PMC3173238.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20101558/DC1.,Non-OADS,/arxiv_data1/oa_pdf/da/c0/JEM_20101558.PMC3173238.pdf
: godfrey@unimelb.edu.au;   OR   J.R.: jamie.rossjohn@monash.eduNew ways to turn on NKT cells Dale Ian Godfrey and Jamie Rossjohn © 2011 Godfrey and Rossjohn  This article is distributed under the  terms of an Attribution–Noncommercial–Share Alike–No Mirror  Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c2/93/JEM_20110983.PMC3173239.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/45/fb/JEM_20110308.PMC3173240.pdf
Online  supplemental material is available at http://www.jem.org/cgi/content/full/   jem.20110308/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/45/fb/JEM_20110308.PMC3173240.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d1/99/JEM_20102177.PMC3173241.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9f/58/JEM_20101712.PMC3173242.pdf
"After six months it  is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/9f/58/JEM_20101712.PMC3173242.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3a/cf/JEM_20101823.PMC3173243.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20101823/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3a/cf/JEM_20101823.PMC3173243.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6e/80/JEM_20102477.PMC3173244.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/6e/80/JEM_20102477.PMC3173244.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20102477/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/80/JEM_20102477.PMC3173244.pdf
This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/26/f2/JEM_20101947.PMC3173246.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a5/4f/JEM_20102630.PMC3173247.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3a/eb/JEM_20102538.PMC3173248.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months   after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6c/27/JEM_20102551.PMC3173249.pdf
"After six months   it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/6c/27/JEM_20102551.PMC3173249.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20102551/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6c/27/JEM_20102551.PMC3173249.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/21/69/JEM_20101874.PMC3173250.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/21/69/JEM_20101874.PMC3173250.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20101874/DC1.,Non-OADS,/arxiv_data1/oa_pdf/21/69/JEM_20101874.PMC3173250.pdf
"6  1229-1242 www.jem.org/cgi/doi/10.1084/jem.20101880To date, 400 clinical trials concern acute  ischemic stroke, of which >270 are considered  to be complete (http://www.strokecenter.org/ trials).",Non-OADS,/arxiv_data1/oa_pdf/3c/dc/JEM_20101880.PMC3173251.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3c/dc/JEM_20101880.PMC3173251.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/3c/dc/JEM_20101880.PMC3173251.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20102555/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3c/dc/JEM_20101880.PMC3173251.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8f/01/JEM_20102419.PMC3173253.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20102419/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8f/01/JEM_20102419.PMC3173253.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/af/6d/JEM_20101751.PMC3173254.pdf
Online supplemental material is a available at  http://www.jem.org/cgi/content/full/jem.20101751/DC1.,Non-OADS,/arxiv_data1/oa_pdf/af/6d/JEM_20101751.PMC3173254.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the   publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3c/de/JEM_20102555.PMC3173255.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Un - ported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/3c/de/JEM_20102555.PMC3173255.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20102555/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3c/de/JEM_20102555.PMC3173255.pdf
This article is distributed under the terms of an At - tribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4a/fd/JEM_20102229.PMC3173256.pdf
"All rights reserved.This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/licen-ses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/a5/jir512.PMC3173506.pdf
"Networks were then submitted to Hub ObjectsAnalyser ( http://hub.iis.sinica.edu.tw/Hubba/ )[16]t oi d e n t i f y hub proteins (network nodes that are the most highly connected to other DE genes), bottleneck proteins (network nodes that are 1238 dJID 2011:204 (15 October) dSchreiber et al",OADS,/arxiv_data1/oa_pdf/e1/a5/jir512.PMC3173506.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Prostate Size Correlates with Fasting Blood Glucose in Non- Diabetic Benign Prostatic Hyperplasia Patients with Normal  Testosterone Levels  We evaluated the correlations between BMI, fasting glucose, insulin, testosterone level,  insulin resistance, and prostate size in non-diabetic benign prostatic hyperplasia (BPH)  patients with normal testosterone levels.",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/jkms-26-1214.PMC3173509.pdf
"This research was also supported  by the Basic Science Research Program through the National  Research Foundation of Korea (NRF), which is funded by the  Ministry of Education, Science and Technology (2010-0001730).http://dx.doi.org/10.3346/jkms.2011.26.9.1214   •  J Korean Med Sci 2011; 26: 1214-1218ORIGINAL ARTICLE Urology INTRODUCTION Benign prostatic hyperplasia (BPH) is the most common pros - tate disease, characterized by nonmalignant enlargement of  the prostate gland in aging men.",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/jkms-26-1214.PMC3173509.pdf
• Association between Prostate Size and Fasting Glucose Level http://jkms.org   1215  http://dx.doi.org/10.3346/jkms.2011.26.9.1214opment of BPH in non-DM men.,Non-OADS,/arxiv_data1/oa_pdf/f7/ed/jkms-26-1214.PMC3173509.pdf
"• Association between Prostate Size and Fasting Glucose Level 1216   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1214size, PSA, or fasting glucose.",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/jkms-26-1214.PMC3173509.pdf
"• Association between Prostate Size and Fasting Glucose Level http://jkms.org   1217  http://dx.doi.org/10.3346/jkms.2011.26.9.1214dependent, higher testosterone levels do not necessarily result  in enhanced prostate growth (25).",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/jkms-26-1214.PMC3173509.pdf
• Association between Prostate Size and Fasting Glucose Level 1218   http://jkms.org  http://dx.doi.org/10.3346/jkms.2011.26.9.1214abetologia 1985; 28: 412-9.,Non-OADS,/arxiv_data1/oa_pdf/f7/ed/jkms-26-1214.PMC3173509.pdf
Pathogenic alleles at over 100 loci have been linked to hearing deficits in humans ( http://webh01.ua.ac.,Non-OADS,/arxiv_data1/oa_pdf/73/ea/10162_2011_Article_270.PMC3173551.pdf
Available at:  http://www.diabetes.org/diabetes-basics/diabetes-   statistics/?utm_source=WWW&utm_medium= DropDownDB&utm_content=Statistics&utm_campaign=CON.,Non-OADS,/arxiv_data1/oa_pdf/99/8a/13300_2011_Article_4.PMC3173594.pdf
Available at: http://www.novo-pi.com/victoza.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/f7/13300_2011_Article_5.PMC3173595.pdf
Available at: http://diabetes.niddk.nih.gov/dm/pubs/statistics/.,Non-OADS,/arxiv_data1/oa_pdf/be/4f/13300_2011_Article_6.PMC3173597.pdf
Available at: http://www.diabetesatlas.org/.,Non-OADS,/arxiv_data1/oa_pdf/26/e6/13300_2011_Article_3.PMC3173598.pdf
Available at: http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/26/e6/13300_2011_Article_3.PMC3173598.pdf
Avail- able from: https://www.kngfrichtlijnen.nl/612/Richtlijnen.htm .,Non-OADS,/arxiv_data1/oa_pdf/56/a6/10926_2010_Article_9271.PMC3173611.pdf
Available from: http://statline.cbs.nl/Stat Web.html .,OADS,/arxiv_data1/oa_pdf/f7/f3/10926_2010_Article_9274.PMC3173614.pdf
Available from: http://www.scp.nl/onderzoek/statusscores/ .,Non-OADS,/arxiv_data1/oa_pdf/f7/f3/10926_2010_Article_9274.PMC3173614.pdf
Available from: http://www.cbs.nl/nl-NL/ menu/methoden/classiﬁcaties/overzicht/sbc/default.htm .,Non-OADS,/arxiv_data1/oa_pdf/f7/f3/10926_2010_Article_9274.PMC3173614.pdf
Available from: http://www.stat.ruhr- uni-bochum.de/tda.html .,Non-OADS,/arxiv_data1/oa_pdf/f7/f3/10926_2010_Article_9274.PMC3173614.pdf
Available from: http://www-dep.iarc.fr/globocan/database.html .,OADS,/arxiv_data1/oa_pdf/d5/5a/10926_2011_Article_9319.PMC3173615.pdf
Available from: http://statline.cbs.nl/stat web/ .,OADS,/arxiv_data1/oa_pdf/d5/5a/10926_2011_Article_9319.PMC3173615.pdf
Available from: http://www.tno.nl/ downloads/TNO-KvL NEA Brochure 2007 Eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/5a/10926_2011_Article_9319.PMC3173615.pdf
http://www.voice-of-the-people.net/ .,Non-OADS,/arxiv_data1/oa_pdf/1b/e8/127_2010_Article_270.PMC3173616.pdf
Available from: http://www.renine.nl/static?id=prev_ years&var=dg&style=line&render=png .,OADS,/arxiv_data1/oa_pdf/7e/c1/10926_2011_Article_9317.PMC3173627.pdf
"and Popa, R. (2010) Applied Biochemistry and Technology, online http://www.citeulike.org/ article/7821425 .",Non-OADS,/arxiv_data1/oa_pdf/29/9e/12010_2011_Article_9249.PMC3173631.pdf
Available from: http://www.cbs.nl/ nl-NL/menu/themas/gezondheid-welzijn/cijfers/default.htm 9.,Non-OADS,/arxiv_data1/oa_pdf/c5/4c/127_2010_Article_266.PMC3173635.pdf
Available from:http://apps.who.int/globalatlas/predeﬁnedReports/default.asp 43.,OADS,/arxiv_data1/oa_pdf/c5/4c/127_2010_Article_266.PMC3173635.pdf
Available from: http://www.who.int/countries/ nld/en/ andhttp://www.who.int/countries/aus/en/ 44.,Non-OADS,/arxiv_data1/oa_pdf/c5/4c/127_2010_Article_266.PMC3173635.pdf
"423Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyREVIEW http://dx.doi.org/10.4070/kcj.2011.41.8.423 Open Access Computational Fluid Dynamics in Cardiovascular Disease Byoung-Kwon Lee, MD Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea ABSTRACT Computational fluid dynamics (CFD) is a mechanical engineering field for analyzing fluid flow, heat transfer, and associated  phenomena, using computer-based simulation.",Non-OADS,/arxiv_data1/oa_pdf/35/dc/kcj-41-423.PMC3173660.pdf
"431Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyEDITORIAL http://dx.doi.org/10.4070/kcj.2011.41.8.431 Open Access Correspondence:  Hui-Nam Pak, MD,  Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, 50 Yonsei-ro, Seodae - mun-gu, Seoul 120-752, Korea Tel: 82-2-2228-8459, Fax : 82-2-393-2041, E-mail : hnpak@yuhs.ac • The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/f8/0d/kcj-41-431.PMC3173661.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Refer to the page 447-452 Historical Perspective Radiofrequency catheter ablation of atrial fibrillation (AF)  is an effective rhythm control strategy, and its efficacy has been  proved to be superior to anti-arrhythmic drugs.1-3) Recently,  the European Society of Cardiology’s 2010 revised guidelines  for AF management suggested catheter ablation as the first- line treatment in patients with paroxysmal lone AF .4) When  Haissaguerre et al.5) initially reported catheter ablation of AF ,  it was focal ablation of the pulmonary vein (PV) origin of AF .",Non-OADS,/arxiv_data1/oa_pdf/f8/0d/kcj-41-431.PMC3173661.pdf
"434Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyORIGINAL ARTICLE http://dx.doi.org/10.4070/kcj.2011.41.8.434 Open Access Comparison of Recurrence Rate Based on the Frequency   of Preceding Symptoms in Patients With Neurocardiogenic   Syncope or Presyncope Seon Mee Lee, MD1, Hye Lim Oh, MD1, June Soo Kim, MD2, Jungwae Park, RN2,  Hye Ran Yim, RN2, Dae Hee Shin, MD3, Y oung Keun On, MD2, and Sang Hoon Lee, MD2 1Division of Cardiology, Department of Medicine, Sam Anyang General Hospital, Anyang,  2Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul,   3Division of Cardiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea ABSTRACT Background and Objectives:  In patients with neurocardiogenic syncope or presyncope, symptoms developed unpredictably  and intermittently.",Non-OADS,/arxiv_data1/oa_pdf/19/56/kcj-41-434.PMC3173662.pdf
"440Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyORIGINAL ARTICLE http://dx.doi.org/10.4070/kcj.2011.41.8.440 Open Access Relation Between High-Sensitivity C-Reactive Protein and   Coronary Plaque Components in Patients With Acute Coronary   Syndrome: Virtual Histology-Intravascular Ultrasound Analysis Y oung Joon Hong, MD, Myung Ho Jeong, MD, Yun Ha Choi, RN, Suk Hee Cho, PhD, Seung Hwan Hwang, MD,   Jum Suk Ko, MD, Min Goo Lee, MD, Keun Ho Park, MD, Doo Sun Sim, MD, Nam Sik Y oon, MD,   Hyun Ju Y oon, MD, Kye Hun Kim, MD, Hyung Wook Park, MD, Ju Han Kim, MD,   Y oungkeun Ahn, MD, Jeong Gwan Cho, MD, Jong Chun Park, MD, and Jung Chaee Kang MD Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Sciences,   Gwangju, Korea ABSTRACT Background and Objectives:  We used virtual histology-intravascular ultrasound (VH-IVUS) to evaluate the relationship be- tween high-sensitivity C-reactive protein (hs-CRP) levels and plaque components in 279 acute coronary syndrome (ACS) pa- tients.",Non-OADS,/arxiv_data1/oa_pdf/f0/f6/kcj-41-440.PMC3173663.pdf
"447Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyORIGINAL ARTICLE http://dx.doi.org/10.4070/kcj.2011.41.8.447 Open Access The Feasibility and Efficacy of a Large-Sized Lasso Catheter   Combined With 3 Dimensional Mapping System   for Catheter Ablation of Atrial Fibrillation Sung-Won Jang, MD, Woo-Seung Shin, MD, Ji-Hoon Kim, MD, Min-Seok Choi, MD,   Yun Seok Choi, MD, Y ong-Seog Oh, MD, Man-Y oung Lee, MD, and Tai-Ho Rho, MD  Division of Cardiology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea ABSTRACT Background and Objectives:  We aimed to investigate whether a large-sized Lasso catheter could increase the success rate  of immediate complete pulmonary vein (PV) antral isolation and improve the outcome of catheter ablation in atrial fibrilla - tion (AF) patients.",Non-OADS,/arxiv_data1/oa_pdf/d8/fd/kcj-41-447.PMC3173664.pdf
"453Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyORIGINAL ARTICLE http://dx.doi.org/10.4070/kcj.2011.41.8.453 Open Access Thrombophilia, Left Ventricular Dysfunction and   Intracardiac Thrombi in Children Ibrahim Abu-Kishk, MD1, Shaul Baram, MD2, Eran Kozer, MD1, Baruch Klin, MD3, and Gideon Eshel, MD1 1Pediatric Division, 2Pediatric Cardiology Unit, and 3Department of Pediatric Surgery, Assaf Harofeh Medical Center, Zerifin, Israel,  Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel ABSTRACT Background and Objectives:  Reports on the incidence of intracardiac thrombi (ICT) have increased over the last few de - cades, but ICT are still relatively rare among children.",Non-OADS,/arxiv_data1/oa_pdf/54/5d/kcj-41-453.PMC3173665.pdf
"458Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyORIGINAL ARTICLE http://dx.doi.org/10.4070/kcj.2011.41.8.458 Open Access Effect of Previous Statin Therapy in Patients With Acute Coronary  Syndrome and Percutaneous Coronary Intervention Kyeong Ho Yun, MD, Ik-Sang Shin, MD, Seoung-Nam Shin, MD, Jun-Ho Choi, MD, Seung Hwan Kim, MD,   Sang Jae Rhee, MD, Eun Mi Lee, MD, Nam Jin Y oo, MD, Nam-Ho Kim, MD, Seok Kyu Oh, MD, and Jin-Won Jeong, MD Department of Cardiovascular Medicine, Regional Cardiocerebrovascular Center, Wonkwang University Hospital, Iksan, Korea ABSTRACT Background and Objectives:  Statin therapy after percutaneous coronary intervention (PCI) has been associated with re - duced major adverse cardiovascular events (MACE).",Non-OADS,/arxiv_data1/oa_pdf/f6/64/kcj-41-458.PMC3173666.pdf
"464Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.464 Open Access Aneurysm of Sinus of Valsalva Dissecting Into the Interventricular  Septum After Aortic Valve Replacement: Diagnosis   by Echocardiography and Magnetic Resonance Imaging and   Treatment With Surgical Sealant Kyu-Hwan Park, MD1, Dong-Gu Shin, MD1, Chang-Woo Son, MD1, Jang-Won Son, MD1, Hyun-Su Jo, MD1,  Joon-Cheol Y oon, MD1, Won-Jae Lee, MD1, Sang-Hee Lee, MD1, Geu-Ru Hong, MD1, Jong-Seon Park, MD1,  Y oung-Jo Kim, MD1, Jung-Hyun Choi, MD2, and Dong-Hyup Lee, MD3 1Division of Cardiology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, 2Division of Cardiology, Department of Internal Medicine, College of Medicine, Dankook University, Cheonan, 3Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University, Daegu, Korea ABSTRACT Aneurysm of the sinus of Valsalva that causes dissection of the interventricular septum is an extremely rare entity.",Non-OADS,/arxiv_data1/oa_pdf/5f/9d/kcj-41-464.PMC3173667.pdf
"469Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.469 Open Access Successful Treatment of a Ruptured Aortic Arch   Aneurysm Using a Hybrid Procedure Bo Kyung Choi, MD1, Han Cheol Lee, MD1, Hye-Won Lee, MD1, Jin-Sup Park, MD1,  Junhyok Oh, MD1, Sang-Pil Kim, MD2, and Kwang Soo Cha, MD1 1Division of Cardiology, Departments of Internal Medicine and 2Thoracic and Cardiovascular Surgery, Medical Research Institute,  Pusan National University Hospital, Busan, Korea ABSTRACT Aortic rupture has a high mortality rate and can be considered a medical emergency.",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/kcj-41-469.PMC3173668.pdf
474Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.474 Open Access Is a Metallic Microcoil Really a Permanent Embolic Agent   for the Management of Distal Guidewire-Induced   Coronary Artery Perforation?,Non-OADS,/arxiv_data1/oa_pdf/80/30/kcj-41-474.PMC3173669.pdf
"479Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.479 Open Access Tako-Tsubo Cardiomyopathy Triggered by Misdirection Ziad Dahdouh, MD1, Julien Wain-Hobson, MD1, Vincent Roule, MD1, Houaida Dahdouh, MD2,  Fabien Labombarda, MD1, Tony Abdel-Massih, MD3, Antoine Sarkis, MD3, and Gilles Grollier, MD1 1Cardiology Department, University Hospital of Caen, Caen, France 2Pediatric Department and 3Cardiology Department, Hôtel Dieu de France Hospital, Achrafieh, Beirut, Lebanon ABSTRACT Tako-Tsubo cardiomyopathy (TTC), also known as transient left ventricular apical ballooning syndrome or stress-induced  cardiomyopathy, is a novel reversible cardiomyopathy mimicking acute myocardial infarction without epicardial coronary ar - tery disease.",Non-OADS,/arxiv_data1/oa_pdf/3b/f7/kcj-41-479.PMC3173670.pdf
"482Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.482 Open Access A Case of Staphylococcal Tricuspid Valve Endocarditis   With Para-Aortic Abscess in a Patient With Bicuspid Aortic Valve Woo Shin Kim, MD, Seok Hyung Kang, MD, Shin A Lee, MD, Min Sun Ryu, MD, and Seong-Hoon Park, MD Department of Internal Medicine, Mokdong Hospital, School of Medicine, Ewha Womans University, Seoul, Korea ABSTRACT Paravalvular abscess is a serious complication of infective endocarditis.",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/kcj-41-482.PMC3173671.pdf
"486Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.486 Open Access A Case of Distal Embolization of Left Ventricular Thrombus   due to Blunt Chest Trauma-Induced Coronary Artery Occlusion Ji-Hwan Kim, MD and Tae Soo Kang, MD Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea ABSTRACT Chest trauma can lead to various cardiac complications ranging from simple arrhythmias to myocardial rupture.",Non-OADS,/arxiv_data1/oa_pdf/9e/2f/kcj-41-486.PMC3173672.pdf
"490Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.490 Open Access Hemorrhagic Transformation of Ischemic Stroke:   Severe Complications of Prosthetic Valve Endocarditis Jin-Sun Kim, MD, Woo-In Y ang, MD, Chi Y oung Shim, MD, Jong-Won Ha, PhD, Namsik Chung, MD, and Hyuk-Jae Chang, MD Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea ABSTRACT Ischemic stroke is a common complication of infective endocarditis (IE), occurring in 20-40% of left side IE cases.",Non-OADS,/arxiv_data1/oa_pdf/67/28/kcj-41-490.PMC3173673.pdf
"494Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright © 2011 The Korean Society of CardiologyCASE REPORT http://dx.doi.org/10.4070/kcj.2011.41.8.494 Open Access Modified Damus-Kaye-Stansel/Dor Procedure   for a Newborn With Severe Left Ventricular Aneurysm Dong-Man Seo, MD1, Hye-Sung Won, MD2, Jae Kon Ko, MD3, and Won Kyoung Jhang, MD3 1Division of Pediatric Cardiac Surgery, Departments of Thoracic and Cardiovascular Surgery, 2Obstetrics and Gynecology and  3Pediatrics, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea ABSTRACT Congenital left ventricular aneurysm (CV A) is a rare cardiac malformation.",Non-OADS,/arxiv_data1/oa_pdf/e3/b5/kcj-41-494.PMC3173674.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/b7/ceo-4-113.PMC3173700.pdf
"P ositional vertigo, Recurrence, Prognosis  •Received October 10, 2010   Accepted after revision December 12, 2010   •Corresponding author: Hoon-Shik Y ang, MD Department of Otorhinolaryngology-Head and Neck Surgery, Chung-Ang  University College of Medicine, 224-1 Heukseok-dong, Dongjak-gu,   Seoul 120-752, Korea   Tel: +82-2-6299-1779, Fax: +82-2-825-1765   E-mail: yhsljr@cau.ac.krhttp://dx.doi.org/10.3342/ceo.2011.4.3.113",Non-OADS,/arxiv_data1/oa_pdf/a4/b7/ceo-4-113.PMC3173700.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/47/ceo-4-118.PMC3173701.pdf
"K yphosis, Accidental falls, Dynamic posturography  •Received September 13, 2010   Accepted after revision February 1, 2011   •Corresponding author: Sung Won Chae, MD Department of Otolaryngology-Head and Neck Surgery, Korea University  Guro Hospital, Korea University College of Medicine, 80 Guro-dong,   Guro-gu, Seoul 152-703, Korea   Tel: +82-2-2626-3186 , Fax: +82-2-868-0475 E-Mail: schae@kumc.or.krhttp://dx.doi.org/10.3342/ceo.2011.4.3.118",Non-OADS,/arxiv_data1/oa_pdf/2a/47/ceo-4-118.PMC3173701.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/af/ceo-4-122.PMC3173702.pdf
"Bacteriology, Chronic suppurative otitis media, Nasopharynx  •Received January 10, 2011   Accepted after revision March 22, 2011   •Corresponding author: Hak Hyun Jung, MD Department of Otolaryngology-Head and Neck Surgery, Korea University  Anam Hospital, Korea University College of Medicine, 126-1   Anam-dong 5-ga, Seongbuk-gu, Seoul 136-705, Korea   Tel: +82-2-920-5486, Fax: +82-2-925-5233, E-mail: brune77@naver.comhttp://dx.doi.org/10.3342/ceo.2011.4.3.122",Non-OADS,/arxiv_data1/oa_pdf/57/af/ceo-4-122.PMC3173702.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/45/ceo-4-126.PMC3173703.pdf
"Hearing, Frequency, Otitis media, Chronic, Surgery  •Received November 18, 2010   Accepted after revision March 27, 2011   •Corresponding author: Beom Cho Jun, MD Department of Otolaryngology Head and Neck Surgery , Uijeongbu St.  Mary’s Hospital, The Catholic University of Korea, 65-1 Geumo-dong,  Uijeongbu 480-717, Korea   T el: +82-31-820-3657, Fax: +82-31-847-0038   E-mail: OTOJUN@catholic.ac.krhttp://dx.doi.org/10.3342/ceo.2011.4.3.126",Non-OADS,/arxiv_data1/oa_pdf/8f/45/ceo-4-126.PMC3173703.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/66/ceo-4-131.PMC3173704.pdf
"Kopcinskiego 22, 90-153 Lodz, Poland   Tel: +48 42 677 67 42, Fax: +48 42 677 67 49   E-mail: szychta@yahoo.plhttp://dx.doi.org/10.3342/ceo.2011.4.3.131",Non-OADS,/arxiv_data1/oa_pdf/e0/66/ceo-4-131.PMC3173704.pdf
Available from: http://www.searchenginewatch.,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ceo-4-131.PMC3173704.pdf
Available from: http://www.pewinternet.org/Reports/2000/ The-Online-Health-Care-Revolution.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ceo-4-131.PMC3173704.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/82/ceo-4-137.PMC3173705.pdf
"No: 15 D: 2 (34347), Ortaköy, Istanbul, Turkey   Tel: +90-5326167016, Fax: +90-2122192865   E-mail: dr.gyildirim@yahoo.com.trhttp://dx.doi.org/10.3342/ceo.2011.4.3.137",Non-OADS,/arxiv_data1/oa_pdf/9c/82/ceo-4-137.PMC3173705.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/b5/ceo-4-142.PMC3173706.pdf
"Unilateral vocal fold paralysis, Medialization thyroplasty, Autologous septal cartilage implant  •Received April 22, 2011   Accepted after revision July 22, 2011   •Corresponding author: T amer A. Mesallam, MD Communication and Swallowing Disorders, ENT Department,   King Abdulaziz University Hospital, King Saud University, P .O Box 245,  Riyadh 11411, Saudi Arabia   Tel: +96614786100, Fax: +96614775682   E-mail: tmesallam@ksu.edu.sa http://dx.doi.org/10.3342/ceo.2011.4.3.142",Non-OADS,/arxiv_data1/oa_pdf/b5/b5/ceo-4-142.PMC3173706.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/fc/ceo-4-149.PMC3173707.pdf
"BCL2, Polymorphism, Haplotype, Thyroid cancer, P apillary   •Received April 20, 2011   Accepted after revision August 5, 2011   •Corresponding author: Kee Hwan Kwon, MD Department of Otolaryngology-Head and Neck Surgery,   Kyung Hee University Hospital at Gangdong, 149 Sangil-dong,   Gangdong-gu, Seoul 134-727, Korea   Tel: +82-2-440-8852, Fax: +82-2-440-8853   E-mail: entkhkwon@empal.com   *The first two authors contributed equally to the study.http://dx.doi.org/10.3342/ceo.2011.4.3.149",Non-OADS,/arxiv_data1/oa_pdf/98/fc/ceo-4-149.PMC3173707.pdf
"SNP selection and genotyping  We searched the promoter and coding SNPs of the BCL2 gene  in the SNP database of the National Center for Biotechnology  Information (http://www.ncbi.nlm.nih.gov/SNP, BUILD 132).",OADS,/arxiv_data1/oa_pdf/98/fc/ceo-4-149.PMC3173707.pdf
Available from: http://www.cancer.go.kr/cms/statics/incidence/in - dex.html#2.,Non-OADS,/arxiv_data1/oa_pdf/98/fc/ceo-4-149.PMC3173707.pdf
http://dx.doi.org/10.1002/ijc.25904.,Non-OADS,/arxiv_data1/oa_pdf/98/fc/ceo-4-149.PMC3173707.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/68/ceo-4-155.PMC3173708.pdf
"Hypertrophic pachymeningitis, Multiple cranial neuropathies, p-ANCA, Wegener’s granulomatosis  •Received August 13, 2009   Accepted after revision October 3, 2009  •Corresponding author: Sang-Heun Lee, MD Department of Otorhinolaryngology-Head and Neck Surgery, Kyungpook  National University School of Medicine, 200 Dongduk-ro, Jung-gu,   Daegu 700-721, Korea   Tel: +82-53-420-5777, Fax: +82-53-423-4524   E-mail: leeshu@mail.knu.ac.krhttp://dx.doi.org/10.3342/ceo.2011.4.3.155 Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/c5/68/ceo-4-155.PMC3173708.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/de/ceo-4-159.PMC3173709.pdf
"Nasal heroin, Life threatening, Recurrent epistaxis  •Received June 19, 2009   Accepted after revision August 29, 2009  •Corresponding author: Y usuf Aydın, MD Department of Internal Medicine and Endocrinology Metabolism, Düzce  University Faculty of Medicine, Duzce 81620, Turkey   Tel: +90-505-484-8465, Fax: +90-312-309-3398   E-mail: dryusufaydin@yahoo.comhttp://dx.doi.org/10.3342/ceo.2011.4.3.159 Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/36/de/ceo-4-159.PMC3173709.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/b1/17/emboj2011252a.PMC3173786.pdf
[http://creativecommons.org/licenses/by-nc-sa/3.0/]Novel class of bacterial promoters Y Yuzenkova et al &2011 European Molecular Biology Organization The EMBO Journal VOL 30 |NO 18 |2011 3775,Non-OADS,/arxiv_data1/oa_pdf/b1/17/emboj2011252a.PMC3173786.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/42/e4/emboj2011261a.PMC3173789.pdf
Analyses were carried out using Stata statistical software (http://www.stata.com).,OADS,/arxiv_data1/oa_pdf/e6/a6/jech98087.PMC3173802.pdf
http://www.heartstats.,Non-OADS,/arxiv_data1/oa_pdf/e6/a6/jech98087.PMC3173802.pdf
"Geneva, Switzerland: The Global Fund, 2010. http://www.theglobalfund.org/ documents/replenishment/2010/Global_Fund_2010_Innovation_and_Impact_en.pdf(accessed 7 May 2010).",Non-OADS,/arxiv_data1/oa_pdf/eb/d3/sextrans46060.PMC3173805.pdf
http://www.pepfar.,Non-OADS,/arxiv_data1/oa_pdf/eb/d3/sextrans46060.PMC3173805.pdf
"Glastonbury, CT: Futures Institute, 2009. http://data.unaids.org/pub/Manual/2009/20090414_aim_manual_2009_en.",Non-OADS,/arxiv_data1/oa_pdf/eb/d3/sextrans46060.PMC3173805.pdf
"New York, NY: United Nations, 2009. http://esa.un.org/unpd/wpp2008/ index.htm (accessed 22 Jul 2010).",Non-OADS,/arxiv_data1/oa_pdf/eb/d3/sextrans46060.PMC3173805.pdf
2009. http://www.cpc.unc.edu/measure/publications/pdf/ms-07-26-OB.pdf (accessed 14 Jul 2010).,Non-OADS,/arxiv_data1/oa_pdf/eb/d3/sextrans46060.PMC3173805.pdf
13e16The software is freely and publicly available (http://www.unaids.,OADS,/arxiv_data1/oa_pdf/6e/6e/sextrans46177.PMC3173806.pdf
"Washington, DC: Department of Health and Human Services, 2009. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.",Non-OADS,/arxiv_data1/oa_pdf/6e/6e/sextrans46177.PMC3173806.pdf
2010. http://www.aidsinfo.unaids.org.,Non-OADS,/arxiv_data1/oa_pdf/6e/6e/sextrans46177.PMC3173806.pdf
"Geneva: UNAIDS, 2007. http://www.unaids.org/en/ KnowledgeCentre/Resources/FeatureStories/archive/2007/ 20070925_Resource_needs_methodology.asp.",Non-OADS,/arxiv_data1/oa_pdf/6e/6e/sextrans46177.PMC3173806.pdf
The creation ofregional data centres by the IeDEA initiative of the US National Institutes of Health in 2007 (http://www.iedea-hiv.org/) will ultimately lead to regional and possibly country-speci ﬁc esti- mates in the future.,Non-OADS,/arxiv_data1/oa_pdf/da/15/sextrans44255.PMC3173808.pdf
2009. http://data.unaids.org/pub/Manual/2009/20090414_aim_manual_2009_en.,Non-OADS,/arxiv_data1/oa_pdf/da/15/sextrans44255.PMC3173808.pdf
"New York: UNICEF, 2008. http://www.epidem.org/Publications/UNAIDS_UNICEF_ Paediatric%20HIV%20Report_9%20Dec%202008_Final.pdf (accessed 18 Mar 2010).",Non-OADS,/arxiv_data1/oa_pdf/da/15/sextrans44255.PMC3173808.pdf
"Geneva: World Health Organization, 2010. http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf (accessed 16 Aug 2010).",Non-OADS,/arxiv_data1/oa_pdf/da/15/sextrans44255.PMC3173808.pdf
Theprogram and manuals are updated regularly and available in multiple languages free of charge at http://www.FuturesInstitute.org/.,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/sextrans44222.PMC3173821.pdf
"Glastonbury CT: Futures Institute, 2009. http://www.FuturesInstitute.org and http://www.unaids.org.Table 2 Estimates of the excess risk of double orphanhood (with 95% CIs) from the random-intercept Poisson regression model at two levels of HIV prevalence for mainland African countries with generalised HIV epidemics Children’s age group (years) 1% HIV prevalence 25% HIV prevalence 0e2 12.8 (12.3 to 13.3) 10.9 (10.5 to 11.3) 3e5 6.2 (6.0 to 6.4) 5.7 (5.4 to 5.9) 6e9 4.3 (4.1 to 4.5) 4.2 (4.1 to 4.4) 10e14 3.1 (3.0 to 3.2) 3.4 (3.3 to 3.5) 15e17 2.5 (2.4 to 2.6) 3.0 (2.9 to 3.1)Key messages <The Spectrum software is used to calculate HIV indicators of interest on the basis of previously prepared prevalence estimates.",Non-OADS,/arxiv_data1/oa_pdf/3d/8a/sextrans44222.PMC3173821.pdf
http://esa.un.org/unpd/wpp2008/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/sextrans44222.PMC3173821.pdf
http://www.retroconference.org/2007/data/ﬁles/webpage_for_CROI.htm.,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/sextrans44222.PMC3173821.pdf
http://www.path.org/ﬁles/ Nigel_Rollins.pdf (accessed 26 Dec 2006).,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/sextrans44222.PMC3173821.pdf
Paper#840 http://www.retroconference.org/2010/PDFs/840.,Non-OADS,/arxiv_data1/oa_pdf/3d/8a/sextrans44222.PMC3173821.pdf
"Sources: Estimated number of HIV positive women delivering and estimated ARV coverage: WHO Universal Access report 2010, Unmet need for Family plann ing and ANC coverage: MDG indicator website http://unstats.un.org/unsd/mdg/Data.aspx, Median duration of breastfeeding: DHS surveys.NA, Not available.",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"New York: United Nations, 2006. http://data.unaids.org/pub/ Report/2006/20060615_hlm_politicaldeclaration_ares60262_en.pdf (accessed 9Aug 2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Guidance on global scale-up of the prevention of mother to child transmission of HIV Geneva: World Health Organization, 2007. http://www.unicef.org/aids/ﬁles/ PMTCT_enWEBNov26.pdf (accessed 7 May 2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Geneva: World Health Organization, 2009. http://www.who.int/ hiv/pub/paediatric/advice/en (accessed 1 Jun 2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Geneva: World Health Organization, 2010. http://www.who.int/hiv/pub/mtct/arv_guidelines_mtct.pdf (accessed 9 Aug2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Geneva: World Health Organization, 2009. http://www.who.int/hiv/pub/mtct/advice/en (accessed 7 May 2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Geneva: World Health Organization, 2010. http://www.who.int/hiv/pub/ 2010progressreport/report/en/index.html (accessed 30 Sep 2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Glastonbury, CT: Futures Institute, 2009. http://data.unaids.org/pub/Manual/2009/20090414_aim_manual_2009_en.",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Calverton, Maryland: ICF Macro, 2010. http://www.measuredhs.com/pubs/pdf/CR25/CR25.pdf (accessed 7 May 2009).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Calverton, Maryland: ICF Macro, 2008. http://www.measuredhs.com/pubs/pdf/ AS16/AS16.pdf (accessed 9 Aug 2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
"Geneva: World Health Organization, 2009. http://www.who.int/hiv/pub/2009progressreport/en (accessed 6 May 2010).",Non-OADS,/arxiv_data1/oa_pdf/95/b0/sextrans45989.PMC3173823.pdf
Guidelines are available from theUNAIDS and WHO websites (http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/59/17/sextrans43653.PMC3173824.pdf
and http://www.who.int/hiv/pub/surveillance/en/).,Non-OADS,/arxiv_data1/oa_pdf/59/17/sextrans43653.PMC3173824.pdf
"In addition to the United States Census Bureau ’s HIV surveillance database (http://www.census.gov/ipc/www/ hivaidsn.html), WHO regional of ﬁces and country staff provided information on the number and location of surveillance activi-ties in their countries using a standardised template.",OADS,/arxiv_data1/oa_pdf/59/17/sextrans43653.PMC3173824.pdf
"Several other countries are currently implementing these surveys in 2009 and 2010, and others are planning to conduct surveys inthe next 5 years (http://www.measuredhs.com/aboutdhs/).",Non-OADS,/arxiv_data1/oa_pdf/59/17/sextrans43653.PMC3173824.pdf
2010. http://aidsinfo.unaids.org.,Non-OADS,/arxiv_data1/oa_pdf/6a/79/sextrans46201.PMC3173825.pdf
"Sprengel described four cases of ‘‘Die  angeborene Verschiebung des Schulterblattes nach oben’’  (congenital displacement of the scapula upward) in 1891  and suggested a theory for its formation mechanism, www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:  Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/13 Copyright: © 2011 Dilli A.",Non-OADS,/arxiv_data1/oa_pdf/05/a5/JCIS-1-13.PMC3173831.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/05/a5/JCIS-1-13.PMC3173831.pdf
"[3,4]  The outcome of treatment in acute renal ischemia depends www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:  Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/11 Copyright: © 2011 Arabi M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/25/f7/JCIS-1-11.PMC3173832.pdf
J Clin Imaging Sci 2011;1:11.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/25/f7/JCIS-1-11.PMC3173832.pdf
"Given the age, location, and low chance of  malignant degeneration, conservative management www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:  Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/12 Copyright: © 2011 Hubeny C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/08/7a/JCIS-1-12.PMC3173833.pdf
J Clin Imaging Sci 2011;1:12Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/08/7a/JCIS-1-12.PMC3173833.pdf
"The differential diagnosis for each pattern of involvement  of neurosarcoidosis will also be reviewed.www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:   Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format PICTORIAl ESSA y This article is available from: http://www.clinicalimagingscience.org/content/1/1/15 Copyright: © 2011 Ginat DT.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/JCIS-1-15.PMC3173834.pdf
J Clin Imaging Sci 2011;1:15.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/35/6f/JCIS-1-15.PMC3173834.pdf
"After hematoma formation, there is central liquefaction that leaves a cavity with turbulent blood flow, as a result of persistent communication between the parent artery and www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:   Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/14 Copyright: © 2011 Nanjundan P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ac/a5/JCIS-1-14.PMC3173835.pdf
J Clin Imaging Sci 2011;1:14.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/ac/a5/JCIS-1-14.PMC3173835.pdf
"There www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:   Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/10 Copyright: © 2011 Yadavalli G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/84/72/JCIS-1-10.PMC3173836.pdf
J Clin Imaging Sci 2011;1:10.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/84/72/JCIS-1-10.PMC3173836.pdf
"Prevalence surveys included AIDS indicator surveys (Botswana, Kenya and T anzania; available at http://www.measuredhs.com), demographic and health surveys (Kenya, Zambia and Zimbabwe; available at http://www.",Non-OADS,/arxiv_data1/oa_pdf/24/d6/sextrans44933.PMC3173837.pdf
"T o ensure consistency of the data collection methodology and the de ﬁnition of the indicators, only data from demographic and health surveys (available at http://www.measuredhs.com) or multiple indicator cluster surveys (available at http://www.unicef.org), or the repeated national population- based surveys conducted by the Human Sciences ResearchCouncil in South Africa 17e19were used in this analysis.",Non-OADS,/arxiv_data1/oa_pdf/24/d6/sextrans44933.PMC3173837.pdf
http://www.who.int/ diagnostics_laboratory/links/hiv_incidence_assay/en/index1.html (accessed 18 Oct 2009).,OADS,/arxiv_data1/oa_pdf/24/d6/sextrans44933.PMC3173837.pdf
23This method was incorporated into the estimation and projection package (EPP) produced by UNAIDS and available for download fromhttp://www.unaids.org.,OADS,/arxiv_data1/oa_pdf/8d/99/sextrans44529.PMC3173838.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society www.biochemj.org Biochemical Journal © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
Cloning of xylosyltransferase cDNA fragment and expression in yeast A cDNA fragment encoding the predicted catalytic domain of AgOXT1 (VectorBase accession code AGAP005811; http://www.vectorbase.org) was isolated by RT (reverse transcription)– PCR using the primers AgOXT1/1/EcoRI (5 /prime-CGGAATTCGAC- TTTGTGCCGCCGTG-3/prime) and AgOXT1/2/XbaI (5/prime-GCTCT- AGAACTAGTTCGACGTTACCGATTC-3/prime) from midgut cDNA and Expand polymerase mix (Roche) in the presence of a ‘GC-rich’ polymerase buffer additive.,Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"We observed that the rAgOXT1 (recombinant AgOXT1) transferred a c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"Salivary gland sporozoite infection intensity is partly reduced by RNAi-mediated silencing of HS biosynthesis Since we observed that the raw data are skewed (positive kurtosis and non-Gaussian distribution as determined by a normality c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"These results c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"272, 11171–11175 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"73, 7797–7807 Received 18 April 2011/2 June 2011; accepted 10 June 2011 Published as BJ Immediate Publication 10 June 2011, doi:10.1042/BJ20110694 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/f1/bj4380475.PMC3173866.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Eye website (http://www.nature.com/eye)Referral patterns of OcMMP in the UK GP Williams et al 1218 Eye",Non-OADS,/arxiv_data1/oa_pdf/eb/75/eye2011175a.PMC3173873.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/44/81/PM-7-177.PMC3173891.pdf
Available  from: http://www.naturia.per.sg/buloh/plants/saga_tree.htm.,Non-OADS,/arxiv_data1/oa_pdf/84/dd/PM-7-193.PMC3173893.pdf
Available from: http://www.hibiscus.org/species/tpopulnea.php.,Non-OADS,/arxiv_data1/oa_pdf/84/dd/PM-7-193.PMC3173893.pdf
Available from: http://envis.frlht.org/bot_ search.php.,OADS,/arxiv_data1/oa_pdf/84/dd/PM-7-193.PMC3173893.pdf
: The neuroprotective activity of fermented Hwangryunhaedok-tang Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b9/b1/PM-7-207.PMC3173895.pdf
Available  from: http://www.drugs.com/npc/aconite.html#ixzz118RjCfVi.,Non-OADS,/arxiv_data1/oa_pdf/98/80/PM-7-234.PMC3173899.pdf
Available  from: http://www.farmaciasantantonio.it/Homeoint/clarke/a/ acon.htm.,Non-OADS,/arxiv_data1/oa_pdf/98/80/PM-7-234.PMC3173899.pdf
Available from: http://www.ars-grin.gov/cgi-bin/duke/ farmacy2.pl.,Non-OADS,/arxiv_data1/oa_pdf/98/80/PM-7-234.PMC3173899.pdf
The  adrenergic and cholinergic ligands were downloaded from  the Internet (http://www.pdb.org/).Statistical analysis The mean and SEM values were calculated for each  parameter.,OADS,/arxiv_data1/oa_pdf/3d/cd/PM-7-243.PMC3173900.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/6f/27/PM-7-265.PMC3173904.pdf
"C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Societywww.clinsci.org Clinical Science © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"Func- tional endothelial integrity was assessed by determining relaxation to the endothelium-dependent dilator ACh(acetylcholine; 10 μM) in thromboxane mimetic 9,11- dideoxy-11 α,9α-epoxy methanoprostaglandin (U46619, C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"Mevalonate had no C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"Simvastatin (1 μM, 2 h) signiﬁcantly C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"Here the predominant effect of simvastatin was a NO-dependent reduction in contractile C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"Perspectives The role of AMPK in the maintenance and restoration of metabolic homoeostasis has led to considerable interest in it as a potential target for the treatment of C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"30, 1137–1142 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"3, 403–416 Received 16 May 2011/9 June 2011; accepted 14 June 2011 Published as Immediate Publication 14 June 2011, doi:10.1042/CS20110259 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0d/cs1210449.PMC3174052.pdf
"C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Societywww.clinsci.org Clinical Science © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"As this measure would be affected by differences in plasma C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"The13C enrichment in plasma glucose was determined by gaschromatography–MS of the pentaacetate derivatives of plasma glucose after deproteinization and deionization C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"The fasting muscle glycogen concentration was similar in C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"However, the major reason for the apparent discrepancy is clear from the work of Schrauwen-Hinderling and co-workers [28,29], whodemonstrated that in vivo basal mitochondrial function C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"Diabetes 41, 1400–1408 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"2, e233 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"98, 66–69 Received 23 December 2010/21 February 2011; accepted 10 March 2011 Published as Immediate Publication 10 March 2011, doi:10.1042/CS20100611 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/a8/cs1210169.PMC3174053.pdf
"C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Societywww.clinsci.org Clinical Science © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"Analysis of S1P , sphingosine and hexadecenal (as its semicarbazonederivative) were accomplished using a Shimadzu UFLC (ultra-fast liquid chromatography) coupled with an C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"Unlike in pre-transfusion samples, plasma S1P at 12–24 h after transfusion didnot correlate with Hct (Figure 2B), indicating that replacement of RBC alone may not restore plasma C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"Likewise, the presence of S1P phosphatase activity was detected by the C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"The present study identiﬁes an effect of anaemia on S1P distribution between plasma protein C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"FUNDING This work was supported by the National Institutes of Health [grant numbers HL078663, GM050388, C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"U.S.A. 108, 9613–9618 Received 5 May 2011/28 June 2011; accepted 13 July 2011 Published as Immediate Publication 13 July 2011, doi:10.1042/CS20110236 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/cs1210565.PMC3174054.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
X-ray crystal structures for p110 γ(PDB code 2CHZ) and p110 δ(PDB code 2WXR) were superimposed on to p110 αusing PyMOL (http://www.pymol.org) and docking was performed under the same conditions with the 18 Å cavity centred on the CD1 of Ile 744and Ile777respectively.,OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"Quantitative analysis was per-formed on an Agilent 6460 triple quadrupole LC-MS/MS (tandem MS) (Agilent Technologies) using multiple reaction monitoring c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
and genotypes for cell lines were assigned on the basis of data from the COSMIC database(http://www.sanger.ac.uk/genetics/CGP/CellLines/).,OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
We also tested the inhibitory effects of 10 μM A66 effects on two large panels of 110 protein kinases (Supplementary Figure S1 at http://www.BiochemJ.org/bj/438/bj4380053add.htm) and 318 kinases (Supplementary Figure S2 at http://www.BiochemJ.org/bj/438/bj4380053add.htm).,OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"The top-ranked binding mode for the A66 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
Loading was controlled for by reprobing for total PKB (see Supplementary Figure S3 at http://www.BiochemJ.,Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
As a control we tested the effect of the A66 Rform and found it was not able to inhibit the phosphorylation of Akt/PKB (see Supplementary Figure S4 at http://www.BiochemJ.org/bj/438/bj4380053add.htm).,Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"In these studies we usedPIK-75 as an alternative p110 αinhibitor and we found that a low concentration of PIK-75 also blocks the insulin-stimulated c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"QD dosing of A66 Sin an HCT-116 xenograft model also induced a signiﬁcant reduction in tumour volume with a TGI of 77.2%of control ( P<0.01) at the end of dosing, but caused a non-signiﬁcant reduction in tumour volume in theU87MG xenograft model (Table 4 and Supplementary Figure S5 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
Table 3 Plasma pharmacokinetic properties of A66 Sform and BEZ-235 in mice after a single intraperitoneal dose of 10 mg/kg of body weight Drug Cmax(nM) Tmax(h) AUC o-inf(nM·h) T1/2(h) A66 8247 0.5 6809 0.42 BEZ-235 1863 0.25 7333 2.73 at http://www.BiochemJ.org/bj/438/bj4380053add.htm).,Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"The ﬁnding that TGX-221 and IC87114 alone do not inhibit the phosphorylation of Akt/PKB at Ser 473or Thr308in any of the cell lines tested, c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"Oncotarget 1, 339–348 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"7, 1851–1863 Received 17 March 2011/27 May 2011; accepted 14 June 2011 Published as BJ Immediate Publication 14 June 2011, doi:10.1042/BJ20110502 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"S. Jamieson and others Figure S2 Inhibition of kinases by A66 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"Received 17 March 2011/27 May 2011; accepted 14 June 2011 Published as BJ Immediate Publication 14 June 2011, doi:10.1042/BJ20110502 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/bj4380053.PMC3174055.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society www.biochemj.org Biochemical Journal © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Western blot analysis Either 40 μg of WCE (whole-cell extract) from HEK-293 cells, or 40 μgo fW C Ef r o m6 9 7c e l l s ,o r1 5 μlo fs a m p l e c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Phosphorylation site assignments by Mascotwere validated and veriﬁed manually using the MS-Product tool (University of California San Francisco, Mass Spectrometry Facility, http://prospector.ucsf.edu/) with loss of H 3PO 4and multiple losses enabled as an additional option, focusing on the occurrence of b-a n d y-ions, internal fragments, and neutral losses of H 2O, NH 3or H 3PO 4from these ions and the parent ion respectively.",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"In silico analysis To deﬁne an in silico ‘interactome’ map of AF4, we screened the HPRD (Human Protein Reference Database; freely available at http://www.hprd.org) for AF4 interactions [21].",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"We used the HPRD, the BIND (Biomolecular Interaction Network Database; http://bond.unleashedinformatics.com/Action), DA VID bioin-formatics resources (http://www.david.abcc.ncifcrf.gov) andSTRING (http://string.embl.de) for protein clustering.",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Supporting information available (http://www.BiochemJ.org/bj/ 438/bj4380121add.htm) Identiﬁcation of AF4-1-interacting proteins by nanoLC/ESI- MS/MS, along with identiﬁed peptide sequences, precursor mass, charge state, mass errors, single peptide MASCOT score andsequence coverage (Supplementary Table S1).",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
In silico analysis of AF4 interactors by the Human Protein Reference Database (http://www.hprd.org) (Supplementary Table S4).,OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Consequently, we used the FLAG–AF4-1 construct for large-scale immunoafﬁnity puriﬁcation, and then validated the results in Western blot experiments with the c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Supplementary Table S1 (at http://www.BiochemJ.org/bj/438/bj4380121add.htm) shows, for each protein entry, the peptidesequence identiﬁed, the precursor mass ( m/z), the charge state (z), the mass errors (p.p.m.)",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
These common proteins are shown in Supplementary Table S2 (at http://www.BiochemJ.org/bj/438/bj4380121add.htm).,Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
The peptide sequence was searched for using BLAST software(http://ncbi.nlm.nih.gov/blast).,OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network 125 Table 1 AF4-1-interacting proteins identiﬁed by nano-LC-ESI-MS/MS and their Gene Ontology classiﬁcation Gene symbol Accession number Protein Transcription-regulatory proteins PPARBP , MED1 gi|2765322 Activator-recruited cofactor 205 kDa component MED12 gi|4827042 Mediator of RNA polymerase II transcription, subunit 12 homologue CRSP2, MED14 gi|4580326 Cofactor required for Sp1 transcriptional activation, subunit 2, 150 kDa CRSP3, MED23 gi|28558969 Cofactor required for Sp1 transcriptional activation, subunit 3, 130 kDa THRAP4, MED24 gi|8699628 Vitamin D receptor-interacting protein complex component DRIP100 CRSP6, MED17 gi|28558975 Cofactor required for Sp1 transcriptional activation, subunit 6, 77 kDa CRSP7, MED26 gi|28558977 Cofactor required for Sp1 transcriptional activation, subunit 7, 70 kDa RBBP4 gi|13111851 Retinoblastoma-binding protein 4 RUVBL2 gi|13111851 48 kDa TATA-box-binding protein-interacting protein EAF1 gi|27370592 ELL-associated factor 1 MED4 gi|7141320 p36 TRAP/SMCC/PC2 subunit (Mediator of RNA Pol II transcription, subunit 4 homologue) CRSP8, MED27 gi|7141322 Cofactor required for Sp1 transcriptional activation, subunit 8, 34 kDa MED7 gi|13528909 Cofactor required for Sp1 transcriptional activation, subunit 9 MED6 gi|3329506 RNA polymerase transcriptional regulation mediator MED8 gi|33988564 Mediator of RNA polymerase II transcription subunit 8 activator-recruited cofactor 32 kDa component TRFP , MED20 gi|4323033 Trf (TATA binding protein-related factor)-proximal homologue MED21 gi|1515377 RNA polymerase II holoenzyme component SRB7 ELL gi|10130023 RNA polymerase II elongation factor ELL PCQAP gi|14043091 MED15 TCEA1 gi|313223 Transcription elongation factor A (SII), 1 DNA-directed RNA polymerase proteins POLR2A gi|36124 RNA polymerase II largest subunit POLR2B gi|4505941 RNA polymerase II second largest subunit POLR2C gi|2920711 Polymerase (RNA) II (DNA-directed) polypeptide C, 33kDa DNA-binding proteins MCM3 gi|1552242 DNA polymerase α-holoenzyme-associated protein P1 (p102 protein) RUVBL1 gi|15277588 49 kDa TATA box-binding protein-interacting protein RNA-binding proteins NCL gi|189306 Nucleolin PRPF31 gi|40254869 PRP31 pre-mRNA processing factor 31 homologue SNRPD2 gi|29294624 Small nuclear ribonucleoprotein D2 polypeptide 16.5 kDa Serine/threonine kinase protein CDK9 gi|12805029 Cyclin-dependent kinase 9 (CDC2-related kinase) Serine/threonine phosphatase protein PPP2R1A gi|178663 Protein phosphatase 2 (formerly 2A) regulatory subunit A (PR 65) αisoform Translation regulator protein EEF1B2 gi|12652911 Eukaryotic translation elongation factor 1 β1 Auxiliary transport protein GDI2 gi|285975 Rab GDP dissociation inhibitor β Receptor signalling complex scaffold proteins YWHAE gi|12655169 14-3-3 protein, εisoform (protein kinase C inhibitor protein 1) YWHAQ gi|55594676 14-3-3 protein θ(14-3-3 protein T-cell) SPIN gi|5730065 SPINL AP3S1 gi|4502861 Adapter-related protein complex 3 σ1 subunit Signal transduction proteins CCNT1 gi|2981196 CDK9 associated C-type cyclin S100A8 gi|21614544 S100 calcium-binding protein A8 S100A9 gi|4506773 S100 calcium-binding protein A9 Transmembrane receptor protein tyrosine kinase protein FGFR2 gi|29432 Fibroblast growth factor (FGR) receptor Lipid kinase proteins PIP5K2B gi|1857637 Phosphatidylinositol-4-phosphate 5-kinase type II, β PIP5K2C gi|21322230 Phosphatidylinositol-4-phosphate 5-kinase, type II, γ Heterotrimeric G-protein GTPase protein GNB4 gi|12654119 Guanine-nucleotide-binding protein (G-protein), βpolypeptide 4 Guanyl-nucleotide exchange factor protein ARHGEF4 gi|8809845 Rho guanine-nucleotide-exchange factor (GEF) 4 Enzyme: dehydrogenase GAPDH gi|31645 Glyceraldehyde-3-phosphate dehydrogenase Enzyme: synthase PTS gi|4506331 6-pyruvoyltetrahydropterin synthase Unknown SMAD9 gi|13959539 MAD mothers against decapentaplegic homologue 9 LSM14A gi|16877144 LSM14 homologue A (RNA-associated protein 55) DRG1 gi|17939479 Developmentally regulated GTP-binding protein 1 (neural precursor cell expressed developmentally down-regulated 3) HCCA2 gi|55249549 HCCA2 protein (MOB2) C20orf11 gi|21594655 Chromosome 20 open reading frame 11 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Obviously we cannot exclude that some of the reported interactions may be cell-lineage speciﬁc; however, almost all of the proteins thatform the AF4 interactome, as well as AF4 itself, are variablyexpressed in various cell types, according to the UniGene database (http://www.ncbi.nlm.nih.gov/unigene).",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
The phosphorylation sites identiﬁed were manually conﬁrmed (Supplementary Figure S1 at http://www.BiochemJ.org/bj/438/bj4380121add.htm).,OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"To this aim, we ﬁlled out a comprehensive list ofknown primary and secondary interactions for all proteins found in the present study (see Supplementary Table S3 at http://www.BiochemJ.org/bj/438/bj4380121add.htm).",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Figure 7 shows a c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"ELL is a multifunction factor that exerts transcriptional elongation c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The purple lines indicatesinteractions proved by in vitro and/or in vivo assay and previously reported in the literature (PubMed); the blue lines show proteins that participate in the same complex, as reported in the well-annotated databases HPRD, Database of Interacting Proteins (DIP) and BioGrid(http://www.thebiogrid.org/).",OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"This large multisubunit c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Cell 13, 67–76 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Leukemia 25, 135–144 Received 13 October 2010/12 May 2011; accepted 16 May 2011 Published as BJ Immediate Publication 16 May 2011, doi:10.1042/BJ20101633 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Figure S1 Mascot search results c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Figure S1 Continued c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Figure S1 Continued c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Single peptide Mascot score Sequence coverage Transcription regulatory protein PPARBP SLGMNASVTIEGTSAVYK 922.54 2 + 16 77 3% GNNQADTVDFSIISVAGK 918.55 2 + 16 71 MED12 IEGTLGVLYDQPR 730.89 2 + 06 7 2 % LNLVGGMFDTVQR 733.41 2 + 47 68 CRSP2 FLGSVIMR 469.87 2 + 23 41 8% AGTSSQTMPTNMPPPR 852.90 2 + 11 41 SLLDCTFR 506.44 2 + 37 45 ENIQDLVFR 567.50 2 + 35 49 DGAYSLFDNSK 608.86 2 + 31 43 LELFPDQATQLK 701.91 2 + 42 47 QGECTIFAAVR 626.36 2 + 39 47 LVEGFYPAPGLK 645.95 2 + 39 48 LEILVEDKETGDGR 671.45 3 + 27 61 TFLNMFVDSNQDAR 837.45 2 + 17 94 CRSP3 EVGNALLNVVLK 635.07 2 + 18 47 9% NALADFLPVMK 617.91 2 + 12 43 FLELLPVSK 523.41 2 + 17 43 LITALGSSEVQPQFTR 874.03 2 + 13 46 LFDLLYPEK 569.48 2 + 29 54 NACLLPAYFAVTEIR 869.48 2 + 28 54 SSVALAPALVETYSR 782.50 2 + 10 55 EVGNALLNVVLK 635.07 2 + 29 61 TVLSAESEELNR 674.33 2 + 14 71 THRAP4 QLAGPLFSENTLQFYNER 1064.10 2 + 15 43 4% GSVLQFMPFTTVSELVK 950.20 2 + 10 40 CRSP6 AAATIDSLASR 538.30 2 + 37 57 6% VLITSQGYEQICK 769.95 2 + 35 76 CRSP7 LLQAIDPQSNIR 684.38 2 + 14 45 6% AGLSPAEPLLSR 605.89 2 + 75 4 NEIIQSYLSR 611.82 2 + 85 1 RBBP4 TPSSDVLVFDYTK 736.38 2 + 27 104 4% RUVBL2 GLGLDDALEPR 578.75 2 + 80 50 3% EAF1 GDEVTITLPHIPGSTPPMTVFK 785.06 3 + 17 70 9% MED4 LLSALEDLEVLSR 729.44 2 + 20 73 17% EAEQILATAVYQAK 767.75 2 + 26 76 LGGGLGVAGGNSTR 608.33 2 + 26 62 CRSP8 GYNENVYTEDGK 694.85 2 + 12 64 33% AFIAHFQDNLHSVNR 590.37 2 + 18 51 AQPTTLVLPPQYVDDVISR 704.66 3 + 84 8 SNYQVFQK 507.26 2 + 94 7 MED7 EYTDENIQEGLAPKPPPPIK 514.33 3 + 58 44 9% MED6 VDALLLDLR 514.39 2 + 15 47 17% QRVDALLLDLR 647.92 2 + 74 7 VLTAVHGIQSAFDEAMSYCR 757.73 3 + 12 48 MED8 NQVIIPLVLSPDR 732.46 2 + 34 65 23% VPVFSHEVVPDHLR 544.35 3 + 10 40 QTFNPTDTNALVAAVAFGK 983.07 2 + 16 115 NQVIIPLVLSPDRDEDLMR 741.72 3 + 13 44 TRFP SVQQTVELLTR 637.38 2 + 31 53 10% YQYCDFLVK 618.20 2 + 16 56 MED21 IQSALADIAQSQLK 743.44 2 + 40 55 10% ELL TSLLLLR 405.29 2 + 22 49 5% EPVQALPSSASR 924.12 2 + 04 1 PCQAP TFVPAMTAIHGPPITAPVVCTR 784.68 2 + 18 46 12% QSIPSVLQGEVAR 692.45 2 + 14 58 SLLDILTDPSK 601.51 3 + 19 61 TCEA1 NIPMTLELLQSTR 766.43 2 + 39 63 5% DNA-directed RNA polymerase POLR2A TVITPDPNLSIDQVGVPR 961.01 2 + 16 61 1% POLR2B AGVSQVLNR 472.27 2 + 04 5 4 % NLTYSAPLYVDITK 799.43 2 + 64 7 TVTLPENEDELESTNR 923.89 2 + 18 60 POLR2C ITELTDENVK 581.27 2 + 10 55 12% LGLIPLISDDIVDK 755.92 2 + 12 42 FIIENTDLAVANSIR 838.42 2 + 16 82 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Single peptide Mascot score Sequence coverage DNA-binding protein MCM3 GSSGVGLTAAVTTDQETGER 968.44 2 + 20 100 3% RUVBL1 TALALAIAQELGSK 693.38 2 + 14 70 3% RNA-binding protein NCL SISLYYTGEK 580.96 2 + 28 47 8% GFGFVDFNSEEDAK 781.40 2 + 17 50 NDLAVVDVR 500.84 2 + 13 55 GLSEDTTEETLKESFDGSVR 734.06 3 + 13 62 PRPF31 IYEYVESR 529.66 2 + 18 47 14% LGLTEIR 401.20 2 + 11 47 IMGVAGGLTNLSK 638.87 2 + 39 64 MPACNIMLLGAQR 754.01 2 + 19 40 SSGTASSVAFTPLQGLEIVNPQAAEK 868.14 3 + 27 41 SNRPD2 GDSVIVVLR 479.27 2 + 16 47 17% Protein serine/threonine kinase protein CDK9 LADFGLAR 431.75 2 + 11 42 43% LLVLDPAQR 512.84 2 + 18 42 DPYALDLIDK 581.80 2 + 85 4 IGQGTFGEVFK 591.81 2 + 06 3 NPATTNQTEFER 704.33 2 + 06 5 HENVVNLIEICR 784.45 2 + 87 2 AYVRDPYALDLIDK 551.32 2 + 18 45 NPATTNQTEFERVF 827.70 2 + 16 59 QYDSVECPFCDEVSK 931.84 2 + 13 63 VLMENEKEGFPITALR 621.67 3 + 16 42 VVTLWYRPPELLLGER 647.93 3 + 15 45 Serine/threonine phosphatase protein PPP2R1A IGPILDNSTLQSEVKPILEK 732.21 3 + 26 55 6% VLAMSGDPNYLHR 496.78 3 + 17 47 Translation regulator protein EEF1B2 SPAGLQVLNDYLADK 802.45 2 + 43 88 7% Auxiliary transport protein GDI2 LYSESLAR 469.70 2 + 16 42 4% FVSISDLLVPK 609.30 2 + 18 48 TDDYLDQPCYETINR 952.30 2 + 14 49 Receptor signalling complex scaffold protein YWHAE EAAENSLVAYK 597.84 2 + 12 41 29% DSTLIMQLLR 603.33 2 + 05 1 EALQDVEDENQ 645.21 2 + 10 56 VAGMDVELTVEER 732.36 2 + 69 7 LICCDILDVLDK 738.93 2 + 14 74 AASDIAMTELPPTHPIR 612.70 2 + 15 76 YWHAQ DSTLIMQLLR 595.32 2 + 13 49 38% YLAEVACGDDR 634.73 2 + 18 59 YLIANATNPESK 660.83 2 + 13 65 SICTTVLELLDK/AVTEQGAELSNEER 696.45 2 + 10 73 QTIDNSQGAYQEAFDISK 766.99 2 + 16 97 QTIDNSQGAYQEAFDISKK 999.51 2 + 10 81 SPIN VSALEVLPDR 549.81 2 + 18 57 4% AP3S1 SEAGLAGAPAR 500.27 2 + 39 55 6% Signal transduction CCNT1 QLENMEANVK 587.87 2 + 17 48 38% QQAANLLQDMGQR 736.55 2 + 27 71 TYSLSSSFSSSSSTR 792.37 2 + 12 88 GPSEETGGAVFDHPAK 800.02 2 + 11 78 MPIEGSENPERPFLEK 940.48 2 + 26 40 SQYAYAAQNLLSHHDSHSSVILK 857.12 2 + 27 73 SGNTDKPRPPPLPSEPPPPLPPLPK 876.24 3 + 18 50 TSENLALTGVDHSLPQDGSNAFISQK 910.82 3 + 16 60 S100A8 LLETECPQYIR 711.37 2 + 14 53 25% S100A9 NIETIINTFHQYSVK 904.09 2 + 12 54 21% KDLQNFLK 503.28 2 + 19 42 Transmembrane receptor protein tyrosine kinase protein FGFR2 NVLVTENNVMKIADFGLAR 702.03 3 + 19 40 3% Lipid kinase protein c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Single peptide Mascot score Sequence coverage PIP5K2B FGIDDQDYQNSVTR 829.33 2 + 14 88 8% FFGPGEFDPSVDVYAMK 961.47 2 + 16 42 PIP5K2C FGIDDQDYLVSLTR 821.49 2 + 17 96 11% VSVDNEDSYMLVMR 837.40 2 + 24 94 DRFGIDDQDYLVSLTR 638.40 3 + 13 57 Heterotrimeric G-protein GTPase protein GNB4 LIIWDSYTTNK 677.32 2 + 44 43 7% Guanyl-nucleotide-exchange factor protein ARHGEF4 YPLQLAELLK 594.31 2 + 15 41 2% Enzyme: dehydrogenase GAPDH VPTANVSVVDLTCR 765.90 2 + 0 68 13% LISWYDNEFGYSNR 882.35 2 + 10 64 Enzyme: synthase PTS VYETDNNIVVYKGE 821.83 2 + 73 47 10% Unknown SMAD9 VETPVLPPVLVPR 708.45 2 + 21 52 6% FCLGLLSNVNR 646.84 2 + 75 6 LSM14A EFADFEYR 538.75 2 + 18 49 12% SFFDNISCDDNR 745.35 2 + 67 1 DFDFESANAQFNK 766.86 2 + 32 70 YEGILYTIDTENSTVALAK 1051.06 2 + 19 83 DRG1 IQLLDLPGIIEGAK 740.41 2 + 27 41 4% HCCA2 LVTDEDVFPTK 632.34 2 + 14 55 10% EFPSSFESLVR 649.36 2 + 23 59 C20orf11 LIMNYLVTEGFK 714.36 2 + 17 13 6% c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"Single peptide Mascot acore Sequence coverage FLNA VANPSGNLTETYVQDR 767,51 2 +2+2+ 07 4 4 % GAGTGGLGLAVEGPSEAK 785,93 2 + 31 42 ANLPQSFQVDTSK 882,43 2 + 62 41 JAK1 LSDPGIPITVLSR 684,39 2 + 14 41 3% SDVLTTPWKFK 661,34 2 + 15 48 KIF11 LTDNGTEFSVK 605,83 2 + 59 47 9% TTAATLMNAYSSR 701,88 2 + 64 55 ETTIDGEELVK 617,32 2 + 16 47 EEYITSALESTEEK 814,92 2 + 48 94 FCALEEK 448,73 2 + 33 48 CENIQKPLSSVQENIQQK 715,02 3 + 18 60 SKVEETTEHLVTK 500,96 3 + 53 64 PRMT5 SDLLLSGR 430,76 2 + 33 49 10% KGFPVLSK 438,30 2 + 68 42 YSQYQQAIYK 646,33 2 + 15 74 DTNVQVLMVLGAGR 744,94 2 + 60 77 GPLVNASLR 463 ,81 2 + 10 40 DPEAQFEMPYVVR 798,80 2 + 37 62 HSPA1A NQVALNPQNTVFDAKR 605,63 3 + 44 40 9% ATAGDTHLGGEDFDNR 838,37 2 + 05 6 ARFEELCSDLFR 771,89 2 + 25 57 GGSGSGPTIEEVD 602,77 2 + 04 8 PPM1B YGLSSMQGWR 600,77 2 + 85 0 8 % HIYFINCGDSR 691,34 2 + 28 55 DNMSIVLVCFSNAPK 855,96 2 + 52 80 STK38 LGLEDFESLK 575,56 2 + 78 58 11% DIKPDNLLLDSK 457,60 3 + 22 53 LSDFGLCTGLK 605,79 2 + 33 53 IGAPGVEEIK 506,74 2 + 88 65 RFEGLTAR 475,22 2 + 94 42 PFKFB3 STIQTAEALR 545,17 2 + 73 37 6% YPTGESYQDLVQR 778,04 2 + 43 61 VFNVGEYR 492,24 2 + 20 44 TUBB ISVYYNEATGGK 651,2 2 + 84 59 12% AILVDLEPGTMDSVR 816,37 2 + 64 55 IMNTFSVVPSPK 668,28 2 + 104 78 LAVNMVPFPR 580,27 2 + 86 51 TUBB2C AVLVDLEPGTMDSVR 809,37 2 + 49 41 8% FPGQLNADLR 565,75 2 + 53 44 LAVNMVPFPR 580,27 2 + 86 51 HNRPH1 GLPWSCSADEVQR 752,78 2 + 86 63 12% SNNVEMDWVLK 675,78 2 + 59 58 YGDGGSTFQSTTGHCVHMR 705,24 3 + 85 41 VHIEIGPDGR 546,80 2 + 94 2 PFKFB3 EGGQIAVFDATNTTR 790,29 2 + 126 58 8% YPTGESYQDLVQR 778,26 2 + 140 109 LEPVIMELER 622,74 2 + 144 41 TUBA1A EIIDLVLDR 543,29 2 + 46 41 5% DVNAAIATIK 508,23 2 + 128 58 ATP5A1 VVDALGNAIDGK 586,28 2 + 68 52 4% AVDSLVPIGR 513,79 2 + 19 40 TRIM21 NFLVEEEQR 582,33 2 + 68 37 4% DLDITSPELR 579,79 2 + 25 62 MYC STTTGHLIYK 560,77 2 + 62 40 5% IGGIGTVPVGR 513,30 2 + 19 64 ACTB AVFPSIVGRPR 559,91 2 + 91 49 16% DSYVGDEAQSKR 977,51 2 + 22 61 GYSFTTTAER 566,77 2 + 85 0 SYELPDGQVITIGNER 895,93 2 + 22 52 EITALAPSTMK 589,27 2 + 67 44 WDR77 ETPPPLVPPAAR 622,8 2 + 88 87 8% SDGALLLGASSLSGR 702,37 2 + 14 87 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 In silico analysis of AF4 interactors by HPRD (http://www.hprd.org) Gene name Interactors Type of interaction Transcription regulatory protein PPARBP 14-3-3 Eta (*) Direct Androgen receptor Direct CRSP2 (*) Direct Estrogen receptor alpha Direct Estrogen receptor beta Direct GATA binding protein 1 Direct GATA binding protein 3 Direct Hepatocyte nuclear factor 4 alpha Direct Nuclear receptor subfamily 4,group A, member 1 DirectPeroxisome proliferator activated receptor gamma DirectPeroxisome proliferator activated receptor, alpha Direct RAR related orphan receptor A Direct Retinoid X receptor, alpha DirectTRAP230 (*) Direct Vitamin D receptor Direct p53 Direct NR1I3 Direct TRAP220 (*) Direct PPAR gamma coactivator 1 Direct Retinoic acid receptor alpha DirectMediator of RNA polymerase II transcription subunit 8 (*) DirectThyroid hormone receptor alpha Direct Thyroid hormone receptor, beta Direct GATA binding protein 4 Direct GATA binding protein 6 Direct Mediator of RNA polymerase II transcription subunit 25 homologue Direct MED9 Direct Surfeit 5 Complex TRAP230 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamineTRAP100 (*) Transcriptional coactivator CRSP70 (*) Cyclin dependent kinase 8Cell division cycle 2 like 1Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*)MED18 Trf proximal protein MED9TRAP95Mediator complex subunit 28 THRAP2 Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) CRSP9 (*) MED9Intersex like Thyroid hormone receptor associated protein 6 Mediator complex subunit 28Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7 Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamineTRAP100 (*)Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Trf proximal protein Thyroid hormone receptor associated protein 6SRB7CRSP9 (*) Mediator complex subunit 28 Cyclin C Complex CRSP2 (*)RNA polymerase II transcriptional regulation mediator (*) Cyclin dependent kinase 8 TRAP100 (*)SRB7Cyclin C Complex Cyclin dependent kinase 8 Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) Trf proximal protein Mediator of RNA polymerase II transcription, subunit 31 homologueTRAP 80 (*)Mediator complex subunit 28 Thyroid hormone receptor associated protein 1 TRAP230 (*)CRSP2 (*)Transcriptional coactivator CRSP130 (*) Thyroid hormone receptor associated protein 6 SRB7TRAP100 (*)TRAP95 CRSP9 (*) Mediator complex subunit 28 ComplexThyroid hormone receptor associated protein 1TRAP230 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)TRAP100 (*) TRAP95 Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*)Transcriptional coactivator CRSP70 (*) Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)SRB7CRSP9 (*) Mediator complex subunit 28 Surfeit 5Similar to HSPC296MED9 CRSP9 (*) Mediator complex subunit 28TRAP230 (*)TRAP 80 (*) Cyclin C Cyclin dependent kinase 8Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*)MED18Trf proximal protein MED9 Intersex likeThyroid hormone receptor associated protein 6RING3 Complex Cyclin dependent kinase 8 RNA polymerase IIA 220 kd subunitCRSP2 (*) Complex Thyroid hormone receptor associated protein 1 TRAP230 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine Mediator of RNA polymerase II transcription subunit 25 homologue c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Acyl-coenzyme A dehydrogenase 8 Actin related protein 2/3 complex subunit 2, 34kDaRNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) Peroxisome proliferator activated receptor, alpha Complex CREBBPATP binding cassette, subfamily C, member 9SRC1 E1A binding protein p300 Tryptophan rich basic proteinPPAR gamma coactivator 1Nuclear receptor coactivator 6 TRAP100 (*) Nuclear receptor coactivator 6 interacting proteinTRAP100 (*) Complex Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)Transcriptional coactivator CRSP70 (*)RNA polymerase II transcriptional regulation mediator (*) SRB7 SRB7CRSP2 (*)Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamine Mediator of RNA polymerase II transcription subunit 25 homologue ComplexCyclin dependent kinase 8RNA polymerase II transcriptional regulation mediator (*) CRSP4 Complex CRSP5CRSP2 (*)TRAP 80 (*) Transcriptional coactivator CRSP130 (*) Transcriptional coactivator CRSP70 (*)Transcriptional coactivator CRSP34 (*) CRSP9 (*) MED12 TRAP230 (*) Direct Cyclin dependent kinase 8 DirectTRAP220 (*) Direct Transcriptional coactivator CRSP70 (*) Direct Lysosomal trafﬁcking regulator DirectSOX9 Direct Mediator of RNA polymerase II transcription subunit 8 (*) Direct Thyroid hormone receptor associated protein 1 Direct MED9 Direct Surfeit 5 Complex TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineTRAP100 (*) Transcriptional coactivator CRSP70 (*) Cyclin dependent kinase 8Cell division cycle 2 like 1 Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) MED18 Trf proximal proteinMED9TRAP95 Mediator complex subunit 28 THRAP2Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) CRSP9 (*)MED9 Intersex like c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Thyroid hormone receptor associated protein 6 Mediator complex subunit 28Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7 Mediator complex subunit 28 ComplexThyroid hormone receptor associated protein 1TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)TRAP100 (*)TRAP95 Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)Transcriptional coactivator CRSP70 (*) Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)SRB7CRSP9 (*) Thyroid hormone receptor associated protein 1 Complex TRAP220 (*)CRSP2 (*)Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamine TRAP100 (*)Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*)Trf proximal protein Thyroid hormone receptor associated protein 6 SRB7CRSP9 (*) Mediator complex subunit 28 Cyclin C Complex Cyclin dependent kinase 8Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) Trf proximal proteinMediator of RNA polymerase II transcription, subunit 31 homologueTRAP 80 (*) Mediator complex subunit 28 Thyroid hormone receptor associated protein 1TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) Thyroid hormone receptor associated protein 6SRB7TRAP100 (*) TRAP95 CRSP9 (*)Mediator complex subunit 28 Complex Surfeit 5 Similar to HSPC296MED9CRSP9 (*) Mediator complex subunit 28 TRAP220 (*)TRAP 80 (*)Cyclin C Cyclin dependent kinase 8 Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediatorMediator of RNA polymerase II transcription subunit 8 (*) MED18 Trf proximal proteinMED9 Intersex like c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Thyroid hormone receptor associated protein 6 CRSP2 (*) Complex Thyroid hormone receptor associated protein 1 ComplexTRAP220 (*) Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamineMediator of RNA polymerase II transcription subunit 25 homologueAcyl-coenzyme A dehydrogenase 8 Actin related protein 2/3 complex subunit 2, 34kDa RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) CRSP2 Glucocorticoid receptor Direct Androgen receptor Direct Hepatocyte nuclear factor 4 alpha DirectSTAT2 Direct TRAP220 (*) Direct Intersex like Direct MED9 Direct Surfeit 5 Complex TRAP230 (*) TRAP220 (*)Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine TRAP100 (*) Transcriptional coactivator CRSP70 (*)Cyclin dependent kinase 8Cell division cycle 2 like 1 Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) MED18 Trf proximal proteinMED9 TRAP95 Mediator complex subunit 28THRAP2Thyroid hormone receptor associated protein 1 Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)CRSP9 (*)MED9 Intersex like Thyroid hormone receptor associated protein 6Mediator complex subunit 28Similar to HSPC296 Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*) TRAP220 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine TRAP100 (*) Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*)Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*)Trf proximal proteinThyroid hormone receptor associated protein 6 SRB7 CRSP9 (*)Mediator complex subunit 28Cyclin C Complex RNA polymerase II transcriptional regulation mediator (*) Cyclin dependent kinase 8TRAP220 (*) TRAP100 (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction SRB7 Cyclin C Complex Cyclin dependent kinase 8Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) Trf proximal proteinMediator of RNA polymerase II transcription, subunit 31 homologueTRAP 80 (*) Mediator complex subunit 28 Thyroid hormone receptor associated protein 1TRAP230 (*)TRAP220 (*) Transcriptional coactivator CRSP130 (*) Thyroid hormone receptor associated protein 6SRB7 TRAP100 (*) TRAP95CRSP9 (*)Mediator complex subunit 28 Complex Thyroid hormone receptor associated protein 1 TRAP230 (*)TRAP220 (*)Transcriptional coactivator CRSP130 (*) TRAP100 (*) TRAP95Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Transcriptional coactivator CRSP70 (*) Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*)SRB7 CRSP9 (*) Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*) TRAP220 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineMediator of RNA polymerase II transcription subunit 25 homologue Acyl-coenzyme A dehydrogenase 8 Actin related protein 2/3 complex subunit 2, 34kDaRNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) RNA polymerase II transcriptional regulation mediator (*) Complex Cyclin dependent kinase 8Cyclin CSRB7 Mediator complex subunit 28 Complex TRAP95Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) MED18 Trf proximal proteinSRB7 Mediator of RNA polymerase II transcription, subunit 31 homologue Complex Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*)TRAP95 TRAP 80 (*) Transcriptional coactivator CRSP130 (*)TRAP100 (*)Trf proximal protein Thyroid hormone receptor associated protein 6 SRB7PC2TRAP100 (*) Complex Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)Transcriptional coactivator CRSP70 (*) RNA polymerase II transcriptional regulation mediator (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction SRB7 SRB7TRAP220 (*)Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamine CRSP4 Complex CRSP5TRAP 80 (*) TRAP220 (*) Transcriptional coactivator CRSP130 (*)Transcriptional coactivator CRSP70 (*)Transcriptional coactivator CRSP34 (*) CRSP9 (*) CRSP3 CCAAT/Enhancer binding protein, beta Direct E74 like factor 3 Direct Nuclear receptor coactivator 6 Direct Thyroid hormone receptor associated protein 1 DirectPumilio2 Direct WD and tetratricopeptide repeats 1 Direct Forkhead box J3 Direct MED9 Direct Surfeit 5 Complex TRAP230 (*) TRAP220 (*) CRSP2 (*)Positive cofactor 2 glutamineTRAP100 (*) Transcriptional coactivator CRSP70 (*) Cyclin dependent kinase 8Cell division cycle 2 like 1Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) MED18 Trf proximal proteinMED9TRAP95 Mediator complex subunit 28 THRAP2Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) CRSP9 (*)MED9Intersex like Thyroid hormone receptor associated protein 6 Mediator complex subunit 28Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7 Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*) TRAP220 (*) CRSP2 (*)Positive cofactor 2 glutamineTRAP100 (*) Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*) Trf proximal proteinThyroid hormone receptor associated protein 6SRB7 CRSP9 (*) Mediator complex subunit 28Cyclin C Complex Cyclin dependent kinase 8 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)Trf proximal proteinMediator of RNA polymerase II transcription, subunit 31 homologue TRAP 80 (*) Mediator complex subunit 28Thyroid hormone receptor associated protein 1TRAP230 (*) TRAP220 (*) CRSP2 (*)Thyroid hormone receptor associated protein 6SRB7 TRAP100 (*) TRAP95CRSP9 (*) Mediator complex subunit 28 Complex Thyroid hormone receptor associated protein 1TRAP230 (*)TRAP220 (*) CRSP2 (*) TRAP100 (*)TRAP95Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) Transcriptional coactivator CRSP70 (*)Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) SRB7 CRSP9 (*)CRSP2 (*) Complex Thyroid hormone receptor associated protein 1 TRAP230 (*) TRAP220 (*)Positive cofactor 2 glutamine Mediator of RNA polymerase II transcription subunit 25 homologue Acyl-coenzyme A dehydrogenase 8Actin related protein 2/3 complex subunit 2, 34kDaRNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*) Mediator of RNA polymerase II transcription, subunit 31 homologue ComplexCRSP2 (*)Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) TRAP95TRAP 80 (*)TRAP100 (*) Trf proximal protein Thyroid hormone receptor associated protein 6SRB7PC2 TRAP100 (*) Complex Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Transcriptional coactivator CRSP70 (*) RNA polymerase II transcriptional regulation mediator (*)SRB7SRB7 TRAP220 (*) CRSP2 (*)Positive cofactor 2 glutamineCRSP4 Complex CRSP5 CRSP2 (*)TRAP 80 (*)TRAP220 (*) Transcriptional coactivator CRSP70 (*) Transcriptional coactivator CRSP34 (*)CRSP9 (*) THRAP4 Estrogen receptor alpha Direct c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Peroxisome proliferator activated receptor gamma Direct Peroxisome proliferator activated receptor, alpha DirectRetinoid X receptor, alpha DirectMED9 Direct Surfeit 5 Complex TRAP230 (*)TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamineTranscriptional coactivator CRSP70 (*)Cyclin dependent kinase 8 Cell division cycle 2 like 1 Vitamin D receptor interacting protein (*)Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*)MED18Trf proximal protein MED9 TRAP95Mediator complex subunit 28THRAP2 Thyroid hormone receptor associated protein 1 Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*)CRSP9 (*) MED9 Intersex likeThyroid hormone receptor associated protein 6Mediator complex subunit 28 Similar to HSPC296 Mediator of RNA polymerase II transcription, subunit 31 homologueSRB7 Thyroid hormone receptor associated protein 1 Complex TRAP230 (*)TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamineMediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*)Trf proximal protein Thyroid hormone receptor associated protein 6 SRB7CRSP9 (*)Mediator complex subunit 28 Cyclin C Complex CRSP2 (*)RNA polymerase II transcriptional regulation mediator (*) Cyclin dependent kinase 8 TRAP220 (*)SRB7Cyclin C Complex Cyclin dependent kinase 8 Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*)Trf proximal protein Mediator of RNA polymerase II transcription, subunit 31 homologue TRAP 80 (*)Mediator complex subunit 28Thyroid hormone receptor associated protein 1 TRAP230 (*) TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Thyroid hormone receptor associated protein 6 SRB7TRAP95CRSP9 (*) Mediator complex subunit 28 Complex Thyroid hormone receptor associated protein 1TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)TRAP95Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) Transcriptional coactivator CRSP70 (*)Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) SRB7CRSP9 (*)Peroxisome proliferator activated receptor, alpha Complex CREBBP ATP binding cassette, subfamily C, member 9SRC1E1A binding protein p300 Tryptophan rich basic protein TRAP220 (*)PPAR gamma coactivator 1Nuclear receptor coactivator 6 Nuclear receptor coactivator 6 interacting protein Mediator of RNA polymerase II transcription subunit 25 homologue ComplexTRAP 80 (*)Transcriptional coactivator CRSP70 (*) RNA polymerase II transcriptional regulation mediator (*) SRB7SRB7 TRAP220 (*) CRSP2 (*)Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine Mediator of RNA polymerase II transcription, subunit 31 homologue Complex CRSP2 (*)Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) TRAP95 TRAP 80 (*)Transcriptional coactivator CRSP130 (*)Trf proximal protein Thyroid hormone receptor associated protein 6 SRB7PC2 CRSP6 Mediator of RNA polymerase II transcription subunit 19 Direct Surfeit 5 Direct Thyroid hormone receptor associated protein 6 Directp53 Direct Mediator of RNA polymerase II transcription subunit 8 (*) Direct Ubiquitin speciﬁc protease 49 DirectBRCA1 Complex BRCA1 associated ring domain 1 SMARCA4 RNA polymerase IIA 220 kd subunitSurfeit 5 Complex TRAP230 (*) TRAP220 (*) CRSP2 (*)Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine TRAP100 (*) Transcriptional coactivator CRSP70 (*)Cyclin dependent kinase 8 Cell division cycle 2 like 1 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) MED18 Trf proximal proteinMED9TRAP95 Mediator complex subunit 28 THRAP2Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologue CRSP9 (*) MED9Intersex like Thyroid hormone receptor associated protein 6 Mediator complex subunit 28Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7 Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineTRAP100 (*) Mediator of RNA polymerase II transcription subunit 25 homologue Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) Trf proximal protein Thyroid hormone receptor associated protein 6SRB7 CRSP9 (*) Mediator complex subunit 28Cyclin C Complex Cyclin dependent kinase 8 Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)Trf proximal proteinMediator of RNA polymerase II transcription, subunit 31 homologue Mediator complex subunit 28 Thyroid hormone receptor associated protein 1TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Thyroid hormone receptor associated protein 6SRB7 TRAP100 (*) TRAP95CRSP9 (*) Mediator complex subunit 28 Complex Thyroid hormone receptor associated protein 1TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)TRAP100 (*)TRAP95 Mediator of RNA polymerase II transcription subunit 25 homologue Transcriptional coactivator CRSP70 (*)Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) SRB7 CRSP9 (*)Mediator complex subunit 28 Complex Surfeit 5 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Similar to HSPC296 MED9CRSP9 (*)Mediator complex subunit 28 TRAP230 (*) TRAP220 (*)Cyclin CCyclin dependent kinase 8 Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*)MED18 Trf proximal protein MED9Intersex like Thyroid hormone receptor associated protein 6 Mediator of RNA polymerase II transcription subunit 8 (*) ComplexIntersex likeTRAP100 (*) Complex Mediator of RNA polymerase II transcription subunit 25 homologue Transcriptional coactivator CRSP70 (*)RNA polymerase II transcriptional regulation mediator (*)SRB7 SRB7 TRAP220 (*)CRSP2 (*)Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamine Mediator of RNA polymerase II transcription, subunit 31 homologue ComplexCRSP2 (*)Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) TRAP95Transcriptional coactivator CRSP130 (*) TRAP100 (*) Trf proximal proteinThyroid hormone receptor associated protein 6SRB7 PC2 CRSP4 Complex CRSP5CRSP2 (*) TRAP220 (*) Transcriptional coactivator CRSP130 (*)Transcriptional coactivator CRSP70 (*)Transcriptional coactivator CRSP34 (*) CRSP9 (*) CRSP7 Cyclin dependent kinase 8 Direct TRAP230 (*) Direct Mediator of RNA polymerase II transcription subunit 8 (*) Direct Retinol binding protein 1 Direct MED9 Direct Surfeit 5 Complex TRAP230 (*) TRAP220 (*)CRSP2 (*)Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamine TRAP100 (*)Cyclin dependent kinase 8Cell division cycle 2 like 1 Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) MED18 Trf proximal proteinMED9 TRAP95 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Mediator complex subunit 28 THRAP2Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) CRSP9 (*)MED9Intersex like Thyroid hormone receptor associated protein 6 Mediator complex subunit 28Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7 Mediator complex subunit 28 ComplexThyroid hormone receptor associated protein 1 TRAP230 (*) TRAP220 (*)CRSP2 (*)Transcriptional coactivator CRSP130 (*) TRAP100 (*) TRAP95Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)SRB7CRSP9 (*) Mediator complex subunit 28 Complex MED9Intersex likeMediator of RNA polymerase II transcription subunit 19 TRAP100 (*) Complex Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) RNA polymerase II transcriptional regulation mediator (*) SRB7SRB7TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineCRSP4 Complex CRSP5 CRSP2TRAP 80 (*)TRAP220 (*) Transcriptional coactivator CRSP130 (*) Transcriptional coactivator CRSP34 (*)CRSP9 (*) RBBP4 BRCA1 Direct CREBBP Direct Chromatin assembly factor 1 subunit B DirectHistone H3 K9 methyltransferase 1 Direct Histone deacetylase 1 Direct Inhibitor of growth 1 Direct Retinoblastoma 1 Direct Retinoblastoma binding protein 7 Direct Transcription factor Sp1 Direct Transcription factor Sp3 Direct Sin3 associated polypeptide ,30KD DirectMetastasis associated protein MTA1 Direct Methyl CpG binding domain protein 2 Direct Methyl CpG binding domain protein 3 DirectHistone deacetylase 2 Direct Breast cancer metastasis suppressor 1 Direct Retinol binding protein 1 Direct Metastasis associated protein MTA2 DirectHistone deacetylase 3 Direct SIN3A Direct c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Hypothetical protein MGC4677 Direct AE binding protein 2 DirectBreast cancer metastasis suppressor 1 like DirectHistone deacetylase 4 Direct H2A histone family member Q Direct Histone 2 H3c Direct SHARP Direct CD8 Antigen, alpha polypeptide Complex Histone deacetylase 1 Eukaryotic translation initiation factor 3, subunit 10Retinoblastoma binding protein 7Chromodomain helicase DNA binding protein 4 Sin3 associated polypeptide ,30KD Methyl CpG binding domain protein 2Methyl CpG binding domain protein 3 Histone deacetylase 2 Metastasis associated protein MTA2SIN3AEZH2 protein Complex Polycomb protein SUZ12 EEDAE binding protein 2Histone deacetylase 1 Complex Retinoblastoma binding protein 7 Metastasis associated protein MTA1Histone deacetylase 2Metastasis associated protein MTA2 Methyl-CpG binding domain protein 3-like 1 Histone deacetylase 1 ComplexInhibitor of growth 1Sin3 associated polypeptide ,30KD Retinol binding protein 1 SIN3AHistone deacetylase 1 Complex Retinoblastoma binding protein 7 Sin3 associated polypeptide, 18 kdSin3 associated polypeptide ,30KDHistone deacetylase 2 Histone deacetylase 1 Complex Retinoblastoma binding protein 7Methyl CpG binding domain protein 3Histone deacetylase 2 Metastasis associated protein MTA2 Chromodomain helicase DNA binding protein 3Metastasis associated protein MTA3Polycomb protein SUZ12 Complex EED Chromatin assembly factor 1 subunit B ComplexChromatin assembly factor 1 subunit ASin3 associated polypeptide ,30KD Complex SIN3A Histone deacetylase 2Histone deacetylase 1 Nuclear receptor corepressor 2 Histone deacetylase 3Nuclear receptor corepressor 1mSDS3 Complex Histone deacetylase 1 Retinoblastoma binding protein 7Sin3 associated polypeptide ,30KDHistone deacetylase 2 SIN3A RBP1 like proteinmSin3A-associated protein 130Sds3 Complex Set1 Heat shock 70 KD protein 1AHSP90A Host cell factor C1 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Histone deacetylase 1 Retinoblastoma binding protein 7Sin3 associated polypeptide ,30KDASH2 like Histone deacetylase 2 Heat shock 70 kDa protein 8SIN3ASIN3B WD repeat domain 5 RUVBL2 Activating transcription factor 2 Direct BAF53 Direct Proliferating cell nuclear antigen Direct RuvB like 1 (*) Direct RuvB like 2 (*) DirectCatenin beta Direct Exosome component 10 Direct Bcl 3 Direct Histone deacetylase 1 DirectHistone deacetylase 4 Direct Mortality factor 4 like protein 1 Complex Sarcoma antigen NY-SAR-91Inhibitor of growth family member 3EPC1 Enhancer of polycomb homologue 2 HIV-1 Tat interacting protein, 60kDaActin betaHIV-1 Tat interacting protein, 60kDa Glioma ampliﬁed sequence 41 Bromodomain containing 8350/400 kDa PCAF associated factorActin-like 6A DMAP1 RuvB like 1 (*)E1A binding protein p400 HIV-1 Tat interacting protein, 60kDa Complex Actin betaMortality factor 4 like 2HIV-1 Tat interacting protein, 60kDa Inhibitor of growth family member 3 Glioma ampliﬁed sequence 41Bromodomain containing 8350/400 kDa PCAF associated factor Actin-like 6A DMAP1E1A binding protein p400Mortality factor 4 like protein 1 Sarcoma antigen NY-SAR-91 EPC1Heat shock 70 KD protein 1ARibosomal L1 domain containing 1 C20orf20 protein RuvB like 1 (*)HIV-1 Tat interacting protein, 60kDa Complex 350/400 kDa PCAF associated factor Bromodomain containing 8E1A binding protein p400EPC1 Enhancer of polycomb homologue 2 HIV-1 Tat interacting protein, 60kDaInhibitor of growth family member 3Mortality factor 4 like protein 1 Mortality factor 4 like 2 C20orf20 proteinSarcoma antigen NY-SAR-91DMAP1 RuvB like 1 (*) Glioma ampliﬁed sequence 41Actin-like 6A TCFL1 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction RNA polymerase II subunit 5-mediating protein Complex RuvB like 1 (*)BCR downstream signaling 1S phase kinase associated protein 2 NHP2 like protein 1 Complex Nucleolar protein NOP5FibrillarinNHP2 like protein 1 NOP56 RuvB like 1 (*)RNA EAF1 Elongation factor, RNA polymerase II, 2 Direct RNA polymerase II elongation factor ELL Direct MED4 MED9 Direct Surfeit 5 Complex TRAP230 (*)TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamineTRAP100 (*)Transcriptional coactivator CRSP70 (*) Cyclin dependent kinase 8 Cell division cycle 2 like 1Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*) MED18Trf proximal proteinMED9 TRAP95 Mediator complex subunit 28THRAP2 Thyroid hormone receptor associated protein 1 Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*)CRSP9 (*) MED9 Intersex likeThyroid hormone receptor associated protein 6Mediator complex subunit 28 Similar to HSPC296 Mediator of RNA polymerase II transcription, subunit 31 homologueSRB7Thyroid hormone receptor associated protein 1 Complex TRAP230 (*) TRAP220 (*)CRSP2 (*)Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamine TRAP100 (*)Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*)Trf proximal protein Thyroid hormone receptor associated protein 6 SRB7CRSP9 (*)Mediator complex subunit 28 Cyclin C Complex Cyclin dependent kinase 8RNA polymerase II transcriptional regulation mediator (*)Trf proximal protein Mediator of RNA polymerase II transcription, subunit 31 homologue TRAP 80 (*)Mediator complex subunit 28 Thyroid hormone receptor associated protein 1 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction TRAP230 (*) TRAP220 (*)CRSP2 (*)Transcriptional coactivator CRSP130 (*) Thyroid hormone receptor associated protein 6 SRB7TRAP100 (*)TRAP95 CRSP9 (*) Mediator complex subunit 28 ComplexThyroid hormone receptor associated protein 1TRAP230 (*) TRAP220 (*) CRSP2 (*)Transcriptional coactivator CRSP130 (*) TRAP100 (*) TRAP95Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Transcriptional coactivator CRSP70 (*) RNA polymerase II transcriptional regulation mediator (*)SRB7CRSP9 (*) Mediator complex subunit 28 Complex CRSP2 (*)TRAP95RNA polymerase II transcriptional regulation mediator (*) MED18 Trf proximal proteinSRB7Mediator of RNA polymerase II transcription, subunit 31 homologue Complex CRSP2 (*) RNA polymerase II transcriptional regulation mediator (*)TRAP95 TRAP 80 (*) Transcriptional coactivator CRSP130 (*)TRAP100 (*)Trf proximal protein Thyroid hormone receptor associated protein 6 SRB7PC2 CRSP8 Mediator of RNA polymerase II transcription subunit 19 Direct Surfeit 5 Direct Thyroid hormone receptor associated protein 6 DirectMediator of RNA polymerase II transcription subunit 8 (*) DirectMED9 Direct CRSP4 Complex CRSP5CRSP2 (*)TRAP 80 (*) TRAP220 (*) Transcriptional coactivator CRSP130 (*)Transcriptional coactivator CRSP70 (*) CRSP9 (*) CRSP9 Mediator of RNA polymerase II transcription subunit 8 (*) Direct MED9 Direct Mediator complex subunit 28 Complex Surfeit 5 Similar to HSPC296MED9Mediator complex subunit 28 TRAP230 (*) TRAP220 (*)TRAP 80 (*)Cyclin C Cyclin dependent kinase 8 Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction MED18 Trf proximal proteinMED9Intersex like Thyroid hormone receptor associated protein 6 Surfeit 5 Complex TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineTRAP100 (*) Transcriptional coactivator CRSP70 (*) Cyclin dependent kinase 8Cell division cycle 2 like 1 Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) MED18 Trf proximal proteinMED9TRAP95 Mediator complex subunit 28 THRAP2Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) MED9Intersex likeThyroid hormone receptor associated protein 6 Mediator complex subunit 28 Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7 Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineTRAP100 (*) Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*) Trf proximal proteinThyroid hormone receptor associated protein 6SRB7 Mediator complex subunit 28 Cyclin C Complex Cyclin dependent kinase 8 Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)Trf proximal proteinMediator of RNA polymerase II transcription, subunit 31 homologue TRAP 80 (*) Mediator complex subunit 28Thyroid hormone receptor associated protein 1TRAP230 (*) TRAP220 (*) CRSP2 (*)Transcriptional coactivator CRSP130 (*)Thyroid hormone receptor associated protein 6 SRB7 TRAP100 (*)TRAP95 Mediator complex subunit 28 Complex c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Thyroid hormone receptor associated protein 1 TRAP230 (*)TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) TRAP100 (*)TRAP95Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) Transcriptional coactivator CRSP70 (*)Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) SRB7 CRSP4 Complex CRSP5 CRSP2 TRAP 80 (*)TRAP220 (*)Transcriptional coactivator CRSP130 (*) Transcriptional coactivator CRSP70 (*) Transcriptional coactivator CRSP34 (*) MED 6 ADP ribosyl transferase Direct Retinoic acid receptor alpha Direct SMAD1 Direct SMAD2 Direct Mediator of RNA polymerase II transcription subunit 8 (*) DirectMediator of RNA polymerase II transcription subunit 25 homologue Direct MED9 Direct Surfeit 5 Complex TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine TRAP100 (*) Transcriptional coactivator CRSP70 (*)Cyclin dependent kinase 8Cell division cycle 2 like 1 Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 19Mediator of RNA polymerase II transcription subunit 8 (*)MED18 Trf proximal protein MED9TRAP95Mediator complex subunit 28 THRAP2 Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) CRSP9 (*) MED9Intersex like Thyroid hormone receptor associated protein 6 Mediator complex subunit 28Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7 Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineTRAP100 (*) Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)Vitamin D receptor interacting protein (*) Mediator of RNA polymerase II transcription subunit 8 (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Trf proximal protein Thyroid hormone receptor associated protein 6SRB7CRSP9 (*) Mediator complex subunit 28 Cyclin C Complex Cyclin dependent kinase 8Vitamin D receptor interacting protein (*) Trf proximal protein Mediator of RNA polymerase II transcription, subunit 31 homologueTRAP 80 (*)Mediator complex subunit 28 Thyroid hormone receptor associated protein 1 TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Thyroid hormone receptor associated protein 6SRB7 TRAP100 (*) TRAP95CRSP9 (*)Cyclin C Complex CRSP2 (*) Cyclin dependent kinase 8TRAP220 (*)TRAP100 (*) SRB7 Mediator complex subunit 28 ComplexThyroid hormone receptor associated protein 1TRAP230 (*) TRAP220 (*) CRSP2 (*)Transcriptional coactivator CRSP130 (*) TRAP100 (*) TRAP95Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Transcriptional coactivator CRSP70 (*) Vitamin D receptor interacting protein (*)SRB7CRSP9 (*) Mediator complex subunit 28 Complex Surfeit 5Similar to HSPC296MED9 CRSP9 (*) Mediator complex subunit 28TRAP230 (*)TRAP220 (*) TRAP 80 (*) Cyclin CCyclin dependent kinase 8 Mediator of RNA polymerase II transcription subunit 19 Mediator of RNA polymerase II transcription subunit 8 (*)MED18Trf proximal protein MED9 Intersex likeThyroid hormone receptor associated protein 6CRSP2 (*) Complex Thyroid hormone receptor associated protein 1 TRAP230 (*)TRAP220 (*)Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamine Mediator of RNA polymerase II transcription subunit 25 homologueAcyl-coenzyme A dehydrogenase 8 Actin related protein 2/3 complex subunit 2, 34kDa c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Mediator of RNA polymerase II transcription subunit 8 (*) CRSP2 (*) Complex Cyclin dependent kinase 8Cyclin C SRB7 SRB7 Complex Cyclin dependent kinase 8Cyclin C TRAP100 (*) Complex Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*)Transcriptional coactivator CRSP70 (*) SRB7 SRB7TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineMediator complex subunit 28 Complex CRSP2 (*) TRAP95Vitamin D receptor interacting protein (*)MED18 Trf proximal protein SRB7Mediator of RNA polymerase II transcription, subunit 31 homologue ComplexCRSP2 (*) Vitamin D receptor interacting protein (*) TRAP95TRAP 80 (*)Transcriptional coactivator CRSP130 (*) TRAP100 (*) Trf proximal proteinThyroid hormone receptor associated protein 6 SRB7 PC2TRAP220 (*) Complex Mediator of RNA polymerase II transcription subunit 25 homologue Cyclin dependent kinase 8 Intersex like Complex Thyroid hormone receptor alphaMediator of RNA polymerase II transcription subunit 8 (*) MED8 CRSP9 (*) Direct Cyclin C Direct Cyclin dependent kinase 8 DirectRNA polymerase II transcriptional regulation mediator (*) Direct Surfeit 5 Direct TRAP 80 (*) Direct TRAP220 (*) Direct TRAP230 (*) Direct Transcription elongation factor B, 1 Direct Transcriptional coactivator CRSP34 (*) DirectTranscriptional coactivator CRSP70 (*) Direct Ubiquitin speciﬁc protease 49 Direct Thyroid hormone receptor associated protein 6 DirectMediator of RNA polymerase II transcription subunit 25 homologue DirectMediator complex subunit 28 Direct Mediator of RNA polymerase II transcription, subunit 31 homologue Direct MED9 Direct Similar to HSPC296 Direct Trf proximal protein Direct Mediator of RNA polymerase II transcription subunit 19 Direct Ngg1 interacting factor 3 like 1 binding protein 1 DirectMediator of RNA polymerase II transcription subunit 8 (*) DirectSurfeit 5 Complex TRAP230 (*) TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Positive cofactor 2 glutamine TRAP100 (*)Transcriptional coactivator CRSP70 (*)Cyclin dependent kinase 8 Cell division cycle 2 like 1 Vitamin D receptor interacting protein (*)Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*) MED18 Trf proximal proteinMED9TRAP95 Mediator complex subunit 28 THRAP2Thyroid hormone receptor associated protein 1 Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*)CRSP9 (*)MED9 Intersex like Thyroid hormone receptor associated protein 6Mediator complex subunit 28Similar to HSPC296 Mediator of RNA polymerase II transcription, subunit 31 homologue SRB7Thyroid hormone receptor associated protein 1 ComplexTRAP230 (*) TRAP220 (*) CRSP2 (*)Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine TRAP100 (*) Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*)Trf proximal proteinThyroid hormone receptor associated protein 6 SRB7 CRSP9 (*)Mediator complex subunit 28Mediator complex subunit 28 Complex Surfeit 5 Similar to HSPC296MED9CRSP9 (*) Mediator complex subunit 28 TRAP230 (*)TRAP220 (*)TRAP 80 (*) Cyclin C Cyclin dependent kinase 8Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediator (*) MED18Trf proximal proteinMED9 Intersex like Thyroid hormone receptor associated protein 6CRSP2 (*) Complex Thyroid hormone receptor associated protein 1 TRAP230 (*) TRAP220 (*)Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamine Mediator of RNA polymerase II transcription subunit 25 homologue Acyl-coenzyme A dehydrogenase 8Actin related protein 2/3 complex subunit 2, 34kDa RNA polymerase II transcriptional regulation mediator (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Transcription elongation factor B, 2 Complex Transcription elongation factor B, 1Cullin 2Ring-box 1 TRAP 80 (*) Complex Intersex likeRNA polymerase II transcriptional regulation mediator (*) ComplexIntersex like Thyroid hormone receptor alpha TRFP Mediator of RNA polymerase II transcription subunit 8 Direct MED18 Direct Intersex like Direct Surfeit 5 Complex TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*)Positive cofactor 2 glutamineTRAP100 (*) Transcriptional coactivator CRSP70 (*) Cyclin dependent kinase 8Cell division cycle 2 like 1Vitamin D receptor interacting protein Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*)MED18 MED9 TRAP95Mediator complex subunit 28THRAP2 Thyroid hormone receptor associated protein 1 Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 (*) CRSP9 (*) MED9Intersex likeThyroid hormone receptor associated protein 6 Mediator complex subunit 28 Similar to HSPC296Mediator of RNA polymerase II transcription, subunit 31 homologueSRB7 Thyroid hormone receptor associated protein 1 Complex TRAP230 (*)TRAP220 (*)CRSP2 (*) Transcriptional coactivator CRSP130 (*) Positive cofactor 2 glutamineTRAP100 (*)Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 (*) Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription subunit 8 (*) Thyroid hormone receptor associated protein 6SRB7CRSP9 (*) Mediator complex subunit 28 Cyclin C Complex Cyclin dependent kinase 8Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) Mediator of RNA polymerase II transcription, subunit 31 homologueTRAP 80 (*)Mediator complex subunit 28 Thyroid hormone receptor associated protein 1 TRAP230 (*)TRAP220 (*) CRSP2 (*) Transcriptional coactivator CRSP130 (*) c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Thyroid hormone receptor associated protein 6 SRB7TRAP100 (*)TRAP95 CRSP9 (*) Mediator complex subunit 28 Complex Surfeit 5Similar to HSPC296 MED9 CRSP9Mediator complex subunit 28TRAP230 (*) TRAP220 (*) TRAP 80 (*)Cyclin C Cyclin dependent kinase 8 Mediator of RNA polymerase II transcription subunit 19RNA polymerase II transcriptional regulation mediator (*)Mediator of RNA polymerase II transcription subunit 8 (*) MED18 MED9Intersex likeThyroid hormone receptor associated protein 6 Mediator complex subunit 28 Complex CRSP2 (*)TRAP95Vitamin D receptor interacting protein (*) RNA polymerase II transcriptional regulation mediator (*) MED18SRB7Mediator of RNA polymerase II transcription, subunit 31 homologue Complex CRSP2 (*) Vitamin D receptor interacting protein (*)RNA polymerase II transcriptional regulation mediator (*) TRAP95 TRAP 80 (*)Transcriptional coactivator CRSP130 (*)TRAP100 (*) Thyroid hormone receptor associated protein 6 SRB7PC2 SURB7 BRCA1 Direct Basic transcription factor 3 Direct Cyclin dependent kinase 8 Direct RNA polymerase IIA 220 kd subunit Direct TRK fused gene Direct Transcription elongation factor B, 3 Direct Cyclin dependent kinase 9 Direct RNA polymerase IIA 220 kd subunit Complex SMARCC1 SMARCB1 SMARCA2SMARCC2 Cyclin C Cyclin dependent kinase 8SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1Thyroid hormone receptor associated protein 1 Complex TRAP230 (*) TRAP220CRSP2Transcriptional coactivator CRSP130 Positive cofactor 2 glutamine TRAP100Mediator of RNA polymerase II transcription subunit 25 homologueTRAP 80 Vitamin D receptor interacting protein RNA polymerase II transcriptional regulation mediatorMediator of RNA polymerase II transcription subunit 8 Trf proximal protein Thyroid hormone receptor associated protein 6 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction CRSP9 Mediator complex subunit 28Cyclin C Complex CRSP2 RNA polymerase II transcriptional regulation mediator Cyclin dependent kinase 8TRAP220TRAP100 Cyclin C Complex Cyclin dependent kinase 8Vitamin D receptor interacting proteinRNA polymerase II transcriptional regulation mediator Trf proximal protein Mediator of RNA polymerase II transcription, subunit 31 homologueTRAP 80 Mediator complex subunit 28 Thyroid hormone receptor associated protein 1TRAP230TRAP220 CRSP2 Transcriptional coactivator CRSP130Thyroid hormone receptor associated protein 6TRAP100 TRAP95 CRSP9Mediator complex subunit 28 ComplexThyroid hormone receptor associated protein 1 TRAP230 TRAP220CRSP2Transcriptional coactivator CRSP130 TRAP100 TRAP95Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 Transcriptional coactivator CRSP70Vitamin D receptor interacting proteinRNA polymerase II transcriptional regulation mediator CRSP9 Surfeit 5 Complex TRAP230TRAP220 CRSP2 Transcriptional coactivator CRSP130Positive cofactor 2 glutamineTRAP100 Transcriptional coactivator CRSP70 Cyclin dependent kinase 8Cell division cycle 2 like 1Vitamin D receptor interacting protein Mediator of RNA polymerase II transcription subunit 19 RNA polymerase II transcriptional regulation mediatorMediator of RNA polymerase II transcription subunit 8 MED18 Trf proximal proteinMED9TRAP95 Mediator complex subunit 28 THRAP2Thyroid hormone receptor associated protein 1Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 CRSP9MED9Intersex like Thyroid hormone receptor associated protein 6 Mediator complex subunit 28Similar to HSPC296 Mediator of RNA polymerase II transcription, subunit 31 homologue CRSP2 Complex c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction RNA polymerase II transcriptional regulation mediator Cyclin dependent kinase 8Cyclin CRNA polymerase II transcriptional regulation mediator Complex Cyclin dependent kinase 8 Cyclin CTRAP100 Complex Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80 Transcriptional coactivator CRSP70RNA polymerase II transcriptional regulation mediatorTRAP220 CRSP2 Transcriptional coactivator CRSP130Positive cofactor 2 glutamine Mediator complex subunit 28 Complex CRSP2TRAP95Vitamin D receptor interacting protein RNA polymerase II transcriptional regulation mediator MED18Trf proximal proteinMediator of RNA polymerase II transcription, subunit 31 homologue Complex CRSP2 Vitamin D receptor interacting proteinRNA polymerase II transcriptional regulation mediatorTRAP95 TRAP 80 Transcriptional coactivator CRSP130TRAP100Trf proximal protein Thyroid hormone receptor associated protein 6 PC2TRAP100 Complex Mediator of RNA polymerase II transcription subunit 25 homologue TRAP 80Transcriptional coactivator CRSP70RNA polymerase II transcriptional regulation mediator TRAP220 CRSP2Transcriptional coactivator CRSP130Positive cofactor 2 glutamine ELL3 None TCEA1 Transcription factor IIE, alpha subunit Direct CTD phosphatase, subunit 1 DirectCBF1 interacting corepressor Direct RNA polymerase IIA 220 kd subunit Direct EAF2 Direct Elongin A binding protein 1 DirectHypothetical protein FLJ10006 Direct DNA-directed RNA polymerase protein POLR2A ABL Direct ATP-dependent RNA helicase A Direct Actin beta Direct BAF53 Direct BRCA1 Direct BRCA1 associated ring domain 1 Direct CREBBP Direct CTD phosphatase, subunit 1 DirectCaspase 10 DirectCleavage and polyadenylation speciﬁcity factor 1 Direct Cleavage and polyadenylation speciﬁcity factor 2 Direct Cleavage and polyadenylation speciﬁcity factor 3 DirectCstF 50 Direct Cyclin dependent kinase 8 Direct EBNA2 coactivator p100 Direct ERCC6 Direct FUS Direct Heterogenous nuclear ribonucleoprotein F Direct Non pou domain containing octamer binding protein Direct c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Pin1 Direct Polyglutamine binding protein 1 Direct Polymerase II, RNA, subunit F Direct Polymerase II, RNA, subunit L Direct RENT1 Direct RNA polymerase II elongation factor ELL Direct RNA polymerase II subunit 3 Direct RNA polymerase II subunit D Direct RNA polymerase II subunit G Direct RNA polymerase IIA 25 kd subunit Direct SUPT5H Direct Scaffold Attachment Factor B Direct Small CTD phosphatase 1 Direct Survival of motor neuron 1, telomeric Direct TATSF1 Direct Transcription elongation factor A, 1 Direct Zinc ﬁnger protein 74 Direct Kallikrein 2 Direct ERCC5 Direct Transcription initiation factor IIB Direct Cyclin K Direct Cyclin L2 Direct Peptidyl prolyl isomerase G Direct TAF10 RNA polymerase II TATA box binding protein TBP-associated factor 30 Kd Direct XPA binding protein 2 Direct RNA polymerase II, polypeptide H Direct MCM3 (*) Direct OIP106 Direct SRB7 Direct Chorionic somatomammotropin hormone 2 DirectTranslocation associated membrane protein 2 Direct Phosphorylated CTD interacting factor 1 Direct CDC2 related protein kinase 7 Direct Transcription elongation regulator 1 Direct Ku antigen, 80kDa Direct Ccctc binding factor Direct Cyclin dependent kinase 9 Direct BRCA1 Complex BRCA1 associated ring domain 1 SMARCA4TRAP 80 (*)SMARCC1 Complex SMARCB1 SMARCA2SMARCC2Cyclin C SRB7 Cyclin dependent kinase 8SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1RING3 Complex Cyclin dependent kinase 8 TRAP220 (*)NELFE Complex SUPT5H Wolf-Hirschhorn syndrome candidate 2Nucleolin Complex Cyclin T1 PPAR gamma coactivator 1 Cleavage and polyadenylation speciﬁcity factor 2Cyclin dependent kinase 9BRCA1 Complex BRCA1 associated ring domain 1 Human capping enzyme 1 Complex mRNA-cap:m7G methyltransferaseThyroid hormone receptor interactor 15 Complex Ring-box 1 COP9, subunit 5Cullin 4A COP9,subunit 3 DNA excision repair protein ERCC-8 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction COP9 signalosome subunit 4 Damage-speciﬁc DNA binding protein 1, 127kDaG protein pathway suppressor 1COP9 constitutive photomorphogenic homologue subunit 6 COP9 constitutive photomorphogenic homologue subunit 7A COP9 constitutive photomorphogenic homologue subunit 8RNA polymerase II subunit D ComplexRNA polymerase IIA 25 kd subunit Polymerase II, RNA, subunit F RNA polymerase II subunit GRNA polymerase II, polypeptide HPolymerase 2, RNA, subunit K Polymerase II, RNA, subunit L RNA polymerase II subunit JRNA polymerase II subunit I BRCA1 RNA polymerase II subunit 2RNA polymerase II subunit 3CSN4 Complex CSN5 CSN7Thyroid hormone receptor interactor 15Ring-box 1 Cullin 4A COP9,subunit 3DNA excision repair protein ERCC-8Damage-speciﬁc DNA binding protein 1, 127kDa G protein pathway suppressor 1 COP9 constitutive photomorphogenic homologue subunit 6COP9 constitutive photomorphogenic homologue subunit 8Cullin 4A Complex DNA excision repair protein ERCC-8 Casein kappaDamage-speciﬁc DNA binding protein 1, 127kDa COP9 constitutive photomorphogenic homologue subunit 6 COP9 constitutive photomorphogenic homologue subunit 8Thyroid hormone receptor interactor 15Ring-box 1 Chorionic somatomammotropin hormone 2 Complex XPA binding protein 2 POLR2C ATF4 Direct Activating transcription factor 7 interacting protein Direct Myogenic factor 4 Direct Polymerase 2, RNA, subunit K DirectPolymerase II, RNA, subunit L DirectRNA polymerase II subunit D Direct RNA polymerase II subunit G Direct RNA polymerase IIA 25 kd subunit DirectTAF15 Direct RNA polymerase II subunit J Direct RNA polymerase II, polypeptide H Direct RNA polymerase II subunit 3 DirectRNA polymerase II subunit 2 Direct RNA polymerase IIA 220 kd subunit Direct Polymerase ii, rna, subunit f DirectRNA polymerase II associated protein 1 ComplexRNA polymerase II subunit 2 RNA polymerase II subunit D Complex RNA polymerase IIA 25 kd subunitPolymerase II, RNA, subunit FRNA polymerase II subunit G RNA polymerase II, polypeptide H Polymerase 2, RNA, subunit KPolymerase II, RNA, subunit LRNA polymerase II subunit J RNA polymerase II subunit I BRCA1RNA polymerase IIA 220 kd subunit RNA polymerase II subunit 2 DNA-binding protein c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction MCM3 Cyclin dependent kinase 2 Direct MCM6 Direct MCM7 Direct Minichromosome maintenance protein 2 Direct Origin recognition complex subunit 2 Direct Polo like kinase Direct RNA polymerase IIA 220 kd subunit DirectMCM5 Direct Minichromosome maintenance 3 associated protein Direct ORC5 Direct MCM4 Direct Origin recognition complex, subunit 4 Direct CDC45 Direct Cell division cycle 7 DirectActivator of S phase kinase Direct Coiled-coil domain containing 5 Direct RAD52 Direct Minichromosome maintenance protein 10 DirectCDC6 Direct CDC5 Direct Minichromosome maintenance protein 2 ComplexMCM7MCM6 MCM5 Histone 3, H3MCM4 RUVBL1 BAF53 Direct Catenin beta Direct Plasminogen Direct RuvB like 2 (*) Direct C20orf20 protein Direct HIV-1 Tat interacting protein, 60kDa Complex Actin betaMortality factor 4 like 2 HIV-1 Tat interacting protein, 60kDa Inhibitor of growth family member 3Glioma ampliﬁed sequence 41Bromodomain containing 8 350/400 kDa PCAF associated factor Actin-like 6ADMAP1E1A binding protein p400 Mortality factor 4 like protein 1 Sarcoma antigen NY-SAR-91EPC1Heat shock 70 KD protein 1A Ribosomal L1 domain containing 1 C20orf20 proteinRuvB like 2 (*)HIV-1 Tat interacting protein, 60kDa Complex Actin beta Mortality factor 4 like 2HIV-1 Tat interacting protein, 60kDa Inhibitor of growth family member 3 Glioma ampliﬁed sequence 41Bromodomain containing 8350/400 kDa PCAF associated factor Actin-like 6A DMAP1E1A binding protein p400Mortality factor 4 like protein 1 Sarcoma antigen NY-SAR-91 EPC1Heat shock 70 KD protein 1ARibosomal L1 domain containing 1 C20orf20 protein RuvB like 2 (*)Mortality factor 4 like protein 1 Complex Sarcoma antigen NY-SAR-91 Inhibitor of growth family member 3 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction RuvB like 2 (*) EPC1Enhancer of polycomb homologue 2HIV-1 Tat interacting protein, 60kDa Actin beta HIV-1 Tat interacting protein, 60kDaGlioma ampliﬁed sequence 41Bromodomain containing 8 350/400 kDa PCAF associated factor Actin-like 6ADMAP1E1A binding protein p400 RNA polymerase II subunit 5-mediating protein Complex RuvB like 2 (*)BCR downstream signaling 1 S phase kinase associated protein 2 NHP2 like protein 1 ComplexNucleolar protein NOP5RuvB like 2 (*) Fibrillarin NHP2 like protein 1NOP56RNA RNA-binding protein NCL Autoantigen La (*) Direct Casein kinase II, alpha 1 DirectCasein kinase II, alpha 2 Direct DNA topoisomerase I Direct Glucocorticoid receptor DirectGranzyme A DirectMidkine Direct Nucleophosmin 1 Direct Protein kinase C, zeta DirectTelomere reverse transcriptase Direct c-Myb Direct p53 Direct Fragile X mental retardation 1 protein DirectStaufen Direct Calgizzarin Direct PPAR gamma coactivator 1 DirectProtein phosphatase 2C delta isoform DirectMyb-related protein A Direct CD3E Direct Centaurin, alpha 1 DirectSplicing factor arginine/serine rich 12 DirectFXR1 Complex FXR2 Cytoplasmic FMR1 interacting protein 1Cyclin T1 Complex PPAR gamma coactivator 1 Cleavage and polyadenylation speciﬁcity factor 2 RNA polymerase IIA 220 kd subunitCyclin dependent kinase 9 TATSF1 Complex Polymerase II, RNA, subunit FSUPT5H60 kDa Ro protein Complex Autoantigen La (*) GAJ/ Bop1 ComplexNIFKNNP1 Ribosomal protein L3 Ribosomal protein L8YTM1PCell division cycle 2 like 2 Fibronectin 1 Ribosomal protein S3aRibosomal protein L4 Ribosomal phosphoprotein large P0 DDX5 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Ribosomal protein L7a Tubulin alpha 1Peptidyl prolyl cis/trans isomerase nima interacting, 4DDX1 Ribosomal protein S9 Ribosomal protein L21Ribosomal protein L17Ribosomal protein L6 Ribosomal protein L26 Ribosomal protein L7P160Growth arrest speciﬁc protein 8 Pescadillo homologue 1 C20ORF1 proteinDDX24 DDX21 GTP binding protein 4NOP56Ribosomal protein L10a Ribosomal protein S3 Nucleolar protein NOP5Nucleophosmin 1 ComplexSwitch associated protein 70 ADP ribosyl transferase PRPF31 None SNRPD2 EGF receptor Direct Small nuclear ribonucleoprotein polypeptide D1 Direct Survival of motor neuron 1, telomeric Direct Small nuclear ribonucleoprotein polypeptide D2 DirectSyntaxin binding protein 2 DirectSMN interacting protein 1 Direct Small nuclear ribonucleoprotein polypeptide F Direct DDX20 Direct Gemin 5 Direct Gemin 6 Direct LSM2 Direct LSM6 Direct Gemin 4 Direct Survival of motor neuron 2, centromeric Direct Syntaxin binding protein 3 DirectMethylosome protein 50 DirectHIV-1 Tat interacting protein, 60kDa Direct Gemin 7 Direct Small nuclear ribonucleoprotein polypeptide E ComplexSmall nuclear ribonucleoprotein polypeptide D3Small nuclear ribonucleoprotein polypeptide E Complex YB-1 Small nuclear ribonucleoprotein polypeptide D3Small nuclear ribonucleoprotein polypeptide D1Small nuclear ribonucleoprotein polypeptide F Small nuclear ribonucleoprotein polypeptide G Splicing factor, arginine/serine-rich 7Programmed cell death 7 Chromosome 16 open reading frame 33 Small nuclear ribonucleoprotein polypeptide E ComplexU2AF1L2Small nuclear ribonucleoprotein polypeptide D3 Small nuclear ribonucleoprotein polypeptide D1 DDX15Small nuclear ribonucleoprotein polypeptide FSmall nuclear ribonucleoprotein polypeptide G Splicing factor 3B subunit 1 Pre mRNA branch site protein p14Programmed cell death 7U11/U12 snRNP 35K p175 Complex CD69 antigenSmall nuclear ribonucleoprotein polypeptide E Small nuclear ribonucleoprotein 70 kD CD2 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Survival of motor neuron 1, telomeric Small nuclear ribonucleoprotein polypeptide D3Small nuclear ribonucleoprotein polypeptide D1U1 snRNP protein C Small nuclear ribonucleoprotein polypeptide F Small nuclear ribonucleoprotein polypeptide GWD repeat endosomal proteinCCAP4 Complex CCAP6 CCAP8NMP200SAP49 DNA topoisomerase II alpha Ribosomal protein S25Ribosomal protein L12 Small nuclear ribonucleoprotein polypeptide A RBMXSplicing factor, arginine/serine rich 1Splicing factor, arginine/serine rich 2 DNA dependent protein kinase catalytic subunit Small nuclear ribonucleoprotein polypeptide D3Small nuclear ribonucleoprotein polypeptide D1CDC5 Interleukin enhancer binding factor 2 Ribosomal protein S16Protein phosphatase 2C delta isoformRibosomal protein L13 Splicing factor 3 subunit 1 Spliceosome associated protein 145Serine arginine repetitive matrix protein 1Hypothetical protein HSPC148 CCAP4 Complex CCAP6CCAP8 PRL1 PSFRNPGSAP49 SPF27 SRM160DNA topoisomerase II alphaRibosomal protein S25 Ribosomal protein L12 Small nuclear ribonucleoprotein polypeptide ARBMXSplicing factor, arginine/serine rich 1 Splicing factor, arginine/serine rich 2 DNA dependent protein kinase catalytic subunitSmall nuclear ribonucleoprotein polypeptide D3Small nuclear ribonucleoprotein polypeptide D1 CDC5 Interleukin enhancer binding factor 2Ribosomal protein S16 Protein phosphatase 2C delta isoform Ribosomal protein L13Splicing factor 3 subunit 1Spliceosome associated protein 145 Serine arginine repetitive matrix protein 1 Nuclear matrix protein 200Hypothetical protein HSPC148PUF60 Complex SF3b10 SF3b125SF3b14bSPF31 SR140 hPrp5pHeat shock 60 KD protein 1 Small nuclear ribonucleoprotein polypeptide E SNRPB c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction U2AF35 U2AF65Splicing factor, arginine/serine rich 1Small nuclear ribonucleoprotein polypeptide D3 Small nuclear ribonucleoprotein polypeptide D1 DDX15SMN related proteinU2 small nuclear ribonucleoprotein B U2A prime Small nuclear ribonucleoprotein polypeptide FSmall nuclear ribonucleoprotein polypeptide GHigh mobility group protein 20B Heat shock protein, 75 kDa Splicing factor, 45 kdCHERP PUF60 Complex SF3b10SF3b14bSPF31 SR140 hPrp5pHeat shock 60 KD protein 1Small nuclear ribonucleoprotein polypeptide E SNRPB U2AF35U2AF65Splicing factor 3A, subunit 2 Splicing factor, arginine/serine rich 1 Small nuclear ribonucleoprotein polypeptide D3Small nuclear ribonucleoprotein polypeptide D1DDX15 SMN related protein U2 small nuclear ribonucleoprotein BU2A prime Small nuclear ribonucleoprotein polypeptide F Small nuclear ribonucleoprotein polypeptide GHigh mobility group protein 20BHeat shock protein, 75 kDa Splicing factor 3 subunit 1 Splicing factor, 45 kdPre mRNA branch site protein p14Spliceosome associated protein 145 Splicing factor 3A, subunit 3 Splicing factor 3B, subunit 3Splicing factor 3B subunit 4CHERP Serine/threonine kinase protein Serine/threonine phosphatase protein PPP2R1A Glutamate receptor ionotropic, N-methyl D-aspartate 1 Direct Heat-shock transcription factor 2 Direct NMDAR2D Direct Protein phosphatase 2, regulatory subunit B (B56), alpha DirectProtein phosphatase 2, regulatory subunit B’, alpha Direct Protein phosphatase 5 catalytic subunit Direct Protein phostase 2A regulatory subunit,48kD DirectSolute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 DirectImportin 9 Direct Guanine nucleotide binding protein, alpha 12 Direct CDC42 Complex Ubiquitin-speciﬁc protease 9P160 Cytoplasmic FMR1 interacting protein 1 Ubiquitin speciﬁc protease 7KIAA0802Dedicator of cytokinesis 7 Rho guanine nucleotide exchange factor 2 Protein kinase C, iota typeTGFB1 induced anti apoptotic factor 1 Hypothetical protein KIAA0889 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction Cytoplasmic FMR1 interacting protein 2 SMARCA4Paraneoplastic antigen MA1Paraneoplastic antigen ma2 Ring ﬁnger protein 41 Protein phosphatase 2A, catalytic subunit, beta isoform14-3-3 zeta14-3-3 Eta (*) Chromosome 6 open reading frame 69 Translation regulator protein EEF1B2 Histidyl-tRNA synthetase Direct Casein kinase II, alpha 2 Direct Casein kinase II, alpha 1 Direct Alanyl tRNA synthetase DirectElongation factor 1 alpha 1 Complex Eukaryotic translation elongation factor 1,delta Eukaryotic translation elongation factor 1 gammaValyl tRNA synthetase 2 ComplexElongation factor 1 alpha 1 Eukaryotic translation elongation factor 1,delta Elongation factor G 1 Auxiliary transport protein GDI2 RAB8 Direct Ras associated protein RAB9 Direct Ras associated protein Rab2 DirectRas associated protein Rab4 DirectRas related protein Rab 5A Direct Ras family, member rab 11A Direct Receptor signalling complex scaffold protein YWHAE ASK1 Direct Ataxin 1 Direct BCL2 antagonist of cell death Direct CDC 25A Direct CDC 25B Direct Calmodulin 1 Direct Cyclin dependent kinase inhibitor 1B DirectDNA topoisomerase II alpha DirectIGF-I receptor Direct IRS 1 Direct IRS2 Direct Keratin 18 Direct Kinesin family member 1C Direct MAP3K10 Direct Mitogen-activated protein kinase kinase kinase 3 DirectNGFR associated protein 1 DirectPCTAIRE protein kinase 1 Direct Potassium channel, voltage gated subfamily H, member 2 Direct RAF1 Direct Regulator of G protein signaling 3 DirectSHC Direct Synuclein alpha Direct TGF beta 1 Direct Tafazzin Direct Tuberin Direct Vimentin Direct Zinc ﬁnger protein A20 Directc-Src Direct Retinitis pigmentosa GTPase regulator Direct Histone deacetylase 4 DirectRAS inhibitor 1 DirectNude like protein Direct Ras protein speciﬁc guanine nucleotide releasing factor 1 Direct Histone deacetylase 5 DirectTAZ Direct MAP3K2 Direct Poly A polymerase alpha Direct Rho guanine nucleotide exchange factor 2 DirectREM1 Direct Rho guanine nucleotide exchange factor Direct c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Tuberous sclerosis 1 gene Direct Nuclear receptor corepressor 2 DirectCell division cycle 2 like 1 DirectHeat shock 70 KD protein 1A Complex HSP90A 14-3-3 zeta14-3-3 BetaInsulin receptor substrate 4 WD repeat domain 6 Mitogen-activated protein kinase kinase kinase 3 Complex14-3-3 zeta14-3-3 Beta 14-3-3 Eta (*) 14-3-3 gamma14-3-3 theta p53 and DNA damage regulated 1 CDC37Mortalin 2HSPCAL3 HSP90B EMK1MAP2K5Prefoldin 2 SPIN None YWHAQ CDC 25B Direct Calpain 3 Direct Follicle stimulating hormone receptor Direct Heat shock 70 KD protein 1A Direct NIF3L1 Direct 14-3-3 theta Direct B-Raf Direct Fgr Direct CBL Direct 6-phosphofructo-2 kinase/fructose-2,6-biphosphatase 2 Direct Telomere reverse transcriptase Direct Tuberin Direct BAX Direct NFAT1 Direct Casein kinase 1, alpha 1 Direct Myocyte speciﬁc enhancer factor 2D DirectCyclin dependent kinase inhibitor 1B DirectMtor Direct Kinesin light chain 2 like Direct Uncoupling protein 2 DirectUncoupling protein 3 DirectSH3 domain binding protein 2 Direct Regulator of G protein signaling 3 Direct ASK1 Direct Regulator of G protein signaling 7 DirectTubulin, alpha 2 Direct MAGOH Direct Phosphatidylinositol 3-kinase, catalytic beta DirectUbiquitin speciﬁc protease 8 Direct BCL2 antagonist of cell death Direct Icln-binding protein, 72 kd Direct3 Phosphoinositide dependent protein kinase 1 DirectProtein kinase C, mu Direct Lysosomal trafﬁcking regulator Direct Keratin 9 Direct DDX48 Direct Heat shock 70 kDa protein 8 Direct Kinesin family member 5B Direct NFAT3 Direct Yes associated protein DirectPhosphatidylinositol 4 kinase catalytic beta polypeptide Direct Methylosome protein 50 Direct REM1 Direct Tuberous sclerosis 1 gene Direct Calcineurin binding protein 1 Direct Cell division cycle 2 like 1 Direct c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction HS1 binding protein Direct B-Raf Complex RAP1 GTPase activating protein 1Mitogen-activated protein kinase kinase kinase 3 Complex 14-3-3 zeta 14-3-3 Beta14-3-3 epsilon14-3-3 Eta (*) 14-3-3 gamma p53 and DNA damage regulated 1CDC37Mortalin 2 HSPCAL3 HSP90BEMK1 MAP2K5 Prefoldin 2 AP3S1 IRS 1 Direct SCARB2 Direct Adaptor related protein complex 3, beta-2 subunit Direct Clathrin adaptor complex AP3, sigma 3B subunit DirectSolute carrier family 30, member 3 DirectAdaptin, delta Direct Adaptin, delta Complex Centaurin gamma 2 Transmembrane receptor protein tyrosine kinase protein FGFR2 Calcium channel voltage dependent, L type alpha 1D subunit Direct Fibroblast growth factor 1 Direct Fibroblast growth factor 5 DirectFibroblast growth factor 7 DirectPhospholipase C, gamma 1 Direct Fibroblast growth factor 2 Direct Integrin alpha 5 Direct Fibroblast growth factor receptor 2 Direct Fibroblast growth factor 9 Direct Fibroblast growth factor 10 DirectCBLLyn Fyn Complex Lipid kinase protein PIP5K2B Tumour necrosis factor receptor 1 Direct Phosphatidylinositol-4-phosphate 5-kinase type II beta Direct PIP5K2C None Heterotrimeric G-protein GTPase protein GNB4 Guanine nucleotide binding protein, gamma 13 Direct Guanine nucleotide binding protein, gamma 12 Direct Guanyl-nucleotide exchange factor protein ARHGEF4 APC Direct RhoA Direct Catenin beta Complex APC Calcium-binding protein (signal transduction) S100A8 Neutrophil cytosolic factor 2 Direct S100 Calcium binding protein A9 Direct Carcinoembryonic antigen related cell adhesion molecule 3 DirectS100 Calcium binding protein A8 Direct S100A9 S100 Calcium binding protein A8 Direct S100 Calcium binding protein A9 Direct Enzyme: dehydrogenase GAPDH Actin beta Direct Amyloid beta A4 protein Direct Calcyclin Direct Solute carrier family,member 1 DirectGlyceraldehyde 3 phosphate dehydrogenase DirectHuntingtin Direct Diphosphoglycerate mutase Direct Protein kinase C, iota type DirectPhosphoglycerate kinase 1 Direct Androgen receptor Direct c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"The human AF4 protein network Table S3 Continued Gene name Interactors Type of interaction Ataxin 1 Direct Dynein light chain 1 Direct Phospholipase D2 Direct Metabotropic glutamate receptor 1 Direct Protein disulﬁde isomerase A2 Direct HIV-1 Tat interacting protein, 60kDa DirectSIAH-1 Direct MDH2 Citrate synthase Direct Fumarase Direct Glutamate oxaloacetate transaminase, mitochondrial DirectMalate dehydrogenase mitochondrial DirectNADH ubiquinone oxidoreductase Fe-S protein 1 Direct Pyruvate carboxylase Direct Enzyme: synthase PTS BRG1 associated factor,180 KD Direct 6 pyruvoyl tetrahydrobiopterin synthase Direct Fibronectin type III domain containing 5 DirectProtein kinase cGMP dependent Type II Direct Unknown LSM14 None DRG1 Leukemia lymphoid 1 Direct T cell acute lymphocytic leukemia 1 Direct HCCA2 Serine/threonine protein kinase 38 Direct NDRG family member 2 Direct C20orf11 None SMAD9 Activin A receptor, type I Direct BTG2 Direct Bullous pemphigoid antigen 1 Direct HEY1 Direct Leucyl cystinyl aminopeptidase DirectRibosome binding protein 1 Direct Small nuclear ribonucleoprotein 70 kD Direct Upstream regulatory element binding protein 1 DirectTOB1 Direct SMAD4 Direct SMAD, mothers against DPP homologue 2 (Drosophila) DirectLow density lipoprotein receptor related protein 5 DirectMLL2 Direct Hypothetical protein FLJ32214 Direct Splicing factor 3B subunit 1 DirectPotential carboxypeptidase like protein X2 DirectExophilin 5 Direct Regulatory factor X 1 Direct MAN antigen 1 Direct Zinc ﬁnger and SCAN domain containing 4 DirectE4F transcription factor 1 Direct Hypothetical protein KIAA0226 Direct SECIS binding protein 2 DirectAryl hydrocarbon receptor nuclear translocator DirectChorionic somatomammotropin hormone 1 Direct Zinc ﬁnger protein 484 Direct Zinc ﬁnger protein 587 DirectRho GTPase activating protein 9 Direct Plakophilin 2 Direct Proline glutamic acid leucine-rich protein 1 DirectGranulin Direct Hypothetical protein FLJ10747 Direct ASH2 like Direct Prosaposin Direct KIAA0372 Direct N-acetylglucosamine kinase Direct BiP associated protein Direct TID 1 Direct Dickkopf 1 Direct Poly(A) binding protein 4 Direct Plectin 1 Direct Lipocalin 7 Direct Ubiquitously transcribed TPR protein on the X chromosome Direct EIF3S8 Direct Protein phosphatase 2 regulatory subunit B (B56) epsilon Direct c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
"G. Esposito and others Table S3 Continued Gene name Interactors Type of interaction KIAA0804 Direct RAN binding protein 9 DirectHairy/enhancer-of-split related with YRPW motif-like DirectSH2 domain binding protein 1 Direct MLLT2 Direct XPA binding protein 2 DirectTRIM29 Direct Minichromosome maintenance 3 associated protein Direct Peroxisome proliferator activated receptor, delta Direct EIF3S5 Direct Bromodomain adjacent to zinc ﬁnger domain 1A DirectZinc ﬁnger protein 592 Direct Hypothetical protein FLJ20313 Direct Mannosidase alpha class 1A member 2 DirectOTUBAIN 1 Direct FLJ10808 Protein Direct Fibronectin 1 Direct LIM domain only 4 Direct Fodrin beta Direct Ubiquilin 1 Direct Hypothetical protein FLJ13910 DirectPhosphorylase kinase liver alpha 2 subunit DirectDnaJ homologue subfamily C member 7 Direct Tubulin speciﬁc chaperone D Direct 14-3-3 theta Direct Ferritin light chain Direct Patatin like phospholipase domain containing 2 Direct Cisplatin resistance associated Direct PI3 kinase related kinase SMG1 DirectUbiquitin protein ligase E3A DirectDIAPH3 Direct Cytochrome P450, subfamily XIA Direct SKD3 Direct Zinc ﬁnger protein 83 Direct MGAT1 Direct Adaptor related protein complex 2 alpha 1 subunit DirectASB2 Direct Alpha mannosidase B Direct Smooth muscle cell associated protein 1 Direct Methyl CpG binding domain protein 1 DirectSMAD3 Direct Pregnancy associated plasma protein A Direct Glutaminyl tRNA synthetase Direct Ataxin 1 ubiquitin like interacting protein DirectChromosome 9 open reading frame 13 DirectPirin Direct Stromal antigen 1 Direct Centrosome protein 4 DirectLimbin Direct CXXC ﬁnger 5 Direct Thyroid hormone receptor interactor 12 Direct Actin beta Direct Zinc ﬁnger protein 557 Direct Destrin (actin depolymerizing factor) Direct ARID1B Direct Mannosidase, alpha, class 1C, member 1 DirectEukaryotic translation initiation factor 3, subunit 6 48kDa Direct Chondroitin polymerizing factor Direct Ring ﬁnger protein 123 DirectElongation factor 1A binding protein DirectProteasome 26S subunit, non ATPase 8 Direct FLI1 Direct C10orf2 protein Direct SMAD interacting protein 1 DirectTelomeric repeat binding factor NIMA-interacting 1 Direct Received 13 October 2010/12 May 2011; accepted 16 May 2011 Published as BJ Immediate Publication 16 May 2011, doi:10.1042/BJ20101633 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2011 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/15/bj4380121.PMC3174057.pdf
The Figures of the models were prepared using the program PyMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/7f/57/bj4380291.PMC3174058.pdf
Comparison of the two SOUL molecules present in the crystallographic asymmetric unit of theorthorhombic crystal form with the two NMR models of murine p22HBP revealed that the four models differ substantially only in rather limited areas (Supplementary Figure S1 athttp://www.BiochemJ.org/bj/438/bj4380291add.htm).,OADS,/arxiv_data1/oa_pdf/7f/57/bj4380291.PMC3174058.pdf
Additional details onthis structure have been included as Supplementary information (at http://www.BiochemJ.org/bj/438/bj4380291add.htm).,OADS,/arxiv_data1/oa_pdf/7f/57/bj4380291.PMC3174058.pdf
"For this reason, the UV–visible spectrum of haemin was examined alone and in the presence of ten times the molar ratio of SOUL,with BSA used as a control (Supplementary Figure S2A at http://www.BiochemJ.org/bj/438/bj4380291add.htm).",Non-OADS,/arxiv_data1/oa_pdf/7f/57/bj4380291.PMC3174058.pdf
The Figure was prepared using the program PyMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/7f/57/bj4380291.PMC3174058.pdf
"The interactions of the SOUL BH3 domain peptide with Bcl-xL are mostly hydrophobic (Supplementary Table S1 at http://www.BiochemJ.org/bj/438/bj4380291add.htm, andFigure 4), but they also include other more speciﬁc contacts, due to charged residues: Gln 154(BH3)–Gln111(Bcl-xL), Ser160(BH3)– Glu129(Bcl-xL), Arg163(BH3)–Glu129(Bcl-xL), Asp165(BH3)– Tyr101(Bcl-xL) and Asp170(BH3)–Tyr195(Bcl-xL).",Non-OADS,/arxiv_data1/oa_pdf/7f/57/bj4380291.PMC3174058.pdf
The Figures of the models were prepared using the program PyMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/7f/57/bj4380291.PMC3174058.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Medical Education Online 2011, 16: 7362 - DOI: 10.3402/meo.v16i0.7362",Non-OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Available from: http://www.osteopathic.org/inside-aoa/accreditation/postdoctoral-training-approval/Documents/core-competency-compli ance-program-part-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Available from: http://www.acgme.org/Outcome/comp/ GeneralCompetenciesStandards21307.pdf).,Non-OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Archived on 8June 2011 at: http://www.webcitation.org/5zIFGOLtn.,Non-OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Available from: http://www.acopeds.org/residents/prog_dir_ann_report.iphtml).,OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Archived on 8 June 2011 at http://www.webcitation.org/5zIFOCa2I.,Non-OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Avail-able from: http://www.eric.ed.gov/PDFS/ED514030.pdf (cited10 March 2011).,Non-OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Available from: http://www.nrmp.org/data/resultsanddata2009.pdf.,OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
Archived on 8 June 2011 at: http://www.webcitation.org/5zIFWoEeW .,Non-OADS,/arxiv_data1/oa_pdf/87/2b/MEO-16-7362.PMC3174084.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.1058-4838/2011/538-0022$14.00DOI: 10.1093/cid/cir509 Campylobacter jejuni andCampylobacter coli Bacteremia in Finland dCID 2011:53 (15 October) de99",Non-OADS,/arxiv_data1/oa_pdf/49/54/cir509.PMC3174097.pdf
"The European Union summary re- port on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2009, Available at: http://www.efsa.europa.eu/en/ efsajournal/pub/2090.htm.",Non-OADS,/arxiv_data1/oa_pdf/49/54/cir509.PMC3174097.pdf
Available at: http://www.fda.gov/AnimalVeterinary/ SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResis- tanceMonitoringSystem/ucm182896.htm .,Non-OADS,/arxiv_data1/oa_pdf/49/54/cir509.PMC3174097.pdf
Available at: http://www.fda.gov/Animal- Veterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicro- bialResistanceMonitoringSystem/ucm091417.htm .,Non-OADS,/arxiv_data1/oa_pdf/49/54/cir509.PMC3174097.pdf
"National infectious diseases register, Available at: http://www3.ktl.ﬁ/stat/ .",Non-OADS,/arxiv_data1/oa_pdf/49/54/cir509.PMC3174097.pdf
"Infectious diseases in Finland 1995–2009, Available at: http://www.thl.ﬁ/thl-client/pdfs/ d6d63c66-9690-4f4d-9ee1-319bb5648eaf .",Non-OADS,/arxiv_data1/oa_pdf/49/54/cir509.PMC3174097.pdf
"Key words: Excessive crying, Behavioral and emotional regulation  disorder, InfantJoon Sik Kim, MD Department of Pediatrics, Keimyung University  Dongsan Medical Center, Daegu, Korea Received: 19 April 2011, Accepted: 11 May 2011 Corresponding author: Joon Sik Kim, MD Department of Pediatrics, Keimyung University Dongsan Medical Center, Dalseong-ro, Jung-gu,, Junggu, Daegu 700-712, KoreaTel: +82-53-250-7525, Fax: +82-53-250-7783E-mail: jskim@dsmc.or.kr Copyright © 2011 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/d4/kjped-54-229.PMC3174357.pdf
"Key words:  Acute disseminated encephalomyelitis, Multiple sclerosis,  Children, ChildYun Jin Lee, MD Department of Pediatrics, Pusan National University  Children’s Hospital, Pusan National University School of Medicine, Yangsan, Korea Received: 18 April 2011, Accepted: 11 May 2011 Corresponding author: Yun-Jin Lee, MD Department of Pediatrics, Pusan National University Chil - dren’s Hospital, Pusan National University School of Medi - cine, Beomeo-ri, Mulgeum-eup, Yangsan 626-770, KoreaTel: +82-55-360-2180, Fax: +82-55-360-2181E-mail: jinnyeye@hanmail.net  Copyright © 2011 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/e2/kjped-54-234.PMC3174358.pdf
"Key words:  Tuberous sclerosis complex, mTOR inhibitorWon Seop Kim, MD Department of Pediatrics, Chungbuk National Univer­ sity, College of Medicine, Cheongju, Korea Received: 19 April 2011, Accepted: 11 May 2011 Corresponding author: Won Seop Kim, MD Department of Pediatrics, Chungbuk National University College of Medicine, 410 Gaesin-dong, Heungdeok-gu, Cheongju 361-763, KoreaTel: +82-43-269-6044, Fax:+82-43-264-6620E-mail: wskim@chungbuk.ac.kr Copyright © 2011 by The Korean Pediatric Society This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by ­ nc/3.0/) which permits unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/c6/kjped-54-241.PMC3174359.pdf
"Copyright © 2011 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/3c/kjped-54-246.PMC3174360.pdf
Available from:  http://kosis.kr.,Non-OADS,/arxiv_data1/oa_pdf/f3/3c/kjped-54-246.PMC3174360.pdf
"Key words: Cancer survivor, Metabolic syndrome, Body composition,  Fat percentageYoung Bae Sohn, MD1, Su Jin Kim, MD2, Sung  Won Park, MD1, Se-Hwa Kim, MD1, Sung- Yoon Cho, MD1, Soo Hyun Lee, MD1, Keon  Hee Yoo, MD, PhD1, Ki Woong Sung, MD,  PhD1, Jae Hoon Chung, MD, PhD3, Hong Hoe  Koo, MD, PhD1, Dong-Kyu Jin, MD, PhD1  1Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul,  2Center of Pediatric Oncology, National Cancer Center,  Goyang, 3Division of Endocrinology and Metabolism,  Department of Internal Medicine, Samsung Medical  Center, Sungkyunkwan University School of Medicine,  Seoul, Korea  Received: 13 December 2010, Revised: 7 March 2011 Accepted: 11 April 2011 Corresponding author: Dong-Kyu Jin, MDDepartment of Pediatrics, Samsung Medical Center, Sung - kyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-3525, Fax: +82-2-3410-0043 E-mail: jindk@skku.edu Copyright © 2011 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/75/kjped-54-253.PMC3174361.pdf
"Key words: Infant, Liver, Hemangioendothelioma, Corticosteroid,  Interferon-alpha, Therapeutic embolizationEun Hee Kim, MD, Kyung Nam Koh, MD,  Meerim Park, MD, Bo Eun Kim, MD, Ho Joon Im, MD, Jong Jin Seo, MD Department of Pediatrics, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea Received: 13 December 2010, Revised: 26 February 2011 Accepted: 5 April 2011 Corresponding author: Eun Hee Kim, MDDepartment of Pediatrics, Asan Medial Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-3386, Fax: +82-2-473-3725, E-mail: luke2178@naver.com Copyright © 2011 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/af/kjped-54-260.PMC3174362.pdf
"Key words: Duplication 15q, Trisomy chromosome 15qEun Young Kim, MD1, Yu Kyong Kim, MD1, Mi  Kyoung Kim, MD1, Ji Mi Jung, MD1, Ga Won  Jeon, MD1, Hye Ran Kim, MD2, Jong Beom  Sin, MD1 Departments of 1Pediatrics and 2Clinical Pathology,  Pusan Paik Hospital, Inje University College of  Medicine, Busan, Korea Received: 19 August 2010, Revised: 11 November 2010 Accepted: 10 December 2010 Corresponding author: Jong Beom Sin, MD Department of Pediatrics, Pusan Paik Hospital, Inje Uni - versity College of Medicine, 633-165 Gaegeom 2-dong,  Busanjin-gu, Busan 614-735, Korea  Tel: +82-51-890-6126, Fax:+82-51-895-7785  E-mail: pedsin@inje.ac.kr Copyright © 2011 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/c3/kjped-54-267.PMC3174363.pdf
These BAC clones  were selected from genome databases archived at the gene ontology  website (http://www.geneontology.org).,OADS,/arxiv_data1/oa_pdf/d6/c3/kjped-54-267.PMC3174363.pdf
"Key words:  Aortic aneurysm, Thorax, TGF-beta type I receptor, TGF- beta type II receptor, Mutation Jung Sook Ha, MD, P hD1, Yeo Hyang Kim,  MD, PhD2 Departments of 1Laboratory Medicine and 2Pediatrics,  Keimyung University School of Medicine, Daegu,  Korea Received: 30 August 2010, Revised: 16 November 2010 Accepted: 21 December 2010 Corresponding author: Yeo Hyang Kim, MD, PhDDepartment of Pediatrics, Keimyung University School of Medicine, 197 Dongsan-dong, Jung-gu, Daegu 700-712, KoreaTel: +82-53-250-7524, Fax: +82-53-250-7783 E-mail: kimyhped@hanmail.net  Copyright © 2011 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/9d/kjped-54-272.PMC3174364.pdf
"Of  these, one intronic (c.263+7A>G, rs1155705) and one synonymous (c.1167C>T, rs2228048) variations were inherited from one of parents and known-polymorphisms listed in the single nucleotide polymorphism database (dbSNP; http://www.ncbi.nlm.nih.gov/projects/SNP/).",OADS,/arxiv_data1/oa_pdf/94/9d/kjped-54-272.PMC3174364.pdf
"To view a copy of this license,visit http://creativecommons.o rg/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Novel cancer biomarker and function: SPG20 -Spartin GE Lind et al 3978 Oncogene",Non-OADS,/arxiv_data1/oa_pdf/4b/fd/onc2011109a.PMC3174365.pdf
"In the presented work, BACs from FPC contigs were assayed for interspersed repeat content by comparison of their sequence data with the Pooideae-specific Repeat Element Database (http://mips.helmholtz-mue nchen.de/plant/recat/ )f r o m MIPS.",OADS,/arxiv_data1/oa_pdf/a7/01/412_2011_Article_326.PMC3174371.pdf
"Retrieved from http://cran.r-project.org/web/packages/ lme4/index.html Berle, D., & Starcevic, V. (2007).",OADS,/arxiv_data1/oa_pdf/f9/60/13428_2011_Article_89.PMC3174372.pdf
"Retrieved from http://psycnet.apa.org/ journals/psp/ Friedlander, F. (1964).",OADS,/arxiv_data1/oa_pdf/f9/60/13428_2011_Article_89.PMC3174372.pdf
Retrieved from http://psycnet.apa.,Non-OADS,/arxiv_data1/oa_pdf/f9/60/13428_2011_Article_89.PMC3174372.pdf
"Retrieved from http://psycnet.apa.org/journals/cep/ Garcia-Berthou, E., & Alcaraz, C. (2004).",Non-OADS,/arxiv_data1/oa_pdf/f9/60/13428_2011_Article_89.PMC3174372.pdf
"2011, 7      http://www.biolsci.org  1077  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2011; 7(8):1077-1092  Research Paper   Cardioprotective  Effects of Telmisartan against Heart Failure in Rats I n- duced By Experimental Autoimmune Myocarditis through the Modulation  of Angiotensin -Converting Enzyme -2/Angiotensin 1 -7/Mas Receptor Axis    Vijayakumar  Sukumaran1, Punniyakoti T. Veeraveedu1,2, Narasimman Gurusamy3, Ken’ichi Yamaguchi4,  Arun Prasath Lakshmanan1, Meilei Ma1, Kenji Suzuki5, Makoto Kodama6 and Kenichi Watanabe1  1.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7      http://www.biolsci.org  1078  Introduction   Inflammation and autoimmunity are involved in  many cardiac diseases.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1079  Animals   Lewis rats (male, 8 weeks old) were purchased  from Charles River Japan Inc. (Kanagawa, Japan).",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1080  (GRP -78) antibody (Santa Cruz Biotechnolog y); pol y- clonal rabbit anti -caspase -3 antibody (Cell Signaling  Technology).",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1081  Effects of telmisartan on morphometric para m- eters   HW and the ratio of HW/BW were significantly  larger in group EAM than in group N rats (1.54±0.12  vs 1.20±0.05 g/kg ( P < 0.01); 5.9±0.25 vs 3.5±0.14 g/kg  (P < 0.01), respectively; Table 2).",OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1082    Figure 1 : Representative echocardiographic (M -mode) images show ing the left ventricular dimensions.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7      http://www.biolsci.org  1083  Effect s of telmisartan on myocardial protein e x- pressions of ACE -2 and ANG 1 -7 mas receptor    The levels of ACE -2 and ANG 1 -7 mas receptor   in the myocardium were significantly downregulated  in group EAM rats (0.7  and 0.5-fold, respectively)  compared with those of group N rats (Fig.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1084    Figure 4 : Effects of telmisartan  on myocardial protein expressions of 3-NT, p47phox, p67phox and N ox-4.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1085  GRP -78 was significantly increased in the veh i- cle-treated rats compared with those of group N rats  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1086    Figure 6: Effects of telmisartan  on myocardial protein expressions of TRAF -2, CHOP and GRP-78.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1087    Figure 7: Effects of telmisartan on myocardial  apoptosis and its marker molecules.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1088  leukin -6, and the chemokine, monocyte chemoa t- tractant protein -1, as well as increased phosphoryl a- tion of ERK1/2 and JNK1/2 signaling pathways  and  treatment with irbesartan reduced nicotin a- mide -adenine dinucleotide phosphate (NADPH) ox- idase activity, infarct size, matrix matelloproteinase  activation, and myocardial in flammation, ultimately  resulting in improved post -myocardial infarction   ventricular function [33].",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7      http://www.biolsci.org  1089  Several studies have described that oxi dative  stress, apoptosis is involved in the pathogenesis and  development of cardiac diseases including heart fai l- ure, atherosclerosis and hypertension [35 -37].",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1090  ACE -2/ANG1 -7/Mas receptor axis in EAM rats r e- mains to be determined.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1091  25.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
"2011, 7    http://www.biolsci.org  1092  el projects.",Non-OADS,/arxiv_data1/oa_pdf/19/72/ijbsv07p1077.PMC3174385.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fb/43/ijbsv07p1093.PMC3174386.pdf
"2011, 7      http://www.biolsci.org  1101  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2011; 7(8):1101-1113  Research Paper   Molecular Characterization of Porcine  MMP19  and MMP23B  Genes and Its  Association with Immune Traits    Shuanping Z hao1,2*, Yongzhen  Zhao2*, Pengxia N iu2, Ning Wang3, Zhonglin T ang2, Linsen Z an1, Kui L i2   1.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1102  differentiation, angiogenesis, apoptosis and host d e- fenses.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1103  (meat color score, MCS; mobling score, MS; muscle  tender, MT; pH value at 45 -60 min postmortem, pH45;  muscle shear force, MSF; intramuscular fat content,  IMF) and immune traits  (white blood cell counts,  WBC; hemoglobin, HGB; total erythrocytes, RBC;  mean corpuscular volume hemoglobin, MCH; mean  corpuscula r volume hemoglobin concentration,  MCHC; hematocrit, HCT; red cell distribution width,  RDW; concentration of IgG , IgG2).",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"The h u- man MMP19  and MMP23B  transcript s (NM_002429  and NM_006983, respectively) retrieved from the  GenBank database ( http://www.ncbi.nlm.nih.gov/ )  were used as entries to search for homologous s e- quence in the pig EST database  (http://www.ncbi.nlm.nih.gov/genbank/GenbankS earch.html).",OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1104  ase (Fermentas , Vilnius, Lithuania ) and sterile water.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7      http://www.biolsci.org  1105  The association analysis was performed using  the GLM procedure (SAS, 2006).",OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
The porcine MMP19  was predicted to encode a pr o-tein of 540 amino acid residues  (http://genes.mit.edu/GENSCAN.html ) with a ca l- culated molecular mas s of 61.03218 kDa  and an iso e- lectric po int of 6.13  (http://weblab.cbi.pku.edu.cn/   program.inputForm.do?program=pepstats(v6.0.1) ).,OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1106    Fig.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1107  globulin  (IG), similar to the domain s of the human   (O75900)  and mouse  (O88676) MMP 23 proteins   (shown in Fig.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1108    Fig.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1109  Table  2 Structure of pig MMP19  and MMP23B  genes   Gene  Number  Exon size(bp)  Intron size (bp)  5’ splice donor  3’ splice acceptor   MMP19  1 177 283 GTG/GTGAG  TCATAG/GATTAT    2 86 1467  TGAG/GTGAGA  TTTTCAG/AGCTT    3 131 244 GCTGG/GTGA  ACCAG/GCC    4 216 451 CTG/GTAGGT  TCCAG/GGAGGG    5 246 444 CTATG/GTCAG  TGCAG/GCAAG    6 126 684 TGG/GTAAGAC  CTCAG/GGCC    7 165 350 TTAAGG/GTAAC  CTCTCAG/GAG    8 128 188 TAAG/GTACA  TACCTAG/GGCT    9 953     MMP23B  1 162 336 CAA/GTGAG  GAAG/GG    2 137 79 CAG/GTGCG  CCCAG/GATCC    3 140 77 ATAG/GTGGG  CCTAG/GCTTCT    4 168 368 AG/GTGAC  CGCAAG/GCGT    5 165 77 ACG/GTGAGT  TCCCGCAG/GCT    6 111 78 TACG/GTGAG  AGCAG/AGTTC    7 127 78 AGTGTA/GTGA  CCCGCAG/CTGG    8 216       Table 3  RH mapping results of MMP19  and MMP23B  genes   Genes  Cytogenetic position  Linked markers  Retention  Breakage frequency  RH Dist   (Ray)  LOD   score   MMP19  SSC5  DK 44 0.19 0.21 18.02   MMP23B  SSC8  Sw2521  26 0.28 0.33 11.69     Table  4 Allele frequency  in different  pig breeds   SNPs of MMP19  Pig breeds   Tongcheng pig  Yorkshire pig  Landrace  pig LYT pig YLT  pig  C203T in exon  5  NO.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1110  Table  5 Association analysis of different genotype s with traits   trait s genotypes/number  P value   C203T in exon  5 of MMP19    WBC  27.71±3.275  32.72±2.986  19.67±5.23  0.0472*  0.278  0.2236  0.0183*   IgG2  46.919±2.85  55.06±2.287  45.81±3.99  0.0195*  0.0459*  0.8368  0.0256*   C131T in exon  3 of MMP23B     CC/27  TC/77  TT/35       HGB  58.263±9.492  54.322±5.73  29.298±8.322  0.0189*  0.7371  0.0326  0.0074**   MCH  152.94±25.71  147.33±15.52  82.86±22.54  0.0304*  0.8598  0.0558  0.0108*       Temporal and spatial expression  of porcine  MMP19  and MMP23B  gene   Quantitative real -time PCR analysis showed that  while the porcine MMP19  gene was highly expressed  in the liver of both breeds, it  is much higher in Ton g- cheng pig s than in Landrace pig s. In both breeds,  MMP19  was weakly expressed in other tissues .",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1111  cantly higher level s of IgG2  than the genotype TT  (45.81 ± 3.99) and CC (46.919 ± 2.85) individuals  (P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7    http://www.biolsci.org  1112    Fig.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7      http://www.biolsci.org  1113  Acknowledgements   We are grateful to Dr. Martine Yerle for provi d- ing the IMpRH panel.",Non-OADS,/arxiv_data1/oa_pdf/14/54/ijbsv07p1101.PMC3174387.pdf
"2011, 7      http://www.biolsci.org  1114  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2011; 7(8):1114-1121  Research Paper   FRS2 is Essential for the Fibroblast Growth Factor to Regulate the mTOR  Pathway and Autophagy in Mouse Embryonic Fibroblasts    Xiang Lin1,2,#, Yongyou Zhang1,*, Leyuan Liu1, Wallace L. McKeehan1, Yuemao  Shen2, Siyang Song2,, and  Fen Wang1,  1.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7    http://www.biolsci.org  1115  phosphotyrosine -binding (PTB) domain required for  binding to the FGFR, and the C -terminal sequence  that contains multiple tyrosine and serine/threonine  phosphorylation sites.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7    http://www.biolsci.org  1116  ma-Aldrich, Inc. St Louis, MO) for Western blot ana l- yses.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7    http://www.biolsci.org  1117    Fig.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7    http://www.biolsci.org  1118  FRS2 is required for FGF2 to inhibit autop h- agy through the mTOR pathway.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7    http://www.biolsci.org  1119  The results suggest that activation of mTOR C1  is required for FGF2 to suppress the autophagy acti v- ity.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7      http://www.biolsci.org  1120    Fig.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7    http://www.biolsci.org  1121  SNT PTB domain interactions with distinct neurotrophic r e- ceptors.",Non-OADS,/arxiv_data1/oa_pdf/61/67/ijbsv07p1114.PMC3174388.pdf
"2011, 7      http://www.biolsci.org  1045  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2011; 7(7):1045-1055  Research Paper   Repertoire of Porcine MicroRNAs in Adult Ovary and Testis by Deep       Sequencing    Mingzhou Li1*, Yingkai Liu1*, Tao Wang1, Jiuqiang Guan1, Zonggang Luo1, Haosi Chen2, Xin Wang2, Lei  Chen3, Jideng Ma1, Zhiping Mu1, An-an Jiang1, Li Zhu1, Qiulei Lang4, Xiaochuan Zhou4, Jinyong Wang3,  Wenxian Zeng5, Ning Li6, Kui Li7, Xiaolian Gao2, Xuewei Li1  1.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7      http://www.biolsci.org  1046  Introduction   microRNAs (miRNAs) comprise a large family  of ~22 nucleotides (nt ) long non -coding small RNAs  derived from ~70 nt long stem -loop precursors  (pre-miRNAs).",OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1047  follows: equal quantities (5 µg) of small RNA isolated  from individual female or individual male were  pooled.",OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"The mappable sequences were mapped to the  pig genome (~2.26 Bbp) (Sscrofa9, ftp://ftp.sanger.ac.",OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1048  Interestingly, we found that 2.35M (ovary:  13.35%) and 5.59M (testis: 30.0 4%) counts of sequ -seqs  were out of the boundaries of 15 -26 nt in size, and  2.53M (ovary: 14.36%) and 2.41M (testis: 12.94%)  counts of sequ -seqs were mapped to certain other  known classes of RNA sequences , e.g., mRNA, rRNA,  tRNA,  snRNA , snoRNA and repetiti ve sequence el e- ments, which were eliminated from analysis.",OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"The reasons for this are: (1) no porcine  piRNA sequences have been reported or deposited in  the public database, such as in the piRNABank  (http://pirnabank.ibab.ac.in ) [29]; (2) piRNAs s e- quences are not conserved in mammals [30-32]; and  (3) the interaction between PIWI and our small RNAs  is not being tested in this study.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1049  Additional  file 2: Supplementary Table 5 pro- vides a complete sequence, name, and relative abun- dance list for the 732 miRNA s sequences (i.e., the most  abundant isomiR) originat ed from 582 pre -miRNAs  detected in this study.",OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1050  that let -7-family miRNAs are ubiquitously expressed  in various cell and tissues types with a  high -expression level and a re involved in the cell c y- cle as master regulators of cell proliferation pathways  [39-41].",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7      http://www.biolsci.org  1051        Figure 2 .",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1052  Exploring the expression patterns of porcine  X-linked miRNAs   The XX/XY system is one of the most common  sex-determination systems and is found in the vast  majority of mammals.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1053  -0.08), which are separated by 122,184 nt and 267,370  nt respectively.",OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
http://www.biolsci.org/v07p 1045 s1.pdf  Additional  File 2:    Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1054  pressed (DE) between porcine adult ovary and tes tis.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"http://www.biolsci.org/v0 7p1045 s2.pdf  Acknowledgements   This work  was supported by grants from the  National Special Foundation for Transgenic Species of  China (2009ZX08009 -155B and 2008ZX08006 -003), the  National Natural Science Foundation of China  (30901024), the International Science & Technology  Cooperation Program of  China (2011DFB30340) , the  Funds for Distinguished Young Scientists of Chon g- qing (CSTC2010BA1007)  to X.L.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7    http://www.biolsci.org  1055  36.",Non-OADS,/arxiv_data1/oa_pdf/b0/41/ijbsv07p1045.PMC3174389.pdf
"2011, 7      http://www.biolsci.org  1056  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2011; 7(7):1056-1067  Review  Diverse Roles of TGF- β/Smads in Renal Fibrosis and Inflammation    Hui Yao Lan  Li Ka Shing Institute  of Health Sciences and  Department of Medicine & Therapeutics, The Chinese University  of Hong Kong,  Hong Kong SAR, China     Corresponding author:  Hui Y. Lan, M.D., Ph.D., Li Ka Shing Institute of Health Sciences  and Department of Medicine &  Therapeutics , the Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
This is an open -access article  distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1057  proteins (LTBP) [3, 4].",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1058  mune diseases [15, 16].",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1059  counter -regulating activity [29], suggesting the co m- plexity between the TGF -β/Smad and BMP/Smad  pathways under disease conditions.",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1060  Epithelial- mesenchymal transition (EMT) has  been long considered as a process leading to renal  fibrosis [9].",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1061  renal inflammation and the inhibitory effect of  TGF -β1 on interleukin -1β-induced inflammatory r e- sponse in macrophages in vivo and in vitro [59].",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1062  up-regulation of renal Smurf2 causes an ubiqu i- tin-dependent degradation of renal Smad7, resulting  in enhanced TGF -β/Smad signaling and progressive  renal fibrosis [69].",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7      http://www.biolsci.org  1063  The ability of overexpression of renal Smad7 to  inhibit NF- κB activation and renal inflammation in  remnant kidney disease [74], autoimmune crescentic  glomerulonephritis [40], and diabetic nephropathy [32]   confirms the potenti al role of Smad7 -NF-κB crosstalk  pathway in renal inflammation.",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1064    Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1065  Conflict of I nterest s  The author  has declared that no conflict of i n- terest exists.",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1066  flammation in unilateral ureteral obstruction (UUO) in mice.",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
"2011, 7    http://www.biolsci.org  1067  71.",Non-OADS,/arxiv_data1/oa_pdf/22/d8/ijbsv07p1056.PMC3174390.pdf
This is an open -access article distributed under  the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/12/ijbsv07p1068.PMC3174391.pdf
The gene expression atlas is a simple searchable  database  (http://vmolab.whu.edu.cn:8080/Human   GeneSearch/ ).,OADS,/arxiv_data1/oa_pdf/c1/12/ijbsv07p1068.PMC3174391.pdf
"Ministry of Health and Welfare; 2007 [cited 2010 Nov 30], available from http://oralhealth.hp.go.kr/survey/survey_2.aspx.",Non-OADS,/arxiv_data1/oa_pdf/f1/4b/isd-41-1.PMC3174459.pdf
[118]  http://www.gsk-clinicalstudyregister.com/result_detail.jsp?,Non-OADS,/arxiv_data1/oa_pdf/cd/f9/TOMCJ-5-82.PMC3174521.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in an y medium, provided the original work is properly cited.1 Citation: Int J Qualitative Stud Health Well-being 2011, 6: 7291 - DOI: 10.3402/qhw.v6i3.7291",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved March 11, 2011, from http://www.slf.se/templates/AssociationPage.aspx?id /C30 21784 Glaser, B. G. (1978).",OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved January15, 2006, from http://www.icn.ch/1953rev.2000 Jakobsen, R., & So ¨rlie, V. (2010).",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved March 10, 2011,from http://www.socialstyrelsen.se/ansokaomlegitimationochintyg/bevisspecialistkompetens/omlakarnasnyast/Documents/stmal-geriatrik.pdf Noddings, N. (1984).",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved April 19, 2010, from http://www.sweden.gov.se/sb/d/574/a/23125 SFS.",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved March 10, 2011, from http://www.codex.vr.se/en/forskninghumsam.shtml Slettebo, A ˚., & Haugen Bunch, E. (2004).",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved April 16, 2010, from http://www.socialstyrelsen.",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved July 22, 2008, from http://www.who.int/healthinfo/survey/ageing defnolder/en/index.html World Medical Association Declaration of Helsinki (2008).",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
"Retrieved October 22, 2008, from http://www.wma.net/en/ 30publications/10policies/b3/index.htmlL-L. Jonasson et al.",Non-OADS,/arxiv_data1/oa_pdf/83/d9/QHW-6-7291.PMC3174776.pdf
Available from: http://www.cnpp.usda.gov/DGAs2010-DGACReport.htm.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from: http://www.ars.usda.gov/foodsurvey.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available fromhttp://www.ars.usda.gov/Services/docs.htm?docid=12083.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from:http://www.ars.usda.gov/Services/docs.htm?docid=13747.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from: http://www.ars.usda.gov/Services/docs.htm?docid=17031.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from: http://www.ars.usda.gov/Services/docs.htm?docid=17476.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from: http://www.ars.usda.gov/Services/docs.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from: http://www.ars.usda.gov/Services/docs.htm?docid=8964.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from: http://www.ars.usda.,Non-OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
Available from: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm.,OADS,/arxiv_data1/oa_pdf/4a/fb/nut14101847.PMC3174857.pdf
"For mapping purposes, themillion base pair (Mb) as well as the centimorgan (cM)positions of each SNP were derived from the Mouse Map Converter tool provided by The Center for Genome Dynamics at The Jackson Laboratory ( http://cgd.jax.org/ mousemapconverter/ ), which utilizes the National Center for Biotechnology Information (NCBI) mouse genome build 37 and a corrected mouse map (Cox et al.",OADS,/arxiv_data1/oa_pdf/a5/52/438_2011_Article_642.PMC3175031.pdf
Quantitative trait locus (QTL) analysis All QTL analyses were performed with the R/qtl software package (v. 1.18-7 available at http://www.rqtl.org/ ).,OADS,/arxiv_data1/oa_pdf/a5/52/438_2011_Article_642.PMC3175031.pdf
SC-B67 ssb/soxSR NC _006905 _P7 26.7 SPI-4 _TyphiCT18 S.Typhi CT18 ssb NC _003198 _P8 23.4 SPI-4 _TyphimuriumLT2 S.Typhimurium LT2 ssb/soxSR NC _003197 _P5 23.4 SPI-4 _TyphimuriumLT2 _2 S.Typhimurium LT2 ssb/soxSR AF060869 27.3 SPI-4 _TyphimuriumST4-74 S.Typhimurium ST4/74 Not published AJ576316 24.7 SPI-5 _Dublin S.Dublin tRNA-serT AF060858 9.7 SPI-5 _TyphimuriumLT2 S.Typhimurium LT2 tRNA-serT NC _003197 _P1 9.1 SPI-6 _TyphiCT18 S.Typhi CT18 tRNA-asp NC _003198 _P1 58.7 SPI-7 _TyphiCT18 S.Typhi CT18 tRNA-phe NC _003198 _P9 133.6 SPI-7 _TyphiTy2 S.Typhi Ty2 tRNA-phe NC _004631 _P3 131.7 SPI-8 _TyphiCT18 S.Typhi CT18 tRNA-phe NC _003198 _P6 6.9 SPI-9 _TyphiCT18 S.Typhi CT18 Not published NC _003198 _P4 15.7 SPI-10 _TyphiCT18 S.Typhi CT18 tRNA-leu NC _003198 _P10 32.9 SPI-11 _CholeraesuisSC-B67 S.Choleraesuis SC-B67 Gifsy-1 prophage NC _006905 _P2 15.7 SPI-12 _CholeraesuisSC-B67 S.Choleraesuis SC-B67 tRNA-pro NC _006905 _P4 11.1 CS54island _TyphimuriumATCC14028 S.Typhimurium ATCC14028 xseA/yfgK AF140550 25.3 SGI1 _TyphimuriumDT104 S.Typhimurium DT104 thdF AF261825 47.7 aDownloaded from http://www.gem.re.kr/paidb/browse _pais.php?m=p#Salmonella%20enterica496 A. Jacobsen et al.,Non-OADS,/arxiv_data1/oa_pdf/08/0d/248_2011_Article_9880.PMC3175032.pdf
http://www.sanger.ac.uk/resources/ downloads/bacteria/salmonella.,Non-OADS,/arxiv_data1/oa_pdf/08/0d/248_2011_Article_9880.PMC3175032.pdf
Available at: http://www.cbs.nl .,Non-OADS,/arxiv_data1/oa_pdf/dc/2d/431_2011_Article_1433.PMC3175033.pdf
Available at: http://www.veiligheid.nl .,Non-OADS,/arxiv_data1/oa_pdf/dc/2d/431_2011_Article_1433.PMC3175033.pdf
http://www.rivm.nl/vtv/object _document/ o2966n19459.htm .,Non-OADS,/arxiv_data1/oa_pdf/dc/2d/431_2011_Article_1433.PMC3175033.pdf
Retrieved from http://www.kidney.org/PROFESSIONALS/kdoqi/ guideline_upHD_PD_V A/va_guide1.htm .,Non-OADS,/arxiv_data1/oa_pdf/e1/78/12265_2011_Article_9306.PMC3175038.pdf
"1), including several listed in the New York State ﬁsh consump-tion advisory ( http://www.nyhealth.gov/publications/2779 , accessed March 28, 2011).",Non-OADS,/arxiv_data1/oa_pdf/ae/f6/10646_2011_Article_717.PMC3175042.pdf
"2007 ), with (1) relatively high Hg deposition (National Atmospheric Deposition Program Mercury Deposition Network, http://nadp.sws.",Non-OADS,/arxiv_data1/oa_pdf/df/0d/10646_2011_Article_719.PMC3175049.pdf
"These characteristicsare captured by the hydrologic transport distance (HTD) metric, which was derived from the 10-m National Elevation Dataset ( http://seamless.usgs.gov , accessed 8 March 2010) as the overland ﬂow distance metric (OFD, System for Automated Geoscientiﬁc Analysis; Cimmery 2007 ).",OADS,/arxiv_data1/oa_pdf/df/0d/10646_2011_Article_719.PMC3175049.pdf
"Wetland land cover for FB NYwas derived from the Adirondack Park Agency Wetlands map (http://www.apa.state.ny.us/Research/uh/uhreporttitle.html , accessed 7 May 2010).",Non-OADS,/arxiv_data1/oa_pdf/df/0d/10646_2011_Article_719.PMC3175049.pdf
"Developed land cover was derived from National Land Cover Data of 2001( http://www.epa.gov/mrlc/nlcd-2001.html , accessed 1 Mar 2009) DAdrainage area, Wet wetland, OW open water, Dev developed, HTD hydrologic transport distance, FMeHg ﬁltered methylmercury, DOC dissolved organic carbon1532 K. Riva-Murray et al.",OADS,/arxiv_data1/oa_pdf/df/0d/10646_2011_Article_719.PMC3175049.pdf
"However, in our case we used wetland data from high-quality photogrammetric imagery for the FB NY study area ( http://www.apa.state.ny.us/Research/uh/uhre porttitle.html , accessed 7 May 2010).",Non-OADS,/arxiv_data1/oa_pdf/df/0d/10646_2011_Article_719.PMC3175049.pdf
http://www.scdhec.gov/environment/water/ﬁsh .,Non-OADS,/arxiv_data1/oa_pdf/df/0d/10646_2011_Article_719.PMC3175049.pdf
"In Marseille, on June 25th and 26th, 2010, the Canceropo ˆles ‘‘Provence Alpes Co ˆte d’Azur’’ and ‘‘Lyon, Auvergne et Rho ˆne Alpes’’ organised a cancer cell signalling meeting on ‘‘the LKB1-AMPK pathway, from basic science to clinicalapplications’’ ( http://www.lkb1.com ).",Non-OADS,/arxiv_data1/oa_pdf/f2/b3/10689_2011_Article_9474.PMC3175341.pdf
http://www.nbocc.org.au/fraboc/ 8.,Non-OADS,/arxiv_data1/oa_pdf/00/7b/10689_2011_Article_9435.PMC3175342.pdf
http://www.kconfab.org 33.,Non-OADS,/arxiv_data1/oa_pdf/00/7b/10689_2011_Article_9435.PMC3175342.pdf
"Assessment of patient-reported outcomes The European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire, EORTC QLQ- C30, version 3.0 [ 23], was used to assess patient-reported outcomes, supplemented with selected questions fromother relevant EORTC organ- and disease-speciﬁc modules (http://www.eortc.be/ ).",Non-OADS,/arxiv_data1/oa_pdf/13/23/464_2011_Article_1680.PMC3175352.pdf
www.jpis.orgpISSN 2093-2278 eISSN 2093-2286Editorial Copyright © 2011 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).The road less traveledJ Periodontal Implant Sci 2011;41:165-166 • http://dx.doi.org/10.5051/jpis.2011.41.4.165 Traditional approaches for salvaging peri - odontally involved teeth have  faced the test of whether or not the treatment modalities can guarantee  tooth survival for more than a couple of decades.,Non-OADS,/arxiv_data1/oa_pdf/9a/39/jpis-41-165.PMC3175495.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2011 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Gene expression pattern during osteogenic  differentiation of human periodontal ligament  cells in vitro Mi-Hye Choi1, Woo-Chang Noh1,2, Jin-Woo Park1, Jae-Mok Lee1, Jo-Young Suh1,2,* 1Department of Periodontology, 2Institute for Hard tissue and Bio-tooth Regeneration, Kyungpook National University School of Dentistry,  Daegu, Korea Purpose:  Periodontal ligament (PDL) cell differentiation into osteoblasts is important in bone formation.",Non-OADS,/arxiv_data1/oa_pdf/be/05/jpis-41-167.PMC3175496.pdf
"Keywords:  Cell differentiation, Gene expression, Periodontal ligament.J Periodontal Implant Sci 2011;41:167-175 • http://dx.doi.org/10.5051/jpis.2011.41.4.167Research Article INTRODUCTION Periodontal tissue is composed of epithelial tissue and soft  and hard connective tissue.",Non-OADS,/arxiv_data1/oa_pdf/be/05/jpis-41-167.PMC3175496.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2011 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Dimensional change of the healed periosteum on  surgically created defects Eun-Hee Cho, Jung-Chul Park, Jae-Kook Cha, Yong-Tae Kim, Ui-Won Jung, Chang-Sung Kim,   Seong-Ho Choi, Chong-Kwan Kim* Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College of Dentistry, Seoul, Korea Purpose:  The final goal of regenerative periodontal therapy is to restore the structure and function of the periodontium de - stroyed or lost due to periodontitis.",Non-OADS,/arxiv_data1/oa_pdf/aa/03/jpis-41-176.PMC3175497.pdf
"Keywords:  Animal models, Periodontal guided tissue regeneration, Periosteum.J Periodontal Implant Sci 2011;41:176-184 • http://dx.doi.org/10.5051/jpis.2011.41.4.176Research Article INTRODUCTION Periodontitis is an infectious and common disease of the  periodontal tissue that requires proper treatment to prevent  alveolar bone loss or tooth loss.",Non-OADS,/arxiv_data1/oa_pdf/aa/03/jpis-41-176.PMC3175497.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2011 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Tissue reactions to suture materials in the oral  mucosa of beagle dogs Jae-Seok Kim1, Seung-Il Shin2, Yeek Herr2,3, Joon-Bong Park2,3, Young-Hyuk Kwon2,3, Jong-Hyuk Chung2,3,* 1Luden Dental Clinic, Seoul, Korea 2Department of Periodontology, 3Institute of Oral Biology, Kyung Hee University School of Dentistry, Seoul, Korea Purpose:  The objective of this study was to compare and evaluate the inflammatory responses of three widely used suture  materials in the keratinized gingiva and buccal mucosa of beagle dogs.",Non-OADS,/arxiv_data1/oa_pdf/c8/ee/jpis-41-185.PMC3175498.pdf
"Keywords:  Gingiva, Histology, Inflammatory response, Oral mucosa, Suture materials.J Periodontal Implant Sci 2011;41:185-191 • http://dx.doi.org/10.5051/jpis.2011.41.4.185Research Article INTRODUCTION Suturing, which is the final procedure of a surgery, is used  to reattach the removed tissue, to control bleeding, and allow  for primary healing [1].",Non-OADS,/arxiv_data1/oa_pdf/c8/ee/jpis-41-185.PMC3175498.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2011 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Gene expression profile in mesenchymal stem  cells derived from dental tissues and bone marrow Su-Hwan Kim1,2, Young-Sung Kim1,2, Su-Yeon Lee3,4, Kyoung-Hwa Kim5, Yong-Moo Lee5,  Won-Kyung Kim1, Young-Kyoo Lee1,*  1Department of Periodontics, Asan Medical Center, Seoul, Korea  2Department of Dentistry, University of Ulsan College of Medicine, Seoul, Korea  3Seoul National University Biomedical Informatics (SNUBI), Seoul National University, Seoul, Korea 4Systems Biomedical Informatics Research Center, Division of Biomedical Informatics, Seoul National University College of Medicine,  Seoul, Korea 5Department of Periodontology, Seoul National University School of Dentistry, Seoul, Korea Purpose:  The aim of this study is to compare the gene expression profile in mesenchymal stem cells derived from dental tis - sues and bone marrow for characterization of dental stem cells.",Non-OADS,/arxiv_data1/oa_pdf/dd/a1/jpis-41-192.PMC3175499.pdf
"J Periodontal Implant Sci 2011;41:192-200 • http://dx.doi.org/10.5051/jpis.2011.41.4.192Research Article INTRODUCTION Stem cells are undifferentiated cells characterized by the  ability at the single cell level to both self-renew and differen - tiate to produce mature progeny cells [1,2].",Non-OADS,/arxiv_data1/oa_pdf/dd/a1/jpis-41-192.PMC3175499.pdf
"www.jpis.org Journal of Periodontal & Implant Science JPIS pISSN 2093-2278 eISSN 2093-2286 Copyright © 2011 Korean Academy of Periodontology This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).A comparison of different gingival  depigmentation techniques: ablation by  erbium:yttrium-aluminum-garnet laser and  abrasion by rotary instruments Kwang-Myung Lee1, Dong-Yeol Lee1, Seung-Il Shin1, Young-Hyuk Kwon1,2, Jong-Hyuk Chung1,2, Yeek Herr1,2,* Department of 1Periodontology, 2Institute of Oral Biology, Kyung Hee University School of Dentistry, Seoul, Korea Purpose:  The aim of this study is to compare two different gingival depigmentation techniques using an erbium:yttrium- aluminum-garnet (Er:YAG) laser and rotary instruments.",Non-OADS,/arxiv_data1/oa_pdf/03/58/jpis-41-201.PMC3175500.pdf
"Keywords:  Hyperpigmentation, Lasers, Melanins, Pigmentation.J Periodontal Implant Sci 2011;41:201-207 • http://dx.doi.org/10.5051/jpis.2011.41.4.201Case Report INTRODUCTION Oral pigmentation is a discoloration of the oral mucosa or  gingiva associated with several exogenous and endogenous  factors.",Non-OADS,/arxiv_data1/oa_pdf/03/58/jpis-41-201.PMC3175500.pdf
"To quantify transcript expression, we mapped all readsthat remained unmapped to the human reference genome (hg19, buildGRCh37, downloaded from UCSC genome browser, http://genome.ucsc .edu) using the gapped aligner software TopHat.",OADS,/arxiv_data1/oa_pdf/8b/47/mBio.00134-11.PMC3175625.pdf
Metacore version 6.3and Entrez Gene ( http://www.ncbi.nlm.nih .gov/sites ) were used for gene ontology and pathway analysis.,OADS,/arxiv_data1/oa_pdf/71/47/mBio.00172-11.PMC3175626.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/d1/evr080.PMC3175760.pdf
Supplementary Material Supplementary ﬁgures S1 –S5andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/88/d1/evr080.PMC3175760.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/34/evr078.PMC3175761.pdf
"Database URL: http://www.biomart.org ............................................................................................................................... ............................................................................................................................... ............................... Introduction Biological data are complex and require specialized expert- ise for their collection, analysis and interpretation.",OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"http://cancergenome.nih.gov/ (5 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"http://www.ebi.ac .uk/ega/ (5 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"OpenID Authentication 2.0. http://openid.net/specs/openid- authentication-2_0.html (5 August 2011, date last accessed).",OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"http://oauth.net/core/1.0/ (5 August 2011, date last accessed).",OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"http://code.google.com/p/ swoop (5 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"http://pellet.owldl.com/ontology-browser (5 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
"http://protege.stanford.edu (5 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/24/4e/bar038.PMC3175789.pdf
Matlab File Exchange repository ID #8998. http://www.mathworks.com/matlabcentral/ ﬁleexchange/8998 Ghiradella H (1989) Structure and development of iridescent butterﬂy scales: lattices and laminae.,OADS,/arxiv_data1/oa_pdf/37/6c/359_2011_Article_661.PMC3176396.pdf
http://irs.ub.,Non-OADS,/arxiv_data1/oa_pdf/37/6c/359_2011_Article_661.PMC3176396.pdf
Available at http://www.kreftregisteret.,Non-OADS,/arxiv_data1/oa_pdf/de/bf/384_2011_Article_1244.PMC3176397.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/ 3.0/ Supplementary Information accompanies the paper on Cancer Gene Therapy website (http://www.nature.com/cgt)Distribution and antitumoral activity of Dbait N Berthault et al 706 Cancer Gene Therapy",Non-OADS,/arxiv_data1/oa_pdf/8e/c8/cgt201139a.PMC3176463.pdf
"We have entered into an era of ‘mega-sequencing projects’ that include the Genomic Encyclopaedia of Bacteria and Archaeaproject (http://www.jgi.doe.gov/programs/GEBA), the Microbial Earth Project (http://genome.jgi-psf.",Non-OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"org/programs/bacteria-arch aea/MEP/index.jsf), the Human Microbiome Project (http://nihroadmap.nih.",Non-OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"gov/hmp), the Metagenomics of the Human Intest- inal Tract consortium (http://www.metahit.eu), theTerragenome Initiative (http://www.terragenome.",Non-OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"taraexpeditions.org), the National Ecological Obser-vatory Network (NEON-http://www.neoninc.org),the International Census of Marine Microbes (ICoMM-http://icomm.mbl.edu), Microbial Inven- tory Research Across Diverse Aquatic Long-TermEcological Research Sites (http://amarallab.mbl.",Non-OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"edu/mirada/mirada.html), the Earth Microbiome Project (http://www.earthmicrobiome.org) and otherfunded and unfunded projects, with many more visionary projects on the horizon.",Non-OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"Furthermore, to cover the description of phylogenetic and functionalmarker genes an extended standard, the Minimum Information about a MARKer gene Sequence (MI- MARKS) checklist (http://gensc.org/gc_wiki/index.php/MIMARKS) has been developed (Yilmaz et al., 2011).",OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"It provides an example of what an infrastructure to support standards-compliant reporting of contextualdata might look like; as well as encouraging and enabling curation at community level (Rocca-Serra et al., 2010; http://isatab.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"To learn how to describe your data according to MIGS/MIMS/MIMARKS (MIxS) standards, please visit the GSC website for details and options for submitting compliant data sets into public domain databases(http://gensc.org/gc_wik i/index.php/MIGS/MIMS/ MIMARKS).",OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on The ISME Journal website (http: //www.nature.com/ismej)Commentary 1567 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/ce/16/ismej201139a.PMC3176512.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS 2011 plr021 doi:10.1093/aobpla/plr021, available online at www.aobplants.oxfordjournals.org &The Authors 2011 1",Non-OADS,/arxiv_data1/oa_pdf/51/0a/plr021.PMC3176521.pdf
"Parameters of population diversity ( h S,hT,vS,vT) and differentiation ( GST,NST) were estimated following the methods of Pons and Petit ( 1995 ,1996 ) using the program PERMUT (http://www.pierroton.inra.fr/genetics/labo/Software/Permut).",OADS,/arxiv_data1/oa_pdf/51/0a/plr021.PMC3176521.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS 2011 plr023 doi:10.1093/aobpla/plr023, available online at www.aobplants.oxfordjournals.org &The Authors 2011 1",Non-OADS,/arxiv_data1/oa_pdf/47/6c/plr023.PMC3176522.pdf
"2005 Available from: <http://www.cdc.gov/nchs/data/ nhanes/nhanes_03_04/l11pth_c_met.pdf >, accessed 5th October 2011.",OADS,/arxiv_data1/oa_pdf/8c/c3/ajh2011108a.PMC3176582.pdf
"<http://www.cdc.gov/nchs/nhanes/nhanes_01_02/physician_ year_3.pdf >, accessed 5th October 2011.",Non-OADS,/arxiv_data1/oa_pdf/8c/c3/ajh2011108a.PMC3176582.pdf
"<http://www.cdc.gov/nchs/nhanes/nhanes_03_04/physician_ year_3.pdf >, accessed 5th October 2011.",Non-OADS,/arxiv_data1/oa_pdf/8c/c3/ajh2011108a.PMC3176582.pdf
"<http://www.cdc.gov/nchs/nhanes/nhanes_05_06/physician_ year_3.pdf >, accessed 5th October 2011.",Non-OADS,/arxiv_data1/oa_pdf/8c/c3/ajh2011108a.PMC3176582.pdf
"2010 Available from: <http://www.cdc.gov/nchs/data/nhanes/nhanes3/VitaminD_analyticnote.pdf >, accessed 5th October 2011.",OADS,/arxiv_data1/oa_pdf/8c/c3/ajh2011108a.PMC3176582.pdf
Database URL: http://ctd.mdibl.org ............................................................................................................................... ............................................................................................................................... ............................... Introduction Phenotypes (including many disease) result from interactions between genes and the environment.,OADS,/arxiv_data1/oa_pdf/e0/57/bar034.PMC3176677.pdf
"This is Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/57/bar034.PMC3176677.pdf
"Citing and linking to CTD To cite CTD, please see: http://ctd.mdibl.org/about/publica-tions/#citing.",Non-OADS,/arxiv_data1/oa_pdf/e0/57/bar034.PMC3176677.pdf
"If you are inter- ested in establishing links to CTD data, please notify us (http://ctd.mdibl.org/help/contact.go) or follow these in-structions at http://ctd.mdibl.org/help/linking.jsp.",Non-OADS,/arxiv_data1/oa_pdf/e0/57/bar034.PMC3176677.pdf
"Methods We followed the method guidelines of the Cochrane Back Review Group [ 8,9], Campbell and Cochrane Econo- mic Methods Group ( http://www.med.uea.ac.uk/research/ research_econ/cochra ne/cochrane_home.htm ), and the NHS Economic Evaluation Database Handbook [ 10].",Non-OADS,/arxiv_data1/oa_pdf/89/d4/586_2010_Article_1675.PMC3176699.pdf
We used the Cochrane Back Review Group’s search strategies to identify randomised controlled trials in LBP(http://www.cochrane .iwh.on.ca/pdfs/ CBRG_searchstrat_ Sept08.pdf ).,OADS,/arxiv_data1/oa_pdf/89/d4/586_2010_Article_1675.PMC3176699.pdf
"economics, costsand cost analysis) were developed from search strategies used by the NHS Economic Evaluation Database (NHS EED) ( http://www.york.ac.uk/inst/crd/nhseedfaq02.htm ).",OADS,/arxiv_data1/oa_pdf/89/d4/586_2010_Article_1675.PMC3176699.pdf
"[ 16] Perspective: not stated, but collected direct healthcare and indirect costsNot conducted GBP United Kingdom pounds, RMDQ Roland Morris Disability Questionnaire, QALY quality-adjusted life-years Table 5 Comparing the incremental cost-effectiveness ratio (ICER) in cost per quality-adjusted life-year gained from the healthcare sector’s perspective Treatment Original currencyICER in original currencyICER in 2005 GBP (rounded to the nearest pound) Usual GP care plus exercise and behavioural counselling [ 24]2005 GBP 2,847 2,847 Guideline-based GP care plus spinal manipulation and exercise [ 17]2000–2001 GBP 3,800 4,058 Acupuncture [ 27] 2002–2003 GBP 4,241 4,415 Guideline-based GP care plus spinal manipulation [ 17]2000–2001 GBP 4,800 5,125 Exercise and education using a cognitive- behavioural approach [ 26]2003–2004 GBP 5,000 5,136 Massage plus exercise and behavioural counselling [ 24]2005 GBP 5,304 5,304 Alexander technique plus exercise and behavioural counselling [ 24]2005 GBP 5,332 5,332 Alexander technique [ 24] 2005 GBP 5,899 5,899 Guideline-based GP care plus exercise [17]2000–2001 GBP 8,300 8,863 Massage [ 24] 2005 GBP -34,473 -34,473 (more costly and less effective) Costs were converted to 2005 GBP using consumer price indices ( http://www.statistics.gov.uk/downloads/theme_economy/CPI.pdf ) GBP United Kingdom poundsEur Spine J (2011) 20:1012–1023 1019 123",Non-OADS,/arxiv_data1/oa_pdf/89/d4/586_2010_Article_1675.PMC3176699.pdf
"http://www.scb.se ), the Study Center and from the cost diary [ 18].",Non-OADS,/arxiv_data1/oa_pdf/f6/45/586_2010_Article_1607.PMC3176705.pdf
"Patients who failed to respond at any of the six speci- ﬁed follow-up periods were contacted by phone (CB).Clinical data Clinical outcome was determined based on data from the Swedish Spine Register (‘‘SweSpine’’), http://www.4s.nu , which is gathered by questionnaires mailed to all surgically treated spine patients in Sweden.",OADS,/arxiv_data1/oa_pdf/f6/45/586_2010_Article_1607.PMC3176705.pdf
"In Sweden, ausually referred range for the value of a QALY is SEK 500,000–700,000 (LFN http://www.tlv.se ).",Non-OADS,/arxiv_data1/oa_pdf/f6/45/586_2010_Article_1607.PMC3176705.pdf
Search terms were derived from the search strategies of the Cochrane BackReview Group ( http://www.cochrane.iwh.on.ca/pdfs/CBRG_ searchstrat_Sept08.pdf ) and the British National Health Services Economic Evaluation Database (NHS EED) ( http:// www.york.ac.uk/inst/crd/nhseedfaq02.htm ).,OADS,/arxiv_data1/oa_pdf/df/a1/586_2010_Article_1676.PMC3176706.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.RHEUMATOLOGYRheumatology 2011;50:1869 /C1501878 doi:10.1093/rheumatology/ker179 Advance Access publication 6 July 2011 CLINICAL SCIENCE",Non-OADS,/arxiv_data1/oa_pdf/34/0c/ker179.PMC3176713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.RHEUMATOLOGYRheumatology 2011;50:1773 /C1501784 doi:10.1093/rheumatology/ker198 Advance Access publication 4 July 2011 BASIC SCIENCE",Non-OADS,/arxiv_data1/oa_pdf/f3/73/ker198.PMC3176714.pdf
"For Permissions, pleas e email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.RHEUMATOLOGYRheumatology 2011;50:1908 /C1501915 doi:10.1093/rheumatology/ker221 Advance Access publication 13 July 2011CLINICAL SCIENCE",Non-OADS,/arxiv_data1/oa_pdf/28/81/ker221.PMC3176715.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.Vol.",Non-OADS,/arxiv_data1/oa_pdf/b3/59/kwr149.PMC3176829.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.Vol.",Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"The Population Architecture using Genomics and Epidemi- ology (PAGE) Study (http://www.pagestudy.org) is a National Human Genome Research Institute (NHGRI)-created consor-tium of large, well-characteri zed population-based studies that provides an unprecedented opportunity to investigate the epidemiologic architecture of well-replicated genetic variantsassociated with complex diseases.",Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"The PAGE consortium consists of 4 large, ongoing population-based studies or consortia: Epidemiologic Archi- tecture for Genes Linked to Environment (EAGLE), whichis based on data from 3 National Health and Nutrition Ex- amination Surveys (NHANES; https://chgr.mc.vanderbilt.edu/ eagle) (7); the Multiethnic Coh ort Study (http://www.crch.",Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"org/multiethniccohort/) (8); the Women’s Health Initiative (http://www.whi.org) (9); and Causal Variants Across the Life Course (CALiCo), a consortium of 5 cohort studies—Athero-sclerosis Risk in Communities (ARIC; http://www.cscc.unc.edu/aric/) (10), Coronary Artery Risk Development in Young Adults (CARDIA; http://www.cardia.dopm.uab.edu/) (11), the Cardiovascular Health Stud y (http://www.chs-nhlbi.",Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"org/) (12), the Hispanic Community Health Study/Study of Latinos (http://www.cscc.unc.edu/hchs/) (13), and the Strong Heart Study (http://strongheart.ouhsc.edu/) (14, 15).",Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"For each cycle, each laboratory genotypes 360 HapMapsamples (from populations most relevant to PAGE) to serve as cross-laboratory and cross-platform quality control samples (http://hapmap.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"The chip hasthe added value of including thousands of 1,000 Genome SNPs (http://www.1000genomes.org/) that will facilitate transeth- nic ﬁne mapping around key loci, complementing PAGE’sgoal of assessing whether ﬁndings for GWAS-identiﬁed var- iants are generalizable to populations of non-European de- scent.",Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"Although initial plansfor PAGE speciﬁed dissemination of aggregate data via an open-access Web site, subsequent changes to NIH policy (24) (see the NIH’s GW AS Web site (http://grants.nih.gov/grants/gwas/)) require nearly all PAGE data to be accessible only viacontrolled access to approved users, such as that provided through dbGaP.",Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
A com- plete list of members of the PAGE consortium can be foundat http://www.pagestudy.org.,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
A full listing of WHI investigators can be found at http://www.whisc ience.org/publications/ WHI_investigators_shortlist.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
(http://grants.nih.gov/grants/guide/ rfa-ﬁles/RFA-HG-07-014.html).,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
(http://grants.nih.gov/grants/guide/rfa-ﬁles/RFA-HG-07-015.html).,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/kwr160.PMC3176830.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, andreproduction in any medium, provided the original work is properly cited.Open Access Mol.",Non-OADS,/arxiv_data1/oa_pdf/30/be/msr101.PMC3176832.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/30/be/msr101.PMC3176832.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, andreproduction in any medium, provided the original work is properly cited.Open Access Mol.",Non-OADS,/arxiv_data1/oa_pdf/38/61/msr103.PMC3176833.pdf
The unpublished N. caninum sequence data were obtained from http://www.sanger.a- c.uk/resources/downloads/protozoa/neospora-cani-num.html .Babesia bovis data were downloaded form NCBI (http://www.ncbi.nlm.nih.gov/ ).,OADS,/arxiv_data1/oa_pdf/38/61/msr103.PMC3176833.pdf
Plasmodium berghei data were downloaded f r o mt h eA p r i l2 0 1 0r e l e a s ea tW e l l c o m eT r u s tS a n g e rI n s t i -tute ( http://www.sanger.ac.uk/Projects/Pathogens/ ).Theileria annulata data were downloaded from the Wellcome Trust Sanger Institute ( http://www.sanger.ac.uk/Projects/ Pathogens/ ) on 11th August 2008.,OADS,/arxiv_data1/oa_pdf/38/61/msr103.PMC3176833.pdf
"Orthologous gene clusters were identiﬁed using a combi- nation of WU-BLAST ( http://blast.wustl.edu/ ) (version 2.2.6, Evalue cutoff of 1 /C210 /C030) for an all-by-all BLASTP similarity search (all annotated protein-encoding genes from all spe- cies were analyzed) and OrthoMCL ( Li et al.",OADS,/arxiv_data1/oa_pdf/38/61/msr103.PMC3176833.pdf
"Genome sequence data for P. berghei ,P. chabaudi , and N. caninum were produced by the Parasite genomics group at the Wellcome Trust SangerInstitute, provided by Drs Jonathan Wastling and Matt Ber-riman and are available from http://www.sanger.ac.uk/re- sources/downloads/protozoa/ .",OADS,/arxiv_data1/oa_pdf/38/61/msr103.PMC3176833.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, andreproduction in any medium, provided the original work is properly cited.Open Access Mol.",Non-OADS,/arxiv_data1/oa_pdf/4c/c3/msr127.PMC3176834.pdf
"Human models based on mouse evidence were alsovalidated against human RNAseq models generated by S. White at Ensembl, using an Exonerate-based methodology (Slater and Birney 2005 ) for the RNAseq Genome Annota- tion Assessment Project 1; information on the libraries usedis presented at http://gencodegenes.org/rgasp .",OADS,/arxiv_data1/oa_pdf/4c/c3/msr127.PMC3176834.pdf
http://www.repeatmasker.org.,Non-OADS,/arxiv_data1/oa_pdf/4c/c3/msr127.PMC3176834.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d7/e2/gkr305.PMC3177178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/de/a4/gkr336.PMC3177179.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/85/5c/gkr338.PMC3177180.pdf
The primers were designed using Primer3Plus (http://www.bioinformatics.nl/cgi-bin/primer3plus/ primer3plus.cgi) and veriﬁed for speciﬁcity with Primer- BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).,OADS,/arxiv_data1/oa_pdf/85/5c/gkr338.PMC3177180.pdf
"Gene lists obtained by cluster or differential expression analysis were assessed for over-representation of KEGG (50) and Gene Ontology (51) functional terms using the open-source software DAVID (52,53) (http://david.abcc.ncifcrf.gov/).",OADS,/arxiv_data1/oa_pdf/85/5c/gkr338.PMC3177180.pdf
"To identify potential binding sites for OmpR, we have used the online tool Virtual Footprint (http://prodoric.tu-bs.de/vfp/) using the Prodoric library and performingthe Regulon and the Promoter analysis (55).",OADS,/arxiv_data1/oa_pdf/85/5c/gkr338.PMC3177180.pdf
"Microarray data Gene expression proﬁles data are accessible on the Gene Expression Omnibus (GEO) website (http://www.ncbi.nlm.nih.gov/geo/), with accession number GSE13361.",OADS,/arxiv_data1/oa_pdf/85/5c/gkr338.PMC3177180.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/de/35/gkr350.PMC3177181.pdf
"Assay validation, data analysis and statistics The dNTP detection assay described herein was rigorously tested in accordance with the US Food and Drug Administration ‘Analytical Procedures and Methods Validation’ and ‘Bioanalytical Method Validation’ guide-lines available at http://www.fda.gov.",Non-OADS,/arxiv_data1/oa_pdf/de/35/gkr350.PMC3177181.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/fa/a3/gkr375.PMC3177182.pdf
"Available at http://www.who.int/mediacentre/factsheets/fs104/en/ index.html.7412 Nucleic Acids Research, 2011, Vol.",OADS,/arxiv_data1/oa_pdf/fa/a3/gkr375.PMC3177182.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
The PISCES program http://dunbrack.fccc.edu/PISCES.php was used for extracting a clean protein dataset with <30% sequence identity.,OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
Surface points of each protein were computed using the DMS software http://www.cgl .ucsf.edu/Resources/index.html.,OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
"Geometric surface properties were extracted for each protein chain in the database (after removal of the NA chain) using theIRIT modeling package, http://www.cs.technion.ac.il//C24irit/.",OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
The package rpart from the GNU R software http://cran.r-project.org/web/packages/rpart/ index.html was applied to build decision trees based onthe CART recursive partitioning algorithm.,OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
Supprt vector machine (SVM) experiments were carried out with Gist program version 2.1.1 (http://microarray.cpmc.columbia.edu/gist/).,OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
( B) The NA-binding interface (green) is extracted using Intervor http://cgal.inria.fr/abs/Intervor/.,OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
( C) The Gaussian ( K) and mean ( H) curvatures of each point on the NA-binding interface is calculated with the IRIT software http://www.cs.technion.ac.il/ /C24irit/ and further assigned to a local geometric shape.,OADS,/arxiv_data1/oa_pdf/6a/2c/gkr395.PMC3177183.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/cd/6e/gkr397.PMC3177184.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/95/ba/gkr406.PMC3177185.pdf
"The coding sequence of AtTRM112a was PCR ampliﬁed from cDNA clone RAFL22-14-D01 [RIKEN Bio Research Centre (http://www.brc.riken.go .jp/)] using primers AtTRM112a-r and AtTRM112a-f, whereas AtTRM112b was ampliﬁed from cDNA clone U22673 {ABRC [Arabidopsis B iological Research Centre (www.abrc.osu.edu)]} usi ng primers AtTRM112b-r and AtTRM112b-f.",Non-OADS,/arxiv_data1/oa_pdf/95/ba/gkr406.PMC3177185.pdf
"The primary sequence of Arabidopsis tRNAGly UCC(retrieved from the Genomic tRNA data- base; http://lowelab.ucsc.edu/GtRNAdb/) is highly similar to that of silkworm and mammals, and the anti-codon loop is identical (Figure 4A), suggesting that also this tRNA may carry an ( S)-mchm5U modiﬁcation.",Non-OADS,/arxiv_data1/oa_pdf/95/ba/gkr406.PMC3177185.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/46/50/gkr407.PMC3177186.pdf
"( A) Normalized smoothed distributions of the values of the functional score as computed for 19 179 known ‘disease-associated’ and 35 608 ‘common polymorphism’ variants and mutationsannotated in UniProt (HUMSAVAR, release 2010_08; http://www.uniprot.org/docs/humsavar).",Non-OADS,/arxiv_data1/oa_pdf/46/50/gkr407.PMC3177186.pdf
"And, weintroduce a new type of functional impact of mutations in cancer—involving a ‘switch of speciﬁcity’—that may account for /C245% of predicted functional mutations.We conclude that the functional impact score based on evolutionary information (FIS) is useful for rankingmutations by likely functional impact, especially for understanding the role of mutated proteins in cancer, for nominating newly discovered mutations contributingto cancer and for prioritizing mutations for furtheranalyses and experiments involving these alterations.Our computational protocol is fully automated andimplemented as a publicly available server (http://mutationassessor.org) for use in cancer research.",Non-OADS,/arxiv_data1/oa_pdf/46/50/gkr407.PMC3177186.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/52/38/gkr416.PMC3177187.pdf
"Furthermore, we generated standard quality control metrics on both our newly generated and publicly avail- able data using FastQC (http://www.bioinformatics.bbsrc.",OADS,/arxiv_data1/oa_pdf/52/38/gkr416.PMC3177187.pdf
"To explore additional factors that correlate with promoter genes, we ﬁrst identiﬁed genes with any CpG islands in the 3 kb upstream of the TSS using the UCSCtrack (http://genome.ucsc.edu/cgi-bin/hgTables).",Non-OADS,/arxiv_data1/oa_pdf/52/38/gkr416.PMC3177187.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ff/1b/gkr417.PMC3177188.pdf
"17 7803–7815 doi:10.1093/nar/gkr418 Published by Oxford University Press, 2011 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/gkr418.PMC3177189.pdf
"17 Published online 7 June 2011 doi:10.1093/nar/gkr419 Published by Oxford University Press, 2011 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c2/fa/gkr419.PMC3177190.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/72/0e/gkr421.PMC3177191.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/84/3d/gkr426.PMC3177192.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/09/7e/gkr428.PMC3177193.pdf
The model was built by using the program O (http://xray.bmc.uu.se/alwyn) and reﬁned using REFMAC/CCP4 (www.ccp4.ac.uk).,OADS,/arxiv_data1/oa_pdf/09/7e/gkr428.PMC3177193.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/13/ae/gkr429.PMC3177194.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/gkr443.PMC3177195.pdf
"MATERIALS AND METHODS DNase-seq, ChIP-seq, gene expression and Gencode data All data used in this study were freely available for down- load from the University of California, Santa Cruz(UCSC) NCBI36/hg18 Genome Browser (http://genome.ucsc.edu/encode/) (29,30).",OADS,/arxiv_data1/oa_pdf/3c/ef/gkr443.PMC3177195.pdf
"Finally, the 17 751 UCSC known human genes with expression data were obtained from the Gene Expression Omnibus database(series GSE15805 and GSE17793; http://www.ncbi.nlm.nih.gov/projects/geo/).",OADS,/arxiv_data1/oa_pdf/3c/ef/gkr443.PMC3177195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ab/c1/gkr446.PMC3177196.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4f/fa/gkr448.PMC3177197.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/18/cc/gkr450.PMC3177198.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/9e/4d/gkr453.PMC3177199.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/fa/bf/gkr454.PMC3177200.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/79/0e/gkr455.PMC3177201.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f6/f0/gkr456.PMC3177202.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/24/5f/gkr457.PMC3177203.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/84/34/gkr459.PMC3177204.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f4/f2/gkr460.PMC3177205.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/7e/71/gkr461.PMC3177206.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/8c/8a/gkr462.PMC3177207.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f6/20/gkr470.PMC3177208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6e/1b/gkr474.PMC3177209.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/e7/22/gkr475.PMC3177210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/82/ec/gkr476.PMC3177211.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/84/3d/gkr477.PMC3177212.pdf
Homolog prediction and sequence analysis BlastP algorithm was used to predict sequence homologs of ScoRsrA from NCBI nr database (ftp://ftp.ncbi.nih.gov/blast/db/).,OADS,/arxiv_data1/oa_pdf/84/3d/gkr477.PMC3177212.pdf
"(2008) The PyMOL Molecular Graphics System, Version 1.1r1 from http://www.pymol.org.34.",Non-OADS,/arxiv_data1/oa_pdf/84/3d/gkr477.PMC3177212.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6a/d6/gkr479.PMC3177213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f5/7d/gkr480.PMC3177214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/60/da/gkr484.PMC3177215.pdf
This sequence forms a sec-ondary structure with /C1G=/C024 kcal/mol as determined by the RNA mfold algorithm (http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi).,Non-OADS,/arxiv_data1/oa_pdf/60/da/gkr484.PMC3177215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/50/3d/gkr486.PMC3177216.pdf
"Theprogramme is implemented using the Priithon imageanalysis platform (http://priithon.googlecode.com), whichallows fast interactive visualization and comparison of thenon-normalized data versus the resulting segmentationshown as outlines.",OADS,/arxiv_data1/oa_pdf/50/3d/gkr486.PMC3177216.pdf
Software The software and audio video tutorial can be downloaded via: http://www.cardoso-lab.org/publications/Randomizer.zip SUPPLEMENTARY DATA Supplementary Data are available at NAR Online.,Non-OADS,/arxiv_data1/oa_pdf/50/3d/gkr486.PMC3177216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/20/5c/gkr487.PMC3177217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/aa/0f/gkr489.PMC3177218.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/73/c4/gkr494.PMC3177219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/e0/b5/gkr499.PMC3177220.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/18/7b/gkr501.PMC3177221.pdf
The Newbler program (https://valicertext.roche .com/) was used to assemble these reads into 53 806 contigs ranging in size from 95 to 9947 nt.,OADS,/arxiv_data1/oa_pdf/18/7b/gkr501.PMC3177221.pdf
"Data set availability A compressed tar archive containing the Oxytricha and Stylonychia sequence data, the nanoclassiﬁer source code, training and test data, parsable tables of results and other data sets described in the paper are availablefor download at http://selab.janelia.org/publications .html#JungEddy11.",OADS,/arxiv_data1/oa_pdf/18/7b/gkr501.PMC3177221.pdf
RESULTS A data set of 9647 full-length O. trifallax nanochromosomes The O. trifallax macronuclear genome project is an ongoing collaboration between the Genome Center atWashington University and the Landweber laboratoryat Princeton (http://genome.wustl.edu/genomes/view/oxytricha_trifallax/).,OADS,/arxiv_data1/oa_pdf/18/7b/gkr501.PMC3177221.pdf
"MammalianlincRNAs have about the same length distribution as coding mRNAs (mean lengths of 2.5 kb versus 2.4 kb, respectively, according to GENCODE v4 transcript anno-tation; http://www.sanger.ac.uk/PostGenomics/encode/).The length distribution of the Stage 1 data set covers the great majority of coding nanochromosomes, so it is also expected to cover lincRNA-like ncRNA genes.",Non-OADS,/arxiv_data1/oa_pdf/18/7b/gkr501.PMC3177221.pdf
"http://www.wormbook.org pdf (15 June 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/18/7b/gkr501.PMC3177221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/46/54/gkr509.PMC3177222.pdf
"Owing to the popularity of the ChIP-seq method, which generates a snapshot of genome-wide DNA–protein inter-actions in high resolution, genome-wide occupancy proﬁles of various TFs and histone modiﬁcations have accumu- lated in public data repositories such as the gene expres-sion omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and UCSC genome browser (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
MATERIALS AND METHODS CCD tutorials and additional information can be found in the website (http://decode.kaist.ac.kr/).,Non-OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
The executable versions and its source code can be downloaded freely at the website(http://decode.kaist.ac.kr/).,OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"CCD only needs position infor- mation of elements, thereby adopting the BED format as the standard format (http://decode.kaist.ac.kr/).",Non-OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"To calculate the cumulative probabilities Pnb, the ‘pnbinom’ function in the Perl module (Math-CDF- 0.1, http://search.cpan.org/ /C24callahan/Math-CDF-0.1/) has been incorporated into CCD.",OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"For comparison, we con- verted their genome coordinates into mm8 genome assembly by using the liftOver tool (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
VISTA enhancer database We downloaded 745 experimentally validated enhancers (‘positive’ status) from the VISTA enhancer browser(http://enhancer.lbl.gov).,OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"CCD outputs can beanalyzed with the following available tools; R (heatmap, http://www.r-project.org/), GREAT (functional annotation, http://great.stanford.edu/) and UCSC genome browser (visualization, http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"To validate the putative CRMs in terms of biological relevance, functional annotation analysis was conductedby using GREAT (see ‘Materials and methods’ section) (http://great.stanford.edu/), which unpacks genomic re- gions based on the annotation of the nearby genes.",OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
The VISTA enhancer browser is a central resource for the experimentally validated CRMs showing enhanceractivity in a single embryonic timepoint (http://enhancer.lbl.gov) (42).,OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"Therefore, CCD provides an output (‘UCSC_’) to visualize all identiﬁed CRMs and features by means of the UCSC genome browser (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"Based on the trace codes, this CRM appears to regulate the spatial and temporal ex-pression of Jarid2 by interacting with the above com- binations of TFs in two different development stages, although additional investigations are required.The complete map of the identiﬁed genome-wide CRMs can be viewed on the website (http://decode.kaist .ac.kr/).DISCUSSION The progressive increase of the genome-wide data sets, especially from the ChIP-seq method, gives rise to a need for novel applications which fully exploit the datasets for particular purposes.",Non-OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
The CCD program and tutorials can be foundon our website (http://decode.kaist.ac.kr/).,Non-OADS,/arxiv_data1/oa_pdf/a0/93/gkr516.PMC3177223.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/c4/eb/gkr517.PMC3177224.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ff/c2/gkr522.PMC3177225.pdf
The drawings were prepared with Pymol (http://pymol.org).,Non-OADS,/arxiv_data1/oa_pdf/ff/c2/gkr522.PMC3177225.pdf
"Features of the protein–aptamer interface, including number and types of residues at the interface, and gapvolume index, were calculated using the Protein–Protein Interaction Server (http://www.bioinformatics.sussex.ac .uk/protorp/).",OADS,/arxiv_data1/oa_pdf/ff/c2/gkr522.PMC3177225.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/99/31/gkr524.PMC3177226.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f3/dd/gkr544.PMC3177227.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/11/e1/gkr739.PMC3177228.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/43/9c/thnov01p0341.PMC3177243.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c0/32/thnov01p0354.PMC3177244.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/32/12/thnov01p0363.PMC3177245.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/21/evr082.PMC3177325.pdf
"Available from: http://www.wormboo k.org/chapters /www_genomevol/ genomevol.html Consortium Bovine Genome Sequencing and Analysis, et al.",OADS,/arxiv_data1/oa_pdf/f1/21/evr082.PMC3177325.pdf
Available from: http://www.jgi.doe.gov.,OADS,/arxiv_data1/oa_pdf/f1/21/evr082.PMC3177325.pdf
Available from: http://www.sanger.ac.uk/resources/ software/blast/ .,OADS,/arxiv_data1/oa_pdf/f1/21/evr082.PMC3177325.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/34/evr065.PMC3177326.pdf
"On average, there are 368 genes in each subnetwork, and the relevant data were downloaded from http://chemogenomics.stanford.edu:16080/supplements/global/download.html .",OADS,/arxiv_data1/oa_pdf/50/34/evr065.PMC3177326.pdf
The gene pairs with epistatic interactions were downloaded from http://drygin.ccbr.utoronto.ca/ ;costanzo2009/ .,OADS,/arxiv_data1/oa_pdf/50/34/evr065.PMC3177326.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/39/83230 INTRODUCTION Tuberous sclerosis complex (TSC) is a rare autosomal  dominant neurocutaneous syndrome characterized by the  presence of benign congenital tumors in multiple organs.,Non-OADS,/arxiv_data1/oa_pdf/c6/38/JCIS-1-39.PMC3177408.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/26/81293Access this article online Quick Response Code: Website:   www.,Non-OADS,/arxiv_data1/oa_pdf/08/53/JCIS-1-26.PMC3177409.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/35/82339Address for correspondence:   Dr. Francesca Fornasa, Department of Radiology,  San Bonifacio Hospital, 1,   Via Fontanelle, 37042 San Bonifacio  (Verona), Italy.",Non-OADS,/arxiv_data1/oa_pdf/86/fc/JCIS-1-35.PMC3177410.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/31/82243 INTRODUCTION Percutaneous image-guided drainage procedures are  established minimally invasive methods to treat infected  or symptomatic fluid collections and to obtain fluid for  diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/b8/ed/JCIS-1-31.PMC3177411.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/36/82341Address for correspondence:   Dr. Harpreet Walia,   Department of Ophthalmology   3445 Stratford Road Box 1106,  Atlanta, GA 30326, USA.",Non-OADS,/arxiv_data1/oa_pdf/5a/95/JCIS-1-36.PMC3177412.pdf
"J Clin Imaging Sci 2011;1:28Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/28/81771 INTRODUCTION Identified need to reduce imaging expenditures March 24, 2010, marked a historical day in healthcare.",Non-OADS,/arxiv_data1/oa_pdf/b2/96/JCIS-1-28.PMC3177413.pdf
Available from: http://www.acr.org/Hidden/  Economics/FeaturedCategories/WhatsNew/MoranStudy.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/JCIS-1-28.PMC3177413.pdf
Available from: http://www.gao.gov/new.items/d08452.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b2/96/JCIS-1-28.PMC3177413.pdf
Available from: http://www.acr.org/Hidden/Economics/FeaturedCategories/WhatsNew/ DRACutsFactSheet.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/JCIS-1-28.PMC3177413.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/40/83397,Non-OADS,/arxiv_data1/oa_pdf/81/5b/JCIS-1-40.PMC3177414.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/27/81294,Non-OADS,/arxiv_data1/oa_pdf/b7/68/JCIS-1-27.PMC3177415.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and  point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b7/68/JCIS-1-27.PMC3177415.pdf
"See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.AnnouncementSource of Support:  Nil, Conflict of Interest:  None declared.",Non-OADS,/arxiv_data1/oa_pdf/b7/68/JCIS-1-27.PMC3177415.pdf
"CASE REPORT A 22-year-old man presented with a disproportionate www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:   Vik ram S. Dogra, MD  Department of Imaging Sciences, University of   Rochest er Medical Center, Rochester, USAOPEN ACCESS HTML format RADIOLOGIC-PATHOLOGIC CORRELATION This article is available from: http://www.clinicalimagingscience.org/content/1/1/18 Copyright: © 2011 Upadhyay D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/b8/fd/JCIS-1-18.PMC3177416.pdf
J Clin Imaging Sci 2011;1:18.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/b8/fd/JCIS-1-18.PMC3177416.pdf
"1 | Issue 1 | Jan-Mar 2011 1 Journal of Clinical Imaging Science X-ray Digital Linear Tomosynthesis Imaging  for Artificial Pulmonary Nodule Detection Tsutomu Gomi School of Allied Health Sciences, Kitasato University, Kitasato, Kanagawa, Japanwww.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:   Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format PICTORIAl ESSA y This article is available from: http://www.clinicalimagingscience.org/content/1/1/16 Copyright: © 2011 Gomi T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6f/9b/JCIS-1-16.PMC3177417.pdf
J Clin Imaging Sci 2011;1:16.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/6f/9b/JCIS-1-16.PMC3177417.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/24/80522,Non-OADS,/arxiv_data1/oa_pdf/b7/52/JCIS-1-24.PMC3177418.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and  point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b7/52/JCIS-1-24.PMC3177418.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/b7/52/JCIS-1-24.PMC3177418.pdf
"CASE REPORT A 30-year-old male presented to the Emergency www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:  Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/17 Copyright: © 2011 Perera E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in  any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d1/c5/JCIS-1-17.PMC3177419.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/d1/c5/JCIS-1-17.PMC3177419.pdf
"We use sonographic UGI routinely at our institution to www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:  Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format PICTORIAL ESSAY This article is available from: http://www.clinicalimagingscience.org/content/1/1/19 Copyright: © 2011 Herliczek TW.",Non-OADS,/arxiv_data1/oa_pdf/5a/e5/JCIS-1-19.PMC3177420.pdf
J Clin Imaging Sci 2011;1:19 Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/5a/e5/JCIS-1-19.PMC3177420.pdf
Available from:  http://www.acr.org/SecondaryMainMenuCategories/quality_ safety/app_criteria/pdf/ExpertPanelonPediatricImaging/ VomitinginInfantsupto3MonthsofAgeDoc11.aspx [last accessed 2008] 2.,Non-OADS,/arxiv_data1/oa_pdf/5a/e5/JCIS-1-19.PMC3177420.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/33/82245INTRODUCTION Duplications of the alimentary tract are rare congenital  malformations.,Non-OADS,/arxiv_data1/oa_pdf/db/a4/JCIS-1-33.PMC3177425.pdf
"There is only a single report in literature, of a www.clinicalimagingscience.org For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief:  Vikram S. Dogra, MD  Department of Imaging Sciences, University of   Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT This article is available from: http://www.clinicalimagingscience.org/content/1/1/20 Copyright: © 2011 Sener RN.",Non-OADS,/arxiv_data1/oa_pdf/72/1a/JCIS-1-20.PMC3177427.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?,Non-OADS,/arxiv_data1/oa_pdf/72/1a/JCIS-1-20.PMC3177427.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/29/81772 INTRODUCTION Fetal Magnetic Resonance Imaging (MRI) is an important  problem solving and decision making tool utilized in the  work-up of antenatal pathology identified on screening  obstetric ultrasonography.,Non-OADS,/arxiv_data1/oa_pdf/46/dc/JCIS-1-29.PMC3177428.pdf
J Clin Imaging Sci 2011;1:21.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/21/80373,Non-OADS,/arxiv_data1/oa_pdf/e1/df/JCIS-1-21.PMC3177429.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/37/82966 INTRODUCTION Crohn’s disease is a chronic granulomatous  inflammatory bowel disease that is usually managed  medically.,Non-OADS,/arxiv_data1/oa_pdf/66/d9/JCIS-1-37.PMC3177430.pdf
J Clin Imaging Sci 2011;1:23.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/23/80375,Non-OADS,/arxiv_data1/oa_pdf/80/a9/JCIS-1-23.PMC3177432.pdf
J Clin Imaging Sci 2011;1:30.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/30/82082INTRODUCTION The primary indication for parenchymal liver biopsy has  traditionally been for the diagnosis of hepatic disease.,Non-OADS,/arxiv_data1/oa_pdf/e3/8c/JCIS-1-30.PMC3177433.pdf
Available from: http://emedicine.medscape.com .,Non-OADS,/arxiv_data1/oa_pdf/e3/8c/JCIS-1-30.PMC3177433.pdf
J Clin Imaging Sci 2011;1:25.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/25/80523,Non-OADS,/arxiv_data1/oa_pdf/39/f2/JCIS-1-25.PMC3177434.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/32/82244INTRODUCTION Rheumatoid arthritis (RA) is a common inflammatory  joint disease (~1% prevalence).,Non-OADS,/arxiv_data1/oa_pdf/21/d8/JCIS-1-32.PMC3177462.pdf
Available from: http://www.pneumotox.com/  [Last accessed on 2011  Feb 15].A history of RA is important when considering the differential  diagnosis of thoracic pathology.,Non-OADS,/arxiv_data1/oa_pdf/21/d8/JCIS-1-32.PMC3177462.pdf
J Clin Imaging Sci 2011;1:22.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/22/80374from the adjacent joint.,Non-OADS,/arxiv_data1/oa_pdf/22/9d/JCIS-1-22.PMC3177464.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2011/1/1/34/82338Address for correspondence:   Mrs. Ana Delgado Laguna,   Department of Radiology,   C/Narváez 71 5D.",Non-OADS,/arxiv_data1/oa_pdf/99/78/JCIS-1-34.PMC3177465.pdf
E-mail: stefan.knapp@sgc.ox.ac.ukexpert reviews http://www.expertreviews.org/ in molecular medicine 1 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"The BET family isrepresented by four members in humans (BRD2, BRD3, BRD4 and the testis-specific isoform BRDT), with each containing two N-terminalexpert reviews http://www.expertreviews.org/ in molecular medicine 2 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"Bromodomain-containing proteins and their functions Protein Name Function BRDs ASH1L Absent, small or homeotic-like Methyltransferase 1 ATAD2A /B AAA domain-containing protein 2 ATPase, coactivator 1 BAZ1A /B BRD adjacent to zinc finger domain protein 1AChromatin assembly and remodelling1 BAZ2A /B BRD adjacent to zinc finger domain protein 2A /BUnknown 1 BRD1 BRD-containing 1 Transcription factor 1 BRD2 BRD-containing 2 Transcription factor 2 BRD3 BRD-containing 3 Transcription factor 2 BRD4 BRD-containing 4 Transcription factor 2BRDT BRD-containing protein testis specific Transcription factor 2BRD7 BRD-containing 7 Transcriptional repressor 1BRD8A /B BRD-containing 8A /B TRRAP /TIP60 complex 2 BRD9 BRD-containing 9 Unknown 1 BRPF1A /B Peregrin MOZ complex subunit 1 BRPF3A BRD and PHD-finger-containing protein 3Unknown 1 BRWD3 BRD and WD-repeat-containing protein 3JAK/STAT signalling 2 CECR2 Cat eye syndrome critical region 2 Chromatin remodelling 1 CREBBP CREB-binding protein HAT 1EP300 HAT p300 HAT 1 FALZ Fetal Alzheimer antigene Chromatin remodelling 1 GCN5L2 General control of amino acid synthesis protein 5-like 2HAT 1 MLL Mixed lineage leukaemia Histone methyltransferase 1 PB1 Polybromo SWI /SNF PBAF subunit 6 PCAF P300 /CBP-associated factor HAT 1 PHIP PH-interacting protein Insulin signalling 2 PRKCBP1 Protein kinase C-binding protein 1 Transcriptional regulator 1 SMARCA2A /B SWI /SNF-related, matrix-associated, actin-dependent regulator of chromatinSWI/SNF ATPase 1 SMARCA4 SWI /SNF-related, matrix-associated, actin-dependent regulator of chromatinSWI/SNF ATPase 1 SP100 /SP110 / SP140Nuclear body protein Transcriptional regulator TAF1/TAF1L Transcription initiation TFIID-associated factorTranscription initiation 2 TRIM24 /TRIM28 / TRIM33 /TRIM66Transcription intermediary factor Transcriptional silencer 1 WDR9 BRD and WD-repeat-containing protein 1Chromatin remodelling 2 ZMYND11 Zinc finger MYND-domain-containing protein 11Corepressor 1 BRD, bromodomain; HAT, histone acetyltransferase; MOZ, monocytic leukaemia zinc finger protein; PHD, plant homology domain; SNF , sucrose nonfermenting.expert reviews http://www.expertreviews.org/ in molecular medicine 3 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
66) and mediatesexpert reviews http://www.expertreviews.org/ in molecular medicine 4 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
BRG1 /HDAC-containing complexes have been shown to repress expression of genes involved in cell cycleexpert reviews http://www.expertreviews.org/ in molecular medicine 5 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
It is alsoexpert reviews http://www.expertreviews.org/ in molecular medicine 6 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
See Table 1 for an explanation of protein symbols.expert reviews http://www.expertreviews.org/ in molecular medicine 7 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"Abbreviations: FA, stopped-flow fluorescence anisotropy; FP , fluorescent polarization; ITC, isothermal titration calorimetry; NMR, nuclear magnetic resonance; SPR, surface plasmon resonance.expert reviews http://www.expertreviews.org/ in molecular medicine 8 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
See Table 1 for anexplanation of protein symbols.expert reviews http://www.expertreviews.org/ in molecular medicine 9 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
EP300 and PCAF also regulate inflammatory responses through theirexpert reviews http://www.expertreviews.org/ in molecular medicine 10 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"Development of BRD inhibitors BRDs share a conserved fold that comprises a left-handed bundle of four alpha helices ( α Z,αA,αB,expert reviews http://www.expertreviews.org/ in molecular medicine 11 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
176).expert reviews http://www.expertreviews.org/ in molecular medicine 12 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
Specificity and dissociation constants are also indicated.expert reviews http://www.expertreviews.org/ in molecular medicine 13 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"(2000) huASH1 protein, a putative transcription factor encoded by a humanexpert reviews http://www.expertreviews.org/ in molecular medicine 14 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"(2010) Brd2 disruption in mice causes severe obesity without Type 2 diabetes.Biochemical Journal 425, 71-83expert reviews http://www.expertreviews.org/ in molecular medicine 15 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
(2004) Association of the transcriptional corepressor TIF1beta withheterochromatin protein 1 (HP1): an essential roleexpert reviews http://www.expertreviews.org/ in molecular medicine 16 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
(2004) Transcription factors and nuclear receptors interact with the SWI /SNFexpert reviews http://www.expertreviews.org/ in molecular medicine 17 Accession information: doi:10.1017/S1462399411001992; Vol.,Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"Journal of Molecular Biology 304,355-370expert reviews http://www.expertreviews.org/ in molecular medicine 18 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"Journal of Virology 80,8909-8919expert reviews http://www.expertreviews.org/ in molecular medicine 19 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"Chemistryand Biology 13, 81-90expert reviews http://www.expertreviews.org/ in molecular medicine 20 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"Journal of the American ChemicalSociety 127, 2376-2377 Further reading, resources and contacts Websites Bromodomain structures solved by the Structural Genomics Consortium: http://www.sgc.ox.ac.uk /structures /BRO.html Chemical probe resource for epigenetic targets: http://www.thesgc.org /chemical_probes /epigenetics/ Disease-annotated chromatin epigenetic resource: http://wodaklab.org /dancer/ The chromatin database: http://www.chromdb.org/ Human Histone Modification Database (HHMD): http://bioinfo.hrbmu.edu.cn /hhmd/ Features associated with this article Figures Figure 1.",OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"13, e29, September 2011, doi:10.1017/S1462399411001992expert reviews http://www.expertreviews.org/ in molecular medicine 21 Accession information: doi:10.1017/S1462399411001992; Vol.",Non-OADS,/arxiv_data1/oa_pdf/e7/8a/S1462399411001992a.PMC3177561.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work isproperly cited.Human Molecular Genetics, 2011, Vol.",Non-OADS,/arxiv_data1/oa_pdf/48/f8/ddr328.PMC3177649.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work isproperly cited.Human Molecular Genetics, 2011, Vol.",Non-OADS,/arxiv_data1/oa_pdf/2a/df/ddr309.PMC3177650.pdf
"The cohort, including its represen-tativeness, is described in detail on the website http://www.alspac.bris.ac.uk and elsewhere ( 20).",Non-OADS,/arxiv_data1/oa_pdf/2a/df/ddr309.PMC3177650.pdf
"Individual growth trajectories were estimated using a mixed-effects linear spline model [two levels: measurementoccasion (age) and individual], ﬁtted using the statisticalpackage MLwiN version 2.10 (www.cmm.bristol.ac.uk/MLwiN/index.shtml) ( 17), using the Stata command runmlwin (23) (http://www.bristol.ac.uk/cmm/software/runmlwin/).",OADS,/arxiv_data1/oa_pdf/2a/df/ddr309.PMC3177650.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.Human Molecular Genetics, 2011, Vol.",Non-OADS,/arxiv_data1/oa_pdf/70/18/ddr332.PMC3177654.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-CommercialLicense (http://creativecommons.org/licenses/by-nc/2.5) which permits unrestricted non-commercial use, distribution,and reproduction in any medium, provided the original work is properly cited.Corresponding Author: Achim Temme, Professor, Department of Neurosurgery, Section Experimental Neurosurgery /Tumor Immunology, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, 01307 Dresden, Germany (achim.temme@uniklinikum-dresden.de).Received June 22, 2010; accepted June 1, 2011.Neuro-Oncology 13(10):1074–1089, 2011. doi:10.1093 /neuonc /nor098 NEURO-ONCOLOGY Advance Access publication July 25, 2011",Non-OADS,/arxiv_data1/oa_pdf/0f/b3/nor098.PMC3177660.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/13/58/2285.PMC3177707.pdf
A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/13/58/2285.PMC3177707.pdf
Available online at http://www.gmc-uk.org/static/documents/content/End_of_life.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/bc/46/e159.PMC3177708.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/82/ae/2300.PMC3177709.pdf
"Corresponding author: David Simmons, david.simmons@addenbrookes.nhs.uk.Received 16 March 2011 and accepted 8 July 2011.DOI: 10.2337/dc11-0533This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0533/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/7f/af/2217.PMC3177710.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7f/af/2217.PMC3177710.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e2/17/2323.PMC3177711.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b4/f0/2186.PMC3177712.pdf
"Corresponding author: Wolfgang Koenig, wolfgang.koenig@uniklinik-ulm.de.Received 24 April 2011 and accepted 26 July 2011.DOI: 10.2337/dc11-0775This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0775/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/5c/2b/2320.PMC3177713.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5c/2b/2320.PMC3177713.pdf
DOI: 10.2337/dc11-0647 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0647/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ef/a8/2317.PMC3177714.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ef/a8/2317.PMC3177714.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2c/ff/2192.PMC3177715.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/55/f3/2291.PMC3177717.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/89/54/2158.PMC3177718.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c6/21/2259.PMC3177719.pdf
"The measures of insulin action were 1) the homeostasis model assessment in- dex of insulin resistance (HOMA-IR) cal-culated using fasting glucose and insulin concentrations (HOMA2 Calculator v.2.2 at http://www.dtu.ox.ac.uk/homa; Diabe-tes Trials Unit, University of Oxford,Oxford, U.K.) and 2) the insulin sensitiv- ity index (ISI) based on glucose (mg/dL) and insulin concentrations (mU/L) dur- ing the OGTT as described by Matsudaet al.",OADS,/arxiv_data1/oa_pdf/c6/21/2259.PMC3177719.pdf
"Corresponding author: Carole Clair, carole.willi@gmail.com or cclair@partners.org.Received 14 April 2011 and accepted 14 July 2011.DOI: 10.2337/dc11-0710This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0710/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/c1/5d/2250.PMC3177720.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c1/5d/2250.PMC3177720.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/71/38/2180.PMC3177721.pdf
"Corresponding author: Børge G. Nordestgaard, brno@heh.regionh.dk.Received 2 March 2011 and accepted 19 July 2011.DOI: 10.2337/dc11-0416This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0416/-/DC1 /C2112011 by the American Diabetes Association.",Non-OADS,/arxiv_data1/oa_pdf/3c/e2/2256.PMC3177722.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3c/e2/2256.PMC3177722.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/32/e6/2273.PMC3177723.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/73/1a/2265.PMC3177724.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c8/b3/2231.PMC3177725.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ad/87/2220.PMC3177727.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ad/93/2208.PMC3177728.pdf
"ACTRN12609001034224, anzctr.org.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0567/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/34/d4/2146.PMC3177729.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/34/d4/2146.PMC3177729.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3e/9a/2174.PMC3177730.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/58/83/2314.PMC3177731.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b3/9e/2237.PMC3177732.pdf
"NCT00237549, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0903/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/66/7f/2244.PMC3177734.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/66/7f/2244.PMC3177734.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7b/05/2170.PMC3177735.pdf
"Corresponding author: Solveig A. Cunningham, sargese@sph.emory.edu.Received 17 March 2011 and accepted 5 July 2011.DOI: 10.2337/dc11-0462This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0462/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/27/14/2225.PMC3177736.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/27/14/2225.PMC3177736.pdf
Available from http://apps.nccd.cdc.gov/DDTSTRS/default.,OADS,/arxiv_data1/oa_pdf/27/14/2225.PMC3177736.pdf
Available fromhttp://www.cdc.gov/nccdphp/dnpa/obesity/ childhood/prevalence.htm.,Non-OADS,/arxiv_data1/oa_pdf/27/14/2225.PMC3177736.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7b/6c/2211.PMC3177737.pdf
The importance of PPGis reﬂected in the creation of guidelines by the International Diabetes Federation (IDF) for the management of postmeal glucose (http://www.idf.org/guidelines/postmeal-glucose).,Non-OADS,/arxiv_data1/oa_pdf/88/38/2333.PMC3177738.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c7/5b/2198.PMC3177740.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ac/34/2164.PMC3177741.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/02/a0/2306.PMC3177743.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6c/9e/e152.PMC3177747.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b8/d0/2279.PMC3177748.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/97/42/2297.PMC3177749.pdf
"NCT00081328, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0431/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/38/d6/2205.PMC3177750.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/38/d6/2205.PMC3177750.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/07/69/2141.PMC3177751.pdf
Informa- tion on NCRR is available at http://www.ncrr.nih.gov/.,OADS,/arxiv_data1/oa_pdf/07/69/2141.PMC3177751.pdf
"Corresponding author: Jencia Wong, jencia.wong@email.cs.nsw.gov.au.Received 10 March 2011 and accepted 6 July 2011.DOI: 10.2337/dc11-0499This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0499/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/59/2b/2214.PMC3177752.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/59/2b/2214.PMC3177752.pdf
"NCT00017953, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc11-0874/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/26/fd/2152.PMC3177753.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/26/fd/2152.PMC3177753.pdf
"3, Quarter 3, 2010; Available from:  http://www.info.gov.hk/aids/archives/backissuestd/std10q3.pdf.",Non-OADS,/arxiv_data1/oa_pdf/07/be/cop0002-0266.PMC3177808.pdf
http://www.medscape.org/viewarticle/709081 25.,Non-OADS,/arxiv_data1/oa_pdf/14/2f/134_2011_Article_2349.PMC3178014.pdf
Avail- able from: URL: http://apps.who.int/bmi/index.jsp .,OADS,/arxiv_data1/oa_pdf/e8/47/11136_2011_Article_9865.PMC3178016.pdf
from http://www.bepress.,Non-OADS,/arxiv_data1/oa_pdf/35/ba/11136_2011_Article_9863.PMC3178017.pdf
"Orphanet Encyclopedia April 2004, http://www.orpha.net/consor/ cgi-bin/OC_Exp.php?Lng=GB&Expert=35125 8.",OADS,/arxiv_data1/oa_pdf/2f/25/467_2011_Article_1949.PMC3178020.pdf
Available at http://www.nku.edu/~humed1/darkness _in_el_dorado/documents/ 0538.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
"Washington, D.C.: American Anthropological Association.Accessible through http://www.nku.edu/~humed1/darkness _in_el_dorado/documents/0535.htm .",Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Available at http://www.nku.edu/~humed1/ darkness _in_el_dorado/documents/0516.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nku.edu/~humed1/darkness _in_el_dorado/docu ments/0438.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nku.edu/~humed1/darkness _in_el_dorado/documents/0440.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.guardian.co.uk/world/2000/sep/23/paulbrown .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
(May 31) Retrieved from http://www.nku.edu/~humed1/darkness _in_el_dorado/documents/0204.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.amphilsoc.,OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved athttp://www.nku.edu/~humed1/darkness _in_el_dorado/documents/0102.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.anth.ucsb.edu/ucsbpreliminary report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nku.edu/ ~humed1/darkness _in_el_dorado/documents/0514.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.sil.org/~headlandt/measles1.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nku.edu/~humed1/ darkness _in_el_dorado/documents/0109.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.insidehighered.com/news/2009/12/03/eldorado .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nku.edu/~humed1/darkness _ in_el_dorado/documents/0480.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nationalreview.com/20nov00/miller 112000.shtml .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nku.edu/~humed1/darkness _in_el_dorado/documents/0380.htm .Hum Nat (2011) 22:225 –246 245 245,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.nku.edu/~humed1/darkness _in_el_dor ado/documents/0376.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
Retrieved from http://www.slate.com/id/91946/ .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
”Retrieved from http://www.nku.edu/~humed1/darkness _in_el_ dorado/documents/0055.htm .,Non-OADS,/arxiv_data1/oa_pdf/0a/8c/12110_2011_Article_9103.PMC3178026.pdf
"Many of these approaches have been incorporated in commercial products including Roche 454 (Roche 454 Sequencing,http://www.454.com/), Illumina (Illumina Inc,http://www.illumina.com/), SOLiD (Applied Biosystems, https://products.appliedbiosystems.",Non-OADS,/arxiv_data1/oa_pdf/4a/2a/bbq077.PMC3178052.pdf
"com/), Polonator (Applied Biosystems, https://products.appliedbiosystems.com/), Helicos (Helicos BioScience Corporation, http://www.helicosbio.",Non-OADS,/arxiv_data1/oa_pdf/4a/2a/bbq077.PMC3178052.pdf
"com/), Pacific Biosciences (Pacific Biosciences,http://www.pacificbiosciences.com/) and Intelligent Bio Systems (Intelligent Bio Systems, http:// intelligentbiosystems.com/).",Non-OADS,/arxiv_data1/oa_pdf/4a/2a/bbq077.PMC3178052.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4a/2a/bbq077.PMC3178052.pdf
"http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-04-003.html, http://www.genome.gov/10000368 (28November 2010, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/4a/2a/bbq077.PMC3178052.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/62/a6/bbr031.PMC3178054.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b6/20/bbr034.PMC3178055.pdf
"Seven phylogenomic databases are comparedin this study, namely Ensembl Compara (http://www.ensembl.org/) [9], eggNOG (http://eggnog .embl.de/) [10], HOGENOM (http://pbil.univ- lyon1.fr/databases/hogenom/) [11], InParanoid(http://inparanoid.sbc.su.se/) [12], OMA (http://omabrowser.org/) [13], OrthoDB (http://cegg.unige.ch/orthodb) [14] and Panther (http://www .pantherdb.org/) [15].",OADS,/arxiv_data1/oa_pdf/b6/20/bbr034.PMC3178055.pdf
"The preliminary datasets were comple- mented by data from UniProtKB/TrEMBL, Ensembl release 57, BeeBase (http://genomes.arc.georgetown.edu/drupal/beebase/) and WormBase(http://www.wormbase.org/).",OADS,/arxiv_data1/oa_pdf/b6/20/bbr034.PMC3178055.pdf
"The sequence analysiswas performed on local computers of the Swiss Institute of Bioinformatics, at phylogeny.fr [17] as well as at the high performance computing centerVital-IT (http://www.vital-it.ch/).",OADS,/arxiv_data1/oa_pdf/b6/20/bbr034.PMC3178055.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/54/99/bbr036.PMC3178056.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
"Ensembl pipeline [9] alsodetects split genes (http://www.ensembl.org/info/ docs/compara/homology_method.html), but this approach is not readily applicable to newly sequenced genomes by individual researchers, because it is not yet well documented or availableoutside the Ensembl pipeline.",Non-OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
METHODS Preparation of repeat-masked genome assembly The 1.4 /C2coverage C. milii genomic assembly was downloaded from the Elephant Shark Genome Project website (http://esharkgenome.imcb.a-star .edu.sg/resources.html).,OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
"To construct a repeat library customized for this genome, we ran RepeatModelerwith default parameters (http://www.repeatmasker .org/RepeatModeler.html), which detected 501 Figure 1: Phylogenetic position of the C. milii .",OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
"Based on that, RepeatMasker (http://www.repeatmasker.org/) masked 42.2% of the C. milii genome, consist- ing of 38.7% of repeat elements from the library and3.5% of simple repeats, low complexity stretches,small RNAs and satellites.",OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
"Torun est2genome, we input the C. milii cDNA data set available at the Elephant Shark Genome Projectwebsite (http://esharkgenome.imcb.a-star.edu.sg).AllC.",OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
milii peptides predicted by GENSCAN and SNAP were subjected to BLASTP searches againsthuman Ensembl peptides (version 57; http://www.ensembl.org/).,OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
Our predictionsetting trained for this genome is available in theAUGUSTUS installation package as well as its webinterface (http://bioinf.uni-greifswald.de/augustus/submission).,OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
"The code for ESPRIT is available as part of the OMA stand-alone program (http://omabrowser.org/standalone), and is free for non-commercial use.",OADS,/arxiv_data1/oa_pdf/cd/e0/bbr038.PMC3178057.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/7a/bd/bbr040.PMC3178058.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/08/60/bbr042.PMC3178059.pdf
"GO annotations are supported by evidencecodes, as described on the GO consortium website(http://geneontology.org/GO.evidence.shtml).PAINT records the annotation using an evidence code indicating that the annotation is inferred from biological descendant(s) (IBD), which is a subclass ofinferred from sequence similarity, and captures thedatabase identifiers of all the extant descendants withexperimental data for the function as evidence forthe ancestral annotation.",OADS,/arxiv_data1/oa_pdf/08/60/bbr042.PMC3178059.pdf
"To increase the consistency and reproducibility of annotations, we have elaborated detailed annotation guidelines, available at http://wiki.geneontology.org/index.php/PAINT_SOP.",Non-OADS,/arxiv_data1/oa_pdf/08/60/bbr042.PMC3178059.pdf
"Extending annotations to additional species New trees are built periodically to include improved sequences or sequences from additional organisms.Currently the PANTHER trees contain genesfrom 48 completely sequenced genomes, withplans to increase this number to the emergingstandard being developed by the UniProt team in collaboration with the wider ortholog prediction community (http://www.ebi.ac.uk/reference_proteomes/).",Non-OADS,/arxiv_data1/oa_pdf/08/60/bbr042.PMC3178059.pdf
Data availability P AINTannotation tool PAINT can be downloaded at Source Forge (http://sourceforge.net/projects/pantherdb/).,OADS,/arxiv_data1/oa_pdf/08/60/bbr042.PMC3178059.pdf
GOannotations are available from the GO database(http://geneontology.org) and ancestral annotations are available from PanTree (http://pantree.org).,OADS,/arxiv_data1/oa_pdf/08/60/bbr042.PMC3178059.pdf
"PANTHER families, phylogenetic trees andmultiple sequence alignments are available at http://pantherdb.org.",OADS,/arxiv_data1/oa_pdf/08/60/bbr042.PMC3178059.pdf
"10 The potential for sub-optimal clinical outcomes is real.Signiﬁcant vision can be lost in a short time if wet AMDis not treated, 11and this can have a huge impact on independence and quality of life for patients.12 Following several inﬂuential reports on patient safety, learning from clinical failure or incident is now widely regarded as a core principle underpinning improvement in patient safety.13The National Patient Safety Agency (NPSA) (http://www.npsa.nhs.uk) was thus initiated.A patient safety incident (PSI) is considered by the NPSAas an unintended or unexpected incident, which couldhave or did lead to harm for one or more patients.",Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
Another potential weakness of the present reviewis that adverse drug reactions (ADRs) in the UK arereported to the Medicines and Healthcare productsRegulatory Agency (MHRA) through the Yellow Card Scheme (http://www.yellowcard.gov.uk) rather than viapatient safety reports.,Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
"Royal College of Ophthalmologists: London, 2007. http://www.rcophth.ac.uk/documents.asp?section= 39&sectionTitle=Publications&let=C&page=7.",Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
"National Institute for Health and Clinical Evidence: London, 2008. http://www.nice.org.uk/nicemedia/pdf/TA155guidance.pdf.",Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
http://www.rcophth.ac.uk/page.asp?section ¼295&section Title¼AMDþServices þSurvey.,Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
http://www.npsa.nhs.uk/patientsafety/reporting.,Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
Available at http://www.patientsafetyﬁrst.nhs.uk/ashx/ Asset.ashx?path ¼/Intervention-support/Quick% 20guide%20to%20briefngs%20and%20debrieﬁngs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
"The Royal College of Ophthalmologists: London, 2010. http://www.rcophth.",Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
"The Royal College of Ophthalmologists: London, 2011. http://www.rcophth.ac.uk/core/core_picker/download.asp?id ¼852&ﬁletitle ¼Patient þSafetyþinþOphthalmology þFebruary þ2011.",Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Anti-VEGF patient safety incidents SP Kelly and A Barua 716 Eye",Non-OADS,/arxiv_data1/oa_pdf/86/fa/eye201189a.PMC3178143.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/19/70/2484.PMC3178277.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e0/94/2455.PMC3178278.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e3/3c/2571.PMC3178280.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8b/53/2566.PMC3178281.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e1/ef/2450.PMC3178282.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9e/e4/2441.PMC3178283.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ab/97/2635.PMC3178284.pdf
Afull list of the investigators who contributed to the gener- ation of data is available from http://www.wtccc.org.uk/.,OADS,/arxiv_data1/oa_pdf/ab/97/2635.PMC3178284.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/37/7f/2457.PMC3178285.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c9/7f/2598.PMC3178286.pdf
"Results are expressed as mean 6SEM, and the signif- icance between the mean of continuous parameters was evaluated by theMann-Whitney statistical test using the StatEL or R statistics software pack- ages (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/c9/7f/2598.PMC3178286.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c5/88/2506.PMC3178288.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e5/67/2617.PMC3178289.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/aa/e8/2588.PMC3178290.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ad/88/2523.PMC3178291.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e9/32/2465.PMC3178292.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ee/ba/2608.PMC3178293.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d2/25/2496.PMC3178294.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/37/74/2533.PMC3178295.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/86/8d/2546.PMC3178296.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/75/8a/2474.PMC3178297.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/98/cf/2578.PMC3178298.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ec/7c/2515.PMC3178299.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c6/c2/2560.PMC3178300.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b5/d5/2654.PMC3178301.pdf
"Indexes of b-cell secretion and insulin sensitivity, HOMA2%B and HOMA2%S, were computed using software downloaded at http://www.dtu.ox.ac.uk.",OADS,/arxiv_data1/oa_pdf/b5/d5/2654.PMC3178301.pdf
"Single nucleotide polymorphism (SNP) genotyping was per- formed with the SNPlex Technology (Applied Biosystems, Foster City, CA)based on the oligonucleotide ligation assay combined with multiplex PCRtarget ampli ﬁcation (http://www.appliedbiosystems.com).",OADS,/arxiv_data1/oa_pdf/b5/d5/2654.PMC3178301.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.R.J.,Non-OADS,/arxiv_data1/oa_pdf/ea/66/2624.PMC3178302.pdf
"Using current databases of copy number variants (33) and the SNAP software (http://www.broadinstitute.org/ mpg/snap/index.php; CEU, HapMap release 22), we checked whether any of the proinsulin-associated SNPs were within500 kb and in linkage disequilibrium (LD) with any of theSNPs known to tag copy number variants in the human genome.",OADS,/arxiv_data1/oa_pdf/ea/66/2624.PMC3178302.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f8/a6/2645.PMC3178303.pdf
"5% of the total tumour mass in various experimental tumour-model systemsL C Huysentruyt, Z Akgoc and T N Seyfried 184 E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"(2008), reproduced with permission from Wiley,E2008 Wiley-Liss, Inc. ( B) Provided by A. Persson.Neoplastic macrophages/microglia in GBM E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.185",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"These prop- erties would also be expected in microglia since microglia are the resident macrophages of the CNS.L C Huysentruyt, Z Akgoc and T N Seyfried 186 E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"(2003), reproduced with permission from Folia NeuropathologicaETermedia.Neoplastic macrophages/microglia in GBM E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.187",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"(1995)L C Huysentruyt, Z Akgoc and T N Seyfried 188 E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"(2008), reproduced with permission from Wiley,E2008 Wiley-Liss, Inc.Neoplastic macrophages/microglia in GBM E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.189",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"It would be of particular interest to determine if the CD68 +cell population of human GBM has neoplastic properties.L C Huysentruyt, Z Akgoc and T N Seyfried 190 E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"J Leukoc Biol 75:388–397.Neoplastic macrophages/microglia in GBM E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.191",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"Brain 63:1–34.L C Huysentruyt, Z Akgoc and T N Seyfried 192 E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"Received 22 April 2011/1 August 2011; accepted 12 August 2011 Published as Immediate Publication 12 August 2011, doi 10.1042/AN20110011Neoplastic macrophages/microglia in GBM E2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.193",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/an003e064.PMC3178415.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:303-308 The Epidemiology of Diabetes in Korea Dae Jung Kim Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea Diabetes is an increasing global health problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
"According to the data from the Korea Medi - cal Insurance Corporation (KMIC), which provides insurance Review http://dx.doi.org/10.4093/dmj.2011.35.4.303 pISSN 2233-6079 · eISSN 2233-6087",OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
"304Kim DJ Diabetes Metab J 2011;35:303-308 http://e-dmj.org to civil servants and private school workers aged 35 to 59, the  prevalence of diabetes was defined as a mean fasting blood  glucose of ≥126 mg/dL in 1990 to 1992 was 4.7% in men and  1.3% in women [6].",Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
305Epidemiology of diabetes in Korea  Diabetes Metab J 2011;35:303-308 http://e-dmj.org the prevalence of IFG was about 25%.,Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
"306Kim DJ Diabetes Metab J 2011;35:303-308 http://e-dmj.org the annual incidence of diabetes among Korean adults aged 20  to 79 years was 0.76% (0.73% in men, 0.78% in women) in 2003  [15].",Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
307Epidemiology of diabetes in Korea  Diabetes Metab J 2011;35:303-308 http://e-dmj.org sive estimates of the absolute numbers and prevalence of dia - betes and IGT globally [21].,Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
Available from: http://www.index.go.kr (updated 2011 Aug 5).,Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
308Kim DJ Diabetes Metab J 2011;35:303-308 http://e-dmj.org 14.,Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
Available from: http://www.idf.org (updated 2011 Aug 5).,Non-OADS,/arxiv_data1/oa_pdf/24/c6/dmj-35-303.PMC3178689.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:309-316 Glycosphingolipid Modification: Structural Diversity,  Functional and Mechanistic Integration of Diabetes Tadashi Yamashita1,2 1Graduate School of Advanced Life Science, Hokkaido University, Sapporo, Japan,  2World Class University Program, Kyungpook National University School of Medicine, Daegu, Korea Glycosphingolipids (GSLs) are present in all mammalian cell plasma membranes and intracellular membrane structures.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
Review http://dx.doi.org/10.4093/dmj.2011.35.4.309 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
"310Yamashita T Diabetes Metab J 2011;35:309-316 http://e-dmj.org The cause of this immiscibility is uncertain, but the immisci - bility may have a constant effect in events such as phosphory - lation of the signal transduction molecules.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
"311Glycosphingolipid and diabetes Diabetes Metab J 2011;35:309-316 http://e-dmj.org  In this review, I summarize our understanding of the role of  GSLs on the insulin receptor abnormality as one of the patho - physiology of diabetes, and rodent models for the research on  insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
"312Yamashita T Diabetes Metab J 2011;35:309-316 http://e-dmj.org phorylated counterparts, have received the most attention  with regard to bioactivity.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
"313Glycosphingolipid and diabetes Diabetes Metab J 2011;35:309-316 http://e-dmj.org is less sensitive to insulin, and less tolerant to glucose, than  lean Zucker rats.",Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
314Yamashita T Diabetes Metab J 2011;35:309-316 http://e-dmj.org show a remarkable reduction of macrophage accumulation  and expression of pro-inflammatory genes.,Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
315Glycosphingolipid and diabetes Diabetes Metab J 2011;35:309-316 http://e-dmj.org that gC1qR plays essential roles in adipogenesis and insulin  signal transduction.,Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
316Yamashita T Diabetes Metab J 2011;35:309-316 http://e-dmj.org emic Zucker fatty rat.,Non-OADS,/arxiv_data1/oa_pdf/a1/34/dmj-35-309.PMC3178690.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:317-326 Polymeric Gene Delivery for Diabetic Treatment Sung Wan Kim1,2 1Department of Pharmaceutics and Pharmaceutical Chemistry and Department of Bioengineering, University of Utah, Salt Lake City, UT, USA, 2Department of Bioengineering, Hanyang University, Seoul, Korea Several polymers were used to delivery genes to diabetic animals.",Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
The positive Review http://dx.doi.org/10.4093/dmj.2011.35.4.317 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
318Kim SW Diabetes Metab J 2011;35:317-326 http://e-dmj.org charges on the complexes enable stabilization in water or low  concentration buffers.,Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
"319Polymeric gene delivery for diabetic treatment Diabetes Metab J 2011;35:317-326 http://e-dmj.org and stored at -70°C ( n=2 in each group, total n=30).",Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
"320Kim SW Diabetes Metab J 2011;35:317-326 http://e-dmj.org REPRESSION OF GAD AUTOCENTIGEN  EXPRESSION IN PANCREATIC β-CELL BY  DELIVERY OF ANTISENSE PLASMID Silencing the expression of glutamic acid decarboxylase (GAD)  in transgenic NOD mice was reported to completely protect  islet β-cells against the development of diabetes, suggesting  the repression of GAD autoantigen by somatic gene delivery  can prevent autoimmune destruction of pancreatic β-cells.",Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
321Polymeric gene delivery for diabetic treatment Diabetes Metab J 2011;35:317-326 http://e-dmj.org type 2 diabetic patients.,Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
"322Kim SW Diabetes Metab J 2011;35:317-326 http://e-dmj.org  In a second study, the effect of GLP1 gene delivery was eval - uated both in vitro  and in vivo  using a new plasmid construct - ed with a GLP-1 (7–37) cDNA.",Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
323Polymeric gene delivery for diabetic treatment Diabetes Metab J 2011;35:317-326 http://e-dmj.org tored.,Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
324Kim SW Diabetes Metab J 2011;35:317-326 http://e-dmj.org showing a severe cytotoxicity.,Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
325Polymeric gene delivery for diabetic treatment Diabetes Metab J 2011;35:317-326 http://e-dmj.org 15:143-98.,Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
326Kim SW Diabetes Metab J 2011;35:317-326 http://e-dmj.org Absorption of glucagons-like peptide-1 can be protracted by  zinc or protamine.,Non-OADS,/arxiv_data1/oa_pdf/9a/59/dmj-35-317.PMC3178691.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:327-336 Role of Peroxisome Proliferator-Activated Receptor α  in Diabetic Nephropathy Sungjin Chung, Cheol Whee Park Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea With a developing worldwide epidemic of diabetes mellitus, the renal complications associated with diabetes have become a seri - ous health concern.",Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
"PPARs also play an important  role in various pathophysiologic conditions, such as immuni -Review http://dx.doi.org/10.4093/dmj.2011.35.4.327 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
"Diabetes Metab J 2011;35:327-336 http://e-dmj.org ty, inflammation, apoptosis, and cell differentiation [8].",Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
329PPARα and diabetic nephropathy Diabetes Metab J 2011;35:327-336 http://e-dmj.org expression of the PPAR α gene is also affected by other tran - scription factors [17].,Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
"Diabetes Metab J 2011;35:327-336 http://e-dmj.org knockout and wild-type mice showed that the inflammatory  response was significantly prolonged in PPAR α-null mice  compared to the wild-type controls, suggesting that PPAR α  affects the duration of the inflammatory response, possibly by  limiting cytokine expression and also by inducing genes that  metabolize LTB4 [35].",Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
331PPARα and diabetic nephropathy Diabetes Metab J 2011;35:327-336 http://e-dmj.org nists in renal complications of diabetes has also been suggest - ed.,Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
"Diabetes Metab J 2011;35:327-336 http://e-dmj.org increased luciferase activity in mesangial cells, which is con - sistent with the existence of endogenous PPAR α activity in  these cells [48,49].",Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
333PPARα and diabetic nephropathy Diabetes Metab J 2011;35:327-336 http://e-dmj.org efficacy of fibrates on renal outcomes in patients with type 1 or  type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
Diabetes Metab J 2011;35:327-336 http://e-dmj.org vating the ABCA1 cholesterol efflux pathway.,Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
335PPARα and diabetic nephropathy Diabetes Metab J 2011;35:327-336 http://e-dmj.org molecular switch between transactivation and transrepression  activity of the peroxisome proliferator-activated receptor alpha.,Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
"Diabetes Metab J 2011;35:327-336 http://e-dmj.org Choi BS, Kim YS, Chang YS, Park CW .",Non-OADS,/arxiv_data1/oa_pdf/31/4c/dmj-35-327.PMC3178692.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/de/dmj-35-337.PMC3178693.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:337-339 Prevalence, Awareness, and Control of Hypertension  among Diabetic Koreans  Hyun Hee Chung, Kyu Chang Won Division of Endocrinology and Metabolism, Department of Internal Medicine, Y eungnam University College of Medicine, Daegu, Korea Corresponding author:  Kyu Chang Won Division of Endocrinology and Metabolism, Department of   Internal Medicine, Y eungnam University College of Medicine,   317-1 Daemyung-dong, Nam-gu, Daegu 705-717, Korea E-mail: kcwon@med.yu.ac.krHypertension affects approximately 70% of patients with dia - betes and is approximately twice as common in persons with  diabetes as in those without.",Non-OADS,/arxiv_data1/oa_pdf/75/de/dmj-35-337.PMC3178693.pdf
"As  a result of the factorial design of the overall ACCORD study  and the inclusion and exclusion criteria that were applied, the Editorial http://dx.doi.org/10.4093/dmj.2011.35.4.337 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/75/de/dmj-35-337.PMC3178693.pdf
"Diabetes Metab J 2011;35:337-339 http://e-dmj.org study’s statistical power was reduced, and the event rate was  lower than expected.",Non-OADS,/arxiv_data1/oa_pdf/75/de/dmj-35-337.PMC3178693.pdf
"339Prevalence, awareness, and control of hypertension among diabetic Koreans  Diabetes Metab J 2011;35:337-339 http://e-dmj.org 565-74.",Non-OADS,/arxiv_data1/oa_pdf/75/de/dmj-35-337.PMC3178693.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:340-347 Effects of Sulfonylureas on Peroxisome Proliferator- Activated Receptor γ Activity and on Glucose Uptake  by Thiazolidinediones Kyeong Won Lee, Yun Hyi Ku, Min Kim, Byung Y ong Ahn, Sung Soo Chung, Kyong Soo Park  Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Background:  Sulfonylurea primarily stimulates insulin secretion by binding to its receptor on the pancreatic β-cells.",Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
The C-terminal region of Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.340 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
"341Sulfonylureas and PPAR γ  Diabetes Metab J 2011;35:340-347 http://e-dmj.org PPARγ, called ligand binding domain, is dimerized with RXR  and contains the major transcriptional activation domain,  termed the activation-function 2 (AF2) domain.",Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
Diabetes Metab J 2011;35:340-347 http://e-dmj.org taining 0.2 µCi of [3H]deoxyglucose for 15 minutes.,Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
343Sulfonylureas and PPAR γ  Diabetes Metab J 2011;35:340-347 http://e-dmj.org rosiglitazone in the presence of different sulfonylurea concen - trations using glimepiride and gliquidone.,Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
"Diabetes Metab J 2011;35:340-347 http://e-dmj.org ence in luciferase activity at any concentration, although gliq - uidone was similar or more effective than glimepiride at the  indicated dose (Fig.",Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
"345Sulfonylureas and PPAR γ  Diabetes Metab J 2011;35:340-347 http://e-dmj.org third generation sulfonylurea, demonstrated the ability to im - prove insulin sensitivity in a human study [22].",Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
Diabetes Metab J 2011;35:340-347 http://e-dmj.org REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
347Sulfonylureas and PPAR γ  Diabetes Metab J 2011;35:340-347 http://e-dmj.org of the novel sulphonylurea glimepiride.,Non-OADS,/arxiv_data1/oa_pdf/84/26/dmj-35-340.PMC3178694.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:348-353 Management of Blood Pressure in Patients with Type 2  Diabetes Mellitus: A Nationwide Survey in Korean Mi Hae Seo1, Woo Je Lee2 , Cheol Y oung Park1, Sung Rae Kim3, Joong Y eol Park2, Kun-Ho Y oon3,  Moon Kyu Lee4, Sung Woo Park1 1Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine,  2Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine,  3Department of Internal Medicine, The Catholic University of Korea College of Medicine,  4Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  Hypertension is common in patients with type 2 diabetes, affecting up to 60% of patients.",Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
"Therefore, the adequate control of BP has important clinical  and prognostic relevance in reducing economic burden in Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.348 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
349Management of blood pressure in patients with type 2 diabetes mellitus  Diabetes Metab J 2011;35:348-353 http://e-dmj.org subjects with type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
"Diabetes Metab J 2011;35:348-353 http://e-dmj.org (under-40s), the proportion of BMI>30 kg/m2 was reported as  19.1%, and was higher than that of the other age groups (data  not shown).",Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
351Management of blood pressure in patients with type 2 diabetes mellitus  Diabetes Metab J 2011;35:348-353 http://e-dmj.org Hg group.,Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
"Diabetes Metab J 2011;35:348-353 http://e-dmj.org two-thirds of patient utilizing antihypertensive drug therapy  still did not meet the goal for BP control, suggesting that these  patients should be treated more rigorously to achieve controlled  BP .",Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
"353Management of blood pressure in patients with type 2 diabetes mellitus  Diabetes Metab J 2011;35:348-353 http://e-dmj.org enth Report of the Joint National Committee on Prevention,  Detection, Evaluation, and Treatment of High Blood Pressure:  the JNC 7 report.",Non-OADS,/arxiv_data1/oa_pdf/ea/9f/dmj-35-348.PMC3178695.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:354-363 A Comparative Study of Eating Habits and Food Intake  in Women with Gestational Diabetes according to  Early Postpartum Glucose Tolerance Status Y ou Jeong Hwang1, Bo Kyung Park1, Sunmin Park2, Sung-Hoon Kim3 1Department of Nutrition, Cheil General Hospital & Women’s Healthcare Center, Kwandong University College of Medicine, Seoul, 2Department of Food and Nutrition, Hoseo University, Asan, 3Division of Endocrinology and Metabolism, Department of Medicine, Cheil General Hospital and Women’s Healthcare Center, Kwandong University College  of Medicine, Seoul, Korea  Background:  Women with gestational diabetes mellitus (GDM) are at high risk for type 2 diabetes mellitus (T2DM) and car - diovascular disease (CVD); continuous life-style intervention, especially diet, is central to managing T2DM and CVD.",Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
"Additionally, Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.354 pISSN 2233-6079 · eISSN 2233-6087 This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
"355Postpartum food intake of women diagnosed with GDM Diabetes Metab J 2011;35:354-363 http://e-dmj.org the prevalence of GDM is similar in Korea as in other coun - tries (approximately 2% to 3%) [5]; moreover, when the diag - nostic criteria were updated, a 4% increase in the prevalence  was reported [6].",Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
Diabetes Metab J 2011;35:354-363 http://e-dmj.org el) were used to educate the participants.,Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
"357Postpartum food intake of women diagnosed with GDM Diabetes Metab J 2011;35:354-363 http://e-dmj.org levels increased after delivery among patients who had received  treatment for GDM, a significant increase in the use of insulin  was observed ( P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
Diabetes Metab J 2011;35:354-363 http://e-dmj.org from the questionnaire totals did not show any significant dif - ferences.,Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
"359Postpartum food intake of women diagnosed with GDM Diabetes Metab J 2011;35:354-363 http://e-dmj.org the recommended amounts of total lipids, animal fat and cho - lesterol in each study group was determined (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
Diabetes Metab J 2011;35:354-363 http://e-dmj.org increased significantly.,Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
361Postpartum food intake of women diagnosed with GDM Diabetes Metab J 2011;35:354-363 http://e-dmj.org justed for BMI.,Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
Diabetes Metab J 2011;35:354-363 http://e-dmj.org lic of Korea (Grant no.,Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
363Postpartum food intake of women diagnosed with GDM Diabetes Metab J 2011;35:354-363 http://e-dmj.org Dietary fat and meat intake in relation to risk of type 2 diabetes  in men.,Non-OADS,/arxiv_data1/oa_pdf/41/b8/dmj-35-354.PMC3178696.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:364-373 Effects of Aerobic Exercise vs. Resistance Training on  Endothelial Function in Women with Type 2 Diabetes  Mellitus Hwi Ryun Kwon1,*, Kyung Wan Min2,*, Hee Jung Ahn1, Hee Geum Seok1, Jae Hyuk Lee1, Gang Seo Park2, Kyung Ah Han2 1Diabetes Center, Eulji Hospital,  2Department of Internal Medicine, Eulji University College of Medicine, Seoul, Korea Background:  There is controversy over whether aerobic or resistance exercise is more effective for improving endothelial func - tion in type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"As nitric  oxide bioavailability, crucial for maintaining vascular endo - thelial health and function, decrease, the endothelial dysfunc - tion that is measured by flow-mediated dilation (FMD) ac - companies a number of cardiovascular disease states including Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.364 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"365Effects of aerobic exercise vs. resistance training on endothelial function in diabetes Diabetes Metab J 2011;35:364-373 http://e-dmj.org hypertension, diabetes, chronic heart failure, and atheroscle - rosis.",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
Diabetes Metab J 2011;35:364-373 http://e-dmj.org the band length.,Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"367Effects of aerobic exercise vs. resistance training on endothelial function in diabetes Diabetes Metab J 2011;35:364-373 http://e-dmj.org Graded exercise test  The graded exercise test was performed using a stationary bi - cycle (ER 900, D-72475 Bits; JAGER, Wuerzburg, Germany).",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
Diabetes Metab J 2011;35:364-373 http://e-dmj.org was 57.0±6.8 years and the mean duration of diabetes mellitus  was 5.4±4.9 years.,Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"369Effects of aerobic exercise vs. resistance training on endothelial function in diabetes Diabetes Metab J 2011;35:364-373 http://e-dmj.org 0.1±6.4%, but this, too, was not a statistically significant dif - ference.",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"Diabetes Metab J 2011;35:364-373 http://e-dmj.org P=0.002, respectively).",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
371Effects of aerobic exercise vs. resistance training on endothelial function in diabetes Diabetes Metab J 2011;35:364-373 http://e-dmj.org from attaching to the blood vessel walls and interfering with  the interaction between platelets and the blood vessel walls.,Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
Diabetes Metab J 2011;35:364-373 http://e-dmj.org  There are some limitations of the present study.,Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"373Effects of aerobic exercise vs. resistance training on endothelial function in diabetes Diabetes Metab J 2011;35:364-373 http://e-dmj.org differential effects on aerobic fitness, cardiomyocyte contrac - tility, and endothelial function.",Non-OADS,/arxiv_data1/oa_pdf/81/e2/dmj-35-364.PMC3178697.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:374-383 The Correlations between Extremity Circumferences  with Total and Regional Amounts of Skeletal Muscle  and Muscle Strength in Obese Women with Type 2  Diabetes Hwi Ryun Kwon1,*, Kyung Ah Han2,*, Hee Jung Ahn1, Jae Hyuk Lee1, Gang Seo Park2, Kyung Wan Min2 1Diabetes Center, Eulji Hospital,  2Department of Internal Medicine, Eulji University School of Medicine, Seoul, Korea Background:  Insulin resistance is related to central obesity and the amount of skeletal muscle.",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
The increase in muscle mass im - proves insulin sensitivity and helps control blood glucose in Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.374 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"375Circumferences of extremities, muscle mass, muscle strength, diabetes Diabetes Metab J 2011;35:374-383 http://e-dmj.org type 2 diabetes patients [3].",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"Diabetes Metab J 2011;35:374-383 http://e-dmj.org  Insulin resistance was measured using K ITT [9], after fasting  for a minimum of 10 hours prior to visiting the hospital, and a  20 G catheter was inserted into the patients’ antecubital vein  on one side of the body and was used to collect blood samples.",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"377Circumferences of extremities, muscle mass, muscle strength, diabetes Diabetes Metab J 2011;35:374-383 http://e-dmj.org the present study.",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"Diabetes Metab J 2011;35:374-383 http://e-dmj.org The relationships of insulin resistance with muscle mass  with 1RM and extremity circumferences Arm muscles accounted for 10.1% of total muscle mass and  had a strong positive correlation with total muscle mass ( r= 0.772, P<0.001).",OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"379Circumferences of extremities, muscle mass, muscle strength, diabetes Diabetes Metab J 2011;35:374-383 http://e-dmj.org 0.138, P=0.170; r=0.156, P=0.122; r=0.123, P=0.213, respec - tively) (Table 4).",OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"Diabetes Metab J 2011;35:374-383 http://e-dmj.org Study of Obesity [13] was 85 cm, and 74.5% of the participants  (82 patients) in the present study had abdominal obesity.",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"381Circumferences of extremities, muscle mass, muscle strength, diabetes Diabetes Metab J 2011;35:374-383 http://e-dmj.org the upper body results from the present study and 63.6% (70  participants) of the lower body results did not meet the stan - dards.",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
Diabetes Metab J 2011;35:374-383 http://e-dmj.org 5.,Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"383Circumferences of extremities, muscle mass, muscle strength, diabetes Diabetes Metab J 2011;35:374-383 http://e-dmj.org and aerobics capacity in type 2 diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/f6/fb/dmj-35-374.PMC3178698.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:384-389 Long Menstrual Cycle Is Associated with Type 2  Diabetes Mellitus in Korean Women Unjin Shim, Jee-Y oung Oh, Hye Jin Lee, Y oung Sun Hong, Y eon-Ah Sung Division of Endocrinology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea Background:  Long menstrual cycle is a risk factor for developing type 2 diabetes and cardiovascular disease in women.",Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
PCOS could reflect the potential association between risk for  type 2 diabetes and menstrual irregularities.Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.384 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
"385Oligomenorrhea and diabetes  Diabetes Metab J 2011;35:384-389 http://e-dmj.org  In this study, we tried to evaluate the association between  currently having type 2 diabetes and oligomenorrhea before  diabetes was diagnosed.",Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
Diabetes Metab J 2011;35:384-389 http://e-dmj.org in women with type 2 diabetes and 40±5 years in the control  subjects ( P<0.001).,Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
"387Oligomenorrhea and diabetes  Diabetes Metab J 2011;35:384-389 http://e-dmj.org gomenorrhea and diabetes, the OR of obesity X oligomenor - rhea was 2.27 (95% CI, 1.11 to 4.66; P value for Breslow-Day  test for homogeneity=0.09; data not shown).",Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
"Diabetes Metab J 2011;35:384-389 http://e-dmj.org (SHBG) production by the liver [18], and is associated with  low SHBG concentrations, which leads to higher free testos - terone concentrations [19].",Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
389Oligomenorrhea and diabetes  Diabetes Metab J 2011;35:384-389 http://e-dmj.org The association of obesity with infertility and related menstur - al abnormalities in women.,Non-OADS,/arxiv_data1/oa_pdf/ba/fa/dmj-35-384.PMC3178699.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:390-396 Association between Diabetic Polyneuropathy and  Cardiovascular Complications in Type 2 Diabetic  Patients Jin Ook Chung, Dong Hyeok Cho, Dong Jin Chung, Min Y oung Chung Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Background:  Diabetes mellitus is a major independent risk factor for cardiovascular disease (CVD), but high cardiovascular risk  in diabetes mellitus patients is not completely explained by clustering traditional risk factors.",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
"Thus, DPN might be directly related to cardiovascular Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.390 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
391Polyneuropathy and cardiovascular complications Diabetes Metab J 2011;35:390-396 http://e-dmj.org disease.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
Diabetes Metab J 2011;35:390-396 http://e-dmj.org in order to analyze the association of DPN with cardiovascular  disease.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
393Polyneuropathy and cardiovascular complications Diabetes Metab J 2011;35:390-396 http://e-dmj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
Diabetes Metab J 2011;35:390-396 http://e-dmj.org possible role of cardiac autonomic neuropathy and peripheral  polyneuropathy as a strong predictor for CVD mortality [26].,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
395Polyneuropathy and cardiovascular complications Diabetes Metab J 2011;35:390-396 http://e-dmj.org CVD cannot be established.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
Diabetes Metab J 2011;35:390-396 http://e-dmj.org Group.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/dmj-35-390.PMC3178700.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:397-403 Comparison of Attitudes Regarding Quality of Life  between Insulin-Treated Subjects with Diabetes  Mellitus and Healthy Populations Fariba Hashemi Hefz Abad, Maryam Shabany Hamedan Faculty of Paramedical Sciences, Qazvin University of Medical Sciences and Health Services, Qazvin, Iran Background:  Diabetes mellitus is a chronic disease and one of the main causes of mortality in developing countries.",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
Although identifying the concerns of people with diabetes  mellitus and the barriers to using insulin can help determine Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.397 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
"Diabetes Metab J 2011;35:397-403 http://e-dmj.org some dimensions of quality of life (QOL) in these subjects,  various factors may be influential [5].",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
399Quality of life for insulin-dependent diabetics and healthy populations Diabetes Metab J 2011;35:397-403 http://e-dmj.org rality Committee of the Faculty of Nursing and Midwifery of  Isfahan.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
"Diabetes Metab J 2011;35:397-403 http://e-dmj.org  The Kruskal-Wallis test revealed no correlation between in - sulin-dependent subjects with diabetes mellitus complications  and mean score of attitude toward QOL (X2=8.94, df=7, P= 0.26) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
401Quality of life for insulin-dependent diabetics and healthy populations Diabetes Metab J 2011;35:397-403 http://e-dmj.org litus are lower in the mental-emotional dimension than are  those of healthy subjects.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
Diabetes Metab J 2011;35:397-403 http://e-dmj.org opportunities through government assistance.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
Avail - able from: http://www.who.int/diabetes/en/ (cited 2009 Sep  30).,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
Avail - able from: http://www.wpro.who.int/countries/2008/sma/ health_situation.htm (cited 2009 Sep 30).,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
403Quality of life for insulin-dependent diabetics and healthy populations Diabetes Metab J 2011;35:397-403 http://e-dmj.org 21.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/dmj-35-397.PMC3178701.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:404-410 Postprandial Triglyceride Is Associated with Fasting  Triglyceride and HOMA-IR in Korean Subjects with  Type 2 Diabetes Seo Hee Lee, Byung-Wan Lee, Hee Kwan Won, Jae Hoon Moon, Kwang Joon Kim, Eun Seok Kang, Bong Soo Cha,   Hyun Chul Lee Division of Endocrinology and Metabolism, Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea Background:  Recent studies indicate postprandial triglyceride (TG) had a better association with cardiovascular events and  metabolic syndrome than fasting TG.",Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
Several studies reported a very low (5 g) or low (<15  g) amount of dietary fat did not significantly increase post -Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.404 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
"405Postprandial TG is associated with fasting TG and HOMA-IR Diabetes Metab J 2011;35:404-410 http://e-dmj.org prandial TG, a moderate (30 to 50 g) amount of fat increased  postprandial TG dose dependently, and a very high (>80 g)  amount of fat exaggeratedly increased postprandial TG with - out dose-dependence [2,4].",Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
"Diabetes Metab J 2011;35:404-410 http://e-dmj.org age, sex, WC, glucose AC, HDL-C, and HOMA-IR) were en - tered as independent factors.",Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
"407Postprandial TG is associated with fasting TG and HOMA-IR Diabetes Metab J 2011;35:404-410 http://e-dmj.org vs. group II, P=0.052) were not significantly different between  the 2 groups.",Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
"Diabetes Metab J 2011;35:404-410 http://e-dmj.org the use of lipid-lowering agents [15], WC [16,17], glycemic  status [18,19], menopausal status and age [9] also affect the  non-fasting TG profiles.",Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
"409Postprandial TG is associated with fasting TG and HOMA-IR Diabetes Metab J 2011;35:404-410 http://e-dmj.org only postprandial TG showed a significant correlation with  glucose metabolic parameters such as postprandial glucose,  HOMA-IR and fasting C-peptide in subjects with T2D.",Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
Diabetes Metab J 2011;35:404-410 http://e-dmj.org postprandial state.,Non-OADS,/arxiv_data1/oa_pdf/00/c6/dmj-35-404.PMC3178702.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:411-417 Efficacy of Sitagliptin When Added to Ongoing  Therapy in Korean Subjects with Type 2 Diabetes  Mellitus Hye Soo Chung, Moon-Kyu Lee Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  To evaluate the clinical efficacy of sitagliptin for reducing plasma glucose levels in Korean subjects with type 2 dia - betes mellitus during a 14-week treatment period.",Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
Sulphonylureas improve blood glucose levels by stimu -Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.411 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
Diabetes Metab J 2011;35:411-417 http://e-dmj.org lating insulin secretion from pancreatic β-cells in a non-glu - cose–dependent manner [7].,Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
"413Efficacy of sitagliptin Diabetes Metab J 2011;35:411-417 http://e-dmj.org combination therapy, n=135/385), group 3 (glimepiride plus  metformin and acarbose or voglibose, n=73/385), and group  4 (glimepiride plus metformin combination therapy and hy - poglycemia, n=45/385).",Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
"Diabetes Metab J 2011;35:411-417 http://e-dmj.org change was observed in HbA1c or 2h-PPG level; however, FPG  increased significantly (14±29 mg/dL, P<0.01) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
415Efficacy of sitagliptin Diabetes Metab J 2011;35:411-417 http://e-dmj.org els in Korean subjects with T2DM with inadequate glycemic  control with previous medications (HbA1c 7.0% to 10.0%).,Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
"Diabetes Metab J 2011;35:411-417 http://e-dmj.org els by stimulating insulin secretion; however, some kinds of  sulphonylureas have been shown to induce apoptosis in a  dose- and time-dependent manner in β-cell lines and islets of  humans and rodents [16].",Non-OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
"417Efficacy of sitagliptin Diabetes Metab J 2011;35:411-417 http://e-dmj.org vies MJ, Tanaka W , Holst JJ, Deacon CF, Gottesdiener KM,  Wagner JA.",OADS,/arxiv_data1/oa_pdf/03/cb/dmj-35-411.PMC3178703.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:418-426 Effects of Resistance Training and Aerobic Exercise on  Insulin Sensitivity in Overweight Korean Adolescents:  A Controlled Randomized Trial Sunghwan Suh1,*, In-Kyong Jeong2,*, Mi Y eon Kim1, Y eon Soo Kim3, Sue Shin4, Sun Sin Kim5, Jae Hyeon Kim1 1Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 3Department of Physical Education, Seoul National University College of Education,  4Department of Laboratory Medicine, Boramae Medical Center, Seoul National University College of Medicine,  5Seoul National University Hospital Healthcare System Gangnam Center, Healthcare Research Institute, Seoul National University College of Medicine, Seoul,  Korea Background:  Data on the impact of resistance training on insulin resistance in overweight or obese children are inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
Both aerobic and resistance exercise effectively improve in -Original Article http://dx.doi.org/10.4093/dmj.2011.35.4.418 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
419Exercise training effect on insulin sensitivity Diabetes Metab J 2011;35:418-426 http://e-dmj.org sulin sensitivity and lead to better glycemic control in patients  with T2DM [15].,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
Diabetes Metab J 2011;35:418-426 http://e-dmj.org Dietary protocol Each study participant received an individualized dietary edu - cation program that was provided by a professional nutrition - ist twice a week throughout the 12 weeks of the study.,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
"421Exercise training effect on insulin sensitivity Diabetes Metab J 2011;35:418-426 http://e-dmj.org the number of sets, repetitions, and the amount of resistance  used as the participant’s technique and strength improved.",Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
Diabetes Metab J 2011;35:418-426 http://e-dmj.org for lowering body weight in overweight adolescents that may  lead to an improvement in their insulin sensitivity.,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
423Exercise training effect on insulin sensitivity Diabetes Metab J 2011;35:418-426 http://e-dmj.org Table 3.,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
"Diabetes Metab J 2011;35:418-426 http://e-dmj.org (AE and RT) when compared to their baseline values, as re - flected by adecreased insulin AUC values and an increased in - sulin sensitivity index.",Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
425Exercise training effect on insulin sensitivity Diabetes Metab J 2011;35:418-426 http://e-dmj.org of overweight and obesity prevalence in school-aged youth  from 34 countries and their relationships with physical activity  and dietary patterns.,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
Available from: http://www.cdc.go.kr/kcdchome/jsp/home/ common/brd/COMMBRD0200Detail.jsp?menuid=100049&,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
Diabetes Metab J 2011;35:418-426 http://e-dmj.org boardid=1012&pageNum=0&sub=0&boardseq=20915 (up - dated 2008 Aug 21).,Non-OADS,/arxiv_data1/oa_pdf/da/b2/dmj-35-418.PMC3178704.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/30/dmj-35-427.PMC3178705.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:427-428 The Effect of an Angiotensin Receptor Blocker on  Arterial Stiffness in Type 2 Diabetes Mellitus Patients  with Hypertension ( Diabetes Metab J 2011;35:236-42 ) Chul-Hee Kim  Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College  of Medicine, Bucheon, Korea Corresponding author:  Chul-Hee Kim Division of Endocrinology & Metabolism, Department of Internal Medicine,  Soonchunhyang University Bucheon Hospital, 1174 Jung-dong, Wonmi-gu,  Bucheon 420-767, Korea E-mail: chkimem@sch.ac.krAtherosclerotic cardiovascular disease is the major cause of  death in patients with type 2 diabetes and is accelerated by the  coexistence of hypertension.",Non-OADS,/arxiv_data1/oa_pdf/dd/30/dmj-35-427.PMC3178705.pdf
"In addi - tion, although it was not statistically significant, there was also  some difference in the change in mean arterial pressure before  and after treatment between the two groups (16.2 vs. 10.5 mm Letter http://dx.doi.org/10.4093/dmj.2011.35.4.427 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/dd/30/dmj-35-427.PMC3178705.pdf
428Kim C-H Diabetes Metab J 2011;35:427-428 http://e-dmj.org Hg).,Non-OADS,/arxiv_data1/oa_pdf/dd/30/dmj-35-427.PMC3178705.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/3b/dmj-35-429.PMC3178706.pdf
"Copyright © 2011 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2011;35:429-430 The Effect of an Angiotensin Receptor Blocker on  Arterial Stiffness in Type 2 Diabetes Mellitus Patients  with Hypertension ( Diabetes Metab J 2011;35:236-42 ) Ji Hyun Kim1, Su Jin Oh1, Jung Min Lee1, Eun Gyoung Hong2, Jae Myung Yu2, Kyung Ah Han3, Kyung Wan Min3,  Hyun Shik Son1, Sang Ah Chang1 1Department of Internal Medicine, The Catholic University of Korea College of Medicine,  2Department of Internal Medicine, Hallym University College of Medicine, 3Department of Internal Medicine, Eulji University College of Medicine, Seoul, Korea Corresponding author:  Sang Ah Chang Division of Endocrinology and Metabolism, Department of Internal  Medicine, St. Paul’s Hospital, The Catholic University of Korea College of  Medicine, 620-56 Jeonnong 1-dong, Dongdaemun-gu, Seoul 130-709, Korea E-mail: sangah@catholic.ac.krWe appreciate the interest and comments on our study, “The  effect of an angiotensin receptor blocker on arterial stiffness in  type 2 diabetes mellitus patients with hypertension, ” which was  published in Diabetes & Metabolism Journal  2011;35:236-242.",Non-OADS,/arxiv_data1/oa_pdf/95/3b/dmj-35-429.PMC3178706.pdf
"Also, there  were no differences between the two groups in terms of systol - ic or diastolic blood pressure at 12 weeks ( P=0.183, P=0.396) Response http://dx.doi.org/10.4093/dmj.2011.35.4.429 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/95/3b/dmj-35-429.PMC3178706.pdf
"Diabetes Metab J 2011;35:429-430 http://e-dmj.org or drug compliance, which was verified at every patient visit.",Non-OADS,/arxiv_data1/oa_pdf/95/3b/dmj-35-429.PMC3178706.pdf
3b) and is predicted to be tolerated by SIFT (Ng and Henikoff 2003 ;http://sift.jcvi.org/ ) while probably damaging by PolyPhen-2 (Adzhubei et al.,Non-OADS,/arxiv_data1/oa_pdf/58/c0/439_2011_Article_968.PMC3178759.pdf
2010 ; http://genetics.bwh.harvard.edu/pph2/ ) analysis.,Non-OADS,/arxiv_data1/oa_pdf/58/c0/439_2011_Article_968.PMC3178759.pdf
The UCSC Genome Browser(http://genome.ucsc.edu ) view of the deleted region indicating positions of genes is shown with rectangular bars indicating the extent of the deletion in eachpatient500 Hum Genet (2011) 130:495–504 123,Non-OADS,/arxiv_data1/oa_pdf/58/c0/439_2011_Article_968.PMC3178759.pdf
"Although none of these genes represents an obvious candidate for the observed phenotype based on current data ( http://www.ncbi.nlm.nih.gov/omim ), SHORT syndrome may be a contiguous gene deletion syn- drome which requires deletion of one (or more) of these genes in addition to BMP4 .",Non-OADS,/arxiv_data1/oa_pdf/58/c0/439_2011_Article_968.PMC3178759.pdf
"299 Korean J Ophthalmol 2011;25(5):299-304 http://dx.doi.org/10.3341/kjo.2011.25.5.299 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Intravitreal Bevacizumab Al one versus Combined with  Macular Photocoagulation in  Diabetic Macular Edema Soo Jeong Lee, Ei Tae Kim, Yeon Sung Moon Department of Ophthalmology, Inha Unive rsity School of Medicine, Incheon, Korea Purpose:  To compare the efficacy between intravitreal bevacizumab and combination treatment (bevacizumab and  macular photocoagulation) for the treatment of diabetic macular edema (DME).",Non-OADS,/arxiv_data1/oa_pdf/9a/b8/kjo-25-299.PMC3178762.pdf
"305 Korean J Ophthalmol 2011;25(5):305-310 http://dx.doi.org/10.3341/kjo.2011.25.5.305 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Long-Term Results of Lens-Sparing Vitrectomy for Stages  4B and 5 Retinopathy of Prematurity Jin Choi1, Jeong Hun Kim2,3, Seong-Joon Kim2,3, Young Suk Yu2,3 1Department of Ophthalmology, Inje Univer sity Sanggye Paik Hospital, Seoul, Korea 2Department of Ophthalmology, Seoul National Un iversity College of Medicine, Seoul, Korea 3Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research  Institute, Seoul, Korea Purpose:  To assess long-term anatomic and visual outcomes and associated complications of lens-sparing vi- trectomy (LSV) for treatment of tractional retinal detachments (TRDs) associated with stages 4B and 5 retinop-athy of prematurity (ROP) Methods:  We performed a retrospective review of medical records and data analyses of consecutive patients who  presented with stages 4B and 5 ROP and underwent LSV from 1999 to 2007.",Non-OADS,/arxiv_data1/oa_pdf/45/65/kjo-25-305.PMC3178763.pdf
"311 Korean J Ophthalmol 2011;25(5):311-316 http://dx.doi.org/10.3341/kjo.2011.25.5.311 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Retinal Hemorrhage Asso ciated with Perinatal  Distress in Newborns Youn Joo Choi1, Moon Sun Jung2, So Young Kim2 1Department of Ophthalmology, Soonchunhyang Un iversity Hospital, Soonchunhyang Univers ity College of Medicine, Seoul, Korea 2Department of Ophthalmology, Soonchunhyang Univers ity Cheonan Hospital, S oonchunhyang University  College of Medicine, Cheonan, Korea Purpose:  To describe the ophthalmoscopic features and natural history in a case series of eyes that developed in- traocular hemorrhages associated with perinatal distress and to evaluate their clinical courses.",Non-OADS,/arxiv_data1/oa_pdf/29/58/kjo-25-311.PMC3178764.pdf
"317 Korean J Ophthalmol 2011;25(5):317-322 http://dx.doi.org/10.3341/kjo.2011.25.5.317 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Surgical Outcomes of Diff erent Ahmed Glaucoma Valve  Implantation Methods between Scleral Graft and Scleral Flap Ho Young Lee, Jong Seok Park, Yoon Jung Choy, Hyun Joo Lee Department of Ophtha lmology, Eulji General Hospital, Eulji Univ ersity School of Medicine, Seoul, Korea Purpose:  To compare the surgical outcomes of the two different methods used for Ahmed Glaucoma Valve (AGV)  implantation between the donor scleral graft method and the partial-thickness scleral flap method.",Non-OADS,/arxiv_data1/oa_pdf/b9/df/kjo-25-317.PMC3178765.pdf
"323 Korean J Ophthalmol 2011;25(5):323-328 http://dx.doi.org/10.3341/kjo.2011.25.5.323 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Short-Term Effects of Ginkgo biloba  Extract on Peripapillary  Retinal Blood Flow in Normal Tension Glaucoma Jong Woon Park1, Hee Jung Kwon1, Woo Seok Chung2, Chan Yun Kim2, Gong Je Seong2 1Department of Ophthalmology, NHIC Ilsan Hospital, Goyang, Korea 2The Institute of Vision Research, Department of Ophthalmolog y, Yonsei University College of Medicine, Seoul, Korea Purpose:  Based on the vascular theory of glaucoma pathogenesis, we wanted to evaluate the effect of Ginkgo bilo- ba extract (GBE) on peripapillary blood flow in patients with normal tension glaucoma (NTG).",Non-OADS,/arxiv_data1/oa_pdf/f6/91/kjo-25-323.PMC3178766.pdf
"329 Korean J Ophthalmol 2011;25(5):329-333 http://dx.doi.org/10.3341/kjo.2011.25.5.329 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Comparison of Outcomes of Unilateral Lateral Rectus  Recession for Exotropia between First and Second Operations Kyoungsook Lee1, Kyeong Seob Shin2, Yongjune Kim3, Mi Young Choi1 1Department of Ophthalmology, Ch ungbuk National University College of Medicine, Cheongju, Korea 2Department of Laboratory Medicine, Chungbuk National  University College of Medicine, Cheongju, Korea  3Department of Urology, Chungbuk National Univer sity College of Medicine, Cheongju, Korea Purpose:  To compare the outcomes of unilateral lateral rectus recession between the first operation and second op- eration for exotropia.",Non-OADS,/arxiv_data1/oa_pdf/a9/91/kjo-25-329.PMC3178767.pdf
"334 Korean J Ophthalmol 2011;25(5):334-340 http://dx.doi.org/10.3341/kjo.2011.25.5.334 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Study for Analysis of the Multif ocal Visual Evoked Potential  Saemi Park1, Sang Hyouk Park2, Jee Ho Chang1, Young-Hoon Ohn1 1Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea 2Department of Ophthalmology, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Korea Purpose:  To introduce the clinical utility of the absolute value of the reconstructed waveform method in the analysis  of multifocal visual evoked potential (mfVEP).",Non-OADS,/arxiv_data1/oa_pdf/cd/ef/kjo-25-334.PMC3178768.pdf
"341 Korean J Ophthalmol 2011;25(5):341-343 http://dx.doi.org/10.3341/kjo.2011.25.5.341 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Analysis of the Effects of Me dial Rectus Muscle Resection  for Recurrent  Exotropia  Young-Woo Suh, IL Hun Seo, Yoonae A. Cho, Seung-Hyun Kim Department of Ophthalmology, Korea Univ ersity College of Medicine, Seoul, Korea Purpose:  The purpose of this paper is to investigate how much correction is obtained per millimeter of medial rectus  (MR) resection for recurrent exotropia after bilateral lateral rectus (BLR) recession, and to determine the differ-ence in the effects between unilateral and bilateral resection, and the influence of previous lateral rectus (LR) re-cession on the effects of MR resection.",Non-OADS,/arxiv_data1/oa_pdf/b8/f7/kjo-25-341.PMC3178769.pdf
"344 Korean J Ophthalmol 2011;25(5):344-348 http://dx.doi.org/10.3341/kjo.2011.25.5.344 pISSN: 1011-8942 eISSN: 2092-9382 Original Article Microscopic Characteristics of Lower Eyelid Retractors in Koreans Won-Kyung Cho1, Ji-Sun Paik1, Seung-Ho Han2, Suk-Woo Yang1 1Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine , Seoul, Korea 2Department of Anatomy, Catholic  Institute for Applied Anatomy,  Seoul St. Mary’s Hospital,  The Catholic University of Korea College of Medicine, Seoul, Korea Purpose:  To identify the microscopic characteristics of lower eyelid retractors in Korean individuals and to elucidate  age-related changes in lower eyelid retractors.",Non-OADS,/arxiv_data1/oa_pdf/c8/50/kjo-25-344.PMC3178770.pdf
"349 Korean J Ophthalmol 2011;25(5):349-351 http://dx.doi.org/10.3341/kjo.2011.25.5.349 pISSN: 1011-8942 eISSN: 2092-9382 Case Report A Case of Stenotrophomonas maltophilia  Keratitis  Effectively Treated with Moxifloxacin Sung Whan Son, Hyung Jin Kim, Jeong Won Seo Department of Ophthalmology, Sahm  Yook Medical Center, Seoul, Korea A 70-year-old man with a long history of diabetes mellitus presented to our hospital (Department of Ophthalmology,  Sahm Yook Medical Center, Seoul, Korea) complaining of severe ocular pain and visual disturbance in his left eye that had started three days prior to admission.",Non-OADS,/arxiv_data1/oa_pdf/7f/35/kjo-25-349.PMC3178771.pdf
"352 Korean J Ophthalmol 2011;25(5):352-354 http://dx.doi.org/10.3341/kjo.2011.25.5.352 pISSN: 1011-8942 eISSN: 2092-9382 Case Report Unilateral Peters’ Anomaly with Chorioretinal  Coloboma in the Other Eye Dooyoung Cho, Donggyu Choi, Wooho Nam Department of Ophthalmology, Kangnam Sacred Heart Hospital,  Hallym University College of Medicine, Seoul, Korea An 18-year-old man presented with poor vision in both eyes that had been present since birth.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/kjo-25-352.PMC3178772.pdf
"355 Korean J Ophthalmol 2011;25(5):355-357 http://dx.doi.org/10.3341/kjo.2011.25.5.355 pISSN: 1011-8942 eISSN: 2092-9382 Case Report Vortex Keratopathy in a Patient Receiving Vandetanib for  Non-Small Cell Lung Cancer Jeeyun Ahn1, Won Ryang Wee2, Jin Hak Lee1, Joon Young Hyon1 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongna m, Korea  2Department of Ophthalmology, Seoul National University Hospital, Seoul National Unive rsity College of Medicine, Seoul, Korea We report a case of vortex keratopathy in a patient treated with vandetanib for non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/84/39/kjo-25-355.PMC3178773.pdf
"358 Korean J Ophthalmol 2011;25(5):358-361 http://dx.doi.org/10.3341/kjo.2011.25.5.358 pISSN: 1011-8942 eISSN: 2092-9382 Case Report Ophthalmic Artery Obstructio n and Cerebral Infarction  Following Periocular Inject ion of Autologous Fat Chang Mok Lee, In Hwan Hong, Sung Pyo Park Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University  College of Medicine, Seoul, Korea We report a case of ophthalmic artery obstruction combined with brain infarction following periocular autologous fat  injection.",Non-OADS,/arxiv_data1/oa_pdf/90/ae/kjo-25-358.PMC3178774.pdf
"362 Korean J Ophthalmol 2011;25(5):362-365 http://dx.doi.org/10.3341/kjo.2011.25.5.362 pISSN: 1011-8942 eISSN: 2092-9382 Case Report A Case of Cholesterosis Bulb i with Secondary Glaucoma  Treated by Vitrectomy and Intravitreal Bevacizumab Jongseok Park1, Hoyoung Lee1, Young Kook Kim1, Jeong Don Chae2, Hyun Joo Lee1 1Department of Ophtha lmology, Eulji General Hospital, Eulji Univ ersity School of Medicine, Seoul, Korea 2Department of Laboratory Medicine, Eulji General Hospita l, Eulji University School of Medicine, Seoul, Korea We report on a case of cholesterosis bulbi concurrent with secondary glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/9a/ae/kjo-25-362.PMC3178775.pdf
"366 Korean J Ophthalmol 2011;25(5):366-368 http://dx.doi.org/10.3341/kjo.2011.25.5.366 pISSN: 1011-8942 eISSN: 2092-9382 Case Report Computed Tomographic Angiogram of an Anterior  Communicating Artery Aneurysm Causing Acute  Retrobulbar Optic Neur opathy: A Case Report Jee Ho Chang1, Dong-Kyu Lee1, Bum Tae Kim2, Young-Hoon Ohn1 1Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea 2Department of Neurosurgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, K orea Three-dimensional computed tomographic (3D-CT) angiography is a widespread imaging modality for intracranial  vascular lesions.",Non-OADS,/arxiv_data1/oa_pdf/07/7f/kjo-25-366.PMC3178776.pdf
(2007 ) were selected using the marker order and map positions obtained from the Marshﬁeld electronic database (http://www.research.marshﬁeldclinic.org/genetics/Marker Search/searchMarkers.asp ).,OADS,/arxiv_data1/oa_pdf/99/63/439_2011_Article_972.PMC3178777.pdf
"Breast Cancer Res Treat 109:491–501 CBCF (2005) http://www.abtumorbank.com/?about Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB,Haiman CA, Kolonel LK, Henderson BE, Le Marchand L,Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-TrenchG, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-ClosasM, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J,Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, ReedHum Genet (2011) 130:529–537 535 123",Non-OADS,/arxiv_data1/oa_pdf/09/f8/439_2011_Article_973.PMC3178778.pdf
Curr Protoc HumGenet Chapter 2:Unit 2.12 GeneCards (2010) http://www.genecards.org/ .,Non-OADS,/arxiv_data1/oa_pdf/09/f8/439_2011_Article_973.PMC3178778.pdf
"N Engl J Med 358:2796–2803 PolyomX (2001) http://www.abtumorbank.com/?aboutPrice AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratiﬁcation in genome-wide association studies.",OADS,/arxiv_data1/oa_pdf/09/f8/439_2011_Article_973.PMC3178778.pdf
"Nat Genet 41:579–584 Tomorrow Project (2001) http://www.albertahealthservices.ca/1476.asp Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, Hughes D, Warren-Perry M, Tapper W, Eccles D, Evans DG, Hooning M,Schutte M, van den Ouweland A, Houlston R, Ross G, LangfordC, Pharoah PD, Stratton MR, Dunning AM, Rahman N, Easton DF (2010) Genome-wide association study identiﬁes ﬁve new breast cancer susceptibility loci.",Non-OADS,/arxiv_data1/oa_pdf/09/f8/439_2011_Article_973.PMC3178778.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 11, 31 May 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101447, ijic2011-19Copyrig ht:  Submitted: 3 November 2010, revised 11 March 2011, accepted 5 April 2011 Policy Determining eligibility for long-term care—lessons from   Germany Andreas Büscher, Prof., Dr., Institute of Nursing Science at the University of Bielefeld, PO Box 100131, D-33501 Bielefeld,  Germany; University of Applied Sciences Osnabrück, Faculty of Business Administration and Social Sciences, PO Box 1940,  D-49009 Osnabrück, Germany Klaus Wingenfeld, PH, Dr., Institute of Nursing Science at the University of Bielefeld, PO Box 100131, D-33501 Bielefeld,  GermanyDoris Schaeffer, Prof., Dr., Institute of Nursing Science at the University of Bielefeld, PO Box 100131, D-33501 Bielefeld,  GermanyCorrespondence to: Andreas Büscher, University of Applied Sciences Osnabrück, Faculty of Business Administration and Social  Sciences, PO Box 1940, D-49009 Osnabrück, Germany, Phone: +49 541 969-3591, Fax: +49 969-2971, E-mail: A.buescher@ hs-osnabrueck.de Abstract Objectives: This paper addresses recent steps for reforming the eligibility criteria of the German long-term care insurance that have been  initiated to overcome shortcomings in the current system.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ One of the key questions in any long-term care system  is the definition of eligibility for LTC benefits and ser- vices.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3  3was focused on the narrow concept of ‘dependency on  nursing care’ that only includes somatic and neglects other aspects, such as consequences from cognitive impairments, mental and behavioural health problems, communication ability or various challenges in the management of chronic illness.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ in the German LTC insurance, which results in the  need for developing a new tool.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5the existing eligibility criteria were to be expanded  • considerably, particularly in terms of including peo- ple with cognitive impairments, the tool was to ensure a valid and reliable assess- • ment of dependency from other persons,the procedure of the assessment process and its  • results needed to be transparent and understand - able for LTC users, the assessment process with the new tool needed  • to be feasible for the Medical Boards of the insur-ances,the results of the assessment were to be used for  • care planning purposes.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ to overcome the narrow focus on physical aspects  in the existing system without stressing the men-tal aspects too strongly and neglecting the physical ones at the same time.Finally, module 5 reflects that the need for care  • often arises from chronic illness that requires a  range of activities for the person affected and that  these activities have an influence on the person’s  degree of dependence.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  7of dependency on nursing care.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ References 1.  WHO.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
Available from: http://ec.europa.eu/social/main.jsp?catId=792&langId=e n. 4.,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
Available from: http://www.bmg.bund.de/fileadmin/ redaktion/pdf_english/Report_by_the_advisory_board_to_review_the_definition_of_the_need_for_long-term_care.pd f. 7.,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
Available from: http://www.bmg.bund.,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
Available from: http://www.uni-bielefeld.de/ gesundhw/ag6/downloads/ipw_bericht_pflegebedurftigkeit.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"International Journal of Integrated Care  – Volume  11, 31 May – URN:NBN:NL:UI:10-1-101447/ijic 2011-19 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  922.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
Available from: http://webarchive.national - archives.gov.uk/+/www.dh.gov.uk/en/SocialCare/Chargingandassessment/SingleAssessmentProcess/index.htm .,OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
Available from: http://www.uni-bielefeld.de/gesundhw/ag6/downloads/Abschlussbericht_ IPW_MDKWL_25.03.08.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ijic2011-2011019.PMC3178799.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 11, xx xxx 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101458, ijic2011-21Copyrig ht:  Submitted: 20 September 2010, revised 17 March 2011, accepted 20 April 2011 Research and theory What happens to quality in integrated homecare?",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ The lack of a commonly accepted definition of inte- grated care is widely acknowledged [e.g.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3  3Organisational context and site Finnish municipalities have a statutory obligation to  arrange health and social services including home-care for their residents [31, 32].",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ comprising practitioners, managers, researchers and  teachers from the health and social sectors.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5Statistical methods The three sum-scales presented in this article to mea- sure the three aspects of homecare quality investi-gated were constructed from the items in Tables 4–6  by factor analyses of combined client data for 1994 and 1997.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ Table 2.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  7Most of the relatives were daughters of the clients  in their 50s and early 60s.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ them lower in all measurements than did the clients.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  9sum-scales (Figures 2a,b) indicate rather stable qual - ity throughout the follow-up period, a major decrease  in quality was noted on this dimension in the first fol- low-up (1997; Figure 2c) according to clients and to  some extent also according to relatives.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 10International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ Some differences between the groups were revealed  in their quality assessments.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  11of structural integration.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 12International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ Despite organisational changes and cuts in staff and  services, homecare quality was at the same high level in the last follow-up (2009) as at baseline (1994) in most of the investigated areas.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  1310.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 14International Journal of Integrated Care  – Volume  11, xx xxx – URN:NBN:NL:UI:10-1-101458/ijic2011-21 – http://www.ijic.org/ 32.",Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/45/e9/ijic2011-2011021.PMC3178800.pdf
"Volume 11, 8 June 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101459/ijic2011-22Copyrig ht:  Editorial Integrate now, create health On a bright early morning of 25 February 2011, almost  1200 healthcare professionals gathered in a packed hotel ballroom in Singapore to witness the opening of a 2 day Conference on Integrated Care—the first academic and practitioner focused event solely devoted to the challenges of Integration of Care in Asia.",Non-OADS,/arxiv_data1/oa_pdf/10/d9/ijic2011-2011022.PMC3178801.pdf
"International Journal of Integrated Care  – Volume 11, 8 June – URN:NBN:NL:UI:10-1-101459/ijic2011-22 – http://www.ijic.org/ References 1.",Non-OADS,/arxiv_data1/oa_pdf/10/d9/ijic2011-2011022.PMC3178801.pdf
"International Journal of Integrated Care  – Volume 11, 8 June – URN:NBN:NL:UI:10-1-101459/ijic2011-22 – http://www.ijic.org/ 4.",Non-OADS,/arxiv_data1/oa_pdf/10/d9/ijic2011-2011022.PMC3178801.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 11, 30 June 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101516 / ijic2011-79Copyrig ht:  Submitted: 28 January 2011, revised 28 May 2011, accepted 28 May 2011 Research and theory Do ‘virtual wards’ reduce rates of unplanned hospital   admissions, and at what cost?",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care – Volume 11, 30 June – URN:NBN:NL:UI:10-1-101516 / ijic2011-79 – http://www.ijic.org/ based health coaching and advice.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"International Journal of Integrated Care – Volume 11, 30 June – URN:NBN:NL:UI:10-1-101516 / ijic2011-79 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3  3because they wrongly assume that it is being delivered  or secured by another professional).",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care – Volume 11, 30 June – URN:NBN:NL:UI:10-1-101516 / ijic2011-79 – http://www.ijic.org/ Moreover, there is little evidence to date on the optimal  configuration of community-based hospital avoidance initiatives.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"International Journal of Integrated Care – Volume 11, 30 June – URN:NBN:NL:UI:10-1-101516 / ijic2011-79 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5chosen as those with the greater level of balance, as  determined by accepted metrics [32].",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care – Volume 11, 30 June – URN:NBN:NL:UI:10-1-101516 / ijic2011-79 – http://www.ijic.org/ As well as using financial data from each site, the costs  of the intervention will be validated by means of staff interviews, questionnaires and work diaries.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"International Journal of Integrated Care – Volume 11, 30 June – URN:NBN:NL:UI:10-1-101516 / ijic2011-79 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  7The evaluation team will not request or receive any  identifiable patient data: only pseudonymous or anony - mous data will be obtained.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.nuffieldtrust.org.uk/publications/ detail.aspx?id=145&PRid=71 4.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.cms.hhs.gov/CCIP/.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from http://www.cms.hhs.gov/Demo- ProjectsEvalRpts/downloads/CC_Fact_Sheet.pd f. 7.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care – Volume 11, 30 June – URN:NBN:NL:UI:10-1-101516 / ijic2011-79 – http://www.ijic.org/ 10.",Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.kingsfund.org.uk/search_clicks.rm?id=6746&destinationtype=2&instanceid =34968 4.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.medicine.manchester.ac.uk/primarycare/npcrdc- archive/Publications/evercare%20report1.pd f. 21.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.download.bham.ac.uk/ hsmc/pdf/transforming_chronic_care.pd f. 25.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.pssru.ac.uk/pdf/uc/uc2009/uc2009_s08.pd f. 35.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
Available from: http://www.pssru.ac.uk/pdf/uc/uc2009/uc2009_listusefulsources.pd f.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/ijic2011-2011079.PMC3178802.pdf
"215 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org Spirometry is the only objective clinical tool available to phy - sicians in the outpatient setting.",Non-OADS,/arxiv_data1/oa_pdf/1e/3e/aair-3-215.PMC3178818.pdf
"2011 October;3(4):215-216. http://dx.doi.org/10.4168/aair.2011.3.4.215 pISSN 2092-7355 • eISSN 2092-7363 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/3e/aair-3-215.PMC3178818.pdf
"2011 October;3(4):215-216.  http://dx.doi.org/10.4168/aair .2011.3.4.215Volume 3, Number 4, October 201 1 216 http://e-aair.orgthis study, it is likely that tolerance to β-agonists would no  longer be a concern when medications are withheld for more  than seven days.",Non-OADS,/arxiv_data1/oa_pdf/1e/3e/aair-3-215.PMC3178818.pdf
"217 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION The American Thoracic Society/European Respiratory Society  (ATS/ERS) statement on asthma control defines asthma control  as ‘the extent to which manifestations of asthma are reduced or  removed by treatment’ .1 This definition is further clarified into  two components: current clinical asthma control and future  risk.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225. http://dx.doi.org/10.4168/aair.2011.3.4.217 pISSN 2092-7355 • eISSN 2092-7363 Despite international and national guidelines, poor asthma control remains an issue.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"Key Words:  Asthma; control; disease exacerbation; primary health careThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217Volume 3, Number 4, October 201 1 218 http://e-aair.orgreported that current asthma control is a predictor of future in - stability in asthma control and asthma exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217AAIR  219 http://e-aair.orgnaire [ATAQ]) has been associated with increased risk of severe  asthma related events,22 defined as oral steroid bursts, emer - gency room visits or a hospital admission.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217Volume 3, Number 4, October 201 1 220 http://e-aair.orgTable 2.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217AAIR  221 http://e-aair.orgAdherence to therapy Good adherence to asthma therapy is essential for maximal  therapeutic benefit and avoidance of exacerbations.,Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217Volume 3, Number 4, October 201 1 222 http://e-aair.orgPsychological dysfunction There is considerable literature on the relationship between  asthma and psychological dysfunction.40 Although anxiety is a  normal response to asthma symptoms, excessive anxiety may  lead to hyperventilation and subsequently cause airways cool - ing and bronchoconstriction.41 Cross-sectional surveys have  shown that, independently of objective asthma severity and  other confounding factors, anxiety and depression influences  symptomatic control and asthma related health status.42,43 Fear  of the physical symptoms of uncontrolled asthma has been  suggested to be linked to poor asthma control.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217AAIR  223 http://e-aair.orgrace/ethnicity data are unavailable in these databases making  analyses beyond asthma severity, and disease control using ex - acerbations and SABA usage very difficult, if not impossible.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217Volume 3, Number 4, October 201 1 224 http://e-aair.orgtion and Prevention Program.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"2011 October;3(4):217-225.  http://dx.doi.org/10.4168/aair .2011.3.4.217AAIR  225 http://e-aair.orgMJ, Hopper JL, Dharmage SC.",Non-OADS,/arxiv_data1/oa_pdf/7e/5c/aair-3-217.PMC3178819.pdf
"226 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Chronic rhinosinusitis (CRS) is a common condition associat - ed with significant morbidity and healthcare costs.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235. http://dx.doi.org/10.4168/aair.2011.3.4.226 pISSN 2092-7355 • eISSN 2092-7363 Despite the high prevalence of chronic rhinosinusitis (CRS) worldwide, the exact pathogenesis of the disease remains unknown.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"Key Words:  Rhinosinusitis; anti-inflammatory, antibioticsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226AAIR  227 http://e-aair.orgcytokine profile of IFN- γ, TNF-α, IL-1, IL-3, IL-6, and IL-8.5,6 Im- munoregulatory factors such as TGF- β1 is increased in expres - sion and the key transcription factor implicated in Foxp3+ T reg - ulatory cell populations appear similar to the normal nasal mu - cosa.7 Why such severe immune dysregulation occurs, and  what sustains inflammation is currently unknown, but it is like - ly that there are additional immunological factors that may pro - mote disease severity will emerge.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226Volume 3, Number 4, October 201 1 228 http://e-aair.orgfor mucosal recognition of gram-positive bacteria and initiation  of mucosal defence.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226AAIR  229 http://e-aair.org16 weeks failed to show any effect of the INS fluticasone propi - onate 400 mcg per day, although two patients per group each  had co-existent polyps.28 The study was insufficiently powered  to detect significant clinical response.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226Volume 3, Number 4, October 201 1 230 http://e-aair.orgdischarge and smell.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226AAIR  231 http://e-aair.orgonstrate any effect on the nasal airway using 16 mg of intrana - sal lysine aspirin every 48 hours after 6 months.58 However im - munohistochemistry revealed significant decrease of CyslLT 1  receptor in the turbinate mucosa of the patients with active  treatment, compared to placebo, so further trials were suggest - ed (REF).",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226Volume 3, Number 4, October 201 1 232 http://e-aair.orgular CRS-sub-phenotype will respond better to long term mac - rolides therapy and provides a mechanistic insight into immu - nopathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226AAIR  233 http://e-aair.org6.,Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226Volume 3, Number 4, October 201 1 234 http://e-aair.orgnasal budesonide with placebo for nasal polyposis.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
2011 October;3(4):226-235.  http://dx.doi.org/10.4168/aair .2011.3.4.226AAIR  235 http://e-aair.orgsystematic review.,Non-OADS,/arxiv_data1/oa_pdf/c7/74/aair-3-226.PMC3178820.pdf
"236 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Asthma is a genetically complex disease that is associated with  the familiar segregation of atopy and increased levels of total  serum IgE.1 Asthma and atopy are also closely associated with  increased bronchial hyper-reactivity and elevated blood eosin - ophil count.2,3 These intermediate phenotypes are highly heri - table and the subject of much asthma genetics research.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"2011 October;3(4):236-244. http://dx.doi.org/10.4168/aair.2011.3.4.236 pISSN 2092-7355 • eISSN 2092-7363 For the past two decades, a huge number of genetic studies have been conducted to identify the genetic variants responsible for asthma risk.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"Key Words:  Asthma; epigenetics; gene; genome; linkage; polymorphism; variantsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236AAIR  237 http://e-aair.orgsatellite markers and a positional cloning approach has led to  the discovery of several genes for asthma and related pheno - types (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
More than 300 genes  have SNPs associated with asthma and allergy subtypes based  on the NCBI website (http://www.ncbi.nlm.nih.gov).,Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236Volume 3, Number 4, October 201 1 238 http://e-aair.orgmay be smaller than expected.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"As of June 2010, 904 statistically sig - nificant GWAS have been published for 165 traits of common  allele complex diseases (NHGRI catalog at (http://www.ge - nome.gov/gwastudies/).",OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236AAIR  239 http://e-aair.orgtion of the previously defined SNPs, including ORMDL3 and  IL1RL1.38 However, the ORs were within the range of 0.5 to 1.5.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236Volume 3, Number 4, October 201 1 240 http://e-aair.orgof environment factors in genetic studies of asthma.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236AAIR  241 http://e-aair.orgthe genetic analysis.,OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236Volume 3, Number 4, October 201 1 242 http://e-aair.orgAs a result, the methylation patterns were significantly different  in nasal polyps, but not so different in the buffy coat.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236AAIR  243 http://e-aair.orggy.,Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"2011 October;3(4):236-244.  http://dx.doi.org/10.4168/aair.2011.3.4.236Volume 3, Number 4, October 201 1 244 http://e-aair.orgMalerba G, Pignatti PF , Boner A, Pescollderungg L, Girelli D, Oliv - ieri O, Martinelli N, Ludviksson BR, Ludviksdottir D, Eyjolfsson GI,  Arnar D, Thorgeirsson G, Deichmann K, Thompson PJ, Wjst M,  Hall IP , Postma DS, Gislason T, Gulcher J, Kong A, Jonsdottir I,  Thorsteinsdottir U, Stefansson K. Sequence variants affecting eo - sinophil numbers associate with asthma and myocardial infarc - tion.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/aair-3-236.PMC3178821.pdf
"245 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION The reversibility of bronchoconstriction with β2-adrenergic  agonists and increased airway responsiveness to a variety of  stimuli are hallmarks of asthma.1 Current treatment guidelines  recommend the use of inhaled corticosteroids and β2-adrenergic  agonists for individuals with mild to moderate persistent asth - ma.2 However, acute asthma attacks caused by extensive airway  obstruction following airway smooth muscle constriction some - times occur in patients receiving asthma medications.3 Inhaled  short-acting β2-adrenergic agonists (SABAs) play an important  role in the treatment of acute bronchoconstriction.4 Bronchodilator responsiveness (BDR) is the improvement of  forced expiratory volume in 1 second (FEV1) after inhalation of  β2-agonists and is typically measured as the change in airflow  after the administration of SABAs.",Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
2011 October;3(4):245-250. http://dx.doi.org/10.4168/aair.2011.3.4.245 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   The  aim of this study  was to investigate  bronchodilator  responsiveness  (BDR)  following  methacholine-induced  bronchoconstriction  and  to determine  differences  in BDR according  to clinical  parameters  in children  with asthma.,Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
"Key Words:   Atopy;  asthma;  beta-adrenergic  agonist;  child;  eosinophilia;  methacholineThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
"2011 October;3(4):245-250.  http://dx.doi.org/10.4168/aair.2011.3.4.245Volume 3, Number 4, October 201 1 246 http://e-aair.orgchoconstriction by bronchodilators is a useful and standard - ized model for the determination of airway responsiveness to  bronchodilators.9,10 The knowledge of factors affecting BDR in children with asth - ma is limited.",Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
"2011 October;3(4):245-250.  http://dx.doi.org/10.4168/aair.2011.3.4.245AAIR  247 http://e-aair.orgkit (Pharmacia ECP UniCAP System FEIA; Pharmacia Diagnos - tics, Uppsala, Sweden) with a detection limit of less than 2.0 µg/L.",Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
"2011 October;3(4):245-250.  http://dx.doi.org/10.4168/aair.2011.3.4.245Volume 3, Number 4, October 201 1 248 http://e-aair.orgdiffer between the atopic and non-atopic patients, although the  BDR was significantly higher in atopic subjects compared with  non-atopic subjects (37.4 ±17.7% vs. 30.5 ±10.7%, respectively;  P=0.037; Fig.",Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
"2011 October;3(4):245-250.  http://dx.doi.org/10.4168/aair.2011.3.4.245AAIR  249 http://e-aair.orgpendent patterns of inheritance, the presence of atopy may cor - relate with the increased airway responsiveness that follows  bronchodilator inhalation.",Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
"2011 October;3(4):245-250.  http://dx.doi.org/10.4168/aair.2011.3.4.245Volume 3, Number 4, October 201 1 250 http://e-aair.orgbronchial inhalation challenge procedures.",Non-OADS,/arxiv_data1/oa_pdf/96/5f/aair-3-245.PMC3178822.pdf
"251 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION A number of epidemiologic studies have suggested that vita - min D deficiency is associated with an increased incidence of  asthma symptoms.1-3 Vitamin D deficiency was thought to be  eradicated with the fortification of foods and the apparent dis - appearance of rickets.",Non-OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
2011 October;3(4):251-255. http://dx.doi.org/10.4168/aair.2011.3.4.251 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Asthma and other allergic disorders have increased over the past decades in nearly all nations.,Non-OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
"An interventional study in  asthmatic patients with low serum vitamin D concentration may establish a causal relationship between asthma and vitamin D. Key Words:  Asthma; vitamin D; allergyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
"2011 October;3(4):251-255.  http://dx.doi.org/10.4168/aair.2011.3.4.251Volume 3, Number 4, October 201 1 252 http://e-aair.orgtion measures, severity, and control of asthma.",Non-OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
2011 October;3(4):251-255.  http://dx.doi.org/10.4168/aair.2011.3.4.251AAIR  253 http://e-aair.orgger relationship between vitamin D levels and asthmatic state  can be seen compared with the univariate analysis.,Non-OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
"2011 October;3(4):251-255.  http://dx.doi.org/10.4168/aair.2011.3.4.251Volume 3, Number 4, October 201 1 254 http://e-aair.orgthrough the direct induction of antimicrobial peptide (catheli - cidin) gene expression.15,16 Vitamin D promotes the induction  of T regulatory cells, including the expression of inhibitory cy - tokines (IL-10 and TGF β) and control of CD4-positive T lym - phocytes (Th1 and Th2).17,18 Vitamin D may reverse resistance  to glucocorticoids in steroid resistant asthma19 and potentiate  the effect of allergen immunotherapy.20 Observational studies  suggest that vitamin D deficiency increases the risk of respira - tory infection, which may contribute to the incidence of wheez - ing illnesses in children and adults and cause asthma exacerba - tions.21 Polymorphisms in the gene encoding the vitamin D re - ceptor have been associated with asthma phenotypes in two  studies.22,23 Additionally, some evidence has suggested the ef - fects of vitamin D on lung growth and development in neo - nates24 and also on lung function in adults.9 For the reasons not - ed above, vitamin D may be related to asthma and its severity.",Non-OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
2011 October;3(4):251-255.  http://dx.doi.org/10.4168/aair.2011.3.4.251AAIR  255 http://e-aair.orgAcad Sci 2004;1037:84-95.,OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
Available from:  http://www.nhlbi.nih.gov/guidelines/asthma/ 14.,Non-OADS,/arxiv_data1/oa_pdf/f1/b2/aair-3-251.PMC3178823.pdf
"256 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Aspirin-exacerbated respiratory diseases (AERD) refers to the  development of bronchoconstriction and naso-ocular manifes - tations in asthmatic individuals following the ingestion of aspi - rin or other nonsteroidal anti-inflammatory drugs (NSAIDs).1  Recently, aspirin hypersensitivity has attracted a great deal of  attention because of its association with increased asthma se - verity, including life threatening asthma attacks and possible  remodeling of both the upper and lower airways.2 Twenty-five  percent of asthma patients who required emergency mechani - cal ventilation were aspirin intolerant.3,4 Aspirin has been the  most commonly used medication for pain control or as a pro - phylactic for primary and secondary prevention of coronary ar -Diagnostic Value of Clinical Parameters in the Prediction of  Aspirin-Exacerbated Respiratory Disease in Asthma Hun Soo Chang,1 Jong-Sook Park,2 An-Soo Jang,2 Sung-Woo Park,2 Soo-Taek Uh,3 Young Hoon Kim,4 Choon-Sik Park2* 1Pharmacogenetic Research Center for Psychotropic Drugs, Korea University, Seoul, Korea 2Genome Research Center for Allergy and Respiratory Disease, Soonchunhyang University Bucheon Hospital, Bucheon, Korea 3Division of Allergy and Respirtorty Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea 4Division of Allergy and Respiratory Disease, Soonchunhyang University Cheonan Hospital, Cheonan, Korea tery disease and other vascular diseases.5 However, AERD re - mains widely underdiagnosed in the asthmatic population due  to insufficient awareness of the relationship of aspirin ingestion  and asthma exacerbation.",Non-OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
2011 October;3(4):256-264. http://dx.doi.org/10.4168/aair.2011.3.4.256 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   Aspirin-exacerbated  respiratory  disease  (AERD)  has attracted  a great  deal of attention  because  of its association  with increased  asthma   severity.,Non-OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
"Key Words:   Aspirin-exacerbated  respiratory  disease  (AERD);  aspirin  hypersensitivity;  history;  nasal  polyp;  chronic  sinusitis;  oral aspirin  challenge   (OAC)This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256AAIR  257 http://e-aair.orgThe diagnosis of aspirin hypersensitivity and AERD is usually  obvious from taking a clear history.,Non-OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
"2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256Volume 3, Number 4, October 201 1 258 http://e-aair.orgRESULTS Comparison of clinical and laboratory parameters between  AERD and ATA A total of 836 subjects were recruited from the asthma cohort.",OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256AAIR  259 http://e-aair.orgsignificantly higher in AERD patients than in those with ATA.,Non-OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
"2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256Volume 3, Number 4, October 201 1 260 http://e-aair.orgATA groups and AERD groups with or without a history of aspi - rin hypersensitivity.",OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
"2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256AAIR  261 http://e-aair.organd P=2.08×10-20, Fig.",OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
"2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256Volume 3, Number 4, October 201 1 262 http://e-aair.orgDISCUSSION In the present study, we evaluated clinical parameters as diag - nostic tools to predict AERD.",Non-OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256AAIR  263 http://e-aair.orgpositive OAC result.,OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
"2011 October;3(4):256-264.  http://dx.doi.org/10.4168/aair.2011.3.4.256Volume 3, Number 4, October 201 1 264 http://e-aair.org1999;54:428-35.",Non-OADS,/arxiv_data1/oa_pdf/b4/8e/aair-3-256.PMC3178824.pdf
"265 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Asthma is a common and heterogeneous respiratory disease  characterized by intermittent airway obstruction and respirato - ry symptoms that are related to chronic airway inflammation  and remodeling.1 Pathological features of airway remodeling  include goblet cell hyperplasia, subepithelial fibrosis, collagen  deposition, mucosal gland hyperplasia, smooth muscle hyper - trophy, and changes in the extracellular matrix.1 Inflammation and remodeling are the main causes of airway  hyperresponsiveness and chronic airway obstruction, charac - teristic features of asthma.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"2011 October;3(4):265-272. http://dx.doi.org/10.4168/aair.2011.3.4.265 pISSN 2092-7355 • eISSN 2092-7363 Purpose:   We  sought  to identify  asthma-related  genes  and to examine  the potential  of these  genes  to predict  asthma,  based  on expression  lev- els.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"Key Words:   Asthma;  gene  expression  profiling;  PBMC;  ROCThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"2011 October;3(4):265-272.  http://dx.doi.org/10.4168/aair.2011.3.4.265Volume 3, Number 4, October 2011 266 http://e-aair.orgalso enables the classification of genes causing various diseases  and for a diagnosis to be made at the genetic level.4,5 Several types of tissues have been used in human microarray  studies of asthma, including airway epithelial cells and airway  inflammatory cells from patients and healthy subjects.6-10 Nasal  mucosal cells are a good choice for genomic studies.11 Although an analysis of gene expression in the airways can  provide important information, obtaining airway tissues, in - cluding airway epithelial cells, using bronchoalveolar lavage  (BAL) or brushing is difficult, especially in severe asthma12; thus,  peripheral blood mononuclear cells (PBMCs) have been used  as an alternative.13-16 PBMCs contain lymphocytes, monocytes,  and dendritic cells, which are recognized sources of allergic re - sponse mediators.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"2011 October;3(4):265-272.  http://dx.doi.org/10.4168/aair.2011.3.4.265AAIR  267 http://e-aair.orgsynthesized in the presence of Cy3-dUTP or Cy5-dUTP (1 mM  each, NEN Life Science Products, Boston, MA, USA) at 42°C for  2 hours.",OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
2.8.1;  http://www.r-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"2011 October;3(4):265-272.  http://dx.doi.org/10.4168/aair.2011.3.4.265Volume 3, Number 4, October 2011 268 http://e-aair.orgcreased in the PBMCs of the asthmatics versus the normal con - trols.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"2011 October;3(4):265-272.  http://dx.doi.org/10.4168/aair.2011.3.4.265AAIR  269 http://e-aair.orgMEPE , MLSTD1 , and TRIM37  between asthmatics and normal  controls, we calculated the sensitivity and specificity using a  contingency table of 42 asthmatics and 10 normal controls.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"2011 October;3(4):265-272.  http://dx.doi.org/10.4168/aair.2011.3.4.265Volume 3, Number 4, October 2011 270 http://e-aair.orgdictive for mild asthma.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
2011 October;3(4):265-272.  http://dx.doi.org/10.4168/aair.2011.3.4.265AAIR  271 http://e-aair.orgexpression of the three genes.,OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"2011 October;3(4):265-272.  http://dx.doi.org/10.4168/aair.2011.3.4.265Volume 3, Number 4, October 2011 272 http://e-aair.org17.",Non-OADS,/arxiv_data1/oa_pdf/14/96/aair-3-265.PMC3178825.pdf
"273 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org Aspirin ingestion can induce a wide range of clinically recog - nized allergic reactions, including acetyl salicylic acid (ASA)- exacerbated respiratory disease (AERD), ASA-intolerant urti - caria (AIU), chronic rhinitis, and anaphylaxis.",Non-OADS,/arxiv_data1/oa_pdf/45/93/aair-3-273.PMC3178826.pdf
"2011 October;3(4):273-276. http://dx.doi.org/10.4168/aair.2011.3.4.273 pISSN 2092-7355 • eISSN 2092-7363 Acetyl salicylic acid (ASA) is metabolized by UDP-glucuronosyltransferase 1A6 (UGT1A6), cytochrome P4502C9 (CYP2C9), and N-acetyl transferase  2 (NAT2).",Non-OADS,/arxiv_data1/oa_pdf/45/93/aair-3-273.PMC3178826.pdf
"Key Words:  Aspirin; Cytochrome P4502C9; Metabolizing enzyme; UrticariaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/93/aair-3-273.PMC3178826.pdf
"2011 October;3(4):273-276.  http://dx.doi.org/10.4168/aair .2011.3.4.273Volume 3, Number 4, October 201 1 274 http://e-aair.orgjects (NC) were enrolled at the Ajou University Hospital in Su - won, Korea.",Non-OADS,/arxiv_data1/oa_pdf/45/93/aair-3-273.PMC3178826.pdf
"2011 October;3(4):273-276.  http://dx.doi.org/10.4168/aair .2011.3.4.273AAIR  275 http://e-aair.orgIn addition, the relationship between the CYP2C9  −1188T>C  polymorphism and AIU remained significant after a multiple  comparison test ( Pcorr=0.042 [co-dominant model] for AIU vs.  NC; Table 1).",OADS,/arxiv_data1/oa_pdf/45/93/aair-3-273.PMC3178826.pdf
"2011 October;3(4):273-276.  http://dx.doi.org/10.4168/aair .2011.3.4.273Volume 3, Number 4, October 201 1 276 http://e-aair.orgtion between the C allele of CYP2C9  −1188T>C and AIU, sug - gesting that this allele may modulate the risk for, and contribute  to, the development of the AIU phenotype.",Non-OADS,/arxiv_data1/oa_pdf/45/93/aair-3-273.PMC3178826.pdf
"277 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Various manifestations of allergic reaction caused by steroids  have been reported.",Non-OADS,/arxiv_data1/oa_pdf/21/75/aair-3-277.PMC3178827.pdf
"2011 October;3(4):277-279. http://dx.doi.org/10.4168/aair.2011.3.4.277 pISSN 2092-7355 • eISSN 2092-7363 Although corticosteroids have immunosuppressive, anti-inflammatory, and anti-allergic effects, allergic reactions are rare.",Non-OADS,/arxiv_data1/oa_pdf/21/75/aair-3-277.PMC3178827.pdf
"Key Words:  Drug hypersensitivity; methylprednisolone; urticariaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/75/aair-3-277.PMC3178827.pdf
"2011 October;3(4):277-279.  http://dx.doi.org/10.4168/aair .2011.3.4.277Volume 3, Number 4, October 201 1 278 http://e-aair.orgmethylprednisolone to deflazacort.",Non-OADS,/arxiv_data1/oa_pdf/21/75/aair-3-277.PMC3178827.pdf
"2011 October;3(4):277-279.  http://dx.doi.org/10.4168/aair .2011.3.4.277AAIR  279 http://e-aair.orgmethylprednisolone, and prednisone in any formulation in pa - tients displaying allergic reaction to systemic steroids has been  recommended1.",Non-OADS,/arxiv_data1/oa_pdf/21/75/aair-3-277.PMC3178827.pdf
"280 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org INTRODUCTION Allergic reactions to local anesthetics are very rare and repre - sent <1% of all adverse local anesthetics reactions.1-4 Contact  dermatitis is the most commonly reported allergic reaction to  several amide-type local anesthetics.5-7 Adverse local anesthet - ic-induced reactions through an IgE-mediated allergic mecha - nism (type I reaction) are still debated.5-8 Butane is a gas with  the formula C 4H10.9 When oxygen is plentiful, butane burns to  form carbon dioxide and water vapor; when oxygen is limited,  carbon (soot) or carbon monoxide may also be formed.",Non-OADS,/arxiv_data1/oa_pdf/28/f5/aair-3-280.PMC3178828.pdf
2011 October;3(4):280-282. http://dx.doi.org/10.4168/aair.2011.3.4.280 pISSN 2092-7355 • eISSN 2092-7363 Allergic reactions to local anesthetics are very rare and represent <1% of all adverse local anesthetics reactions.,Non-OADS,/arxiv_data1/oa_pdf/28/f5/aair-3-280.PMC3178828.pdf
"Key Words:  Anaphylaxis; immediate hypersensitivity; inhalation; lidocaineThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/f5/aair-3-280.PMC3178828.pdf
2011 October;3(4):280-282.  http://dx.doi.org/10.4168/aair .2011.3.4.280AAIR  281 http://e-aair.orgreducing the gag reflex.,Non-OADS,/arxiv_data1/oa_pdf/28/f5/aair-3-280.PMC3178828.pdf
"2011 October;3(4):280-282.  http://dx.doi.org/10.4168/aair .2011.3.4.280Volume 3, Number 4, October 201 1 282 http://e-aair.orgpeople, and female gender is involved in the majority of cases.1,2  Lidocaine is the most often used local anesthetic involved in  such reactions, because it is the most commonly used in clini - cal practice.1-5 Allergic reactions after an intravenous injection  of local anesthetic include contact dermatitis, which most often  shows cutaneous signs such as erythema, pruritus, urticaria, or  eczema that occur between 6 hours and 1 month after adminis - tration.5 True type I allergic reactions are reported in <1% of lo - cal anesthetic adverse drug reactions.6,7 In a large French survey  reporting the incidence of anaphylaxis during anesthesia over a  2-year period, local anesthetics were involved in only one case  (0.2%).",Non-OADS,/arxiv_data1/oa_pdf/28/f5/aair-3-280.PMC3178828.pdf
"283 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.org Erratum Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/56/f8/aair-3-283.PMC3178829.pdf
"2011 October;3(4):283. http://dx.doi.org/10.4168/aair.2011.3.4.283 pISSN 2092-7355 • eISSN 2092-7363 Erratum Changes in the Prevalence of Childhood Asthma in  Seoul from 1995 to 2008 and Its Risk Factors Ji-Won Kwon, Byoung-Ju Kim, Younghwa Song, Ju-Hee Seo, Tae-Hee Kim, Jinho Yu,   Hyo Bin Kim, So Yeon Lee, Woo-Kyung Kim, Kyoung-Won Kim, Hye-Mi Ji, Kyu-Earn Kim,   Ho Kim, Soo-Jong Hong Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/56/f8/aair-3-283.PMC3178829.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS http://aobplants.oxfordjournals.org/ AoB PLANTS 2011 plr022 doi:10.1093/aobpla/plr022, available online at www.aobplants.oxfordjournals.org &The Authors 2011 1",Non-OADS,/arxiv_data1/oa_pdf/cc/7e/plr022.PMC3178842.pdf
http://plantsci.missouri.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/plr022.PMC3178842.pdf
http://www.ussl.ars.usda.gov/pls/ caliche/Halophyte.query (19 January 2009).,OADS,/arxiv_data1/oa_pdf/cc/7e/plr022.PMC3178842.pdf
choosing a specialty  1. http://www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-  sections/medical-student-section/membership-services/choosing-medical-specialty/spe - cialty-information.page?,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/yjbm_84_3_195.PMC3178848.pdf
2. http://www.ama-assn.org/ama/pub/about-ama/our-people/the-federation-medicine/na - tional-medical-specialty-society-websites.page  3. https://www.aamc.org/students/medstudents/cim/specialties/  4. http://explorehealthcareers.org/en/home  5. http://www.abms.org/who_we_help/physicians/specialties.aspx  Application  1. http://www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-sections/mi - nority-affairs-consortium/transitioning-residency/the-application-process-a-timetable-suc - cess.page?,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/yjbm_84_3_195.PMC3178848.pdf
2. http://www.aafp.org/online/en/home/publications/otherpubs/strolling.html  3. https://www.aamc.org/services/eras/  4. http://www.sfmatch.org/  5. http://www.nrmp.org/  personal statement  1. http://www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-sections/mi - nority-affairs-consortium/transitioning-residency/writing-your-personal-statement.page?,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/yjbm_84_3_195.PMC3178848.pdf
interview  1. http://www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-sections/mi - nority-affairs-consortium/transitioning-residency/general-residency-questions.page?,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/yjbm_84_3_195.PMC3178848.pdf
"2. http://www.medscape.com/viewarticle/733498  3. https://www.aamc.org/download/77936/data/residencyquestions.pdf  specific residency program information  1. http://www.ama-assn.org/ama/pub/education-careers/graduate-medical-  education/freida-online.page  2. http://www.acgme.org/adspublic/  lifestyle/childcare Factors  1. http://www.bestplaces.net/  2. http://childcareaware.org/  3. http://nafcc.org/  4. http://www.nncc.org/states/stateindex.html Olson, et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/ca/yjbm_84_3_195.PMC3178848.pdf
2011 [cited  2011 June 22]; Available from:  http://www.ama-assn.org/ama/pub/about-  ama/our-people/member-groups-sections/mi - nority-affairs-consortium/transitioning-reside  ncy/the-application-process-a-timetable-suc - cess.page?,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/yjbm_84_3_195.PMC3178848.pdf
Available  from: http://www.medscape.com/viewarti - cle/707991.,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/yjbm_84_3_195.PMC3178848.pdf
Available from: https://services.aamc.org/pub - l i c a t i o n s / s h o w f i l e .,Non-OADS,/arxiv_data1/oa_pdf/39/2a/yjbm_84_3_203.PMC3178849.pdf
Available from:  http://www.nrmp.org/data/chartingout - comes2009v3.pdf.,OADS,/arxiv_data1/oa_pdf/39/2a/yjbm_84_3_203.PMC3178849.pdf
Available from: http://www.acgme.org/acWeb - site/navPages/nav_140.asp.,OADS,/arxiv_data1/oa_pdf/39/2a/yjbm_84_3_203.PMC3178849.pdf
Available from:  http://havenfreeclinic.org/wp/index.php/stu  dents/departments-and-roles.,OADS,/arxiv_data1/oa_pdf/39/2a/yjbm_84_3_203.PMC3178849.pdf
Available  from: https://inside.gwumc.edu/smhs/negea/.,Non-OADS,/arxiv_data1/oa_pdf/39/2a/yjbm_84_3_203.PMC3178849.pdf
2010 Apr  Available from http://i.zdnet.com/blogs/time-  to-decide-nature-education-report-1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/a0/yjbm_84_3_211.PMC3178850.pdf
Available from: http://www.yale.edu/gradu - ateschool/teaching/modules.html 12.,Non-OADS,/arxiv_data1/oa_pdf/21/a0/yjbm_84_3_211.PMC3178850.pdf
Available from: http://www.nsf.gov/statis - tics/nsf11306/.,OADS,/arxiv_data1/oa_pdf/37/09/yjbm_84_3_219.PMC3178851.pdf
Available  from: http://chem.ou.edu/~djn/diversity/brief - ings/Diversity%20Report%20Final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/09/yjbm_84_3_219.PMC3178851.pdf
Available from:  http://www.nsf.gov/statistics/doctoratework/.,Non-OADS,/arxiv_data1/oa_pdf/37/09/yjbm_84_3_219.PMC3178851.pdf
Available from:  http://www.huffingtonpost.com/jeffrey-  sachs/aid-ironies_b_207181.html.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from: http://www.huffington - post.com/dambisa-moyo/aid-ironies-a-response-  to_b_207772.html.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from:  http://www.ft.com/cms/s/0/0d1218c8-3b35-  11de-ba91-00144feabdc0.html#axzz1Pa3uNtq9.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from: http://www.doctorswithout - borders.org/.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from: http://www.icrc.org/eng/.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available  from: http://www.pih.org.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from: http://www.brac.net/.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from: http://www.unite - forsight.org/volunteer-abroad.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Avail - able from: http://www.fistulanetwork.org/Fis - tulaNetwork/index.php?option=com_content  &task=blogcategory&id=35&Itemid=50.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Avail - able from: http://www.aap.org/sections/ich/.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from:  http://www.ama-assn.org/ama/pub/about-  ama/our-people/member-groups-sections/of - fice-international-medicine.page.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from: http://www.isid.org/.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from: http://www.unite - forsight.org/conference/.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Available from:  http://www.fogartyscholars.org/welcome-to-  ficrsf/scholars/international-clinical-re - search-scholars-program.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
Aval - able at: http://www.ddcf.org/Medical-Re - search/Program-Strategies/Clinical-Research/  Clinical-Research-Fellowship-for-Medical-  Students/International-Opportunities/.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/yjbm_84_3_227.PMC3178852.pdf
"While there are many more fellowship  opportunities that exist, I admit that I hit my  personal threshold for personal statements  and recommendation requests after filing the  following applications:  • AAAS Science and Technology Policy  Fellowship (http://fellowships.aaas.org).",Non-OADS,/arxiv_data1/oa_pdf/2d/2a/yjbm_84_3_237.PMC3178853.pdf
• California Science and Technology  Policy Fellowship (http://fellows.ccst.us).,Non-OADS,/arxiv_data1/oa_pdf/2d/2a/yjbm_84_3_237.PMC3178853.pdf
• Christine Mirzayan Policy Fellowship  (http://www7.nationalacademies.org/poli - cyfellows).,Non-OADS,/arxiv_data1/oa_pdf/2d/2a/yjbm_84_3_237.PMC3178853.pdf
• American Society for Biochemistry  and Molecular Biology (ASBMB) Policy  Fellowship (http://www.asbmb.org/advo - cacy/Advocacy.aspx?id=13624).,Non-OADS,/arxiv_data1/oa_pdf/2d/2a/yjbm_84_3_237.PMC3178853.pdf
Available from: http://nces.ed.gov/sur - veys/pisa/pisa2009highlights_4.asp.,Non-OADS,/arxiv_data1/oa_pdf/06/b8/yjbm_84_3_247.PMC3178855.pdf
Available from:  http://www.who.int/hiv/data/global_data/en/index  .html.,OADS,/arxiv_data1/oa_pdf/0a/83/yjbm_84_3_301.PMC3178861.pdf
Available from:  http://www.clinicaltrials.gov/ct2/show/NCT0115  3646?term=gene+transfers+for+hiv+using+au - tologous+t+cells&rank=1.,OADS,/arxiv_data1/oa_pdf/0a/83/yjbm_84_3_301.PMC3178861.pdf
Available from:  http://www.virxsys.com/pages/human-  therapies/hiv-rna-therapy.php.,Non-OADS,/arxiv_data1/oa_pdf/0a/83/yjbm_84_3_301.PMC3178861.pdf
Available: http://www.rollbackmalaria.org/ patnership/country/docs/SAfrica/reaping_zimbabwe.pdf .,Non-OADS,/arxiv_data1/oa_pdf/50/de/S0031182011001181a.PMC3178872.pdf
Internet J Health 9: Available: http://www.ispup.com/journal/the_internet_journal_of_ health/volume_9_number_1_12/article/impact-of-urinary-schistosomiasis-on-nutritional-status-of-school-children-in-south-eastern-nigeria.html .A c c e s s e d 07 July 2011.,Non-OADS,/arxiv_data1/oa_pdf/50/de/S0031182011001181a.PMC3178872.pdf
Prevalence of the dhfr 164L mutation All publications in which surveys of dhfr164L were carried out are listed in the supplementary bibli- ography S2 (see http://journals.cambridge.org/ PAR).,Non-OADS,/arxiv_data1/oa_pdf/81/ae/S0031182011000746a.PMC3178874.pdf
Prevalence of the dhps 581G mutation All publications in which surveys of dhps 581G were carried out are listed in the supplementary biblio- graphy S3 (see http://journals.cambridge.org/PAR ).,Non-OADS,/arxiv_data1/oa_pdf/81/ae/S0031182011000746a.PMC3178874.pdf
The development of the website http://www.drugresistan- cemaps.org/ipti/ was funded by the IPTi consortium.,OADS,/arxiv_data1/oa_pdf/81/ae/S0031182011000746a.PMC3178874.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/86/TOCHGENJ-5-62.PMC3178875.pdf
Hum Mutat 2010;  DOI: 10.1002/humu.21416: Available from:  http://dx.doi.org/10.1002/humu.21416.,Non-OADS,/arxiv_data1/oa_pdf/5d/53/TOCHGENJ-5-72.PMC3178896.pdf
"[101] For the latest unpublished progress in this area, see:  http://www.thesgc.org/chemical_probes/UNC0638/#overview   [102] Chang Y, Ganesh T, Horton JR , et al .",OADS,/arxiv_data1/oa_pdf/5d/53/TOCHGENJ-5-72.PMC3178896.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/53/TOCHGENJ-5-72.PMC3178896.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/ca/TOCHGENJ-5-48.PMC3178898.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/8d/TODENTJ-5-150.PMC3178899.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/f2/TOCHGENJ-5-85.PMC3178901.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/f0/TODENTJ-5-158.PMC3178902.pdf
1http://lucene.apache.org/java/docs/index.html  2http://trec.nist.,OADS,/arxiv_data1/oa_pdf/4a/e8/TOMINFOJ-5-50.PMC3178904.pdf
"8) Tamura texture , [22] is consisted of six texture  features corresponding to human visual perception:                                                   3http://www.sema nticmetadata.net/lire/.",OADS,/arxiv_data1/oa_pdf/4a/e8/TOMINFOJ-5-50.PMC3178904.pdf
"In Table 4 w e  r e p e a t  t h e  s a m e   process in reverse order, that is we use the values of the                                                   4http://www.rsna.org/  5http://www.",OADS,/arxiv_data1/oa_pdf/4a/e8/TOMINFOJ-5-50.PMC3178904.pdf
"Computer  Research Repository (CoRR), abs/0911.5046 (2009) available from:  http://arxiv.org/PS_cache/arxiv/pdf/0911/0911.5046v2.pdf  [18] Lux M, Chatzichristofis SA.",OADS,/arxiv_data1/oa_pdf/4a/e8/TOMINFOJ-5-50.PMC3178904.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/96/TOCHGENJ-5-115.PMC3178905.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/bb/TODENTJ-5-154.PMC3178913.pdf
"In the Asian population almost all cases of esophageal cancer are squamous cell cancers, whereas in the Western world adenocarcinoma occurs more often and its incidence has risen over recent decades (source: GLOBOCAN; http://globocan.iarc.fr).",Non-OADS,/arxiv_data1/oa_pdf/76/65/SJG-17-299.PMC3178915.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/65/33/SJG-17-318.PMC3178919.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/2a/39/SJG-17-360.PMC3178927.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/93/TOCHGENJ-5-106.PMC3178935.pdf
Available from: http://en.wikipedia.org/wiki/Guar_gum 8.,Non-OADS,/arxiv_data1/oa_pdf/5b/53/IJPhS-72-689.PMC3178968.pdf
Available from: http://www.msumain.edu.ph/ mindanaojournal/pdf/mj4-2005.pdf [Last accessed on 2009 Apr 25].,Non-OADS,/arxiv_data1/oa_pdf/5e/56/IJPhS-72-818.PMC3178992.pdf
Available from: http://ucjeps.berkeley.edu/moorea/Baltrushes2006pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/56/IJPhS-72-818.PMC3178992.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Global Health Action 2011, 4: 7913 - DOI: 10.3402/gha.v4i0.7913",Non-OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Available from: http://hdr.undp.,Non-OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Available from:http://www.cwhn.ca/fr/print/fr/node/39364 [cited 22 June 2011].,Non-OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Available from: http://redorbit.com/modules/news/tools.php?tool /C30print&id /C30890479 [cited 24 June 2011].,OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Available from: http://www.who.int/globalchange/publications/reports/gender_climate_change/en/ [cited 24 June2011] 28.,Non-OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Avail-able from: http://www.undp.org/publications [cited 22 June2011] 29.,Non-OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Availablefrom: http://www.norden.org/no/publikasjoner/publikasjoner/ 2011-527 [cited 21 June 2011].,OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Available from: http://www.barnard.edu/sfonline/ice/print_intro.htm [cited 23 June 2011].,Non-OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Available from: http://www.nikk.no/Men /C27in/C27the/C27 Arctic/C27area/C27hit/C27by/C27climate/C27change.b7C_wlbI2f.ips [cited 25 May 2011].43.,OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
Available from: http://www2.parl.gc.ca/content/lop/re searchpublications/prb0809-e.htm [cited 24 June 2011].,Non-OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
"Available from: http://hdr.undp.org/en/reports/regionalreports/other/ name,3262,en.html [cited 25 May 2011].",OADS,/arxiv_data1/oa_pdf/0f/2d/GHA-4-7913.PMC3179263.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Global Health Action 2011, 4: 5435 - DOI: 10.3402/gha.v4i0.5435",Non-OADS,/arxiv_data1/oa_pdf/c2/78/GHA-4-5435.PMC3179265.pdf
Biological pathway annotations and related data Reactome http://www.reactome.org/ Pathway Commons http://www.pathwaycommons.org/pc/ KEGG PATHWAY—Kyoto Encyclopedia of Genesand Genomes http://www.genome.jp/kegg/pathway.,OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
html  WikiPathways http://www.wikipathways.org/ GO—Gene Ontology http://www.geneontology.org/,Non-OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
utoronto.ca/i2d/ STRING—Search Tool for the Retrieval of InteractingGenes http://string-db.org/ BioGRID—Biological General Repository for Interac-tion Datasets http://thebiogrid.org/ HPRD—Human Protein Reference Database http://www.,OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
hprd.org/ IntAct http://www.ebi.ac.uk/intact/main.xhtml MINT—Molecular INTeraction Database http://mint.,OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
bio.uniroma2.it/IMEx—International Molecular Exchange Consortiumhttp://www.imexconsortium.org/ Gene expression CDIP—Cancer Data Integration Portal http://ophid.,Non-OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
utoronto.ca/cdipOncomine https://www.oncomine.org/ GeneSigDB http://compbio.dfci.harvard.edu/genesigdb/ ArrayExpress http://www.ebi.ac.uk/arrayexpress/ GEO—Gene Expression Omnibus http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
nlm.nih.gov/geo/ Mutations Sanger Cancer Gene Census http://www.sanger.ac.uk/ genetics/CGP/Census/COSMIC—Catalogue of Somatic Mutations in Cancerhttp://www.sanger.ac.uk/resources/databases/cosmic.html Proteomics PRIDE—PRoteomics IDEnti Wcations database http:// www.ebi.ac.uk/pride/ PhosphoSite http://www.phosphosite.org/ microRNAs mirDIP—microRNA Data Integration Portal http://ophid.,OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
"utoronto.ca/mirDIP Network visualization software NAViGaTOR—Network Analysis, Visualization, & Graphing TORonto http://ophid.utoronto.ca/navigator/ Cytoscape http://www.cytoscape.org/Gene function prediction GeneMania http://genemania.org/ Cancer genome initiatives TCGA—The Cancer Genome Atlas http://cancergenome.",OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
"http://www.medsum.info Gautier L, Moller M, Friis-Hansen L, Knudsen S (2004) Alternative mapping of probes to genes for A Vymetrix chips.",OADS,/arxiv_data1/oa_pdf/75/d0/439_2011_Article_983.PMC3179275.pdf
http://www.who.int/tdrold/publications/tdrnews/ news71/schisto.htm.,Non-OADS,/arxiv_data1/oa_pdf/5c/88/S0031182011000412a.PMC3179331.pdf
"In addition, there are no prevalent mutations,but, instead, 415 different allelic variants have been identiﬁed thus far (http://www.dmd.nl).",Non-OADS,/arxiv_data1/oa_pdf/0d/f6/ejhg201170a.PMC3179367.pdf
Bioinformatic software Splice View software was useful to verify the effect of intronic variants onmRNA splicing (http://bioinfo.itb.cnr.it/oriel/splice-view.html).,OADS,/arxiv_data1/oa_pdf/0d/f6/ejhg201170a.PMC3179367.pdf
Conservation analysis was performed using ClustalW2 (http://www.ebi.ac.uk/T ools/clustalw2/ index.html).,OADS,/arxiv_data1/oa_pdf/0d/f6/ejhg201170a.PMC3179367.pdf
"T o assess intronic and exonic mutations leading to splicing defects,the Human Splicing Finder website (http://www.umd.be/SSF/) was consulted.",Non-OADS,/arxiv_data1/oa_pdf/0d/f6/ejhg201170a.PMC3179367.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Marked Dysferlin deﬁciency is primary M Cacciottolo et al 980 European Journal of Human Genetics,Non-OADS,/arxiv_data1/oa_pdf/0d/f6/ejhg201170a.PMC3179367.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work isproperly cited.Human Molecular Genetics, 2011, Vol.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/ddr378.PMC3179379.pdf
http://seer.cancer.gov/csr/ 1975_2008/.,Non-OADS,/arxiv_data1/oa_pdf/d0/b7/ddr378.PMC3179379.pdf
http://www.genome.gov/sequencingcosts/.,OADS,/arxiv_data1/oa_pdf/d0/b7/ddr378.PMC3179379.pdf
"Pro- gress has been facilitated by the availability of phased haplo- type training sets (notably, from the HapMap project: http://hapmap.ncbi.nlm.nih.gov/downloads/phasing) and the ac- companying genotype imputation software (for example, MACH: www.sph.umich.edu/csg/abecasis/MACH/index.htmlor IMPUTE: mathgen.stats.ox.ac.uk/impute/impute_v2.html).",Non-OADS,/arxiv_data1/oa_pdf/aa/70/ddr384.PMC3179381.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work isproperly cited.Human Molecular Genetics, 2011, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/70/ddr384.PMC3179381.pdf
The compilation of an exhaustive list of human genetic variation through the dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP) and HapMap (http://hapmap.ncbi.nlm.nih.gov/)projects is being systematically expanded by the 1000Genomes project (http://www.1000genomes.org).,Non-OADS,/arxiv_data1/oa_pdf/aa/70/ddr384.PMC3179381.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work isproperly cited.Human Molecular Genetics, 2011, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7f/db/ddr386.PMC3179384.pdf
Available at: http://www.asbs.org/ html/pdf/PsychPreSurgicalAssessment.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c2/08/11695_2010_Article_287.PMC3179584.pdf
http://www.cdc.gov/pcd/issues/2009/jul/08 _0150.htm .,Non-OADS,/arxiv_data1/oa_pdf/c2/08/11695_2010_Article_287.PMC3179584.pdf
"In addition, various structural properties of theoriginal and randomized networks can be calculated, facilitating theidentiﬁcation of the salient properties of metabolic networks with abiologically meaningful null model.Availability and Implementation: JMassBalance is implemented in Java and freely available on the web athttp://mathbiol.mpimp-golm.mpg.de/massbalance/.Contact: basler@mpimp-golm.mpg.de Received on May 30, 2011; revised on July 26, 2011; accepted on July 27, 2011 1 INTRODUCTION Network-based studies of biological systems attempt to relate topological properties to biological function.",OADS,/arxiv_data1/oa_pdf/17/ec/btr448.PMC3179655.pdf
"Here, we present a tool which can be run via a graphical user interface (GUI) or from the commandline, and implements mass-balanced randomization of metabolicnetworks provided in one of three standard data formats: (i) BioCyc(http://www.biocyc.org); (ii) Systems Biology Markup Language(SBML, http://sbml.org); or (iii) a customizable text ﬁle format.",OADS,/arxiv_data1/oa_pdf/17/ec/btr448.PMC3179655.pdf
"For instance, when considering the six most abundant elements in biological systems: carbon (C), hydrogen (H), nitrogen (N),oxygen (O), phosphorus (P) and sulfur (S), then the mass vector of waterism H2O=(0,2,0,1,0,0)·(C,H,N,O,P,S)T. The set of considered chemical elements can be speciﬁed in a conﬁguration ﬁle (see Reference Manual,available online at http://mathbiol.mpimp-golm.mpg.de/massbalance/).",Non-OADS,/arxiv_data1/oa_pdf/17/ec/btr448.PMC3179655.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/17/ec/btr448.PMC3179655.pdf
"Hence, an installation is not required, and it can be used onany operating system with installed Java (http://www.oracle.com).",OADS,/arxiv_data1/oa_pdf/17/ec/btr448.PMC3179655.pdf
Availability: GPL source code and a usage tutorial is at http://ngopt.googlecode.comContact: aarondarling@ucdavis.edu Supplementary information: Supplementary data is available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/85/8a/btr451.PMC3179657.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/85/8a/btr451.PMC3179657.pdf
"Onthe BioCreative III test data, the current version of G NAT achieves a T ap-20 score of 0.1987.Availability: The library and web services are implemented in Java and the sources are available from http://gnat.sourceforge.net.Contact: jorg.hakenberg@roche.com Received on May 18, 2011; revised on July 26, 2011; accepted on July 30, 2011 1 INTRODUCTION The extremely rapid growth of published literature in the biological sciences necessitates the constant improvement of automated text-mining tools to extract relevant information and convert it intostructured formats.",Non-OADS,/arxiv_data1/oa_pdf/7f/f6/btr455.PMC3179658.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/7f/f6/btr455.PMC3179658.pdf
[15:12 5/9/2011 Bioinformatics-btr455.tex] Page: 2771 2769–2771GNAT for gene mention normalization service for a set of 10 common model organisms (available at http://gnat.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/7f/f6/btr455.PMC3179658.pdf
"6 CONCLUSION Here we presented the Gnat library for gene name recognition and normalization in biomedical text, now freely available fromSourceForge at http://gnat.sourceforge.net.",OADS,/arxiv_data1/oa_pdf/7f/f6/btr455.PMC3179658.pdf
"Subsequent study of the samples usingquantitative real time polymerase chain reaction (qRT -PCR) of severaldifferential transcription sites identiﬁed by FDM, conﬁrmed signiﬁcantdifferences at these sites.Availability: http://csbio-linux001.cs.unc.edu/nextgen/software/FDM Contact: darshan@email.unc.edu ∗To whom correspondence should be addressed.Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/33/93/btr458.PMC3179659.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/33/93/btr458.PMC3179659.pdf
We ran rDiff.web as provided in http://galaxy.tuebingen.mpg.de/.,OADS,/arxiv_data1/oa_pdf/33/93/btr458.PMC3179659.pdf
"Available at http://www.hpa.org.uk./infections/topics_az/antimicrobial_resistance/amr.pdf, pp.",Non-OADS,/arxiv_data1/oa_pdf/33/93/btr458.PMC3179659.pdf
"Evaluation results showed that, while asupervised machine-learning model yielded the best precision, recalland F1 scores, the other methods achieved reasonable performanceand less cost to develop.Availability: The angiogenesis vocabularies, gold standard corpus, annotation guidelines and software described in this article areavailable at http://text0.mib.man.ac.uk/ ∼mbassxw2/angiogenesis/ Contact: xinglong.wang@gmail.com Received on May 4, 2011; revised on July 5, 2011; accepted on July 31, 2011 1 INTRODUCTION 1.1 Background and motivation Biological processes (i.e.",Non-OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
Their method beneﬁtedfrom the functional annotation of genes in the Gene Ontology (GO)(http://www.geneontology.org/GO.doc.shtml#biological_process).,OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"In order to examine how often angiogenesis bioprocess is expressedin the form of events, we created a corpus of 262 medline abstracts (http://www.nlm.nih.gov/databases/databases_medline.html), where angio-genesis terms and events, as well as several types of bioentities that wereconsidered to closely relate to angiogenesis bioprocess, were manuallyannotated.",OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"While GO and MeSH(http://www.nlm.nih.gov/mesh/) contain branches for biological processes,the information provided for each speciﬁc process is very limited.",OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
We used the Lexical Variants Generation Tool from NIH (http://lexsrv3.nlm.nih.gov/LexSysGroup/Projects/lvg/current/web/) for generating the derivations.,OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"For example, the review articles in the Nature special issue on angiogenesis (DeWitt, 2005) and the Wikipedia page on thissubject (http://en.wikipedia.org/wiki/Angiogenesis) are readily available asangiogenesis-related texts.",Non-OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"We constructed the tissue dictionary using a subset of the UMLS ontology (http://http://www.nlm.nih.gov/research/umls/), which containsthe following branches: body, body parts, organ, tissue, cell and cellcomponents.",OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"UMLS was chosen because it is relatively comprehensiveand integrated a number of biomedical ontology and vocabularies,such as MeSH (http://www.nlm.nih.gov/mesh/) and NCI thesaurus(http://ncit.nci.nih.gov/).",OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
See the additional material to this article(http://text0.mib.man.ac.uk/ ∼mbassxw2/angiogenesis/additional.html) for more discussion on how the parameters αandβaffect the event extraction performance.,Non-OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
Theannotation was carried out using the Callisto tool (http://callisto.mitre.org/)for its relative simplicity to use.,OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"In our experiments, we used CRFSuite (http://www.chokkan.org/software/crfsuite/), a fast implementation of CRF,for tagging the angiogenesis terms and events.",OADS,/arxiv_data1/oa_pdf/f1/67/btr460.PMC3179660.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.a range of deleterious outcomes ( Royal College of Physicians,  2010 ), including increased risk for respiratory problems ( Pattenden  et al., 2006 ; Vork, Broadwin, & Blaisdell, 2007 ), and acute damage  to arterial structures by age 13 ( Kallio et al., 2010 ).",Non-OADS,/arxiv_data1/oa_pdf/bb/4b/ntr093.PMC3179668.pdf
"Retrieved  from SSRN Web site: http://ssrn.com/abstract=919963 Akhtar, P. C., Currie, D. B., Currie, C. E., & Haw, S. J.",OADS,/arxiv_data1/oa_pdf/bb/4b/ntr093.PMC3179668.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/64/kfr176.PMC3179673.pdf
Available at: http://www.apvma.gov.au.,Non-OADS,/arxiv_data1/oa_pdf/66/64/kfr176.PMC3179673.pdf
"Available at: http://www.epa.gov/scipoly/sap/ Accessed Augsut 12, 2011.",OADS,/arxiv_data1/oa_pdf/66/64/kfr176.PMC3179673.pdf
Available at: http://www.epa.gov/scipoly/sap/meetings/2010/091410meeting.html.,OADS,/arxiv_data1/oa_pdf/66/64/kfr176.PMC3179673.pdf
Available at: http://www.fedfocus.org/science/lon- don.html.,Non-OADS,/arxiv_data1/oa_pdf/66/64/kfr176.PMC3179673.pdf
http://www.epa.gov/spc/pdfs/assess2.pdf.,OADS,/arxiv_data1/oa_pdf/66/64/kfr176.PMC3179673.pdf
Available at: http://www.epa.,OADS,/arxiv_data1/oa_pdf/66/64/kfr176.PMC3179673.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/3a/kfr194.PMC3179684.pdf
Randomization and Bowel Preparation Protocol All eligible patients were randomly assigned to ingest one of two preparation regimens using a randomization sche- dule generated by the website http://www.randomization.,Non-OADS,/arxiv_data1/oa_pdf/1d/41/10620_2011_Article_1772.PMC3179840.pdf
5.http://www.gov-book.or.jp/cont ents/pdf/ofﬁcial/96_1.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/0b/22/10620_2011_Article_1679.PMC3179841.pdf
Available: /http://www.goldcopd.org/S.,Non-OADS,/arxiv_data1/oa_pdf/1c/c4/cln-66-10-1797.PMC3180141.pdf
Available from: http://www.who.int/healthinfo/global_burden_disease/Global HealthRisks_report_full.pdf (accessed December 2010).,Non-OADS,/arxiv_data1/oa_pdf/af/69/cln-66-10-1779.PMC3180145.pdf
"We included the Latin American and Caribbean Center on Health Sciences (LILACS, http://bases.bvs.br) and Medline databases (Table 1) in our study.",Non-OADS,/arxiv_data1/oa_pdf/02/e1/cln-66-10-1707.PMC3180146.pdf
Available from: http://www.canola-council.org/pdf/ nutritionalprop.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/36/cln-66-10-1811.PMC3180158.pdf
"Current evidence suggests the involvement of at least 14 distinct loci in autosomal recessive LGMD (http://www.musclegenetable.org).9 LGMD2C – F are autosomal recessive LGMDs, also known as sarcoglycanopathies (SGP), which are caused by mutations in the genes encoding the c-,a-,b-, and d-sarcoglycan proteins (SG), respectively.10-13The SGs are glycosylated proteins with single transmembrane domains,14and correct assembly of the sarcoglycan complex is required for the maintenance of the sarcolemma.15,16Together with sarco- span, dystrophin, dystroglycans, syntrophins, and a-dystro- brevin, the SGs constitute the dystrophin-glycoprotein complex (DGC).17The DGC acts as a link between the muscle cell cytoskeleton and the extracellular matrix, providing mechanical support for the plasma membrane during myofiber contraction.14,18The function of the SGs is not fully understood, but they appear to play both mechan- ical and non-mechanical roles that mediate interactions among the extracellular matrix, the sarcolemma and the cytoskeleton.19,20A primary mutation in any one of the sarcoglycan genes ( a,b,cord) can lead to the total or partial loss of that sarcoglycan, secondary deficiencies of the other sarcoglycans and the occasional reduction of dystrophin labeling in muscle tissue.21Inter- and intra-familial hetero- geneity is frequent.22Mutations in the gene for a-sarcoglycan are the most common sarcoglycan mutations, whereas mutations in d-sarcoglycan are the rarest.23 The phenotypes of the sarcoglycanopathies overlap with the dystrophinopathies with the important distinction that the learning disability specifically associated with Duchenne’s is not present, and scapular winging is more frequent in SGPs.6,9,22,24 Some studies have shown distinct patterns of sarcoglycan expression and labeling in various SGPs,1,14,16,24but we believe that further studies are required to obtain more conclusive information because the characteristics of each population vary greatly.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-66-10-1713.PMC3180160.pdf
Available from: http://www.who.int/child_adolescent/Neu_publications/the Lancet_paper1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/62/9a/cln-66-10-1773.PMC3180163.pdf
Available from: http://www.who.int/bulletin/volumes/88/1/08-062554/en/.,Non-OADS,/arxiv_data1/oa_pdf/62/9a/cln-66-10-1773.PMC3180163.pdf
Available from: http://www.portalmedico.org.br/ cbhpm/CBHPM_2005.pdf.,OADS,/arxiv_data1/oa_pdf/62/9a/cln-66-10-1773.PMC3180163.pdf
Available from: http://www.connectmed.com.br/amb/novo/inst_ Table.php3.,OADS,/arxiv_data1/oa_pdf/62/9a/cln-66-10-1773.PMC3180163.pdf
Available from: http://w3.datasus.,OADS,/arxiv_data1/oa_pdf/62/9a/cln-66-10-1773.PMC3180163.pdf
Available from: http://genderstats.worldbank.org.,Non-OADS,/arxiv_data1/oa_pdf/62/9a/cln-66-10-1773.PMC3180163.pdf
[cited 2009 Jan 20] Available from: http://www.nccmerp.org.,OADS,/arxiv_data1/oa_pdf/e4/ee/cln-66-10-1691.PMC3180166.pdf
Available from: https://ismp.org/Tools/ highalertmedications.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/ee/cln-66-10-1691.PMC3180166.pdf
[Cited em: 2010 Jun 18] Available from: http://www.anvisa.gov.br/e-legis/ resol/10.,Non-OADS,/arxiv_data1/oa_pdf/e4/ee/cln-66-10-1691.PMC3180166.pdf
Available at: http://www.ccac.ca/en/ CCAC_Programs/Guidelines_Policies/GUIDES/SPANISH/toc_v1.htm.,Non-OADS,/arxiv_data1/oa_pdf/4f/c3/cln-66-10-1787.PMC3180168.pdf
"To date, no fewer than six high-throughput screens of epigenetic targets have been per- formed with more than 200,000 compounds and published  on the open-access PubChem database (http://pubchem.ncbi.",OADS,/arxiv_data1/oa_pdf/8c/02/TOCHGENJ-5-95.PMC3180180.pdf
beads are commercially available (http://las.perkinelmer.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/TOCHGENJ-5-95.PMC3180180.pdf
The high failure rate prompted the authors to create a website for posting these and new results of antibody specificity tests for the detection of epigenetic  marks (http://compbio.med.harvard.edu/antibodies/).,Non-OADS,/arxiv_data1/oa_pdf/8c/02/TOCHGENJ-5-95.PMC3180180.pdf
"[cited 2011  Jan]; Available from: http://www.biocius.com/pdfs/RapidFire  HTMS_EpigeneticTargets_Poster.pdf  [36] Ong SE, Blagoev B, Kratchmarova I, et al.",OADS,/arxiv_data1/oa_pdf/8c/02/TOCHGENJ-5-95.PMC3180180.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/02/TOCHGENJ-5-95.PMC3180180.pdf
"Ingenuity Pathway Analysis (IPA; Ingenuity® Systems, http://www.ingenuity.com )v e r - sion 7.5 was used to identify pathways, networks, and for gene list matching to published datasets of genes involved in specific transcription regulation systems (Mef2, cAMPresponse element [CRE], and GR).",OADS,/arxiv_data1/oa_pdf/cd/1c/213_2011_Article_2313.PMC3180555.pdf
Available at http://www.cdc.gov/hiv/topics/surveillance/ resources/factsheets/pdf/incidence.pdf Accessed 1 July 2009.,Non-OADS,/arxiv_data1/oa_pdf/8e/34/10461_2010_Article_9812.PMC3180557.pdf
Available from http://www.wpro.who.int/internet/ resources.ashx/HSI/docs/100CUP(China)2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/34/10461_2010_Article_9812.PMC3180557.pdf
Available from http://www.wpro.who.int/ publications/pub_9290610921.htm .,Non-OADS,/arxiv_data1/oa_pdf/8e/34/10461_2010_Article_9812.PMC3180557.pdf
Available from http://www.wpro.who.int/internet/resources.,OADS,/arxiv_data1/oa_pdf/8e/34/10461_2010_Article_9812.PMC3180557.pdf
Available from http://www.wpro.who.int/ internet/resources.ashx/HSI/report/MtgRep_UNFPA_WHO_100 CUP.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/34/10461_2010_Article_9812.PMC3180557.pdf
"The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine athttp://www.plosmedicine.org/ , Annals of Internal Medicine at http://www.annals.org/ , and Epidemiology at http://www.epidem.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/c5/787_2011_Article_201.PMC3180558.pdf
"ICH Efﬁcacy Guidelines EG (R1): Good Clinical Practice con- solidated guidelines, http://ich.org/cache/compo/475-175.html 22.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/280_2011_Article_1572.PMC3180559.pdf
"The revised common toxicity criteria: version 20, http://ctep.info.nih.gov 26.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/280_2011_Article_1572.PMC3180559.pdf
http://ccf.buffalo.edu/pdf/MedAsses.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0a/ed/787_2011_Article_206.PMC3180560.pdf
http://vrosario.bol.ucla.edu/forms/snapIV.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0a/ed/787_2011_Article_206.PMC3180560.pdf
World Health Organization Medica Center ‘‘Cancer’’ 2011. http://www.who.int/mediacentre/factsheets/fs297/en/ .,Non-OADS,/arxiv_data1/oa_pdf/bb/3e/10434_2011_Article_1960.PMC3180563.pdf
http://www3.ha.org.hk/can cereg/default.asp .,Non-OADS,/arxiv_data1/oa_pdf/bb/3e/10434_2011_Article_1960.PMC3180563.pdf
25.http://www.cancerstaging.org .,Non-OADS,/arxiv_data1/oa_pdf/bb/3e/10434_2011_Article_1960.PMC3180563.pdf
2004. http://www.censtatd.gov.hk/products_and_ services/products/publications/statistical_report/population_and_ vital_events/index_cd_B112001604_dt_detail.jsp .,OADS,/arxiv_data1/oa_pdf/bb/3e/10434_2011_Article_1960.PMC3180563.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 163Parastomal Hernia-the Achilles Heel of a Permanent  Colostomy Suk-Hwan Lee Department of Surgery, Kyung Hee University School of Medicine, Seoul, Korea Editorial  J Korean Soc Coloproctol 2011;27(4):163-164 http://dx.doi.org/10.3393/jksc.2011.27.4.163 the paper; the authors did not use mesh repair for emergency  cases.",Non-OADS,/arxiv_data1/oa_pdf/3a/08/jksc-27-163.PMC3180594.pdf
"Department of Surgery, Kyung Hee University Hostpital at Gangdong,  Kyunghee University School of Medicine, 149 Sangil-dong, Gangdong-gu,  Seoul 134-727, Korea Tel: +82-2-440-6134, Fax: +82-2-440-6295 E-mail: leeshdr@khu.ac.kr © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/08/jksc-27-163.PMC3180594.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 165Condition for Good Quality of Life after Surgery for Slow  Transit Constipation Yong Hee Hwang Department of Surgery, Sahmyook Medical Center, Seoul, KoreaEditorial  J Korean Soc Coloproctol 2011;27(4):165 http://dx.doi.org/10.3393/jksc.2011.27.4.165 with the author’s opinion, and I think a total abdominal colec - tomy can be recommended to patients with well-established  colonic inertia.",Non-OADS,/arxiv_data1/oa_pdf/53/14/jksc-27-165.PMC3180595.pdf
"Department of Sugery, Sahmyook Medical Center, 29-1 Hwigyeong 2-dong,  Dongdaemun-gu, Seoul 130-71 1, Korea Tel: +82-2-2210-3563, Fax: +82-2-2212-2673 E-mail: hwangyon@hotmail.com © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/14/jksc-27-165.PMC3180595.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 166Management of Colorectal Trauma Won Jun Choi Department of Surgery, Konyang University College of Medicine, Daejeon, KoreaReview J Korean Soc Coloproctol 2011;27(4):166-173 http://dx.doi.org/10.3393/jksc.2011.27.4.166 Although the treatment strategy for colorectal trauma has advanced during the last part of the twentieth century and the  result has improved, compared to other injuries, problems, such as high septic complication rates and mortality rates, still  exist, so standard management for colorectal trauma is still a controversial issue.",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/jksc-27-166.PMC3180596.pdf
"Department of Surgery, Konyang University College of Medicine,   685 Gasuwon-dong, Seo-gu, Daejeon 302-718, Korea Tel: +82-42-600-8956, Fax: +82-42-543-8956 E-mail: cwj@kyuh.co.kr © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/jksc-27-166.PMC3180596.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 174Surgical Treatment of a Parastomal Hernia Seung Chul Heo, Heung-Kwon Oh1, Yoon Suk Song1, Mi Sun Seo1, Eun Kyung Choe2, Seungbum Ryoo3,  Kyu Joo Park1 Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul; 1Department of Surgery,  Seoul National University Hospital, Seoul; 2Seoul National University Hospital Health Care System Kangnam Center, Seoul; 3Department of  Surgery, Dongnam Institute of Radiological and Medical Sciences, Busan, KoreaOriginal Article J Korean Soc Coloproctol 2011;27(4):174-179 http://dx.doi.org/10.3393/jksc.2011.27.4.174 Purpose:  Parastomal hernia is a major complication of an intestinal stoma.",Non-OADS,/arxiv_data1/oa_pdf/da/bf/jksc-27-174.PMC3180597.pdf
"Department of Surgery, Seoul National University College of Medicine,   28 Yeongeon-dong, Jongno-gu, Seoul 1 10-744, Korea Tel: +82-2-2072-2901, Fax: +82-2-766-3975 E-mail: kjparkmd@plaza.snu.ac.kr © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/bf/jksc-27-174.PMC3180597.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 180Surgical Outcomes after Total Colectomy with Ileorectal  Anastomosis in Patients with Medically Intractable Slow  Transit Constipation Guiyun Sohn, Chang Sik Yu, Chan Wook Kim, Jae Young Kwak, Tae Young Jang, Kyung Ho Kim,   Song Soo Yang, Yong Sik Yoon, Seok-Byung Lim, Jin Cheon Kim Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaOriginal Article J Korean Soc Coloproctol 2011;27(4):180-187 http://dx.doi.org/10.3393/jksc.2011.27.4.180 Purpose:  The aim of this study was to evaluate outcomes of a total colectomy with ileorectal anastomosis in patients with slow  transit constipation.",Non-OADS,/arxiv_data1/oa_pdf/67/2a/jksc-27-180.PMC3180598.pdf
"Department of Colon and Rectal Surgery, Asan Medical Center, University of  Ulsan College of Medicine, 388-1 Pungnap 2-dong, Songpa-gu, Seoul   138-736, Korea Tel: +82-2-3010-3494, Fax: +82-2-3010-6701 E-mail: csyu@amc.seoul.kr © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/2a/jksc-27-180.PMC3180598.pdf
":   A Prospective Study Tae Jung Kim, In Kyu Lee, Jong Kyung Park, Yoon Suk Lee, Youn Si, Hun Jung, Hyung Jin Kim,   Sang Chul Lee, Dae Young Cheung1, D. Lee Gorden2, Seung Taek Oh  Departments of Surgery and 1Internal Medicine, The Catholic University of Korea School of Medicine, Seoul, Korea; 2Department of Surgery,  Vanderbilt University Medical Center, Nashville, TN, USAOriginal Article J Korean Soc Coloproctol 2011;27(4):188-193 http://dx.doi.org/10.3393/jksc.2011.27.4.188 Purpose:  The goals of this study were to identify whether conservative treatment with antibiotics in right colonic divertic - ulitis (RCD) patients, our empirical method used until now, is adequate and to determine how the natural history of RCD  is affected by conservative treatment.",Non-OADS,/arxiv_data1/oa_pdf/9e/f8/jksc-27-188.PMC3180599.pdf
"Department of Surgery, Yeouido St. Mary’s Hospital, The Catholic University  of Korea School of Medicine, 62 Yeouido-dong, Yeongdeungpo-gu, Seoul  150-713, Korea Tel: +82-2-3779-2235, Fax: +82-2-786-0802 E-mail: cmcgslee@catholic.ac.kr © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/f8/jksc-27-188.PMC3180599.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 194Value and Interpretation of Resection Margin after   a Colonoscopic Polypectomy for Malignant Polyps Eun Jung Jang, Dae Dong Kim, Chang Ho Cho1 Colorectal Clinic, Department of Surgery, 1Department of Pathology, Daegu Catholic University Medical Center, Catholic University of Daegu  College of Medicine, Daegu, KoreaOriginal Article J Korean Soc Coloproctol 2011;27(4):194-201 http://dx.doi.org/10.3393/jksc.2011.27.4.194 Purpose:  This study was designed to compare the clinicopathologic findings of an endoscopic polypectomy for malignant  polyps with subsequent surgery and to evaluate the appropriateness of the pathologic finding criterion of the resection mar - gin as an indicator for surgery in cases of malignant colorectal polyps.",Non-OADS,/arxiv_data1/oa_pdf/c0/76/jksc-27-194.PMC3180600.pdf
"Colorectal Clinic, Department of Surgery, University of Daegu Catholic  Medical Center, 3056-6 Daemyung 4-dong, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4065, Fax: +82-53-624-7185 E-mail: silverpop@daum.net © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/76/jksc-27-194.PMC3180600.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 202Clinical Applications of Radio-Frequency Ablation   in Liver Metastasis of Colorectal Cancer Ji Hun Gwak, Bo-Young Oh, Ryung Ah Lee, Soon Sup Chung, Kwang Ho Kim Department of Surgery, Ewha Womans University School of Medicine, Seoul, KoreaOriginal Article J Korean Soc Coloproctol 2011;27(4):202-210 http://dx.doi.org/10.3393/jksc.2011.27.4.202 Purpose:  The aim of this study is to evaluate long-term survival and prognostic factors for radio-frequency ablation (RFA)  in colorectal liver metastases.",Non-OADS,/arxiv_data1/oa_pdf/28/39/jksc-27-202.PMC3180601.pdf
"Department of Surgery, Ewha Womans University School of Medicine,   Mok 5-dong, Yangcheon-gu, Seoul 158-710, Korea Tel: +82-2-2650-5585, Fax: +82-2-2644-7984 E-mail: eastgate@ewha.ac.kr © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/39/jksc-27-202.PMC3180601.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 211A Case of Successful Colonoscopic Treatment of Colonic  Obstruction Caused by Phytobezoar Sang Seok Yoon, Min Seong Kim, Dong Yoon Kang, Tack Su Yun, Jun Ho Jeon, Yong Kyu Lee,   Se Woong Choi, Chi Hoon Kim Department of Internal Medicine, Good Gang-An Hospital, Busan, KoreaCase Report J Korean Soc Coloproctol 2011;27(4):211-214 http://dx.doi.org/10.3393/jksc.2011.27.4.211 A phytobezoar is the most common type of bezoar, which is a gastrointestinal mass composed of vegetable.",Non-OADS,/arxiv_data1/oa_pdf/20/6b/jksc-27-211.PMC3180602.pdf
"Department of Internal Medicine, Good Gang-An Hospital,   40-1 Namcheon-dong, Suyeong-gu, Busan 613-815, Korea Tel: +82-51-610-9615, Fax: +82-51-621-1500 E-mail: orga001@gmail.com © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/6b/jksc-27-211.PMC3180602.pdf
"pISSN 2093-7822   eISSN 2093-7830 www.coloproctol.orgJournal of the Korean Society of Coloproctology www.coloproctol.org 215A Case of Endoscopic Resection of a Colonic  Semipedunculated Leiomyoma Seung Hwa Lee, Gun Yoong Huh1, Yoo Seock Cheong Health Promotion Center, Dankook University College of Medicine, Cheonan; 1Department of Surgery, Osan Hankook Hospital, Osan, Korea Case Report J Korean Soc Coloproctol 2011;27(4):215-219 http://dx.doi.org/10.3393/jksc.2011.27.4.215 During colonoscopic examination, epithelial lesions, such as adenomatous polyps, are frequently encountered, unlike sub - epithelial lesions, such as leiomyomas, which are uncommon.",Non-OADS,/arxiv_data1/oa_pdf/97/af/jksc-27-215.PMC3180603.pdf
"Health Promotion Center, Dankook University College of Medicine,   San16-5 Anseo-dong, Dongnam-gu, Cheonan 330-715, Korea Tel: +82-41-550-6385, Fax: +82-41-550-3998 E-mail: drloved@hanmail.net © 201 1 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/af/jksc-27-215.PMC3180603.pdf
http://www.cdc.gov/hiv/topics/women/resources/factsheets/pdf/ women.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8a/cc/10461_2010_Article_9840.PMC3180610.pdf
"Retrieved April 1, 2008, from http://www.aapor.org/uploads/ standarddefs_4.pdf .",Non-OADS,/arxiv_data1/oa_pdf/2a/a6/10508_2010_Article_9644.PMC3180617.pdf
"Retrieved July 10,2009, from http://www.cbs.nl/nl-NL/menu /themas/vrije-tijd-cultuur/ publicaties/artikelen/archief/2008/2008-2641-wm.htm .",Non-OADS,/arxiv_data1/oa_pdf/2a/a6/10508_2010_Article_9644.PMC3180617.pdf
http://www.phac-aspc.gc.ca/hepc/pubs/pcs- rep/youthco-eng.php .,Non-OADS,/arxiv_data1/oa_pdf/7b/95/10461_2010_Article_9876.PMC3180618.pdf
"Ampliﬁcation was performed on genomic DNA eitherobtained from the Global Musa Genomics Consortium(GMGC, http://www.musagenomics.org ) for ‘Tani’ (ITC.",OADS,/arxiv_data1/oa_pdf/c2/af/425_2011_Article_1421.PMC3180632.pdf
Trees were visual- ized using the njplot freeware ( http://pbil.univ-lyon1.fr/ software/njplot.html ).,OADS,/arxiv_data1/oa_pdf/c2/af/425_2011_Article_1421.PMC3180632.pdf
"Sequences used for phylogenetic analysis either originated from this work or from publicly available databases (National Center for BiotechnologyInformation, http://www.ncbi.nih.gov ).",OADS,/arxiv_data1/oa_pdf/c2/af/425_2011_Article_1421.PMC3180632.pdf
A full gel image for ‘Cachaco’ meristems can be found at http://www.pdata.ua.ac.be/musaPlanta (2011) 234:785–798 793 123,Non-OADS,/arxiv_data1/oa_pdf/c2/af/425_2011_Article_1421.PMC3180632.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is properly cited.doi:10.1093/eurpub/ckq115 Advance Access published on 26 August 2010",Non-OADS,/arxiv_data1/oa_pdf/0f/de/ckq115.PMC3180633.pdf
"Available at: http://www.who.int/hiv/HIVCP_RUS.pdf (22 November 2009, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0f/de/ckq115.PMC3180633.pdf
"Available at: http://www.afew.org (22 November 2008, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/0f/de/ckq115.PMC3180633.pdf
"Available at: http://apps.who .int/globalatlas/predefinedReports/EFS2008/full/EFS2008_RU.pdf (18 June 2010, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0f/de/ckq115.PMC3180633.pdf
"Available at: http://www.cdc.gov/nchstp/od/GAP/docs/surveillance (30 September 2009, date last accessed).",OADS,/arxiv_data1/oa_pdf/0f/de/ckq115.PMC3180633.pdf
"Available at: http://data.unaids.org/pub/EPISlides/2006/Statement_BED_Policy_13Dec05_en.pdf(30 September 2009, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0f/de/ckq115.PMC3180633.pdf
"Available at:http://www.iom.edu/Object.File/Master/37/074/11731_brief.pdf (13 March 2007, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/0f/de/ckq115.PMC3180633.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/be/ckq185.PMC3180634.pdf
Medscape Psychiatry Mental Health http://cme.medscape.,Non-OADS,/arxiv_data1/oa_pdf/40/89/787_2011_Article_203.PMC3180635.pdf
"Retrieved June 29, 2010, from http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2006/default.asp .",OADS,/arxiv_data1/oa_pdf/fa/e4/10508_2011_Article_9779.PMC3180636.pdf
"Retrieved June 29, 2010, from http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2008/2008_Global_report.asp .",OADS,/arxiv_data1/oa_pdf/fa/e4/10508_2011_Article_9779.PMC3180636.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):281-287 http://dx.doi.org/10.4162/nrp.2011.5.4.281 Antioxidant activity and analysis of proanthocyanidins from pine ( Pinus densiflora )  needles Yong Soo Park1, Min Hee Jeon1, Hyun Jung Hwang1, Mi Ra Park1, Sang-Hyeon Lee2, Sung Gu Kim3 and Mihyang Kim1§ 1Department of Food and Nutrition, Silla University, 140 Baegyang-daero 700beon-gil, Sasang-gu, Busan 617-736, Korea 2Department of Bioscience and Biotechnology, Silla University, Busan 617-736, Korea 3Bioport Korea Co., Marine Bio-industry Development Center, Busan 619-912, Korea Abstract In this study, we evaluated the antioxidant activity of pine needle extracts prepared with hot water, ethanol, hexane, hot wate r-hexane (HWH),  and hot water-ethanol (HWE), using the DPPH (1,1-diphenyl-2-picrylhydrazyl) radical method.",Non-OADS,/arxiv_data1/oa_pdf/05/61/nrp-5-281.PMC3180677.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):288-293 http://dx.doi.org/10.4162/nrp.2011.5.4.288 Radish ( Raphanus  sativus  L. leaf) ethanol extract inhibits protein and mRNA expressio n of ErbB 2 and ErbB 3 in MDA-MB-231 human breast cancer cells Woo Kyoung Kim1, Ji Hae Kim1, Da Hee Jeong2, Young Hee Chun2, Sun Hee Kim2, Kang Jin Cho3 and  Moon-Jeong Chang2§ 1Department of Food Science and Nutrition, Dankook University, Gyeonggi 448-701, Korea  2Department of Food and Nutrition, Kookmin Unive rsity, 861-1 Chongneung-dong, Sungbuk-gu, Seoul 136-702, Korea 3Functional Food and Nutrition Division, Rural National Academy of Agricultural Science, Suwon 441-707, Korea Abstract In this study, we investigated the effects of the ethanol extract of aerial parts of Raphanus sativus  L. (ERL) on breast cancer cell proliferation  and gene expression associated with cell proliferation and apoptosis in MDA-MB-231 human breast cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/0d/ee/nrp-5-288.PMC3180678.pdf
Available from: http://ncc.re.kr/common/downloadByNTC.jsp?attnum=232&code=999_101.,OADS,/arxiv_data1/oa_pdf/0d/ee/nrp-5-288.PMC3180678.pdf
Available from: http://knhanes.cdc.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/0d/ee/nrp-5-288.PMC3180678.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):294-300 http://dx.doi.org/10.4162/nrp.2011.5.4.294 Effects of Takju intake and moderate exercise training on brain acetylcholinesterase  activity and learning ability in rats Boram Kim, Hyun-Jung Yang, Moon-Jeong Chang and Sun-Hee Kim§ Department of Foods and Nutrition, Kookmin Unive rsity, 861-1 Jeongneung-dong, Seongbuk-gu, Seoul 136-702, Korea Abstract Takju  is a Korean alcoholic beverage made from rice, and is brewed with the yeast Saccharomyces cerevisiae.",Non-OADS,/arxiv_data1/oa_pdf/e4/00/nrp-5-294.PMC3180679.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):301-307 http://dx.doi.org/10.4162/nrp.2011.5.4.301 Hypolipidemic and hypoglycemic effects of Orostachys japonicus  A. Berger extracts in streptozotocin-induced diabetic rats Soo Jung Lee, Gui Fang Zhang and Nak Ju Sung§ Department of Food and Nutrition, Institute of Agriculture and Life Science, Gyeongsang National University, 501 Jinjudaero,  Jinju, Gyungnam 660-701, Korea Abstract The hypolipidemic and hypoglycemic effects of two dietary dosages (0.1% and 0.5%) of water and 80% ethanol extracts from hot-ai r dried Orostachy s japonicus  A. Berger were evaluated in the serum and organ tissues of streptozotocin-induced diabetic rats.",Non-OADS,/arxiv_data1/oa_pdf/da/3f/nrp-5-301.PMC3180680.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):308-312 http://dx.doi.org/10.4162/nrp.2011.5.4.308 Association of infant feeding practices in the general population with infant growth an d stool characteristics Youngshin Han1, Eun-Young Chang1, Jihyun Kim1, Kangmo Ahn1, Hye-Young Kim2, Eun-Mi Hwang3, Dianne Lowry4, Colin Prosser4§ and Sang-Il Lee1 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea  2Department of Pediatrics, Medical Research Institute, Pusan National University College of Medicine, Pusan 602-739, Korea 3Department of Customer Service, Il Dong Foodis, Seoul 143-712, Korea 4Department of R&D, Dairy Goat Co-operative (N.Z.)",Non-OADS,/arxiv_data1/oa_pdf/f0/42/nrp-5-308.PMC3180681.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):313-321 http://dx.doi.org/10.4162/nrp.2011.5.4.313 A study of consumers’ perceptions and prediction of consumption patterns for generic  health functional foods Nam E Kang1, Ju Hyeon Kim2, Yeon Kyoung Lee3, Hye Young Lee4 and Woo Kyoung Kim5§ 1Department of Food and Nutrition, Eulji University, Seongnam, Gyunggi 461-723, Korea  2Major of Hotel Culinary Art, Department of Tourism Information Management, Dong Seoul College, Seongnam, Gyunggi 461-714, Korea  3Food Standardization Division, Food Standardization Department,  Food Safety Bureau, Korea Food & Drug Administration,  Osong Health Technology Administration Complex, Chungcheong 363-951, Korea 4Functional Food Standardization Division, Food Standardizati on Department, Food Safety Bureau, Korea Food & Drug  Administration, Osong Health Technology Administration Complex, Chungcheong 363-951, Korea 5Department Food Science and Nutrition, Dankook University, 126 Jukjeon-dong, Suji-gu, Yongin, Gyunggi 448-701, Korea  Abstract The Korea Food and Drug Administration (KFDA) revised the Health Functional Food Act in 2008 and extended the form of health fu nctional foods to general food types.",Non-OADS,/arxiv_data1/oa_pdf/c5/4f/nrp-5-313.PMC3180682.pdf
Available from: http://hfoodi.kfda.go.kr/material/material.jsp?cate Idx=57.,Non-OADS,/arxiv_data1/oa_pdf/c5/4f/nrp-5-313.PMC3180682.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):322-328 http://dx.doi.org/10.4162/nrp.2011.5.4.322 Evaluation of dietary quality of adolescents using Healthy Eating Index Nilufer Acar Tek§, Hilal Yildiran, Gamze Akbulut, Saniye Bi lici, Eda Koksal, Makbule Gezmen Karadag an d Nevin Sanl ıer Department of Nutrition and Dietetics Besevler, Gazi University Faculty of Health Sciences, Ankara, Turkey Abstract The aim of this study was to use the Healthy Eating Index-2005 (HEI-2005) to assess diet quality and determine the relationship  between the  HEI-2005 and the energy and nutrient intakes of adolescents.",Non-OADS,/arxiv_data1/oa_pdf/06/b8/nrp-5-322.PMC3180683.pdf
[accessed 8 October 2010] Available from: ftp://ftp.fao.org/es/esn/nutrition/ncp/turmap.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/b8/nrp-5-322.PMC3180683.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):329-336 http://dx.doi.org/10.4162/nrp.2011.5.4.329 Comparison of the dietary intake and clinical characteristics of obese and normal  weight adults Kyeong Jin Jeon1, Okeui Lee2, Hye-Kyeong Kim3 and Sung Nim Han1,4§ 1Department of Food and Nutrition, College of Human Ecology, Seoul National University, Gwanak-ro, Gwanak-gu, Seoul 151-742,  Korea 2Seoul National University Health Service Center, Seoul 151-742, Korea  3Department of Food Science and Nutrition, The Catholic University of Korea, Bucheon 420-743, Korea 4Human Ecology Research Institute, Seoul National University, Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea Abstract Obesity contributes to an increased risk for chronic diseases, including diabetes, cardiovascular diseases, and certain types o f cancer.",Non-OADS,/arxiv_data1/oa_pdf/27/40/nrp-5-329.PMC3180684.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):337-348 http://dx.doi.org/10.4162/nrp.2011.5.4.337 Utilizing the Health Belief Model to predicting female middle school students’ behavioral intention of weight reduction by weight status Dong-Yean Park§ Department of Home Economics Education, College of E ducation, Dongguk University, 707 Sekjang-dong, Gyeongju 780-714,  Korea Abstract Weight reduction behavior is common among adolescent girls.",Non-OADS,/arxiv_data1/oa_pdf/fc/d6/nrp-5-337.PMC3180685.pdf
Available from: http://www.korea.kr/expdoc/view,Non-OADS,/arxiv_data1/oa_pdf/fc/d6/nrp-5-337.PMC3180685.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):349-356 http://dx.doi.org/10.4162/nrp.2011.5.4.349 Anti-doping education and dietary supplementation practice in Korean elite university athletes Jongkyu Kim1, Namju Lee1§, Eung-Joon Kim2, Sun-kyung Ki1, Jaeryang Yoon1 and Mi-sook Lee1 1Sports Science Institute, Korea National Sport Univ ersity, 88-15 Oryun-dong, Songpa-gu, Seoul 138-763, Korea  2Department of Physical Education, College of Phys ical Education, Kyonggi University, Suwon 443-760, Korea Abstract This study was conducted to investigate relationships and gender differences in dietary supplement (DS) and oriental supplement  (OS) prevalence as well as anti-doping awareness during training and the game pe riod.",Non-OADS,/arxiv_data1/oa_pdf/48/14/nrp-5-349.PMC3180686.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):357-364 http://dx.doi.org/10.4162/nrp.2011.5.4.357 Demographic and lifestyle factors and selenium levels in men and women in the U.S. Kyong Park1§, Eric Rimm2,3,4, David Siscovick5, Donna Spiegelman2,6, J. Steven Morris7 and Dariush Mozaffarian2,3,4,8 1Department of Food & Nutrition, Yeungnam Unive rsity, Dae-dong, Gyeongsan, Gyeongbuk 712-749, Korea 2Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA 3Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA 4Channing Laboratory, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA 5Cardiovascular Health Research Unit, Departments of Medicine and Epidemiology, University of Washington, Seattle, WA 98101, USA 6Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA 7University of Missouri Research Reactor, Columbia, MO and Harry S Truman Memorial Veterans Hospital, Columbia, MO  65211, USA 8Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School,  Boston, MA 02115, USA Abstract Selenium is an antioxidant trace element linked to cardiovascular disease and cancer.",Non-OADS,/arxiv_data1/oa_pdf/43/32/nrp-5-357.PMC3180687.pdf
"Short CommunicationNutrition Research and Practice ( Nutr Res Pract ) 2011;5(4):365-369 http://dx.doi.org/10.4162/nrp.2011.5.4.365 Renoprotective and antioxidant effects of  Saururus chinensis  Baill in rats fed a  high-fructose diet Ha-Neul Choi1, Yong-Hyun Park2, Ji-Hye Kim1, Min-Jung Kang1, Soo-Mi Jeong1, Hyeon Hoe Kim2 and Jung-In Kim1§ 1School of Food and Life Science, Inje University, 607 Obang-dong, Gimhae, Gyungnam 621-749, Korea  2Department of Urology, Seoul National University College of Medicine and Clinical Research Institute, Seoul National University   Hospital, Seoul 110-744, Korea Abstract This study investigated the preventive effect of Saururus chinensis  Baill against renal damage induced by a high-fructose diet in rats.",Non-OADS,/arxiv_data1/oa_pdf/4a/2a/nrp-5-365.PMC3180688.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 11, 16 May 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101421, ijic2011-18Copyrig ht:  Submitted: 4 October 2010, revised 26 November 2010, accepted 28 December 2010 Policy Vol 11, Special 10th Anniversary Edition Divergent modes of integration: the Canadian way Izzat Jiwani, PhD, Health Policy Researcher and Management Consultant, IMJ Management Inc. Suite 2801–78 Harrison  Garden Boulevard, North York, Ontario, M2N 7E2, Canada Marie-Josée Fleury, PhD, Associate Professor, Department of Psychiatry, McGill University, Douglas Mental Health  University Institute Research Centre, 6875 LaSalle Blvd.",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ of services, professional or physician integration,  and organisational or relationships between different organisations [1, 7, 8].",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3payer (public) system, they retained clinical autonomy  and control over the administration and location of their  practices.",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ and long-term hospitals were merged into 95 health  and social services centres (CSSS, Centres de santé  et de services sociaux ).",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5imply more training for professionals and patients (i.e.",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ Local Health Integration Networks).",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  7sionals, such as social workers, mental health coun- sellors, dieticians, and pharmacists [45].",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ facilitator of the health system.",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  9limited power of the virtual partnerships among the  regional agencies in both the provinces is problematic in achieving full integration, albeit more so in Ontario than Quebec.",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from: http://www.hsmc.bham.ac.uk/news/ pdfs/Altogether_Now_Report.pd f.   4.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from:http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 10International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ 13.",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from: http://www.healthcouncilcanada.ca/teamsinaction.pd f. 22.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"International Journal of Integrated Care  – Volume 11, 16 May – URN:NBN:NL:UI:10-1-101421/ijic2011-18 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  1137.",Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from: http://www.health.gov.on.ca/transformation/ fht/guides/fht_inter_team.pd f. 46.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
Available from:  http://www.healthforceontario.ca/HealthcareInOntario/PrimaryCare.asp x.,Non-OADS,/arxiv_data1/oa_pdf/c2/cc/ijic2011-2011018.PMC3180698.pdf
"Volume 11, 24 May 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101448, ijic2011-20Copyrig ht:  Letter to the editor Vol 11, Special 10th Anniversary Edition PRISMA: a good example of transferring research evidence  into public policy Dear Editor, The paper by Vedel et al.",Non-OADS,/arxiv_data1/oa_pdf/34/05/ijic2011-2011020.PMC3180699.pdf
"11, 24 May – URN:NBN:NL:UI:10-1-101448/ijic2011-20 – http://www.ijic.org/ References 1.",Non-OADS,/arxiv_data1/oa_pdf/34/05/ijic2011-2011020.PMC3180699.pdf
"11, 24 May – URN:NBN:NL:UI:10-1-101448/ijic2011-20 – http://www.ijic.org/   8.",Non-OADS,/arxiv_data1/oa_pdf/34/05/ijic2011-2011020.PMC3180699.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/34/05/ijic2011-2011020.PMC3180699.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 1Volume 11, 25 July 2011 Publisher: Igitur publishing URL:http://www.ijic.org URN:NBN:NL:UI:10-1-101517 / ijic2011-80Copyrig ht:  Submitted: 20 January 2011, revised 6 June 2011, accepted 8 June 2011 Research and Theory Vol 11, Special 10th Anniversary Edition Buffer management to solve bed-blocking in the Netherlands  2000–2010.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 2International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ constraints and then taking measures to manage them  properly.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  3 Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 4International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ Investigating the tenability   of the objections: methods   and results Van Hartingsveldt [7] conducted three small case stud- ies to further explore care providers’ beliefs about BM  (regarding both the sub-processes and the chain as a whole) and to investigate whether or not providers held the four negative beliefs about BM as we assumed.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  5its patient flow [cf.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 6International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ Discussion and conclusion With respect to the ICD case, we must question whether  the Dutch hospitals and nursing homes are aware of their interdependency on a daily basis.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  7In order to make BM not only theoretically feasible, but  also practically applicable, the vicious cycle of percep - tions and RPBs should be broken.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 8International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ colleagues of the advantages of cooperation.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ This article is published in a peer reviewed section of the International Journal of Integrated Care  915.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
Available from: http://www.ijic.org.,Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"This article is published in a peer reviewed section of the International Journal of Integrated Care 10International Journal of Integrated Care – Volume 11, 25 July – URN:NBN:NL:UI:10-1-101517 / ijic2011-80 – http://www.ijic.org/ 49.",Non-OADS,/arxiv_data1/oa_pdf/d3/b7/ijic2011-2011080.PMC3180700.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/56/ac/ajg2010218a.PMC3180711.pdf
SUPPLEMENTARY MATERIAL   is linked to the online version of the paper at  http://www.nature.com/ajg.,Non-OADS,/arxiv_data1/oa_pdf/ae/16/ajg2010252a.PMC3180712.pdf
"To view a copy of this license, visit http://creative-commons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/ae/16/ajg2010252a.PMC3180712.pdf
: Tumor volume delineation on PET-CT Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d1/f1/IJNM-26-22.PMC3180716.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/9f/79/IJNM-26-34.PMC3180720.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/9f/79/IJNM-26-34.PMC3180720.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/68/33/IJNM-26-44.PMC3180724.pdf
7.UN Millenium Development Goals Available at:  http://www.un.org/millenniumgoals.,Non-OADS,/arxiv_data1/oa_pdf/61/79/NMJ-52-13.PMC3180744.pdf
Bulletin of the World Health Organization (BLT);  2005 (available from: http://www.who.int/- bulletin/volumes/83/6/editorial30605html/en/   2.Uba A.F.,Non-OADS,/arxiv_data1/oa_pdf/8c/27/NMJ-52-1.PMC3180745.pdf
"http://www.new.bio-medicine.org (accessed  14/7/08) 9.Araoye MO, Kayode O, Akande TM and Ndom RJE.",Non-OADS,/arxiv_data1/oa_pdf/86/26/NMJ-52-49.PMC3180746.pdf
13Expanding HIV Screening Is Cost Effective  http://scienceblog.com/cms/node/6947 (accessed  14/7/08).,Non-OADS,/arxiv_data1/oa_pdf/86/26/NMJ-52-49.PMC3180746.pdf
"2011, 8      http://www.medsci.org  529  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2011; 8(7):529-536  Research Paper   The Clinical Significance of Digital Examination –Indicated Cerclage in  Women with a Dilated Cervix at 14 0/7 – 29 6/7 Weeks   Hyun Sun Ko1, Yun Seong Jo1, Ki Cheol Kil1, Ha Kyun Chang1, Yong -Gyu Park2, In Yang Park1, Guisera  Lee1, Sajin Kim1, Jong Chul Shin1  1.",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8    http://www.medsci.org  530  with second -trimester cervical dilation .",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8    http://www.medsci.org  531  membranes through the  cervix  if the membrane is  protruded through the cervical canal  or visible  be- yond the  external oriﬁce of the uterus.",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8      http://www.medsci.org  532      Figure 1 .",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8    http://www.medsci.org  533  Birth weight, Apgar score, preterm birth at less   than 28 , 32, 34, and 37 weeks, and birth weight less  than 1500 and 2000g  were all improved by clinica l- ly-indicated cerclage.",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8    http://www.medsci.org  534    Figure 2 .",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8    http://www.medsci.org  535  ated  with cerclage in women with a dilated cervix   when compared with bed rest  (3).",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8    http://www.medsci.org  536  tremely low birth weight infants.",Non-OADS,/arxiv_data1/oa_pdf/0e/28/ijmsv08p0529.PMC3180767.pdf
"2011, 8      http://www.medsci.org  537  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2011; 8(7):537-539  Case Report   A Rare Cause  of Bacteremia in a Pediatric Patient with Down Syndrome :  Sphingomonas Paucimobilis   Mehmet Özdemir1, Sevgi Pekcan2, Mehmet Emin Demircili1, Fatma Esenkaya Taşbent1, Bahadır  Feyzioğlu1, Şerife Pirinç2, Mahmut Baykan1   1.",Non-OADS,/arxiv_data1/oa_pdf/42/cf/ijmsv08p0537.PMC3180768.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/cf/ijmsv08p0537.PMC3180768.pdf
"2011, 8    http://www.medsci.org  538  postoperative endophtalmitis, septic shock, septic  arthritis and osteomyelitis (1,4,5).",Non-OADS,/arxiv_data1/oa_pdf/42/cf/ijmsv08p0537.PMC3180768.pdf
"2011, 8    http://www.medsci.org  539  There are cases in which this microorganism  causes epidemics in hospitals (8).",Non-OADS,/arxiv_data1/oa_pdf/42/cf/ijmsv08p0537.PMC3180768.pdf
"2011, 8      http://www.medsci.org  540  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2011; 8(7):540-546  Research Paper   Evaluation of Q T and P Wave Dispersion and Mean Platelet Volume among  Inflammatory Bowel Disease Patients   Yuksel DOGAN1, Aliye SOYLU2, Gulay A. EREN3, Sule POTUROGLU4, Can DOLAPCIOGLU5, Kenan  SONMEZ6, Habibe DUMAN7, Isa SEVINDIR7   1.",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
This is an open -access article distributed under the terms of the Creative Commons License  (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
"2011, 8      http://www.medsci.org  541  Introduction   Crohn’s  disease and ulcerative colitis are the  main entities of inflammatory bowel disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
"2011, 8    http://www.medsci.org  542  as its return to the T -P baseline.",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
"2011, 8    http://www.medsci.org  543  Table 1 : Group evaluation    Study group   (n=69)  Control group   (n=38)  p  Mean±SD  Mean±SD     Age   LVEF (%)   Pmax (ms)    39.69±13.21   64.10±5    102.75±22.10    41.59±13.12   65.13±4   97.89±13.59  0.456   0.158   0.163   Pmin (ms)  56.95±20.88  59.73±15.15  0.472   Pd (ms)  45.50±16.98  38.15±14.86  0.027*   QTd (ms)  76.68±31.99  79.92±28.31  0.603   QTc (ms)  412.01±35.97  413.60±21.83  0.777   WBC  7.65±2.32  7.47±1.93  0.235   Hct 39.88±4.56  39.60±4.09  0.702   MPV  8.51±1.34  8.56±0.83  0.584   Plt  291.67±78.73  266.39±55.23  0.085   The Student t test was used .",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
"2011, 8    http://www.medsci.org  544  duration and P -wave dispersion were reported.",OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
"2011, 8    http://www.medsci.org  545  probability o f ventricular arrhythmia or thromboe m- bolism and/or acute coronary syndrome may be low.",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
"2011, 8    http://www.medsci.org  546  37.",Non-OADS,/arxiv_data1/oa_pdf/6c/c6/ijmsv08p0540.PMC3180769.pdf
"2011, 8      http://www.medsci.org  547  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2011; 8(7):547-553  Case Report   Iatrogenic  Mandibular Fracture Associated with Third Molar Removal   Abdulkadir Burak Cankaya1, Mehmet Ali Erdem1, Sirmahan Cakarer1, Muhsin Cifter2, Cuneyt Korhan Oral1   1.",Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
"2011, 8    http://www.medsci.org  548  luxate the tooth using a straight bein elevator between  the second and third molars wit h a normal applic a- tion of force, a cracking noise was heard.",Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
"2011, 8      http://www.medsci.org  549  Case 2   A 33 -year -old male patient was referred to the  Department of Oral Surgery, Faculty of Dentistry,  Istanbul University, after an unsuccessful attempt to  extract a partially erupted left third molar 1 week  previously.",Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
"2011, 8    http://www.medsci.org  550    Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
"2011, 8    http://www.medsci.org  551  line that lacks structural damage, is not subluxated,  and remains in a functional position is retained, and  antibiotics are administered.",Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
"2011, 8    http://www.medsci.org  552  radiologically u ndetectable.",Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
"2011, 8    http://www.medsci.org  553  21.",Non-OADS,/arxiv_data1/oa_pdf/c1/88/ijmsv08p0547.PMC3180770.pdf
"2011, 8      http://www.medsci.org  554  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2011; 8(7):554-557  Research Paper   Risk Factors  of Neonatal Anemia in Placenta Previa   Dong Gyu  Jang, Yun Sung  Jo, Sung Jong Lee, Gui Se Ra Lee   Department of Obstetrics and Gynecology , College of Medicine, The Catholic University of Korea     Corresponding author : Gui Se Ra Lee , Department of Obstetrics and Gynecology,  St. Vincent’s Hospital , 93-6 Ji-dong,  Paldal -gu, Suwon, Kyeonggi 442 -723, Korea .",Non-OADS,/arxiv_data1/oa_pdf/82/58/ijmsv08p0554.PMC3180771.pdf
"2011, 8    http://www.medsci.org  555  pregnancies were studied: maternal age, previous  cesarean sections, admission due to vaginal bleeding  after 20 weeks of gestation, placental location by u l- trasonography and oper ation findings, placenta a c- creta, maternal hemoglobin level prior to and 1 day  after surgery, and estimated blood loss during su r- gery.",Non-OADS,/arxiv_data1/oa_pdf/82/58/ijmsv08p0554.PMC3180771.pdf
"2011, 8    http://www.medsci.org  556  Table 2 .",Non-OADS,/arxiv_data1/oa_pdf/82/58/ijmsv08p0554.PMC3180771.pdf
"2011, 8    http://www.medsci.org  557  This is the first study indicating that anterior  placental location is an independent risk factor of  neonatal anemia in placenta previa patients.",Non-OADS,/arxiv_data1/oa_pdf/82/58/ijmsv08p0554.PMC3180771.pdf
"2011, 8      http://www.medsci.org  558  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2011; 8(7):558-563  Case Report   Multicentric  Epithelioid Hemangioendothelioma Involving the Same Lower  Extremity: A Case Report and Review of Literature   Qingjun Liu*, Jianyun Miao*, Kejian Lian, Lianshui Huang, Zhenqi Ding  Department of Orthopaedic Surgery, the Affiliated Southeast Hospital of Xiamen University, Orthopaedic Trauma Center of  PLA, Zhan gzhou, 363000,  PR China.",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/ijmsv08p0558.PMC3180772.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9f/3f/ijmsv08p0558.PMC3180772.pdf
"2011, 8    http://www.medsci.org  559  boid bone and calcaneus  (Figure 2) .",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/ijmsv08p0558.PMC3180772.pdf
"2011, 8    http://www.medsci.org  560    Figure 3 .",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/ijmsv08p0558.PMC3180772.pdf
"2011, 8      http://www.medsci.org  561  Table 1 .",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/ijmsv08p0558.PMC3180772.pdf
"2011, 8    http://www.medsci.org  562  thelioid sarcoma  typically strongly express c y- tokeratin.",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/ijmsv08p0558.PMC3180772.pdf
"2011, 8    http://www.medsci.org  563  [4] Kleer CG, Unni KK, McLeod RA.",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/ijmsv08p0558.PMC3180772.pdf
"2011, 8      http://www.medsci.org  564  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2011; 8(7):564-572  Research Paper   Atorvastatin Inhibits Myocardial Cell Apoptosis in a Rat Model with   Post-myocardial Infarction Heart Failure by Downregula ting ER Stress  Response   Xian Jing Song1,2, Chun  Yan Yang1, Bin Liu2, Qun Wei1, Melvin T.  Korkor1, Jie Yu Liu3, Ping Yang1  1.",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8      http://www.medsci.org  565  Introduction   Heart failure  (HF) after myocardial infarction   (MI) is a common clinical  syndrome with  high mor- bidity and mortality  [1].",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8    http://www.medsci.org  566  Hemodyna mic examination   After the final drug administration , rats were  anesthetized with 3% sodium pentobarbital  (30  mg/ kg) by intraperitoneal injection .",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8    http://www.medsci.org  567  Eight weeks after LAD  ligation , hearts from rats in the  model group presented with abnormal enlarged v en- tricular  cavity (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8      http://www.medsci.org  568  Hemodynamic  index was then compared among  different groups.",OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8    http://www.medsci.org  569    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8    http://www.medsci.org  570    Figure 4 .",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8    http://www.medsci.org  571  the appearance  of apoptosis .",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
"2011, 8    http://www.medsci.org  572  9.",Non-OADS,/arxiv_data1/oa_pdf/ae/00/ijmsv08p0564.PMC3180773.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/79/32/CCD-2-134.PMC3180831.pdf
Available from: http://www.nidcr.nih.gov/execsumm.htm.,OADS,/arxiv_data1/oa_pdf/2f/39/CCD-2-98.PMC3180838.pdf
Available  from:http://www.wma.net/e/policy/b3.htm [last accessed on 2009 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/d9/29/CCD-2-84.PMC3180841.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/8b/81/CCD-2-88.PMC3180843.pdf
Available: from:  http://www.fctel.uncc.edu/pedagogy/basicscoursedevelop/ Bloom.html [Last accessed on 2006 Aug 2].,Non-OADS,/arxiv_data1/oa_pdf/c3/32/IJCM-36-104.PMC3180933.pdf
: Rubella immunization campaign in Bhutan Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b3/d7/IJCM-36-109.PMC3180934.pdf
Available from: http://www.indianngos.com/ngos/cmig.,Non-OADS,/arxiv_data1/oa_pdf/dd/eb/IJCM-36-114.PMC3180935.pdf
"Chikungunya, Available from: http://www.en.wikipedia.org/ wiki/Chikungunya: Wikipedia, [Last accessed on 2010 Dec 07].",Non-OADS,/arxiv_data1/oa_pdf/c5/a1/IJCM-36-124.PMC3180937.pdf
Available from: http://www.cdc.gov/travel/other/2006/ chikungunya_india.htm [Last accessed on 2010 Dec 07].,Non-OADS,/arxiv_data1/oa_pdf/c5/a1/IJCM-36-124.PMC3180937.pdf
Official website of available from: http://www.tbcindia.org [Last  accessed on 2009 Sep 10].,Non-OADS,/arxiv_data1/oa_pdf/7e/dc/IJCM-36-146.PMC3180942.pdf
Available from: http://www.censusindia.gov.,OADS,/arxiv_data1/oa_pdf/37/0e/IJCM-36-150.PMC3180943.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/9f/37/IJCM-36-161.PMC3180945.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/3d/7d/IJCM-36-164.PMC3180947.pdf
Available from: http://www.who.int/ entity/immunization_monitoring/data/indicator_data.xls[Last  accessed on 2010 Oct 07].,OADS,/arxiv_data1/oa_pdf/3d/7d/IJCM-36-164.PMC3180947.pdf
Mumbai:  IIPS Available from: http://mohfw.nic.in/dlhs/dlhs08_release_1.,Non-OADS,/arxiv_data1/oa_pdf/3d/7d/IJCM-36-164.PMC3180947.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/82/5d/IJCM-36-165.PMC3180948.pdf
Available from: http://www.who.int/ entity/immunization_monitoring/data/indicator_data.xls[Last  accessed on 2010 Oct 07].,OADS,/arxiv_data1/oa_pdf/82/5d/IJCM-36-165.PMC3180948.pdf
Mumbai:  IIPS Available from: http://mohfw.nic.in/dlhs/dlhs08_release_1.,Non-OADS,/arxiv_data1/oa_pdf/82/5d/IJCM-36-165.PMC3180948.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.,Non-OADS,/arxiv_data1/oa_pdf/72/6e/IJCM-36-167.PMC3180950.pdf
Available from: http://www.undp.org/mdg/basics.shtml.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://www.mohfw.nic.in/NRHM/Documents/ Mission_Document.pdf [Last accessed on 2010 Jul 3].,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://www.planningcommission.gov.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available  from: http://indiabudget.nic.in/es2007-08/esmain.htm [Last  accessed on 2009 Mar 20].,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://data.un.org/Data.,OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://globalis.gvu.unu.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://news.webindia123.com/news/Articles/ India/20081215/1128815.html.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://mohfw.nic.in/Health%20English%20 Report.pdf [Last accessed on 2010 Jan 16].,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://www.nacoonline.org/Quick_ Links/To_Read_More/.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://www.nacoonline.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://www.nacoonline.org/ upload/Policies%20and%20Guidelines/2.%20Condom%20 Promotion%20by%20SACS%20-%20Operational%20 Guidelines.pdf [Last accessed on 2010 Jul 20].,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://www.iaea.org/inisnkm/ nkm/aws/eedrb/data/IN-enemc.html.,OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from:  http://data.undp.org.in/poverty_reduction/Factsheet_IUPR_09a.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available  from: http://jnnurm.nic.in/nurmudweb/toolkit/Overview.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/47/IJCM-36-85.PMC3180952.pdf
Available from: http://www.mciindia.org/ meetings/GB/2009/MNGB18.11.2009/Annexure20itemno.313/ MDDhawan GargCommMedicine.pdf.,Non-OADS,/arxiv_data1/oa_pdf/91/30/IJCM-36-93.PMC3180953.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/28/46/APC-4-111.PMC3180965.pdf
Available from: http://www.lpch.org/DiseaseHealthInfo/ Health Library/cardiac/fcchd.html.,Non-OADS,/arxiv_data1/oa_pdf/76/5b/APC-4-117.PMC3180966.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/48/c2/APC-4-207.PMC3180989.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.,Non-OADS,/arxiv_data1/oa_pdf/da/41/APC-4-218.PMC3180994.pdf
"Statistical and graphical analyses were perfo rmed by using SPSS (version 16.0 for Windows, SPSS Inc., http://www.spss.com/ )a n d Microsoft® Office Excel 2003 (Microsoft Corporation, http:// office.microsoft.com/ ) software, respectively.",OADS,/arxiv_data1/oa_pdf/c6/4a/10096_2011_Article_1191.PMC3181010.pdf
Available from: http://www.tribuneindia.,Non-OADS,/arxiv_data1/oa_pdf/2c/ff/IJMR-134-149.PMC3181014.pdf
"The World Health Report 2002 - Reducing Risks, Promoting  Healthy Life, Available from : http://www.who.int/whr/2002/ en/, accessed on  July 22, 2007.",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/IJMR-134-162.PMC3181015.pdf
"Available from: http://www.who.int/chp/steps/en /, accessed  on July 22, 2007.",OADS,/arxiv_data1/oa_pdf/4d/fe/IJMR-134-162.PMC3181015.pdf
"Available from: http://www.cdc.gov/physicalactivity/everyone/ guidelines/index.html , accessed on July 8, 2008.",OADS,/arxiv_data1/oa_pdf/0c/3c/IJMR-134-174.PMC3181017.pdf
"Available at: http://www.kck.usm.my/ppsg/stats_resources.htm, accessed on December 20,  2009.",Non-OADS,/arxiv_data1/oa_pdf/d1/13/IJMR-134-186.PMC3181019.pdf
"In silico analysis of TLR3 promoter region : In silico   sequence analysis for DNA-binding domain of the  studied promoter region was done using the software  MATINSPECTOR v2.2 (genomatix, Munich,  Germany; http://transfac.gbf.d e).",OADS,/arxiv_data1/oa_pdf/5f/a3/IJMR-134-200.PMC3181021.pdf
Variations in  the amplified regions were screened with multiple  alignments of the sequences based on clustal X output  (Rosalind Franklin Centre for genomics Research;  http://www.hgmp.mcc.ac.u k).,OADS,/arxiv_data1/oa_pdf/5f/a3/IJMR-134-200.PMC3181021.pdf
"23. http://frodo.wi,mit.edu/primer3/ .",Non-OADS,/arxiv_data1/oa_pdf/5f/a3/IJMR-134-200.PMC3181021.pdf
30. http://hapmap.icbi.nlm.nih.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/5f/a3/IJMR-134-200.PMC3181021.pdf
Available  from: http://www.dcp2.org/page/main/BrowseInterventions.,Non-OADS,/arxiv_data1/oa_pdf/47/d7/IJMR-134-232.PMC3181025.pdf
Available from: 3. http://www.and.,Non-OADS,/arxiv_data1/oa_pdf/e3/34/IJMR-134-235.PMC3181026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JOURNAL OF PLANKTON RESEARCH jVOLUME 33jNUMBER 11jPAGES 1679 –1695 j2011",Non-OADS,/arxiv_data1/oa_pdf/cc/5b/fbr074.PMC3181040.pdf
http://www.the heart.org/article/1120273.do 41.,Non-OADS,/arxiv_data1/oa_pdf/a7/58/11239_2011_Article_611.PMC3181405.pdf
"Interestingly, although some of these viruses are related to other European BatCoV, or toAsian CoV, some of the viruses found in Spain cluster in new groups of aandbCoV.The emergence of infectious diseases is a major threat to global public health in this century (WHO, World Health Report http://www.who.int/whr/previous/en/index.html ) and many of these new infectious human diseases are caused by viruses emerging from wildlife.",Non-OADS,/arxiv_data1/oa_pdf/a0/bd/705_2011_Article_1057.PMC3181409.pdf
"In the last 50 years, more than 30 new infectious human diseaseshave been identiﬁed (WHO, World Health Report http://www.who.int/whr/previous/en/index.html ) including the Severe Acute Respiratory Syndrome (SARS).",Non-OADS,/arxiv_data1/oa_pdf/a0/bd/705_2011_Article_1057.PMC3181409.pdf
"The outbreak of SARS-CoV and subsequent identiﬁcation of two additional human coronaviruses (HCoV-NL63[ 3] and HCoV-HKU1 [ 4]) has drawn human and animal health attention to Coronavirinae subfamily, that includes three genera, Alphacoronavirus (aCoV), Betacoronavirus (bCoV) and Gammacoronavirus (cCoV), replacing the classical groups 1, 2 and 3 [ 5](http://talk.ictvonline.org/ media/g/vertebrate-2008/default.aspx ).",Non-OADS,/arxiv_data1/oa_pdf/a0/bd/705_2011_Article_1057.PMC3181409.pdf
"Wikipedia: Stoomvaart Maatschappij Zeeland ,http://nl.wikipedia.",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/12124_2011_Article_9173.PMC3181410.pdf
"The Conference Quite likely, somewhere in the early morning of July 19, Vygotsky arrived in the harbour of Folkestone, which was the destination of the ferry in 1925 (Wikipedia: Stoomvaart Maatschappij Zeeland ,http://nl.wikipedia.",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/12124_2011_Article_9173.PMC3181410.pdf
"website Institute of Education , http://www.ioe.ac.uk/about/761.html ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/12124_2011_Article_9173.PMC3181410.pdf
"website Oak Lodge School ,http://www.oaklodge.",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/12124_2011_Article_9173.PMC3181410.pdf
"website Jewish Deaf Community Center ,http://www.jdcc.org/november- december-1995-issue?layout=blog ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/12124_2011_Article_9173.PMC3181410.pdf
"Wikipedia: History of Margate ,http://en.wikipedia.org/wiki/History _of_ Margate#Royal _School _for_Deaf _Children ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/12124_2011_Article_9173.PMC3181410.pdf
"website National Gallery ,http://nationalgallery.org.uk/ paintings/collect ion-overview/ ).",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/12124_2011_Article_9173.PMC3181410.pdf
"For detailed information and an update on the genes and mutations in familial AD and FTD, we refer the reader to two websites— http://www.molgen.",Non-OADS,/arxiv_data1/oa_pdf/59/1c/18_2011_Article_750.PMC3181413.pdf
ua.ac.be/ADMutations and http://www.molgen.ua.ac.be/ FTDMutations —both of which are continually updated resources.,OADS,/arxiv_data1/oa_pdf/59/1c/18_2011_Article_750.PMC3181413.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Statins mitigate doxorubicin-induced cardiac damage J Huelsenbeck et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/21/b2/cddis201165a.PMC3181415.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ROS: a potential regulator of mammary involution ET h o m a s et al 7 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/fa/f6/cddis201169a.PMC3181416.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Mechanism of crosslink-induced mammalian cell death T Osawa et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/91/08/cddis201170a.PMC3181417.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Yeast-programmed cell death X Teng et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4c/9d/cddis201172a.PMC3181418.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Anticancer effects of a tellurium compound in mice R Coriat et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/40/0e/cddis201173a.PMC3181419.pdf
"We studied the effects with a particular focus on the DNA-binding domain (DBD) ofTable 1 PPAR gpolymorphisms and mutations related to disease Disease Variant dbSNPa Modiﬁer of obesity, insulin resistance Pro12Ala rs1805192 Obesity, severe Pro115Gln rs1800571 Lipodystrophy, familial partial, type 3 Cys190Ser rs121909245 Lipodystrophy, familial partial, type 3 Arg194Trp rs121909246 Colon cancer, somatic Gln314Pro rs121909242 Colon cancer, somatic Arg316His rs28936407Colorectal cancer Ser317Cys – Lipodystrophy, familial partial, type 3 Val318Met rs72551362 Colon cancer, somatic Lys347Ter rs121909243Lipodystrophy, familial partial, type 3 Phe388Leu rs72551363 Lipodystrophy, familial partial, type 3 Arg425Cys rs72551364 Glioma susceptibility 1 His477His rs3856806 Lipodystrophy, familial partial, type 3 Pro495Leu rs121909244 aIdentiﬁer in dbSNP, http://www.ncbi.nlm.nih.gov/snp Figure 1 PPAR gtranscriptional regulation.",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/cddis201174a.PMC3181420.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)PPAR cand its disease-related network W Jurkowski et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/cddis201174a.PMC3181420.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Celastrol inhibits aminoglycoside-induced ototoxicity SP Francis et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5a/c3/cddis201176a.PMC3181421.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/hERG channels in cell proliferation and apoptosis J Jehle et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/77/d5/cddis201177a.PMC3181422.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/TNF and the extrinsic apoptotic pathway in myeloma cells H Rauert et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d0/f2/cddis201178a.PMC3181423.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)PD-associated protein LRRK2 impairs UPS M Lichtenberg et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ff/04/cddis201181a.PMC3181424.pdf
"Statin therapy for primary preventionSurvey of all UK general practitioners registered on http://www.doctors.net.uk, an online organisation forUK doctors800 Internet survey, presented as a link in a targeted electronic bulletinAdapted and piloted from Pathman’s original questionnaire2004 Guidelines from British Hypertension Society GuidelinesMay 2006 Pathman et al , 1996 3Paediatric vaccine recommendations1.",Non-OADS,/arxiv_data1/oa_pdf/7e/07/postgradmedj116012.PMC3181428.pdf
"Competing interests All authors have completed the Uniﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from thecorresponding author) and declare that (1) SM, AB and PG have support from theDepartment of Primary HealthCare, University of Oxford, and Bond University for thesubmitted work; (2) have no relationships with any companies that might have aninterest in the submitted work in the previous 3 years; (3) their spouses, partners, or children have no ﬁnancial relationships that may be relevant to the submitted work; and (4) SM, AB and PG have no non-ﬁnancial interests that may be relevant to thesubmitted work.",Non-OADS,/arxiv_data1/oa_pdf/7e/07/postgradmedj116012.PMC3181428.pdf
http://www.surescripts.com/about-e- prescribing/progress-reports/national-progress-reports.aspx(accessed 19 Aug 2010).,Non-OADS,/arxiv_data1/oa_pdf/21/a3/qhc49635.PMC3181429.pdf
http://www.hschange.com/CONTENT/1133/#ib2 (accessed 21 Jun 2011).,Non-OADS,/arxiv_data1/oa_pdf/21/a3/qhc49635.PMC3181429.pdf
http://www.msfaccess.org/main/hiv-aids/introduction-to-hivaids/children-and-hivaids/ (accessed 17 March 2010).,Non-OADS,/arxiv_data1/oa_pdf/e8/35/adc-95-6-414.PMC3181433.pdf
Antiretroviral therapy of HIV infection in infants and children in resource  limited settings: Towards universal accses 2006 [cited 2006 July]; available from: https://www.who.int/entity/hiv/pub/guidelines/art/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e8/35/adc-95-6-414.PMC3181433.pdf
"Boca Raton, FL: Chapman and Hall/CRC, 1984.  http://books.google.",Non-OADS,/arxiv_data1/oa_pdf/e8/35/adc-95-6-414.PMC3181433.pdf
http://www.cdc.gov/nccdphp/dnpa/ growthcharts/resources/index.htm#BMI.,OADS,/arxiv_data1/oa_pdf/e8/35/adc-95-6-414.PMC3181433.pdf
"Web page: http://www.rrh.org.au Eaker, S., Bergstrom, R., Bergstrom, A., Adami, H. O. and Nyren, O.",Non-OADS,/arxiv_data1/oa_pdf/ea/17/S0031182011001004a.PMC3181434.pdf
Web page: http://www.regjeringen.no/pages/2191078/PDFS/ STP200820090068000DDDPDFS.pdf1303 Head lice prevalence among households in Norway,Non-OADS,/arxiv_data1/oa_pdf/ea/17/S0031182011001004a.PMC3181434.pdf
Web page: http://www.statkart.no/nor/Land/Fagomrader/Arealer_og_tall/ Pedlex Norsk Skoleinformasjon (2010).,OADS,/arxiv_data1/oa_pdf/ea/17/S0031182011001004a.PMC3181434.pdf
"Web page: http://pedlex.no/4daction/ WA_Gruppe/?Gr=130&TP=110113093023#Pulliam, H. R. (1988).",Non-OADS,/arxiv_data1/oa_pdf/ea/17/S0031182011001004a.PMC3181434.pdf
"Web page: http://www.ssb.no/barnehager/arkiv/tab-2010-03-15-01.html Stone, P., Wilkinson-Herbots, H. and Isham, V. (2008).",Non-OADS,/arxiv_data1/oa_pdf/ea/17/S0031182011001004a.PMC3181434.pdf
We usedsfold ( http://sfold.wadsworth.org [21]) to analyze the region of X RNA processing and identiﬁed a possible stem-loop structure(Fig.,OADS,/arxiv_data1/oa_pdf/07/dd/mBio.00189-11.PMC3181467.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/76/bf/emboj2011245a.PMC3181475.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/4a/f7/emboj2011230a.PMC3181481.pdf
[http://creativecommons.org/licenses/by-nc-sa/3.0/]A common gate controls K 2Pfunction SN Bagriantsev et al The EMBO Journal VOL 30 |NO 17 |2011 &2011 European Molecular Biology Organization 3606,Non-OADS,/arxiv_data1/oa_pdf/4a/f7/emboj2011230a.PMC3181481.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).Acknowledgements We thank Niklas Engels for helpful discussions and critical com- ments on the manuscript.,Non-OADS,/arxiv_data1/oa_pdf/2a/02/emboj2011251a.PMC3181483.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/37/bb/emboj2011268a.PMC3181484.pdf
[http://creativecommons.org/licenses/by-nc-sa/3.0/]K2P channel gating PL Piechotta et al &2011 European Molecular Biology Organization The EMBO Journal VOL 30 |NO 17 |2011 3619,Non-OADS,/arxiv_data1/oa_pdf/37/bb/emboj2011268a.PMC3181484.pdf
(http://www.ahcpr.gov/clinic/deprsumm.htm).47.,Non-OADS,/arxiv_data1/oa_pdf/7f/09/DialoguesClinNeurosci-1-113.PMC3181573.pdf
(http://ace.ace.orst.edu/info/extoxnet®/pips/trichlor.htm).,Non-OADS,/arxiv_data1/oa_pdf/85/e6/DialoguesClinNeurosci-2-111.PMC3181592.pdf
"US prescribing information canbe found at the FDA’s web site (http://fda.cder.gov), andat Novartis’ web site (http:/www.novartis.com).",Non-OADS,/arxiv_data1/oa_pdf/85/e6/DialoguesClinNeurosci-2-111.PMC3181592.pdf
Reference to the FDA-approved pre-scribing information (April 2000) notes the higher thanexpected incidence of gastrointestinal disturbancesprinted in bold type (http://www.fda.edu.gov &http://www.novartis.com).,Non-OADS,/arxiv_data1/oa_pdf/85/e6/DialoguesClinNeurosci-2-111.PMC3181592.pdf
"This group synthesizes drug substances for“drug-screening,” pharmacology, and toxicology studies,and also prepares clinical supplies.FDA relations during drug development Jules T. Mitchel, MBA, PhD Keywords: FDA; drug development; regulatory affairs; pharmaceutical develop- ment Author affiliations: Target Health Inc, New York, NY, USAAddress for correspondence: Jules T. Mitchel, Target Health Inc, 305 Madison Avenue, 25th Floor, New York, NY 10165, USAhttp://www.targethealth.com/(e-mail: JulesMitchel@TargetHealth.com)I 213Basic research",Non-OADS,/arxiv_data1/oa_pdf/8e/65/DialoguesClinNeurosci-2-213.PMC3181610.pdf
TheFDA has a web site for each of its divisions with asophisticated search engine and document services(http://www.fda.gov/).,OADS,/arxiv_data1/oa_pdf/8e/65/DialoguesClinNeurosci-2-213.PMC3181610.pdf
Available at: http://www.nara.gov/fedreg/.Accessed 14 September 2000.4.Freedom of Information Reading Room.,Non-OADS,/arxiv_data1/oa_pdf/8e/65/DialoguesClinNeurosci-2-213.PMC3181610.pdf
Available at: http://www.fda.gov/foi/foia2.htm.,Non-OADS,/arxiv_data1/oa_pdf/8e/65/DialoguesClinNeurosci-2-213.PMC3181610.pdf
Available at: http://www.fda.gov/cder/guid-ance/105-115.htm.,Non-OADS,/arxiv_data1/oa_pdf/8e/65/DialoguesClinNeurosci-2-213.PMC3181610.pdf
"Available at http://www.journals.apa.org/prevention/volume2/pre0020001a.html.Accessed 23 October 2000.5.Leber PD, Davis CS.",Non-OADS,/arxiv_data1/oa_pdf/91/58/DialoguesClinNeurosci-2-309.PMC3181614.pdf
http://www.britannica.com.,Non-OADS,/arxiv_data1/oa_pdf/54/d0/DialoguesClinNeurosci-5-175.PMC3181622.pdf
Available at: http://www.sofres.com/etudes/sante/110601_nonfum.htm.,Non-OADS,/arxiv_data1/oa_pdf/54/d0/DialoguesClinNeurosci-5-175.PMC3181622.pdf
Available at:http://www.norc.uchicago.edu/new/gamb-fin.htm.,Non-OADS,/arxiv_data1/oa_pdf/16/fd/DialoguesClinNeurosci-5-259.PMC3181632.pdf
Available at:http://www.nimh.nih.gov/publicat/anxresfact.cfm.,Non-OADS,/arxiv_data1/oa_pdf/1a/85/DialoguesClinNeurosci-5-237.PMC3181633.pdf
http://www.ncbi.nlm.nih.gov/Omim.,Non-OADS,/arxiv_data1/oa_pdf/5e/96/DialoguesClinNeurosci-3-58.PMC3181640.pdf
http://www.rzpd.de.,Non-OADS,/arxiv_data1/oa_pdf/5e/96/DialoguesClinNeurosci-3-58.PMC3181640.pdf
http://www.fruitfly.org/.,Non-OADS,/arxiv_data1/oa_pdf/5e/96/DialoguesClinNeurosci-3-58.PMC3181640.pdf
http://www.informatics.jax.org.,Non-OADS,/arxiv_data1/oa_pdf/5e/96/DialoguesClinNeurosci-3-58.PMC3181640.pdf
http://gdb.jst.go.jp/gdb/hgpReso urces.html.,OADS,/arxiv_data1/oa_pdf/5e/96/DialoguesClinNeurosci-3-58.PMC3181640.pdf
http://www.ncbi.nlm.nih.gov/Omim.,Non-OADS,/arxiv_data1/oa_pdf/dd/84/DialoguesClinNeurosci-3-7.PMC3181641.pdf
http://www.ncbi.nlm.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/dd/84/DialoguesClinNeurosci-3-7.PMC3181641.pdf
http://www.ensembl.org.,Non-OADS,/arxiv_data1/oa_pdf/dd/84/DialoguesClinNeurosci-3-7.PMC3181641.pdf
Reproduced from reference 3: http://www.maff.gov.uk/animalh/bse/bse-statistics/graph/epidem.pdf.,OADS,/arxiv_data1/oa_pdf/02/fa/DialoguesClinNeurosci-3-25.PMC3181643.pdf
"Reproduced from reference 9:  http://www.doh.gov.uk/cjd/stats/sept00.htm.Copyright © 2000, Department of Health, UK.Year sCJD nvCJD* Total**  1985 26 28  1986 26 26  1987 23 24  1988 22 24  1989 28 32  1990 28 33  1991 32 36  1992 43 51  1993 38 46  1994 51 59  1995 35 3 47  1996 40 10 60  1997 59 10 80  1998 63 18 88  1999 61 14 83  2000 25 27 52 Table II.",Non-OADS,/arxiv_data1/oa_pdf/02/fa/DialoguesClinNeurosci-3-25.PMC3181643.pdf
Reproduced from reference 9:http://www.doh.gov.uk/cjd/stats/sept00.htm.,OADS,/arxiv_data1/oa_pdf/02/fa/DialoguesClinNeurosci-3-25.PMC3181643.pdf
http://www.maff.gov.uk/ani-malh/bse/bse-statistics/graphs/epidem.pdf.,OADS,/arxiv_data1/oa_pdf/02/fa/DialoguesClinNeurosci-3-25.PMC3181643.pdf
http://www.oie.int/eng/info/en_esbmonde.htm.,Non-OADS,/arxiv_data1/oa_pdf/02/fa/DialoguesClinNeurosci-3-25.PMC3181643.pdf
"Department of Health, UK; September 2000. http://www.doh.gov.uk/cjd/stats/sept00.htm.",Non-OADS,/arxiv_data1/oa_pdf/02/fa/DialoguesClinNeurosci-3-25.PMC3181643.pdf
http://www.mad-cow.org/.,Non-OADS,/arxiv_data1/oa_pdf/02/fa/DialoguesClinNeurosci-3-25.PMC3181643.pdf
http://www.update-software.com/abstracts/ab000560.htm.Accessed 24 July 2002.61.Meyer V. Modifications of expectations in cases with obsessional rituals.,Non-OADS,/arxiv_data1/oa_pdf/83/b6/DialoguesClinNeurosci-4-305.PMC3181686.pdf
Available at http://www.emea.eu.int/sitemap.htm.,Non-OADS,/arxiv_data1/oa_pdf/1a/fb/DialoguesClinNeurosci-4-449.PMC3181691.pdf
Available at: http://www.emea.eu.int/htms/human/ich/efficacy/ichfin.htm.,Non-OADS,/arxiv_data1/oa_pdf/1a/fb/DialoguesClinNeurosci-4-449.PMC3181691.pdf
http://www.imm.ki.se/CYPalleles/.,Non-OADS,/arxiv_data1/oa_pdf/1a/fb/DialoguesClinNeurosci-4-449.PMC3181691.pdf
Available at http://www.emea.eu.int/htms/human/ich/efficacy/ichfin.htm.,Non-OADS,/arxiv_data1/oa_pdf/1a/fb/DialoguesClinNeurosci-4-449.PMC3181691.pdf
Pharmaceutical Administration and Regulations in Japan 2002. http://www.jpma.or.jp/12english/parj/index.html.,Non-OADS,/arxiv_data1/oa_pdf/31/54/DialoguesClinNeurosci-4-470.PMC3181698.pdf
Available at http://www.nihs.go.jp/ dig/ich/eindex-e.html.,Non-OADS,/arxiv_data1/oa_pdf/31/54/DialoguesClinNeurosci-4-470.PMC3181698.pdf
Available at: http://www.alzheimers.org.uk/society/p_demography.html#world5.,Non-OADS,/arxiv_data1/oa_pdf/19/39/DialoguesClinNeurosci-5-27.PMC3181716.pdf
Available at: http://www.nice.org.uk/pdf/CG1NICEguideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/f8/DialoguesClinNeurosci-7-7.PMC3181721.pdf
The genetics of endophenotypes and schizophrenia.Available at: https://npistat.com/cogs.,Non-OADS,/arxiv_data1/oa_pdf/94/a9/DialoguesClinNeurosci-7-125.PMC3181726.pdf
Available at: http://www.emea.eu.int/ pdfs/hhuman/ich/036496en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/04/DialoguesClinNeurosci-7-249.PMC3181733.pdf
Available at: http://www.nimh.nih.gov/publicat/numbers.cfm.,OADS,/arxiv_data1/oa_pdf/2d/7d/DialoguesClinNeurosci-7-291.PMC3181745.pdf
Available at: http://www.nimh.nih/gov/publicat/bur-den.cfm.,Non-OADS,/arxiv_data1/oa_pdf/2d/7d/DialoguesClinNeurosci-7-291.PMC3181745.pdf
The 6- question Adult Self-Report Scale – V 1.1 (ASRS - V 1.1)Screener (http://www.hcp.med.harvard.edu/ncs/fpdir/adhd)is a subset of the WHO's 18-question Adult Self-ReportScale – V 1.1 (ASRS - V 1.1) Symptom Checklist.,Non-OADS,/arxiv_data1/oa_pdf/17/26/DialoguesClinNeurosci-8-29.PMC3181750.pdf
Comparison of ADHD symptoms in adulthood according to ASRS (http://www.med.nyu.edu/psych/assets/adhdscreen18.pdf.),Non-OADS,/arxiv_data1/oa_pdf/17/26/DialoguesClinNeurosci-8-29.PMC3181750.pdf
"57.http://www.fda.gov/cder/drug/antidepressants/PI_template.pdf (accessed June 2005).58.http://www.fda.gov/cder/drug/antidepressants/MG_template.pdf (accessed June 2005).59.Akiskal HS, Benazzi F, Perugi G, Rihmer Z. Agitated ""unipolar"" depres- sion re-conceptualized as a depressive mixed state: implications for the anti-depressant-suicide controversy.",Non-OADS,/arxiv_data1/oa_pdf/45/a0/DialoguesClinNeurosci-8-151.PMC3181770.pdf
Available at: http://www.cet.org.,Non-OADS,/arxiv_data1/oa_pdf/34/3a/DialoguesClinNeurosci-5-389.PMC3181778.pdf
"Office of Communications and Public Liaison, National Institute of Neurological Disorders and Stroke, Bethesda, Md.Available at: http://www.ninds.nih.gov/index.htm.",Non-OADS,/arxiv_data1/oa_pdf/bd/dd/DialoguesClinNeurosci-5-371.PMC3181779.pdf
Available at: http://www.tigr.org.,Non-OADS,/arxiv_data1/oa_pdf/4f/94/DialoguesClinNeurosci-6-27.PMC3181785.pdf
Available at:http://www.ncbi.nlm.nih.gov:80/Genomes/index.html.,OADS,/arxiv_data1/oa_pdf/4f/94/DialoguesClinNeurosci-6-27.PMC3181785.pdf
Available at: http://www.genet.sickkids.on.ca.,Non-OADS,/arxiv_data1/oa_pdf/4f/94/DialoguesClinNeurosci-6-27.PMC3181785.pdf
Availableat: http://www.gbm-online.de.,Non-OADS,/arxiv_data1/oa_pdf/4f/94/DialoguesClinNeurosci-6-27.PMC3181785.pdf
Available at: http://snp.cshl.org.,Non-OADS,/arxiv_data1/oa_pdf/4f/94/DialoguesClinNeurosci-6-27.PMC3181785.pdf
http://www.molgen.mpg.de/~genetic_variation_program/  Accessed 21 January 2004.7.Mansfield BK.,Non-OADS,/arxiv_data1/oa_pdf/4a/79/DialoguesClinNeurosci-6-5.PMC3181790.pdf
Available athttp://sfn.scholarone.com/itin2002/.,Non-OADS,/arxiv_data1/oa_pdf/10/8c/DialoguesClinNeurosci-6-185.PMC3181793.pdf
Available at http://sfn.scholarone.com/itin2003/.,Non-OADS,/arxiv_data1/oa_pdf/10/8c/DialoguesClinNeurosci-6-185.PMC3181793.pdf
"Online, 2003.Available at http://sfn.scholarone.com/itin2003/.",Non-OADS,/arxiv_data1/oa_pdf/10/8c/DialoguesClinNeurosci-6-185.PMC3181793.pdf
Available athttp://www.eletel.p.lodz.pl/cost/publications.html.,Non-OADS,/arxiv_data1/oa_pdf/90/da/DialoguesClinNeurosci-6-243.PMC3181797.pdf
Available athttp://www.uib.no/costb11/.,Non-OADS,/arxiv_data1/oa_pdf/90/da/DialoguesClinNeurosci-6-243.PMC3181797.pdf
"Available at http://www.eletel.p.lodz.pl/cost/software.html.Accessed 3 December 2003.5.Rosenfeld A, Kak A.",Non-OADS,/arxiv_data1/oa_pdf/90/da/DialoguesClinNeurosci-6-243.PMC3181797.pdf
"Available at http://www.eletel.p.lodz.pl/ cost/ Accessed 3 December 2003.34.Krzanowski W. Principles of Multivariable Data Analysis , Oxford, UK: Oxford University Press; 1988.35.Mao J, Jain A.",Non-OADS,/arxiv_data1/oa_pdf/90/da/DialoguesClinNeurosci-6-243.PMC3181797.pdf
Available athttp://www.uib.no/costb11/.,Non-OADS,/arxiv_data1/oa_pdf/77/d0/DialoguesClinNeurosci-6-235.PMC3181798.pdf
"Available at http://www.eletel.p.lodz.pl/ cost/ Accessed 3 December 2003.7.Materka A, Strzelecki M, Lerski R, Schad L. Feature evaluation of texture test objects for magnetic resonance imaging.",OADS,/arxiv_data1/oa_pdf/77/d0/DialoguesClinNeurosci-6-235.PMC3181798.pdf
Available at: http://www.nimh.nih.gov/about/nimh.cfm.,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/DialoguesClinNeurosci-8-303.PMC3181824.pdf
Electrophysiology Surface area and volume of impaled guard cells were calculated assuming a cylindrical geometry using Henry IV EP software (http://www.psrg.org.uk/henrys-ep-suite.htm).,OADS,/arxiv_data1/oa_pdf/b0/9b/bj4390161.PMC3181827.pdf
"www.biolcell.org | Volume 103 (11) | Pages 499–517 499Biology of the Cell     www.biolcell.org © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"We have previously shown that human Caco- 2/TC7 enterocytes, a clone that derives from theparental Caco-2 cell line, is able to produce TRLand store TAG as CLDs when supplied with lipidmicelles (Chateau et al., 2005; Vidal et al., 2005).After a 24 h incubation with lipid micelles, fattyacid uptake and TAG synthesis are completed, 500C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Underthese conditions, confocal microscopy analysis re-vealed that the lipid droplets, visualized with Bodipy493/503, were mainly localized at the basal pole ofthe cells (see Supplementary Figures S1A and S1Bat http://www.biolcell.org/boc/103/boc1030499add.htm) and were decorated with PLIN-2 in discretepatches (Figure 2A and Supplementary Figure S1A).CLDs appeared as clusters of various sizes (Figure 2A,bottom panel), which were larger than and more nu-merous after the lipid supply as compared with con-trol conditions (Figure 2A, compare the middle andtop panels).",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Lipids from all gradient fractions as well www.biolcell.org | Volume 103 (11) | Pages 499–517 501 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
The percentage of [1- 14C]OA incorporated into TAG increased from 53.4 +−3% in the cell homogenate to 80.2 +−0.6% in the super- natant loaded on the gradient and to 89.6 +−0.6% in fraction 1 (Figure 3B; see Supplementary Table S1at http://www.biolcell.org/boc/103/boc1030499add.htm).,Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Interestingly, compared with the PL/TAG ra- tio, the DGE/TAG and the CE/TAG ratios remained remarkably constant in these samples, indicating a co-enrichment of these hydrophobic lipids with TAG, 502C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"The lipid-droplet-containingfraction was slightly positive for LDH (lactate www.biolcell.org | Volume 103 (11) | Pages 499–517 503 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"For 504C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Entry name Normalized Reported in proteomic Gene name SwissProt Protein name emPAI studies of lipid droplets Lipid metabolism PLIN proteins PLIN2 PLIN2_HUMAN Perilipin-2, adipose differentiation-related protein, adipophilin6.97 a PLIN3 PLIN3_HUMAN Perilipin-3, mannose-6-phosphate receptor-binding protein, TIP473.42 a Fatty acid metabolism ACSL3 ACSL3_HUMAN Long-chain-fatty-acid-CoA ligase 3 2.65 a ACSL4 ACSL4_HUMAN Long-chain-fatty-acid-CoA ligase 4 0.15 a Acylglycerol metabolism MGLL MGLL_HUMAN Monoglyceride lipase 0.67 aABHD5 ABHD5_HUMAN 1-Acylglycerol-3-phosphate O-acyltransferase, abhydrolasedomain-containing protein 5, CGI-580.31 a PNPLA2 PLPL2_HUMAN Patatin-like phospholipase domain-containing protein 2, adiposetriacylglycerol lipase0.15 a Phospholipid metabolism PCYT1A PCY1A_HUMAN Choline-phosphate cytidylyltransferase A 1.58LPCAT2 PCAT2_HUMAN Lysophosphatidylcholine acyltransferase 2 0.30 b Sterol metabolism HSD17B11 DHB11_HUMAN Oestradiol 17- β-dehydrogenase 11 2.78 a LSS ERG7_HUMAN Lanosterol synthase 2.46 aCYB5R3 NB5R3_HUMAN NADH–cytochrome b 5reductase 3 1.63 a NSDHL NSDHL_HUMAN Sterol-4- α-carboxylate 3-dehydrogenase, decarboxylating1.55 a EPHX1 HYEP_HUMAN Epoxide hydrolase 1 0.31 HSD3B1 3BHS1_HUMAN 3- β-Hydroxysteroid dehydrogenase 0.24 DHRS3 DHRS3_HUMAN Short-chain dehydrogenase/reductase 3 0.13 aDHCR7 DHCR7_HUMAN 7-Dehydrocholesterol reductase 0.06HSD17B7 DHB7_HUMAN 3-Oxo-steroid reductase 0.04 a Lipoprotein metabolism APOA4 APOA4_HUMAN Apolipoprotein A-IV 6.24P4HB PDIA1_HUMAN Protein disulﬁde-isomerase 4.71 aMTTP MTP_HUMAN Microsomal triacylglycerol transfer protein large subunit0.53 APOE APOE_HUMAN Apolipoprotein E 0.48 Other lipidic metabolism FAF2 FAF2_HUMAN FAS-associated factor 2, UBXD8 1.77 a RDH10 RDH10_HUMAN Retinol dehydrogenase 10 1.24 www.biolcell.org | Volume 103 (11) | Pages 499–517 505 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"J. Bouchoux and others Table 1 Continued Entry name Normalized Reported in proteomic Gene name SwissProt Protein name emPAI studies of lipid droplets DHRS1 DHRS1_HUMAN Dehydrogenase/reductase SDR family member 10.56 a ECHS1 ECHM_HUMAN Enoyl-CoA hydratase, mitochondrial 0.17 SGPL1 SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 0.11 TRAFFIC RAB7A RAB7A_HUMAN Ras-related protein Rab-7a 2.78 aRAB1A RAB1A_HUMAN Ras-related protein Rab-1A 1.75 aRAB5C RAB5C_HUMAN Ras-related protein Rab-5C 1.66 aRAB10 RAB10_HUMAN Ras-related protein Rab-10 1.15 aRAB25 RAB25_HUMAN Ras-related protein Rab-25 1.02RAB11A RB11A_HUMAN Ras-related protein Rab-11A 0.68 a RAB15 RAB15_HUMAN Ras-related protein Rab-15 0.66 RAB6A RAB6A_HUMAN Ras-related protein Rab-6A 0.20 aRAB33B RB33B_HUMAN Ras-related protein Rab-33B 0.01 a ER (endoplasmic reticulum) ER lumen HSPA5 GRP78_HUMAN 78 kDa glucose-regulated protein 5.76 aPDIA3 PDIA3_HUMAN Protein disulﬁde-isomerase A3 3.27 aCALR CALR_HUMAN Calreticulin 1.97 aHSP90B ENPL_HUMAN Endoplasmin, heat-shock protein 90 kDa βmember 1, 94 kDa glucose-regulated protein1.85 a PDIA6 PDIA6_HUMAN Protein disulﬁde-isomerase A6 1.52 a ERO1L ERO1A_HUMAN ERO1-like protein α 0.82 a PDIA4 PDIA4_HUMAN Protein disulﬁde-isomerase A4 0.81 aSERPINH SERPH_HUMAN Serpin H1 0.38ERP44 ERP44_HUMAN Endoplasmic reticulum resident protein ERp440.29 CALU CALU_HUMAN Calumenin 0.28 POR NCPR_HUMAN NADPH–cytochrome P450 reductase 0.27PLOD2 PLOD2_HUMAN Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 20.19 UBXN4 UBXN4_HUMAN UBX domain-containing protein 4, UBX domain-containing protein 2, Erasin0.19 a ERP29 ERP29_HUMAN Endoplasmic reticulum protein ERp29 0.19 a LRPAP1 AMRP_HUMAN α-2-Macroglobulin receptor-associated protein, low-density lipoproteinreceptor-related protein-associatedprotein 10.17 ER membrane, integral protein CANX CALX_HUMAN Calnexin 0.66 aAUP1 AUP1_HUMAN Ancient ubiquitous protein 1 0.35 aRPN1 RPN1_HUMAN Dolichyl-diphospho-oligosaccharide–protein glycosyltransferase subunit 10.34 a UGT1A6 UD16_HUMAN UDP-glucuronosyltransferase 1-6 0.22 DDOST OST48_HUMAN Dolichyl-diphospho-oligosaccharide–protein glycosyltranferase 48 kDa subunit0.18 a 506C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Lipid droplet proteome of Caco-2/TC7 enterocytes Research article Table 1 Continued Entry name Normalized Reported in proteomic Gene name SwissProt Protein name emPAI studies of lipid droplets RTN4 RTN4_HUMAN Reticulon-4 0.08LRRC59 LRC59_HUMAN Leucine-rich repeat-containing protein 59 0.17 Unknown PRKCSH GLU2B_HUMAN Glucosidase 2 subunit β 0.13 Mitochondria AIFM2 AIFM2_HUMAN Apoptosis-inducing factor 2, apoptosis-inducing factor-likemitochondrion-associated inducerof death1.87 a ATP5B ATPB_HUMAN ATP synthase subunit β, mitochondrial 0.51 HSPA9 GRP75_HUMAN Stress-70 protein, mitochondrial 0.24 aMDH2 MDHM_HUMAN Malate dehydrogenase, mitochondrial 0.20HSPD1 CH60_HUMAN 60 kDa heat-shock protein, mitochondrial 0.18 a Lysosome PCYOX1 PCYOX_HUMAN Prenylcysteine oxidase 1 0.30 GNS GNS_HUMAN N-Acetylglucosamine-6-sulfatase 0.20 Cytosol cytoskeleton TUBB2C TBB2C_HUMAN Tubulin β-2C chain 6.04 TUBB TBB5_HUMAN Tubulin βchain 5.39 TUBB2A TBB2A_HUMAN Tubulin β-2A chain 3.43 ACTB ACTB_HUMAN Actin, cytoplasmic 1 2.70 aTUBA1B TBA1B_HUMAN Tubulin α-1B chain 2.68 ACTN4 ACTN4_HUMAN α-Actinin-4 1.02 ANXA2 ANXA2_HUMAN Annexin A2 0.86 aANXA4 ANXA4_HUMAN Annexin A4 0.35ELMOD2 ELMD2_HUMAN ELMO domain-containing protein 2 0.34 aSLC9A3R1 NHRF1_HUMAN Na +/H+exchange regulatory cofactor NHERF10.27 SEPT2 SEPT2_HUMAN Septin-2 0.17 Carbohydrate metabolism TPI1 TPIS_HUMAN Triosephosphate isomerase 6.85PGK1 PGK1_HUMAN Phosphoglycerate kinase 1 1.67ENO1 ENOA_HUMAN α-Enolase 1.47 ALDOA ALDOA_HUMAN Fructose-bisphosphate aldolase A 1.40GPI G6PI_HUMAN Glucose-6-phosphate isomerase 1.08GAPDH G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogenase0.76 a Cytosolic chaperones HSPA8 HSP7C_HUMAN Heat-shock cognate 71 kDa protein 1.89 a HSPA1A HSP71_HUMAN Heat-shock 70 kDa protein 1 1.78 a HSPA6 HSP76_HUMAN Heat-shock 70 kDa protein 6 0.52HSP90AB1 HS90B_HUMAN Heat-shock protein HSP 90- β 0.20 a Other function in cytoplasm CKB KCRB_HUMAN Creatine kinase B-type 5.18LGALS3 LEG3_HUMAN Galectin-3 1.62 www.biolcell.org | Volume 103 (11) | Pages 499–517 507 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"508C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Altogether, these data clearlyindicate that ectopic expression of ApoA-IV in HeLacells lead to its partial targeting to lipid droplets, as www.biolcell.org | Volume 103 (11) | Pages 499–517 509 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"ABHD5/CGI-58 was shown to facil-itate the mobilization of cytoplasmic TAG and theassembly and secretion of TRL in McA RH7777 rat 510C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"In Drosophila S2 cells, CCT1, the orthologue of mammalian CCT- αlocaliz- ing in the nucleus, translocates to the lipid dropletsurface upon oleate addition and its knockdown leadsto fewer lipid droplets of larger size (Guo et al., 2008).Moreover, liver-speciﬁc CCT- α-knockout mice dis- play impaired VLDL secretion in plasma (Jacobs www.biolcell.org | Volume 103 (11) | Pages 499–517 511 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"ApoA-IV is strongly induced upon lipid 512C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Goat anti-ApoB antibody (for www.biolcell.org | Volume 103 (11) | Pages 499–517 513 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Cell layers (two 75 mm diameter inserts per centrifuge tube) were rinsed brieﬂy (three times with cold PBS)and scraped and the volume of the cell homogenate was adjusted to 2 ml with buffer A (25 mM Tris/HCl, pH 7.4, 100 mM KCl, 1 mM EDTA and 5 mM EGTA) containing a protease inhibitor 514C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"All other authors were involved in theconception, design and realization of the experiments, www.biolcell.org | Volume 103 (11) | Pages 499–517 515 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"279, 47402–47410 516C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"50, 1080–1089 Received 15 February 2011/25 July 2011; accepted 26 July 2011 Published as Immediate Publication 26 July 2011, doi:10.1042/BC20110024 www.biolcell.org | Volume 103 (11) | Pages 499–517 517 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"www.biolcell.org | Volume 103 (11) | Pages 499–517 © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
"Fraction number Lipid or ratio Homogenate Supernatant 1 13 PL (%) 41.1 +−3.2 11.4 +−0.8 1.3 +−0.1 85.5 +−3.1 TAG (%) 53.4 +−3.0 80.2 +−0.6 89.6 +−0.6 14.5 +−3.1 DGE (%) 2.6 +−0.1 4.0 +−0.2 4.3 +−0.1 n.d. CE (%) 2.9 +−0.2 4.4 +−0.3 4.8 +−0.5 n.d. Total (%) 100 100 100 100 PL/TAG ratio 0.772 +−0.107 0.141 +−0.011 0.014 +−0.001 6.166 +−1.753 DGE/TAG ratio 0.048 +−0.003 0.050 +−0.002 0.047 +−0.001 CE/TAG ratio 0.054 +−0.001 0.056 +−0.004 0.054 +−0.006 Received 15 February 2011/25 July 2011; accepted 26 July 2011 Published as Immediate Publication 26 July 2011, doi:10.1042/BC20110024 C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2011 Portland Press Limited © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/65/boc1030499.PMC3181828.pdf
http://www.cdc.gov/nchs/fastats/hypertens html.,OADS,/arxiv_data1/oa_pdf/88/ad/DialoguesClinNeurosci-8-433.PMC3181835.pdf
Available at: http://www.postgradmed.com/issues/2002/0 6_02/shri- vastava.htm.,Non-OADS,/arxiv_data1/oa_pdf/75/db/DialoguesClinNeurosci-9-29.PMC3181843.pdf
Adaptedfrom: http://data.euro.who.int/hfamb.,OADS,/arxiv_data1/oa_pdf/4c/e0/DialoguesClinNeurosci-9-71.PMC3181845.pdf
"Indeed, the originalNIMH Bipolar Genetics Initiative, consisting of threesites (Washington University in St Louis, IndianaUniversity, and Johns Hopkins University) collected atotal of only 145 affected sib pairs with the most severediagnosis (BP-I or schizoaffective, bipolar) over 10 years,as their pedigree selection was based, whether by designor practicality, on a wider phenotype (NIMH Center forGenetic Studies; http://zork.wustl.edu/nimh).Risch and Merikangas 54have estimated that for a genetic risk ratio of λ=1.5, approximately 500 sib pairs will be necessary to have adequate power of mapping a diseasegene in an outbred population such as that of the UnitedStates, although they acknowledge that in a more homo-geneous population the number of sib pairs needed maybe less.",Non-OADS,/arxiv_data1/oa_pdf/de/6b/DialoguesClinNeurosci-10-141.PMC3181866.pdf
"Available at: URL: http://www.who.int/mental_health/manage-ment/depression/definition/en/.11.Bauer M, Whybrow PC, Angst J, Versiani M, Möller H-J, WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders.",Non-OADS,/arxiv_data1/oa_pdf/85/49/DialoguesClinNeurosci-10-309.PMC3181885.pdf
Available at:http://www.census.gov/ipc/www/usinterimprol/.,OADS,/arxiv_data1/oa_pdf/82/7d/DialoguesClinNeurosci-10-419.PMC3181898.pdf
Available at: http://www.alz.co.uk/research/statistics.html.,OADS,/arxiv_data1/oa_pdf/1c/76/DialoguesClinNeurosci-11-217.PMC3181916.pdf
http://www.metlife.com/WPSAssets/ 14050063731156260663V1FAlzheimerCaregivingExperience.pdf Mature Market Institute; 2006.,Non-OADS,/arxiv_data1/oa_pdf/1c/76/DialoguesClinNeurosci-11-217.PMC3181916.pdf
Available at: http://www.alz.org/news_and_events_in_the_ news.asp.,Non-OADS,/arxiv_data1/oa_pdf/1c/76/DialoguesClinNeurosci-11-217.PMC3181916.pdf
Available at: http://www.ixcenter.org/pub- lications/documents/e0067.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/c6/DialoguesClinNeurosci-11-455.PMC3181931.pdf
"Many com- monly prescribed APDs, including FGAs (haloperidol, perphenazine, thioridazine), as well as SGAs (risperidone and aripiprazole), are metabolized in the liver by CYP2D6 (debrisoquine hydroxylase).67The CYP2D6 gene is highly polymorphic, with over 70 known variants (for a current classification, view the allele nomenclature at http://www.imm.ki.se/CYPalleles/).",Non-OADS,/arxiv_data1/oa_pdf/ee/4a/DialoguesClinNeurosci-11-405.PMC3181932.pdf
"In the late 1980s and early 1990s, Karl Friston and his colleagues at the Hammersmith hospital in London began to develop methods for the analysis of changes in brain activation over the whole brain, an endeavor which led to the development of the package known as statistical parametric mapping (SPM—for details see http://www.fil.ion.ucl.ac.uk/spm/doc/#history).",Non-OADS,/arxiv_data1/oa_pdf/48/05/DialoguesClinNeurosci-11-389.PMC3181933.pdf
2003. http://www-935.ibm.com/services/us/index.wss/ibvstudy/imc/ a1001624?cntxt=a1000056.,OADS,/arxiv_data1/oa_pdf/b9/ca/DialoguesClinNeurosci-11-427.PMC3181935.pdf
Last updated 09 Feb 2006.http://www-935.ibm.com/services/us/index.wss/ibvstudy/imc/a1001099.,OADS,/arxiv_data1/oa_pdf/b9/ca/DialoguesClinNeurosci-11-427.PMC3181935.pdf
http://www.nice.org.uk/newsevents/pressreleases/pressrelease archive/pressreleases2002/2002_030_nice_recommends_newer_antipsychotic _drugs_as_one_of_the_first_line_options_for_schizophrenia.jsp.,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/DialoguesClinNeurosci-11-427.PMC3181935.pdf
58.http://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/DialoguesClinNeurosci-11-427.PMC3181935.pdf
61.http://www.fda.gov/cber/ich/ichguid.htm.,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/DialoguesClinNeurosci-11-427.PMC3181935.pdf
Available at: http://www.hhs.gov/myhealthcare/news/presonalized-health- care-9-2007.html.,Non-OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
Available at: http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetic s/ucm083378.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
Available at: http://www.fda.gov/Drugs/ScienceResearch/ ResearchAreas/Pharmacogenetics/ucm083673.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-033.html.,Non-OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
Available at: http://ncicb.nci.nih.gov/NCICB/infrastruc- ture/cacore_overview/cadsr.,OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
Available at: http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_over- sight_report.pdf.,OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
Available at: http://www.cdc.gov/ genomics/gtesting/egapp/about.htm.,OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
Available at: http://www.ahrq.gov/clinic/tp/cyp450tp.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/4d/DialoguesClinNeurosci-11-377.PMC3181936.pdf
"465www.dialogues-cns.orgond report (2008) “seeks to bring into focus a sampling of activities that are now underway in different parts of the private and academic health care sectors toward integrating personalized health care into clinical prac- tice.” HHS Personalized Health Care Initiative, US Department of Health and Human Services [http://www.hhs.gov/myhealthcare/]  HHS Secretary's Advisory Committee on Genetics, Health & Society (SACGHS)  [http://oba.od.nih.gov/sacghs/sacghs_home.html]  ""Personalized Health Care: Opportunities, Pathways, Resources,"" US Department of Health and Human Services, September 2007  [http://www.hhs.gov/myhealthcare/news/phc-report.pdf] ""Personalized Health Care Pioneers, Partnerships, Progress,"" US Department of Health and Human Services, November 2008  [http://www.hhs.gov/myhealthcare/news/ phc_2008_report.pdf]  Letter to HHS Secretary, Kathleen Sebelius, May 5, 2009 [http://www.dnapolicy.org/resources/LtrtoSecSebelius rePersonalizedMedicine.pdf] Another important milestone on the road to attaining personalized medicine was the passage of the US Genetic Information Nondiscrimination Act (GINA) which was signed into law in May 2008, and was designed to prohibit the improper use of genetic infor- mation in health insurance and employment.",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"493, Genetic Information Nondiscrimination Act of 2008  [http://thomas.loc.gov/cgi- bin/bdquery/z?d110:HR00493:@@@L&summ2=m&] Terminology How can researchers and clinicians sift through the petabytes of information on the internet to find relevant information about personalized medicine?",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"All rights reservedTalking Glossary of Genetic Terms, US National Human Genome Research Institute  [http://genome.gov/10002096]  Dictionary of Cancer Terms, US National Cancer Institute  [http://www.cancer.gov/dictionary/] There is an excellent glossary in the new, comprehensive, two-volume book set, Genomic and Personalized Medicine , which was published by Elsevier/Academic Press in 2009.3This book set, available in print or elec- tronically through ScienceDirect, is an excellent starting place for people who are trying to get an understanding of the many concepts and issues that comprise personal- ized medicine.",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"Genomic and Personalized Medicine [http://www.science-direct.com/science/book/ 9780123694201] In short, the terminology that is used in article databases such as PubMed as well as on various Web sites is wide- ranging and makes it difficult to pull all of the relevant information on this topic together.",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"The following Web sites are provided as a sample of the range of projects and Web sites that are available:  US National Institutes of Health (NIH)  National Human Genome Research Institute  (NHGRI)  [http://genome.gov]  PhenX Toolkit, NHGRI  [https://www.phenxtoolkit.org/]  ENCODE Project: ENCyclopedia of DNA Elements, NHGRI [http://www.genome.gov/ENCODE/] Ethical, Legal, and Social Implications ELSI Research Program, NHGRI  [http://www.genome.gov/10001618]  Human Genome Project, NHGRI  [http://www.genome.gov/10001772]  Pharmacogenetics Research Network, National Institute of General Medical Sciences (NIGMS) [http:www.nigms.nih.gov/pharmacogenetics] Environmental Genome Project, National Institute of Environmental Health Sciences (NIEHS)  [http://www.niehs.nih.gov/research/supported/ programs/egp/] NIH Chemical Genomics Center  [http://www.ncgc.nih.gov/]  NIH Data Sharing Policy for Genome Wide Association Studies (GWAS)  [http://grants.nih.gov/grants/guide/notice-files/ NOT-OD-07-088.html] NIH Roadmap for Medical Research  [http://nihroadmap.nih.gov]  NIH neurosciences-related resources NIH Blueprint for Neuroscience Research  [http://neuroscienceblueprint.nih.gov/]  National Institute of Neurological Disorders and Stroke (NINDS): Clinical and Translational Resources  [http://www.",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
ninds.nih.gov/research/scientific_resources/ clinical/]  Neuroscience Information Framework (NIF)  [http://www.neuinfo.org/]  National Center for Biotechnology Information (NCBI) databases Entrez - All Databases  [http://www.ncbi.nlm.nih.gov/sites/gquery] Human Genome Resources  [http://www.ncbi.nlm.nih.gov/projects/genome/  guide/human/]  Online Mendelian Inheritance in Man (OMIM)  [http://www.ncbi.nlm.nih.gov/omim/]  Entrez Gene  [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene] Database of Genotypes and Phenotypes  (dbGaP) [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap]DCNS_43_4.qxd:DCNS#43  1/12/09  23:59  Page 466,Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"4 .2009 Gene Expression Omnibus  [http://www.ncbi.nlm.nih.gov/geo/] PubChem  [http://pubchem.ncbi.nlm.nih.gov/] NCBI BioSystems  [http://www.ncbi.nlm.nih.gov/biosystems/] Other US federal government agency resources HHS Personalized Health Care: Federal Activities [http://www.hhs.gov/myhealthcare/activities/] HHS CDS Collaboratory  [http://healthit.hhs.gov/portal/server.pt?open= 512&objID=1230&parentname=CommunityPage& parentid=1&mode=2&in_hi_userid=10741&cached= true]  CDC Public Health Genomics  [http://www.cdc.gov/genomics/]  CDC Evaluation of Genomic Applications in Practice and Prevention Initiative  [http://www.cdc.gov/genomics/gtesting/EGAPP/ about.htm]  CDC Human Genome Epidemiology Network  (HuGENet)  [http://www.cdc.gov/genomics/hugenet/default.htm]  CDC HuGE Navigator  [http://www.hugenavigator.net/]  CDC Genomics Workforce Competencies  [http://www.cdc.gov/genomics/training/competencies/] Nonprofit organizations Personalized Medicine Coalition  [http://www.personalizedmedicinecoalition.org/] Genetic Alliance  [http://www.geneticalliance.org/] Coalition for 21st Century Medicine  [http://www.twentyfirstcenturymedicine.org/ index.shtml] Resources for the general public Genetics Home Reference  [http://ghr.nlm.nih.gov/] ""From Genes to Personalized Medicines,"" National Institutes of Health  [http://www.nih.gov/about/researchresultsforthe public/Genes_PersonalizedMed.pdf]""Genetics, Disease Prevention and Treatment,"" National Human Genome Research Institute  (NHGRI)  [http://www.genome.gov/19016938]  MedlinePlus: Genes and Gene Therapy  [http://www.nlm.nih.gov/medlineplus/ genesandgenetherapy.html] Commercial companies targeting the general public deCODEme  [http://www.decodeme.com/]  23andMe  [https://www.23andme.com/] Navigenics  [http://www.navigenics.com/] Miscellaneous resources Morningside Initiative, American Medical Informatics Association (AMIA)  [http://www.amia.org/inside/initiatives/cds] ""The Roadmap for National Action on Clinical Decision Support,"" AMIA  [http://www.amia.org/files/cdsroadmap.pdf] National Coalition for Health Professional Education in Genetics (NCHPEG)  [http://www.nchpeg.org] BIG Health Consortium  [http://bighealthconsortium.org/] J.",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"Craig Venter Institute  [http://www.jcvi.org/] UCSC Genome Bioinformatics  [http://genome.ucsc.edu/] GenMAPP: Gene Map Annotator and Pathway Profiler  [http://www.genmapp.org/] Bioconductor: Open Source Software for Bioinformatics  [http://www.bioconductor.org/] Brain Research and Integrative Neuroscience Network (BRAINet)  [http://brainnet.net/] Allen Brain Atlas, Allen Institute for Brain Science [http://www.brain-map.org/] Although this article focuses primarily on US projects and Web sites, progress towards making personalizedDCNS_43_4.qxd:DCNS#43  1/12/09  23:59  Page 467",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"All rights reservedmedicine a reality is an international effort, as is reflected by this sample of project and tool Web sites: International and non-US resources 1000 Genomes Project  [http://www.1000genomes.org/page.php] Human Variome Project  [http://www.humanvariomeproject.org/] International HapMap Project  [http://www.hapmap.org/index.html.en] Structural Genomics Consortium  [http://www.thesgconline.org/] GeneCards  [http://www.genecards.org/] Ensembl Human Genome Browser  [http://www.ensembl.org/Homo_sapiens/Info/] ArrayExpress Database  [http://www.ebi.ac.uk/microarray-as/ae/] International Sequencing Consortium  [http://www.intlgenome.org/] European Bioinformatics Institute  [http://www.ebi.ac.uk/] Swiss Institute of Bioinformatics  [http://www.isb-sib.ch/] Max Planck Institute for Molecular Genetics  [http://www.molgen.mpg.de/] Nationales Genomforschungsnetz (NGFN)  [http://www.ngfn.de/] Riken Genomic Sciences Research Complex (GSC)  [http://www.gsc.riken.go.jp/] Kyoto Encyclopedia of Genes and Genomes  [http://www.genome.jp/kegg/]ExPASy Proteomics Server  [http://expasy.org/] European Proteomics Association (EuPA)  [http://www.eupa.org/] HUPO: Human Proteome Organisation  [http://www.hupo.org/]  HUPO Brain Proteome Project  [http://www.hbpp.org/5602.html] Conclusion Learning about the plethora of concepts, terminology, pro- jects, databases, tools, and stakeholders involved in per- sonalized medicine is a difficult task.",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
"While e-mail alerts are one way to receive this information, an RSS (Really Simple Syndication) reader such as Google Reader (http://reader.google.com) is another way to easily and efficiently read and manage alerts.",Non-OADS,/arxiv_data1/oa_pdf/d5/80/DialoguesClinNeurosci-11-464.PMC3181939.pdf
The specific genetic variations that define variable phenotypes can be located on a Web site maintained by the Karolinska Institute (http://www.cypalleles.ki.se/).,OADS,/arxiv_data1/oa_pdf/66/c2/DialoguesClinNeurosci-12-69.PMC3181940.pdf
"Useful genetic databases National Center for Biotechnology information (NCBI) http://www.ncbi.nlm.nih.gov/ Provides links to many other databases, including many of the databases below.",OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
"Online Mendelian Inheritance in Man (OMIM) http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim A comprehensive, authoritative, and timely compendium of human genes and genetic phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
Genome Database (GDB) http://gdbwww.gdb.org/ Gene and protein sequence database.,OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
UCSC Genome Browser/Bioinformatics site http://genome.ucsc.edu/index.html Provides the reference sequence and working draft assemblies for a large number of genomes.,OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
"ENSEMBL Database http://www.ensembl.org A genome database for vertebrates and other species, providing gene sequence data as well as chromosomal localization overviews and some information regarding transcripts and proteins.",OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
db-SNP Polymorphism Repository http://www.ncbi.nlm.nih.gov/SNP/ Database for single nucleotide polymorphisms and other classes of minor genetic variation.,OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
The SNP Consortium Ltd. (TSC) http://snp.cshl.org/ A non-profit foundation organized to develop up to  300 000 single nucleotide polymorphisms (SNPs) dis- tributed evenly throughout the human genome and to make the information related to these SNPs available to the public without intellectual property restrictions.,Non-OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
"European Bioinformatics Institute (EBI) http://www2.ebi.ac.uk/ A  centre for research and services in bioinformatics, which is part of  the European Molecular Biology Laboratory (EMBL).",Non-OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
"Gene Cards Database http://bioinformatics.weizmann.ac.il/cards/ Summarizes most available information on a particular gene, with links to many other databases, eg, protein data- basesInternational HapMap Project http://hapmap.ncbi.nlm.nih.gov/ A partnership of scientists and funding agencies from Canada, China, Japan, Nigeria, the United Kingdom, and the USA to develop a public resource that will help researchers find genes associated with human disease and response to pharmaceuticals.",OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
The Human Genome Variation Database http://hgvbase.cgb.ki.se/ A reference for the nomenclature of genetic variation; also provides links to various mutation databases The Human Gene Mutation Database http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html Database of published mutations for different disease genes.,OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
The Pharmacogenomics and Pharmacogenetics Knowledgebase http://pharmgkb.org/do/serve?id=home.welcome The Human Variome Project http://www.humanvariomeproject.org/ Web site of the global initiative to collect and curate all human genetic variation affecting human health.,Non-OADS,/arxiv_data1/oa_pdf/4d/c8/DialoguesClinNeurosci-12-116.PMC3181945.pdf
"Following the publication of the first GWAS in age- related macular degeneration,20successful GWASs have been conducted for a variety of common, complex dis- eases including type 2 diabetes, myocardial infarction, breast cancer, and Crohn’s disease (for details of all pub- lished studies see http://www.genome.gov/gwastudies/).",Non-OADS,/arxiv_data1/oa_pdf/21/3a/DialoguesClinNeurosci-12-85.PMC3181946.pdf
"According to OMIM, the comprehensive catalogue of human traits that are inherited in a Mendelian fashion (http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim), only slightly more than 2500 human genes have been linked to disease, and there are approximately 3500 Mendelian diseases for which the molecular cause is not yet known.",Non-OADS,/arxiv_data1/oa_pdf/7e/6f/DialoguesClinNeurosci-12-95.PMC3181948.pdf
"A recent effort has been made to systematize the collec- tion and archiving of association data from studies of schiz- ophrenia, and to provide a framework for continuous updating of both the data and the meta-analytic results164 in the SzGene database (http://www.szgene.org/).",OADS,/arxiv_data1/oa_pdf/84/cd/DialoguesClinNeurosci-12-7.PMC3181950.pdf
"Superstitiousness in  obsessive-compulsive disorder Peter Brugger, PhD; Isabelle Viaud-Delmon, PhD ccording to the Merriam-Webster online dic- tionary (http://www.merriam-webster.com), a supersti- tion is “a belief or practice resulting from ignorance, fear of the unknown, trust in magic or chance, or a false con- ception of causation.” Focusing on one or several aspects of this broad definition, some authors have suggested that superstitions are a fundamental feature of obses- sive-compulsive disorder (OCD).1-5We first elaborate on the dichotomy between behavior and belief, mentioned in the above definition, and differentiate superstitious behavior from superstitious belief , or magical ideation.",Non-OADS,/arxiv_data1/oa_pdf/93/40/DialoguesClinNeurosci-12-250.PMC3181957.pdf
Available at: http://mrw.interscience.wiley.com/ cochrane/clsysrev/articles/CD005332/abstract.html.,OADS,/arxiv_data1/oa_pdf/2d/dc/DialoguesClinNeurosci-12-221.PMC3181960.pdf
Available at: http://www.nice.org.uk/nicemedia/pdf/cg031niceguideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2d/dc/DialoguesClinNeurosci-12-221.PMC3181960.pdf
Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=18106.,Non-OADS,/arxiv_data1/oa_pdf/b7/96/DialoguesClinNeurosci-13-109.PMC3181967.pdf
Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/ UCM088569.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/96/DialoguesClinNeurosci-13-109.PMC3181967.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs297/en/.,Non-OADS,/arxiv_data1/oa_pdf/3e/6d/DialoguesClinNeurosci-13-101.PMC3181973.pdf
ERBB4 and its ligand neuregulin 1 (NRG1) have been associated with schizophrenia in earlier studies (for discussion see http://www.schizophreniaforum.org).,Non-OADS,/arxiv_data1/oa_pdf/7d/72/DialoguesClinNeurosci-12-289.PMC3181975.pdf
"We tend to take for granted many of the postprocessing tools that we have available today, including software packages that enable registration, segmentation, tractography, and region of interest delineations, eg, Slicer (http://www.slicer.org), Brain Voyager (http://www.brainvoyager.com/), Brains2 (http://www.psychiatry.uiowa.edu/mhcrc/IPLpages/BRAI NS.htm), SPM (http://www.fil.ion.ucl.ac.uk/spm/), and FreeSurfer (http://surfer.nmr.mgh.harvard.edu/).",Non-OADS,/arxiv_data1/oa_pdf/26/4c/DialoguesClinNeurosci-12-317.PMC3181976.pdf
Available at: http://www.charlierose.com/view/inter- view/11028?sponsor_id=1.,Non-OADS,/arxiv_data1/oa_pdf/c8/00/DialoguesClinNeurosci-12-533.PMC3181986.pdf
"Paulus, MD  “C Keywords: approach; avoidance; conflict; decision making; anxiety disorder; neuroimaging; insula; prefrontal cortex; amygdala; striatum Author affiliations: Department of Psychiatry, University of California, San Diego (UCSD), California, USA; Psychiatry Service, Veterans Affairs San Diego Health Care System, San Diego, California, USA   Address for correspondence: Martin P. Paulus, Professor in Residence, Department of Psychiatry, Laboratory of Biological Dynamics and Theoretical Medicine, University of California San Diego, 8950 Villa La Jolla Dr. Suite C213, La Jolla CA 92037-0985, USA  (e-mail: mpaulus@ucsd.edu; Web: http://koso.ucsd.edu/~martin/index.html)Approach-avoidance conflict is an important psychologi- cal concept that has been used extensively to better understand cognition and emotion.",Non-OADS,/arxiv_data1/oa_pdf/43/18/DialoguesClinNeurosci-12-517.PMC3181993.pdf
Available at: http://www.fda.gov/NewsEvents/Newsroom/Press Announcements/2004/ucm108361.htm.,Non-OADS,/arxiv_data1/oa_pdf/e2/3a/DialoguesClinNeurosci-13-183.PMC3181998.pdf
Available at: http://www.medterms.com.,Non-OADS,/arxiv_data1/oa_pdf/e2/3a/DialoguesClinNeurosci-13-183.PMC3181998.pdf
26.Food and Drug Administration’s Overall Risk Management Activities Available at: http://www.fda.gov/Safety/SafetyofSpecificProducts/ ucm180589.htm.,Non-OADS,/arxiv_data1/oa_pdf/e2/3a/DialoguesClinNeurosci-13-183.PMC3181998.pdf
Available at : http://www.fda.gov/downloads/AboutFDA/ CentersOffices/CDER/UCM210155.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/3a/DialoguesClinNeurosci-13-183.PMC3181998.pdf
Available at: http://www.emea.eu.int.,Non-OADS,/arxiv_data1/oa_pdf/55/f2/DialoguesClinNeurosci-13-199.PMC3181999.pdf
Available at: http://www.liv.ac.uk/nwhtmr/comet/comet.htm.PAGES_12_AG_1003_BA.qxd:DCNS#49  18/06/11  15:37  Page 215,Non-OADS,/arxiv_data1/oa_pdf/5a/35/DialoguesClinNeurosci-13-209.PMC3182001.pdf
Available at: http://bjp.rcpsych.org/cgi/citmgr?gca=bjprcpsych/188/6/504.,Non-OADS,/arxiv_data1/oa_pdf/1b/b9/DialoguesClinNeurosci-13-173.PMC3182002.pdf
Available at: http://www.cdc.gov/trau- maticbraininjury.,Non-OADS,/arxiv_data1/oa_pdf/1a/22/DialoguesClinNeurosci-13-311.PMC3182009.pdf
Available at: http://pascrell.house.gov/work/ TBI%20Newsletter%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/22/DialoguesClinNeurosci-13-311.PMC3182009.pdf
2008;22:618- 625. http://psycnet.apa.org/journals/neu/22/5/618/.,Non-OADS,/arxiv_data1/oa_pdf/1a/22/DialoguesClinNeurosci-13-311.PMC3182009.pdf
2008; http://www.armymedicine.army.mil/ reports/tbi/TBITaskForceReportJanuary2008.pdf.,OADS,/arxiv_data1/oa_pdf/6a/05/DialoguesClinNeurosci-13-251.PMC3182010.pdf
"Washington DC: Defense and Veterans Brain Injury Center; 2006 [February 28, 2011]; Available at: http://www.pdhealth.mil/downloads/clinical_practice_guideline_recomme ndations.pdf.",OADS,/arxiv_data1/oa_pdf/91/e4/DialoguesClinNeurosci-13-325.PMC3182011.pdf
Available at: http://www.clinicaltri- als.gov/ct2/show/NCT01298830?term=NCT01298830&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/16/01/DialoguesClinNeurosci-13-279.PMC3182013.pdf
"After six months it is available under a Creative   Commons License (Attribution–Noncommercial–Share Alike 3.0   Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1016/   S0960­9822(00)00451­ 6 Malyukova, A., T. Dohda, N. von der Lehr, S.  Akhoondi, M. Corcoran, M. Heyman, C.  Spruck, D. Grandér, U. Lendahl, and O.  Sangfelt.",OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1158/0008­5472.CAN­06­438 1 Maser, R.S., B. Choudhury, P.J.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1038/nature0588 6 Mazur, P.K., H. Einwächter, M. Lee, B. Sipos, H.  Nakhai, R. Rad, U. Zimber ­Strobl, L.J.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1073/pnas.100242310 7 Moran ­Crusio, K., L. Reavie, A. Shih, O. Abdel ­ Wahab, D. Ndiaye ­Lobry, C. Lobry, M.E.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1101/   gad.140600 6 Nicolas, M., A. Wolfer, K. Raj, J.A.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1038/ng109 9 O’Neil, J., J.",OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1084/jem.2007087 6 Palomero, T., W.K.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1016/0168 ­9525  (88)90096 ­0 Chiang, M.Y., L. Xu, O. Shestova, G. Histen, S.  L’heureux, C. Romany, M.E.",OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"118:3181– 3194. http://dx.doi.org/10.1172/JCI3509 0 Demehri, S., and R. Kopan.",OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1242/dev.03070 0 Ellisen, L.W ., J. Bird, D.C. West, A.L.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1016/0092­8674(91)90111­ B Fabbri, G., S. Rasi, D. Rossi, V. Trifonov, H.  Khiabanian, J. Ma, A. Grunn, M. Fangazio,  D. Capello, S. Monti, et al.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1158/0008 ­5472.CAN ­09­4645 Klinakis, A., C. Lobry, O. Abdel­Wahab, P .",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10   .1038/nature0999 9 Leong, K.G., and A. Karsan.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1182/blood­2005­08­332 9 Lowell, S., P. Jones, I.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1038/nrc303 5 Rangarajan, A., C. Talora, R. Okuyama, M.  Nicolas, C. Mammucari, H. Oh, J.C. Aster,  S. Krishna, D. Metzger, P. Chambon,   et al.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1093/   emboj/20.13.342 7 Real, P.J., V. Tosello, T. Palomero, M. Castillo,  E. Hernando, E. de Stanchina, M.L.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1038/nm.190 0 Reedijk, M., S. Odorcic, L. Chang, H. Zhang,  N. Miller, D.R.",OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"65:8530– 8537. http://dx.doi.org/10.1158/0008 ­5472  .CAN ­05­1069 Stransky, N., A.M. Egloff, A.D. Tward, A.D.  Kostic, K. Cibulskis, A. Sivachenko, G.V.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1126/science.120813 0 Thompson, B.J., S. Buonamici, M.L.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10.1084/jem.2007087 2 Viatour, P., U. Ehmer, L.A. Saddic, C. Dorrell,  J.B. Andersen, C. Lin, A.F.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi.org/10   .1126/science.110216 0 Weng, A.P., J.M.",OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"20:2096– 2109. http://dx.doi.org/10.1101/gad.145040 6 Westhoff, B., I.N.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
"http://dx.doi   .org/10.1073/pnas.090778110 6 Zage, P.E., R. Nolo, W. Fang, J. Stewart, G.  Garcia ­Manero, and P.A.",Non-OADS,/arxiv_data1/oa_pdf/28/53/JEM_20111855.PMC3182047.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months   after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
Raw gene expression data are available at http://www.ncbi   .nlm.nih.gov/projects/geo/ under accession no.,OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/   j.jvs.2009.07.00 1 Cho, Y.J., M. Abe, S.Y.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi   .org/10.1016/j.abb.2005.05.00 2 Crabtree, G.R., and E.N.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/   S0092­8674(02)00699­ 2 Curci, J.A.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10   .2310/6670.2008.0008 5 Daugherty, A., and L.A. Cassis.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10   .1161/01.ATV.0000118013.72016.e a Daugherty, A., M.W.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1172/JCI781 8 Davies, K.J., G. Ermak, B.A.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1096/   fj.06­7246co m Eichler, G.S., S. Huang, and D.E.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1093/   bioinfor matics/btg30 7 Emori, T., Y. Hirata, K. Ohta, M. Shichiri, and F. Marumo.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/   10.1016/0006­291X(89)91625­ 2 Esteban, V., O. Lorenzo, M. Rupérez, Y. Suzuki, S. Mezzano, J. Blanco,  M. Kretzler, T. Sugaya, J. Egido, and M. Ruiz­Ortega.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1097/01   .ASN.0000130564.75008.F 5 Forte, A., A. Della Corte, M. De Feo, F. Cerasuolo, and M. Cipollaro.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1093/   cvr/cvq22 4 Fuentes, J.J., M.A.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10   .1006/geno.1997.486 6 Gavrila, D., W .G.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1161/01.ATV .0000172631.50972.0 f Geisterfer, A.A., M.J. Peach, and G.K. Owens.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1042/BJ2003026 7 Goetze, S., X.P .",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1097/   00005344 ­199905000 ­00018 Graef, I.A., F. Chen, L. Chen, A. Kuo, and G.R.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/   S0092­8674(01)00396­ 8 Graef, I.A., F .",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
http://dx.doi.org/10.1016/S0092­8674(03)00390­ 8We thank Dr. T. Minami for providing RCAN1-4 luciferase reporters and adeno - virus; Dr. Ginés Sanz for help and continuous support; Drs.,Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1074/jbc   .M51077520 0 Aramburu, J., M.B.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/   10.1038/nature0806 2 Benigni, A., P. Cassis, and G. Remuzzi.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"2:247– 257. http://dx.doi.org/10.1002/emmm.20100008 0 Berk, B.C.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1136/   pmj.2003.00943 1 Bolstad, B.M., R.A. Irizarry, M. Astrand, and T.P.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10   .1093/bioinformatics/19.2.18 5 Cano, E., A. Canellada, T. Minami, T. Iglesias, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1074/jbc.M50620520 0 Cardenas, M.E., R.S.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi   .org/10.2174/092986704345557 6 Martínez­Martínez, S., A. Rodríguez, M.D.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1074/jbc.M51388520 0 Marx, S.O., and A.R.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1074/   jbc.M40645420 0 Minami, T., K. Yano, M. Miura, M. Kobayashi, J. Suehiro, P.C.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/S0092­8674(00)81573­ 1 Naftilan, A.J., R.E.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1172/JCI11403 2 Nagata, D., R. Takeda, M. Sata, H. Satonaka, E. Suzuki, T. Nagano, and  Y. Hirata.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"110:444– 451. http://dx.doi.org/10.1161/01.CIR.0000136025.96811.7 6 Owens, G.K. 1989.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10   .1093/hmg/ddm04 9 Rodríguez, A., J. Roy, S. Martínez ­Martínez, M.D.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/   j.molcel.2009.01.03 0 Roque, M., J.T.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1161/01.ATV.20.2.33 5 Rothermel, B., R.B.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1074/jbc   .275.12.871 9 Rothermel, B.A., T.A.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1038/ni96 6 Ryeom, S., K.H.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/   j.cellsig.2009.01.03 7 Heeneman, S., J.C. Sluimer, and M.J. Daemen.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi   .org/10.1161/CIRCRESAHA.107.14833 8 Heit, J.J., A.A. Apelqvist, X. Gu, M.M.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"27:13161– 13172. http://dx.doi.org/10.1523/JNEUROSCI.3974­07.200 7 Hogan, P.G., L. Chen, J. Nardone, and A. Rao.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1101/gad.110270 3 Iakovou, I., T. Schmidt, E. Bonizzoni, L. Ge, G.M.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi   .org/10.1001/jama.293.17.212 6 Jain, J., Z.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"12:359– 372. http://dx.doi.org/10.1016/S1074­7613(00)80188­ 0 Kingsbury, T.J., and K.W.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1074/jbc.M70670720 0 Li, F., C. Zhang, S. Schaefer, A. Estes, and K.U.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1152/   ajpheart.00450.200 5 Liu, J., J.D.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10   .1016/0092­8674(91)90124­ H Liu, J., E.S.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi   .org/10.1038/ncb182 3 Liu, Z., C. Zhang, N. Dronadula, Q. Li, and G.N.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1074/ jbc.M50032220 0 Maiellaro, K., and W.R. Taylor.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/   j.cardiores.2007.06.02 3 Martin­McNulty, B., J. Vincelette, R. Vergona, M.E.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
http://dx.doi.org/10.1016/   j.ultrasmedbio.2005.02.01 2,OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/j.ccr.2008.02.01 8 Sakalihasan, N., R. Limet, and O.D.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/S0140­   6736(05)66459­ 8 Sartore, S., R. Franch, M. Roelofs, and A. Chiavegato.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1161/hh2401   .10084 4 Satoh, K., P. Nigro, T. Matoba, M.R.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1038/   nm.195 8 Satonaka, H., E. Suzuki, H. Nishimatsu, S. Oba, R. Takeda, A. Goto, M.  Omata, T. Fujita, R. Nagai, and Y. Hirata.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1161/01.RES.0000118250.67032.5 E Sayeski, P.P., and M.S.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/   S0014­4827(03)00154­ X Schwartz, S.M.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1172/JCI11947 2 Schwartz, S.M., D. deBlois, and E.R.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1097/00005344 ­  199100177 ­00025 Shin, S.Y., H.W.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1242/   jcs.07603 4Smyth, G.K. 2004.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1161/01.RES.0000017629.70769.C C Touyz, R.M.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1113/expphysiol.2005.03008 0 van Kleef, E.M., J. Fingerle, and M.J. Daemen.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1161/01.ATV.16.7.85 7 Vega, R.B., B.A.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi   .org/10.1016/j.jcin.2009.05.01 5 Watanabe, T., R. Pakala, T. Katagiri, and C.R.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1016/S0021­   9150(01)00505­ 6 Weintraub, N.L.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi.org/10.1056/NEJMcibr090524 4 Yang, Y.J., W. Chen, A. Edgar, B. Li, J.D.",OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
"http://dx.doi   .org/10.1084/jem.2008114 0 Yellaturu, C.R., S.K.",Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
http://dx.doi   .org/10.1042/BJ2002034 7,Non-OADS,/arxiv_data1/oa_pdf/56/5a/JEM_20110503.PMC3182048.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months   after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/56/2d/JEM_20110767.PMC3182049.pdf
"After six months it  is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/56/2d/JEM_20110767.PMC3182049.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20110767/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/56/2d/JEM_20110767.PMC3182049.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20110750/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1172/JCI10497 0 Ballem, P .J., G.M.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1073/   pnas.93.15.746 4 Galluzzi, L., N. Joza, E. Tasdemir, M.C.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/cdd.2008.2 8 Green, D.R., and G. Kroemer.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1126/   science.109932 0 Heilmann, E., P .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
http://dx.doi   .org/10.1111/j.1365-2141.1993.tb03216.,Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1182/blood-   2007-05-08968 0 Houwerzijl, E.J., N.R.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1182/   blood-2003-01-027 5 Italiano, J.E.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1083/jcb.147.6.129 9 Josefsson, E.C., H.H.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1074/jbc.M50117820 0 Junt, T., H. Schulze, Z. Chen, S. Massberg, T. Goerge, A. Krueger, D.D.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1126/science.114630 4 Kaluzhny, Y ., and K. Ravid.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1159/   00007448 7 Kaluzhny, Y ., G. Y u, S. Sun, P .A.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1182/blood-2001-12-026 3 Kirsch, D.G., P .M.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1126/   science.116620 2 Knudson, C.M., K.S.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1126/   science.270.5233.9 6 Kodama, T., T. Takehara, H. Hikita, S. Shimizu, M. Shigekawa, W .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1074/jbc.M110.19537 0 Kozuma, Y ., H. Kojima, S. Y uki, H. Suzuki, and T .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
http://dx.doi.org/10.1111/j.1538-7836.2007.02546.,Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760010 4 Boldin, M.P ., T.M.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81265- 9 Bouillet, P ., D. Metcalf, D.C. Huang, D.M.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1126/science.286.5445.173 5 Bruey, J.M., N. Bruey-Sedano, F .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/   j.cell.2007.01.04 5 Budd, G.T., R. Ganapathi, L. Wood, J. Snyder, D. McLain, and R.M.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1023/   A:102411691693 2 Chang, M., P .A.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1182/   blood-2002-05-147 5 Chauvier, D., S. Ankri, C. Charriaut-Marlangue, R. Casimir, and E. Jacotot.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/sj.cdd.440204 4 Cheng, E.H., M.C.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/   S1097-2765(01)00320- 3 Chernick, M.R.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/   nrm245 0 Clarke, M.C., J. Savill, D.B.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1083/jcb.20021011 1 De Botton, S., S. Sabri, E. Daugas, Y .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1182/blood-2002-03-068 6 Dolle, R.E., D. Hoyer, C.V .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1021/jm00031a00 3 Dowling, M.R., E.C.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1182/   blood-2009-12-25966 3 Drachman, J.G., D.F .",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
http://dx.doi.org/10.1111/j.1365-2796.2005.01570.,Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1016/j.cell.2005.07.00 2 Petros, A.M., J.R. Huth, T. Oost, C.-M. Park, H. Ding, X. Wang, H. Zhang,  P .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/j.bmcl.2010.09.03 3 Pleines, I., A. Eckly, M. Elvers, I. Hagedorn, S. Eliautou, M. Bender, X. Wu,  F .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1182/blood-2009-09-24227 1 Rathmell, J.C., T. Lindsten, W .-X.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10   .1038/ni83 4 Ren, D., H.C. Tu, H. Kim, G.X.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1126/science.119021 7 Roberts, A.W ., J.F .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1210/   me.14.7.103 8 Sanz, C., I. Benet, C. Richard, B. Badia, E.J.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/S0301-472X(01)00635- X Schaefer, B.C., M.L.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1006/cimm.2001.189 5 Schoenwaelder, S.M., Y .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1182/blood-2009-01-20034 5 Shivdasani, R.A., M.F .",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1016/0092-8674(95)90531- 6 Siegel, R.M.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/nri180 9 Solary, E., F .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1038/ng0408-37 9 Takeuchi, O., J. Fisher, H. Suh, H. Harada, B.A.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1128/MCB.26   .6.2215-2225.200 6 T erui, Y ., Y .",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
http://dx.doi.org/10.1038/leu.2009.,Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/   cdd.2008.15 0 Kruse, E.A., S.J.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1073/   pnas.090655610 6 Leber, B., F .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1017/S146239941000157 2 Lecine, P ., J.L.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)00136- 2 Mason, K.D., M.R.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/j.cell.2007.01.03 7 Matic, G.B., E.S.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1532/IJH97.0416 8 Motoyama, N., F .P .",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1126/science.787847 1 Motoyama, N., T. Kimura, T. Takahashi, T. Watanabe, and T. Nakano.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1084/jem.189.11.169 1 Muzio, M., A.M. Chinnaiyan, F .C.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"85:817– 827. http://dx.doi.org/10.1016/S0092-8674(00)81266- 0 Norol, F ., N. Vitrat, E. Cramer, J. Guichard, S.A. Burstein, W .",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/nature0357 9 Patel, S.R., J.H.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"109:1503– 1506. http://dx.doi.org/10.1182/blood-2006-04-02036 2 Vadhan-Raj, S. 2009.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1053/j.seminhematol.2008.12.00 7 Vairo, G., K.M.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi   .org/10.1126/science.105910 8 Willis, S.N., J.I.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1126/science.113328 9 Wilson, W .H., O.A.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1016/S1470-2045(10)70261- 8Wozniak, A.J., and W .E.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/cdd.2010.7 2 Y oule, R.J., and A. Strasser.",OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1038/nrm230 8 Zauli, G., L. Catani, D. Gibellini, M.C.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
92:711– 717. http://dx.doi.org/10.1046/j.1365-2141.1996.367904.,Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-06-430 3 Zucker-Franklin, D., C.S.",Non-OADS,/arxiv_data1/oa_pdf/47/ff/JEM_20110750.PMC3182050.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months   after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"After six months it  is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"Protocols allowing the animal experiments have  been approved by the local ethical committee and communicated to the   relevant Italian authority (Ministero della Salute, Ufficio VI), in compliance  of Italian Animal Welfare Law (Law n 116/1992; http://www.unipd   .it/unipdWAR/page/unipd/organizzazione1/it_Book75_Page3).",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20101956/DC1.,Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1021/pr900039 c Allavena, P., G. Bianchi, D. Zhou, J. van Damme, P. Jílek, S. Sozzani, and   A. Mantovani.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1002/eji.183024124 9 Andrew, P.J., and B. Mayer.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/   S0008-6363(99)00115- 7 Apolloni, E., V. Bronte, A. Mazzoni, P. Serafini, A. Cabrelle, D.M.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1126/science.112913 9 Gattinoni, L., D.J.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1038/nri184 2 Griscavage, J.M., A.J.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/S1054-3589(08)61088- 1 Grohmann, U., and V. Bronte.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
http://dx.doi   .org/10.1111/j.1600-065X.2010.00915.,Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1038/nature0686 8 Harlin, H., Y. Meng, A.C. Peterson, Y. Zha, M. Tretiakova, C. Slingluff,  M. McKee, and T.F.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-08-228 1 Homey, B., A. Müller, and A. Zlotnik.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1038/nri74 8 Hu, H., L. Sun, C. Guo, Q. Liu, Z. Zhou, L. Peng, J. Pan, L. Yu, J. Lou,  Z. Yang, et al.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"15:5485– 5493. http://dx.doi.org/10.1158/1078-0432.CCR-08-249 1 Huang, B., Z. Lei, J. Zhao, W. Gong, J. Liu, Z. Chen, Y. Liu, D. Li, Y.  Yuan, G.M.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/j.canlet.2006.12.01 2 Izhak, L., G. Wildbaum, U. Weinberg, Y .",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.4049/   jimmunol.090272 5 Johnson, L.A., R.A. Morgan, M.E.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1182/blood-2009-03-21171 4 June, C.H.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1172/JCI3244 6 Kaplan-Lefko, P .J., T .M.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1002/pros.1021 5 Kasic, T., P. Colombo, C. Soldani, C.M.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/S0076-6879(09)05401- 9 Marigo, I., E. Bosio, S. Solito, C. Mesa, A. Fernandez, L. Dolcetti, S. Ugel, N.  Sonda, S. Bicciato, E. Falisi, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/S0140-6736(00)04046- 0 Boissonnas, A., L. Fetler, I.S.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1084/   jem.2006189 0 Bottazzi, B., S. Walter, D. Govoni, F. Colotta, and A. Mantovani.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1172/JCI3438 8 Bronte, V., and P. Zanovello.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1038/nri166 8 Bronte, V., P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni,  D.M.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1084/jem.2004202 8 Brown, C.E., R.P.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1038/nm169 9 Butcher, E.C., and L.J.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1126/science.272.5258.6 0 Carr, M.W., S.J.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1038/nrc225 0 Corzo, C.A., T. Condamine, L. Lu, M.J. Cotter, J.I.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1084/jem.2010058 7 De Palma, R., I. Marigo, F. Del Galdo, C. De Santo, P. Serafini, S. Cingarlini,  T. Tüting, J. Lenz, G. Basso, G. Milan, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-04-006 7 De Santo, C., P. Serafini, I. Marigo, L. Dolcetti, M. Bolla, P. Del Soldato, C.  Melani, C. Guiducci, M.P.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-143 9 Frederick, M.J., and G.L.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1017/S146239940100330 1 Fridlender, Z.G., G. Buchlis, V. Kapoor, G. Cheng, J.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
70:109– 118. http://dx.doi.org/10.1158/0008-5472.CAN-09-232 6,Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/j.immuni   .2010.05.01 0 Mariotto, S., L. Cuzzolin, A. Adami, P. Del Soldato, H. Suzuki, and G.  Benoni.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1084/jem.182.6.168 3 Mennuni, C., S. Ugel, F. Mori, B. Cipriani, M. Iezzi, T. Pannellini,  D. Lazzaro, G. Ciliberto, N. La Monica, P. Zanovello, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1158/0008-5472   .CAN-08-160 3 Monegal, A., D. Ami, C. Martinelli, H. Huang, M. Aliprandi, P. Capasso,  C. Francavilla, G. Ossolengo, and A. de Marco.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1093/protein/gzp00 2 Morgan, R.A., M.E.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1126/science.112900 3 Mukai, S., J. Kjaergaard, S. Shu, and G.E.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1056/   NEJM20010913345111 3 Muzaffar, S., N. Shukla, G. Angelini, and J.Y.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1161/01   .CIR.0000139851.50067.E 4 Nagaraj, S., K. Gupta, V. Pisarev, L. Kinarsky, S. Sherman, L. Kang, D.L.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1038/nm160 9 Nathan, C., and A. Ding.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/j.cell.2010.03.00 8 Noda, S., S.A. Aguirre, A. Bitmansour, J.M.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1182/blood-2005-05-183 3 Pagès, F., A. Berger, M. Camus, F. Sanchez-Cabo, A. Costes, R. Molidor,  B. Mlecnik, A. Kirilovsky, M. Nilsson, D. Damotte, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1056/NEJMoa05142 4 Pfeiffer, S., A. Lass, K. Schmidt, and B. Mayer.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1074/jbc.M10058520 0 Pivarcsi, A., A. Müller, A. Hippe, J. Rieker, A. van Lierop, M. Steinhoff,  S. Seeliger, R. Kubitza, U. Pippirs, S. Meller, et al.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1073/   pnas.070567310 4 Quezada, S.A., K.S.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1172/JCI2774 5Rollins, B.J., and M.E.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1016/j.coi.2009.03.00 2 Rosenberg, S.A., N.P.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10   .1038/nrc235 5 Rossi, C.A., M. Flaibani, B. Blaauw, M. Pozzobon, E. Figallo, C. Reggiani,  L. Vitiello, N. Elvassore, and P. De Coppi.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1096/fj.10-17475 5 Sato, E., S.H.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1073/pnas.050918210 2 Serbina, N.V., T. Jia, T.M.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26.021607.09032 6 Sozzani, S., M. Locati, D. Zhou, M. Rieppi, W. Luini, G. Lamorte, G.  Bianchi, N. Polentarutti, P. Allavena, and A. Mantovani.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10   .1016/S0006-8993(02)03145- 1 Szabó, C., H. Ischiropoulos, and R. Radi.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1038/nrd222 2 Ugel, S., E. Scarselli, M. Iezzi, C. Mennuni, T. Pannellini, F. Calvaruso,  B. Cipriani, R. De Palma, L. Ricci-Vitiani, E. Peranzoni, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"48:171– 197. http://dx.doi.org/10.1146/annurev.pharmtox.48.121806.15484 1 Weishaupt, C., K.N.",Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi   .org/10.1158/1078-0432.CCR-06-245 0 Xia, Y., and J.L.",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
"http://dx.doi.org/10.1074/jbc.273.35.2263 5 Zhang, B., Y .",OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/87/05/JEM_20101956.PMC3182051.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1172/JCI3626 4 Fahlgren, C., A. Hagström, D. Nilsson, and U.L.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1128/   AEM.02092-0 9 Fujii, S., K. Liu, C. Smith, A.J.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi   .org/10.1084/jem.2004031 7 Fujii, S., K. Shimizu, H. Hemmi, and R.M.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
http://dx.doi   .org/10.1111/j.1600-065X.2007.00561.,Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"197:1051– 1057. http://dx.doi.org/10.1084/jem.2002161 6 Ganeshan, K., C.V. Neilsen, A. Hadsaitong, R.P.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/j.jaci.2008.10.01 1 Geissmann, F., T.O.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1371/journal.pbio.003011 3 Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D.G.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/j.immuni   .2007.08.02 0 Johnston, B., C.H.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
http://dx.doi.org/10.1046/j.1432-1327.2000.01189.,Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/j.jaci.2004.09.00 4 Kinjo, Y., D. Wu, G. Kim, G.W.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"434:520– 525. http://dx.doi.org/10.1038/nature0340 7 Kinjo, Y., E. Tupin, D. Wu, M. Fujio, R. Garcia-Navarro, M.R.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1038/ni138 0 Kinjo, Y., B. Pei, S. Bufali, R. Raju, S.K.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/   j.chembiol.2008.05.01 2 Lang, G.A., T.S.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1182/blood-2007-   10-11730 9 Leadbetter, E.A., M. Brigl, P. Illarionov, N. Cohen, M.C.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
http://dx.doi.org/10.1038/ni.185 5Online supplemental material.,Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
Online supplemental material is available  at http://www.jem.org/cgi/content/full/jem.20110522/DC1.,Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1084/jem.2005077 3 Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama,  M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1038/nm85 1 Akbari, O., J.L.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1056/NEJMoa05361 4 Barrett, N.A., and K.F.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi   .org/10.1016/j.immuni.2009.08.01 4 Bendelac, A., P.B.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1146/annurev   .immunol.25.022106.14171 1 Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi   .org/10.1084/jem.191.11.189 5 Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko,  H. Koseki, M. Kanno, and M. Taniguchi.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1126/science.278.5343.162 3 Das, J., P. Eynott, R. Jupp, A. Bothwell, L. Van Kaer, Y. Shi, and G.  Das.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1038/nm1206-134 5 De Santo, C., M. Salio, S.H.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/   j.jim.2006.02.00 9 Long, X., S. Deng, J. Mattner, Z. Zang, D. Zhou, N. McNary, R.D.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1038/nchembio.2007.1 9 Mattner, J., K.L.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1038/nature0340 8 Mattner, J., P.B.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/j.chom.2008.03.00 9 Meyer, E.H., S. Goya, O. Akbari, G.J.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"7:811– 817. http://dx.doi.org/10.1038/ni136 8 Patel, A.M., J.H.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1067/mai.2001.11957 0 Pereira, J.P., J.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1038/ni.171 0 Purwar, R., J. Campbell, G. Murphy, W.G.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1371/journal.pone.001624 5 Roark, J.H., S.-H. Park, J. Jayawardena, U. Kavita, M. Shannon, and A.  Bendelac.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1038/ni.184 8 Singh, N., S. Hong, D.C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg,  Y. Koezuka, and L. Van Kaer.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi   .org/10.1002/eji.20052615 7 Thomas, S.Y., R. Hou, J.E.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/   j.jaci.2010.01.03 2 Thomas, S.Y., S.T.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi   .org/10.1084/jem.2010263 0 Thomas, W.R., B.J.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1007/   s11882-005-0012- 1 Tonti, E., G. Galli, C. Malzone, S. Abrignani, G. Casorati, and P.  Dellabona.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi   .org/10.1182/blood-2008-06-16624 9 Trompette, A., S. Divanovic, A. Visintin, C. Blanchard, R.S.",Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"http://dx.doi.org/10.1016/S1081-1206   (10)60983- 0 Wingender, G., P. Rogers, G. Batzer, M.S.",OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
http://dx.doi.org/10.1084/jem.2010222 9,Non-OADS,/arxiv_data1/oa_pdf/4b/01/JEM_20110522.PMC3182052.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0  Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1084/   jem.2006071 0 Nagaraj, S., A.G. Schrum, H.I.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.03.00 8 Nishikawa, H., and S. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1056/   NEJMoa110462 1 Rodríguez, P.C., and A.C. Ochoa.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"222:180– 191. http://dx.doi.org/10.1111/j.1600-065X   .2008.00608. x Rosenberg, S.A., J.C. Yang, R.M.",OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi   .org/10.1158/1078-0432.CCR-11-011 6 Schaer, D.A., Y. Li, T. Merghoub, G.A.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1371/ journal.pone .002121 4 Schreiber, R.D., L.J.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi   .org/10.1126/science.120348 6 Tsukahara, H., H. Ende, H.I.",OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1158/   0008-5472.CAN-11-131 6 Gajewski, T.F., M. Fuertes, R. Spaapen, Y.  Zheng, and J. Kline.",OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi   .org/10.1126/science.112913 9 Hamzah, J., M. Jugold, F. Kiessling, P. Rigby,  M. Manzur, H.H.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi   .org/10.1038/nature0686 8 Hodi, F.S., S.J.",OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1111/j.1600-065X.2008   .00602. x Molon, B., Stefano Ugel, Federica Del Pozzo,  Cristiana Soldani, Serena Zilio, Debora  Avella, Antonella De Palma, PierLuigi Mauri,  Ana Monegal, Maria Rescigno, et al.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1677/erc   .1.0107 7 Berger, M., G. Bergers, B. Arnold, G.J.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1084/jem.2006189 0 Breart, B., F. Lemaître, S. Celli, and P. Bousso.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10.1172/   JCI3438 8 Bronte, V., and P. Zanovello.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi   .org/10.1084/jem.2004202 8 Buckanovich, R.J., A. Facciabene, S. Kim, F .",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
"http://dx.doi.org/10   .1097/00000441-189305000-0000 1 De Santo, C., P. Serafini, I. Marigo, L. Dolcetti,  M. Bolla, P. Del Soldato, C. Melani, C.  Guiducci, M.P.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/JEM_20111856.PMC3182053.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20102392/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/j.immuni   .2007.01.00 2 Alvarez, D., E.H. Vollmann, and U.H.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.08.00 6 Angeli, V., F. Ginhoux, J. Llodrà, L. Quemeneur, P.S.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/j.immuni   .2006.01.00 3 Baluk, P., J. Fuxe, H. Hashizume, T. Romano, E. Lashnits, S. Butz, D.  Vestweber, M. Corada, C. Molendini, E. Dejana, and D.M.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10   .1084/jem.2006259 6 Banchereau, J., and R.M.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/3258 8 Bedoui, S., P.G.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/   10.1038/ni.172 4 Brewig, N., A. Kissenpfennig, B. Malissen, A. Veit, T. Bickert, B. Fleischer,  S. Mostböck, and U. Ritter.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1002/eji.20093992 1 Campbell, J.J., J. Hedrick, A. Zlotnik, M.A.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/   10.1126/science.279.5349.38 1 Cavanagh, L.L., and W. Weninger.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/icb.2008.2 52.5–3.5 × 106 DCs, 50 ng LPS (Sigma-Aldrich), and 200 µg anti-LYVE1  was s.c. injected into the hind footpad.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1084/jem.2005175 9 Kabashima, K., N. Shiraishi, K. Sugita, T. Mori, A. Onoue, M.  Kobayashi, J. Sakabe, R. Yoshiki, H. Tamamura, N. Fujii, et al.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/   10.2353/ajpath.2007.07022 5 Kamath, A.T., S. Henri, F. Battye, D.F.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1002/ar.109190010 3 Kerjaschki, D., H.M. Regele, I. Moosberger, K. Nagy-Bojarski, B.  Watschinger, A. Soleiman, P. Birner, S. Krieger, A. Hovorka, G.  Silberhumer, et al.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/j   .immuni.2005.04.00 4 Lämmermann, T., B.L.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/   nature0688 7 Ley, K., C. Laudanna, M.I.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/nri215 6 Lim, H.Y., J.M.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"175:1328– 1337. http://dx.doi.org/10.2353/ajpath.2009.08096 3 Lindquist, R.L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich,  M.L.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/   ni113 9 Lutz, M.B., N. Kukutsch, A.L.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/   S0022-1759(98)00204- X Mäkinen, T., C. Norrmén, and T.V.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1007/s00018-007-7040- z Martín-Fontecha, A., S. Sebastiani, U.E.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1084/jem   .2003044 8 Merad, M., F. Ginhoux, and M. Collin.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/   nri245 5 Miller, M.J., O. Safrina, I. Parker, and M.D.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1084/jem   .2004123 6 Miteva, D.O., J.M.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi   .org/10.1161/CIRCRESAHA.109.20727 4Czeloth, N., G. Bernhardt, F. Hofmann, H. Genth, and R. Förster.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-06-072 8 De Vries, I.J., D.J.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1084/jem.188.2.37 3 Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, E.  Wolf, and M. Lipp.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)80059- 8 Friedman, R.S., J. Jacobelli, and M.F.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/ni138 4 Gale, N.W., R. Prevo, J. Espinosa, D.J.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/   10.1128/MCB.01503-0 6 Germain, R.N., M.J. Miller, M.L.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/nri188 4 Gunn, M.D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L.T.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/   10.1084/jem.189.3.45 1 Harrell, M.I., B.M.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/   10.1016/j.jim.2007.11.01 2 Hayashi, K., P. Jiang, K. Yamauchi, N. Yamamoto, H. Tsuchiya, K.  Tomita, A.R.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1158/0008-5472   .CAN-07-123 7 Helft, J., F. Ginhoux, M. Bogunovic, and M. Merad.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1111/j.0105-2896.2009   .00885. x Hirose, J., H. Kawashima, O. Yoshie, K. Tashiro, and M. Miyasaka.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1074/jbc   .M00754220 0 Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S.  Muramatsu, and R.M.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1084/jem.176.6.169 3 Itano, A.A., S.J.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi   .org/10.1016/S1074-7613(03)00175- 4 Johnson, L.A., and D.G.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
http://dx.doi.org/   10.1093/intimm/dxq43 5,Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1371/journal.ppat   .100022 2 Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kiafard, J. Zwirner, T.  Blankenstein, G. Henning, and R. Förster.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/j.immuni.2004.06.01 4 Patel, D.D., W. Koopmann, T. Imai, L.P. Whichard, O. Yoshie, and  M.S.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1006/   clim.2000.499 7 Pflicke, H., and M. Sixt.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1084/jem.2003215 2 Randolph, G.J., V. Angeli, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/nri167 0 Romani, N., M. Thurnher, J. Idoyaga, R.M.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/   10.1038/icb.2010.3 9 Saeki, H., A.M. Moore, M.J. Brown, and S.T.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.04.01 7 Sen, D., L. Forrest, T.B.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1016/j.ccr.2007   .04.02 0 Swartz, M.A., J.A.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi   .org/10.1016/j.smim.2007.11.00 7 Vassileva, G., H. Soto, A. Zlotnik, H. Nakano, T. Kakiuchi, J.A.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1084/jem.190.8.118 3 Woolf, E., I. Grigorova, A. Sagiv, V. Grabovsky, S.W.",Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
"http://dx.doi.org/10.1038/   ni149 9 Yang, B.G., T. Tanaka, M.H.",OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
http://dx.doi.org/10.1007/s00011-007-7195- y,Non-OADS,/arxiv_data1/oa_pdf/22/3b/JEM_20102392.PMC3182054.pdf
This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/7d/c6/JEM_20110200.PMC3182055.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20110200/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7d/c6/JEM_20110200.PMC3182055.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/b0/b5/JEM_20101568.PMC3182056.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0 /).M.",Non-OADS,/arxiv_data1/oa_pdf/b0/b5/JEM_20101568.PMC3182056.pdf
Online supplemental material is available  at http://www.jem.org/cgi/content/full/jem.20101568/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/b5/JEM_20101568.PMC3182056.pdf
"http://dx.doi.org/10.1016/j.jpeds   .2010.04.02 0 Alcaïs, A., L. Quintana-Murci, D.S.",OADS,/arxiv_data1/oa_pdf/b0/b5/JEM_20101568.PMC3182056.pdf
